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STELLINGEN 
1. Het baculovirus GP64 eiwit bevat signalen die bet uittreden van virusdeeltjes via de basolaterale 
zijde van gemfecteerde middendarmcellen regelen. 
Dit proefschrift 
2. De concentratie van GP64 aan de uiceinden van het staafvormige budded virion' suggereert dat 
GP64 een rol speeit bij de membraanronding ter iniriarie van virus 'budding'. 
Dit proefschrift 
3. Alle NPV virussen die op basis van fylogenetische analyses ondergebracht worden in de 
gepostuleerde NPV subgroep I bevatten een gp64 gen. 
Dit proefschrift 
lanotto el al. (1993). J. Invert Pathol. 62: 147-164 
Hu, ZH. (1998). PkD. thesis 
4. Het effect van cytochalasine B en D op de 'budding' van AcMNPV is moeilijk te interpreteren en 
de conclusie dat het cytoskelet geen rol speeit bij dit proces is derhalve voorbarig. 
Volkmtm et aL (1987). Virology 156: 32-39 
5. Chimeraplastie biedt mogelijkheden bij de genezing van erfeiijke ziekten, o.a. door het nauw-
keurig aanbrengen van gewenste mutaties via het gebruik van aiet-virale carriers (liposomen). Het 
gebruik van virussen, van op virus gebaseerde carriers of van een combinatie van liposomen en 
virale componenten, verhoogt de efficiemie van chimeraplastie op organismaal niveau. 
Cura (1999). Science 285: 316-318 
6. Het bewijs, dat het niet-incorporeren van het HTV gpl20/160 in VSV virions wordt veroorzaakt 
doordat dit glycoprotein wordt verankerd op plaatsen van het plasmamembraan die afwijken van 
de plaats van VSV 'budding', is niet overtuigend. 
Johnson et al. (1998). Virology 251: 244-252 
7. In het streven naar publiekelijk begrip en ondersteuning voor verdere ontwikkeling van 
wetenschapsgebieden die generische modificarie betreffen, zou ais eerste het verband tussen 
research en technologic enerzijds en reeds geconsumeerde genetisch gemodificeerde producten 
zoals voedsel, medicijnen en vaccins anderzijds, moeten worden benadrukt. 
8. GP64 fungeert voor een baculovirus als liuissleutel'. Zonder sleutel komt het virus de eel slechts 
in of uit als per toeval de deur wordt opengedaan. 
9. Het eeuw-oud advies (1897) van Ramdn y Cajal (een grondlegger van de moderne neurobiologie) 
voor de jonge onderzoeker om geen rijke vrouw te trouwen, is niet meer van deze tijd. 
J.H. Kaas (1999). Science 284: 2097 
S Ramon y Cajal. Precepts and councels in scientific investigation: Stimulants of the spirit 
(1951). Translated by Ma. Sanchez-Perez. C.B Courville, Ed (Pacific, Mountain View, CA). 
10. Een significant verschil tussen Nederland en de VS is de franje op de friet. 
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Preface 
Let me begin by saying that I am very excited to soon finish my graduate work 
and (by the time the thesis will be printed) to have begun a post-doctoral position in 
pursuit of a Ph.D. career track. Despite the excitement, the decision to follow such a 
track did not come easily. For a long time I have been trying to figure out, in a 
somewhat philosophical fashion, whether pursuiing a Ph.D. degree was the right thing 
to do for me, and some of my 'stellingen' (statements) may reflect that. My first thanks 
go out to the people who have, through the many years, discussed with me their 
personal experiences during and after obtaining their Ph.D., in particular Gary Blissard 
and Peter Roelvink. It is, needless to say, unpredictable what a Ph.D. will bring or lead 
to, nevertheless these discussions were always very helpful and well appreciated. 
Ultimately, entering the Ph.D. track has enhanced my thinking and enthusiasm with 
regards to virology in many ways, and I am happy to be where I am. To get where I 
am, I have had help and support from a great many people. From our lab and Cornell I 
would like to thank for good colleagueship John Wenz, Phil Kogan, Xiaoying Chen, 
Jeff Slack, David Garrity, Min-Ju Chang, Kathy Hefferon, Guangyun Lin, Debbie 
Letham, Casey Finnerty, Marlinda Lobo de Souza, Pat Lilja, Jodie Mangor, Rodolfo 
Lopez-Gomez, Bob Granados, Alan Wood, Pat Hughes, Ping Wang, Marc Harper, 
Lokesj Joshi, and last but not least Scott Monsma. For my Ithaca friends, I'll simply say 
thanks to Paul and to the Gary (Matassarin) group, which includes just about 
everybody else I know. A special thank you go out to the Boyce Thompson Institute for 
providing excellent opportunities and an encouraging scientific environment, to Andy 
Grefig for putting me up in his house for several years, to my promotor Just Vlak for all 
of the timely arrangements and tasks carried out in Wageningen on my behalf in 
preparation of the defense, to my Dutch friends Toon Rijkers, Belinda Oude-Essink 
and Inca Kusters for their enduring friendship, and to my supervisor Gary Blissard for 
the never ending enthusiasm and encouragement and for giving me the opportunity to 
develop my skills. Gary, it has been a (intense :) ) privilege to get introduced to 
virology in your laboratory. Finally, I'd like to thank my family for a life-long support, 
everybody I have not mentioned above, and most of all Katie, my wife, for all of the 
patience, understanding, and encouragement. 
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Chapter 1 
Introduction and scope of the thesis 
Introduction to the Baculoviridae and their life cycle 
The field of baculovirology has advanced rapidly in recent years. One reason for 
this advance was the potential to use baculoviruses for insect pest control, as the main 
target of baculoviruses, Lepidopteran larvae, cause feeding damage to agricultural 
crops and forests. Along with an increased understanding of the molecular biology of 
baculoviruses came the potential to use baculoviruses as systems for foreign gene 
expression and to study fundamental virological questions. It is within the latter category 
that the focus of this thesis falls. 
The Baculoviridae are a family of large, enveloped, double-stranded DNA 
viruses that are found almost exclusively in insects. Most baculoviruses have a narrow 
host range, and infect hosts within the order Lepidoptera. Some have been identified in 
other insect orders such as Hymenoptera and Diptera, as well as in crustaceans. The 
virions of the Baculoviridae are typically rod-shaped (~ 30-60 x 250-300 nm), and are 
often found embedded within proteinaceous occlusion bodies (Fig. 1). All known 
baculoviruses are currently classified in one of two genera: the Nucleopolyhedroviruses 
(NPVs), or the Granuloviruses (GVs), which can be differentiated (among others) by the 
size of their occlusion bodies. The GVs occlude single virions within smaller occlusion 
bodies called 'granules', whereas the NPVs contain multiple virions within each large 
occlusion body (OB) or 'polyhedron'. The NPVs are designated SNPV or MNPV 
depending on whether single (S) or multiple (M) nucleocapsids (NCs) are packaged 
within each virion. Virions of the NPVs derived from polyhedra, are termed 'occlusion 
derived virus' or 'ODV. Not all NPV virions however are occluded within polyhedra. 
Characteristic for the NPVs is the production of a second, non-occluded phenotype 
during their infection cycle: the 'budded virus' (BV). While apparently containing 
identical NCs, BV and ODV differ in composition of their envelopes, and serve distinctly 
different roles in the infection cycle. Whereas the ODV is highly infectious only to the 
epithelial cells of the midgut and is responsible for the spread of the virus from insect to 
insect, the apparent role of the BV in the infection cycle is to spread the infection from 
cell to cell within the insect (128, 265). BV is highly infectious to cells and tissues 
(except midgut) in vivo as well as in tissue culture. 
Baculovirus occlusion bodies are released into the environment upon cell lysis 
and death of an insect host. Horizontal transmission occurs through feeding on foliage 
contaminated with occlusion bodies. After ingestion, ODVs are released in the insect 
midgut when the occlusion bodies dissolve upon exposure to the alkaline pH (Fig. 2). 
Upon entering the epithelial cells, NCs are released into the cytoplasm and migrate to 
Budded Virus (BV) Occlusion Derived Virus (ODV) 
BV specific 
Components 
GP64 
Virion Envelope — 
Lipid Composition (%) 
LPC 
SPH 
PC 
PI 
PS 
PE 
5.9 
13.2 
10.7 
12.3 
50.2 
7.6 
Common Virion 
Components 
Virus DNA 
Basic DNA Binding 
Protein (P6.9) 
Major Capsid Protein 
(P39) 
Capsid Protein (P80/87) 
Capsid Protein (P24) 
Capsid Protein (P78/83) 
ODV specific 
Components 
Occlusion 
LPC 0.8 
SPH 1.5 
PC 39.0 
PI 8.2 
PS 20.5 
PE 30.1 
Polytiedrin 
PEP(PP34) 
FIG. 1. Structural composition of the two baculovirus phenotypes, 'budded virus' (BV) and 
'occlusion-derived virus' (ODV)(adapted from Blissard, 1996). The ODV structure in this illustration 
represents the Multicapsid (M) Nucleopolyhedrovirus (NPV) group. Proteins specific to either BV or ODV 
are indicated on the left and right of the diagrams. Proteins common to both virion phenotypes are indicated 
in the center. The baculovirus capsid is of a polar nature, illustrated by a structure described as claw-like at 
the bottom, and by a ring-like nipple structure at the top. Although the specific locations of most capsid 
proteins are not known, the P78/83 capsid protein was reported to be localized at one end of the capsid. 
The possible location of the P74 protein is indicated by a dashed line. Lipid compositions of the BV and 
ODV envelopes derived from AcMNPV infected- Sf9 cells (14) are indicated (LPC, 
lysophosphatidylcholine; SPH, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PE, 
phosphatidylethanolamine) 
the nucleus where transcription of viral genes and replication of the viral genome takes 
place. The - 134,000 bp genome of the prototype baculovirus, Autographs californica 
Multicapsid Nucleopolyhedrovirus (AcMNPV), was recently sequenced and contains 
154 open reading frames (ORF) potentially encoding proteins of > 50 amino acids (2). 
Genes are expressed sequentially, in a cascade-like fashion in which each successive 
phase is dependent on the previous one (for reviews, see (7, 167)). Regulation of 
baculovirus gene expression occurs primarily at the transcriptional level, and three 
separate phases are distinguished during a baculovirus infection: early, late and very 
late. Early genes are transcribed by a host cell-encoded RNA polymerase II, and 
contain typical eukaryotic consensus transcription signals such as the TATA box and 
CAGT motif. Among the early gene products are powerful transcriptional regulators, 
such as the immediate- early gene ie1 (81). Late genes are transcribed by an alpha-
amanitin resistant virus-encoded RNA polymerase (56, 82), and this transcription 
initiates at a consensus A/GTAAG motif. Many late genes are involved in virion structure 
Midgut Epithelium 
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FIG. 2. The baculovirus infection cycle (from Blissard, 1996). On the left, the infection of midgut 
epithelial cells by the occlusion derived Virus (ODV) is illustrated. After fusion of the ODV at the plasma 
membrane, two possible routes of nucleocapsid migration are indicated (a and b). In what is thought to be 
the typical route (a), nucleocapsids (NCs) are transported to the nucleus where gene expression, DNA 
replication, and assembly of progeny NCs occur. Newly assembled NCs then migrate from the nucleus 
towards the plasma membrane. A portion of the incoming NCs may bypass the nucleus (b), and migrate 
directly to the basolateral plasma membrane. NCs bud from the basal side of the epithelial cell at sites where 
GP64, the major envelope glycoprotein of the BV phenotype (indicated by arrows), has accumulated. 
During the budding process, GP64 is acquired along with a loosely adhering envelope. The right side of the 
figure represents the infection of insect cells, other than midgut epithelial, by the 'budded virus' (BV) 
phenotype. After BV binding and uptake into the endosome, the acidification of the endosome triggers 
fusion of the viral and endosomal membrane, after which the NCs are released into the cytoplasm. Although 
the modes of entry of the ODV and BV are different and specific for each virus phenotype, once NCs are 
released into the cytoplasm, progression of infection appears similar. Except for midgut epithelial cells, at 
the very late stage of the infection cycle nucleocapsids become embedded within proteinaceous occlusion 
bodies (OBs) in the nucleus. Upon death and liquefaction of the host, OBs are released into the 
environment to initiate a new round of infection. 
and morphogenesis, whereas the very late genes such as polyhedrin and p10, are 
associated with virus occlusion (253, 255). The very late genes are expressed from very 
strong viral promoters, and these promoters are extensively utilized in baculovirus 
systems for heterologous protein production. When viral DNA has been replicated and 
structural proteins are produced in sufficient quantities, NCs are assembled within the 
nucleus, and subsequently migrate towards the plasma membrane. NCs line up along 
the plasma membrane (90) at sites where GP64, the major envelope glycoprotein of the 
BV, has accumulated (258). As NCs egress by budding through the plasma membrane, 
they acquire from the host cell a loosely adhering envelope (249), and GP64 is 
acquired by the BV in the process of budding. The BV phenotype then, is responsible 
for the spread of infection beyond the initially infected midgut epithelium. This is thought 
to occur by budding of the BV from the initially infected midgut epithelial cell at the basal 
plasma membrane, as this was experimentally observed by several groups (for 
example (74, 249)). Recent studies suggest that the BV may also use the tracheal 
system to spread the infection beyond the midgut epithelium, since tracheoblasts are 
among the first cells infected after midgut epithelial cells (47, 51, 127). The mechanism 
of virus budding and the role of GP64 in this process are not well understood, and this is 
one of the research topics (chapter 4) of this thesis. Contrary to epithelial cells, at the 
very late stage of infection of non-epithelial cells, a portion of the newly assembled NCs 
remain in the nucleus where they are occluded within proteinaceous occlusion bodies 
(OB), termed polyhedra. Upon death and liquefaction of an infected insect, these OBs 
remain in the environment to initiate a new infection upon ingestion by a susceptible 
insect larva. 
A history of GP64 literature preceding the thesis 
The early history. One of the earliest reports of the baculovirus protein currently 
known as GP64, GP64/67, or GP64 envelope Fusion Protein (GP64 EFP) was a study 
by Carstens (21). In that study, a protein of an estimated molecular weight of 67 was 
shown to be a major structural BV component, and could be detected in AcMNPV 
infected Spodoptera frugiperda (Sf) cells as early as 6-8 h pi, peaking at 24 h pi. Other 
studies found a similarly sized BV protein to be phosphorylated (161) and glycosylated 
(68). Monoclonal antibodies (MAb) were raised against the non-occluded or BV 
phenotype of AcMNPV (97). Two antibodies from that study, AcV5 and AcV1, have since 
been extensively utilized in the quest for GP64 structure and function. These two 
antibodies differed in their reactivity for GP64. In Western blot analyses of B-
mercaptoethanol-reduced BV proteins, MAb AcV5 displayed strong reactivity for a 
protein with an estimated molecular weight of 64, but did not neutralize BV infectivity. In 
contrast, AcV1 neutralized BV infectivity but did not react with any viral proteins on 
Western blots. Neither of the two antibodies reacted with proteins derived from ODV. In 
a later study (264), the target antigen for AcV1 was further investigated: AcV1 was 
shown to immunoprecipitate proteins of various molecular weight (among which a 
protein of 64 kD), all of which were glycosylated. In retrospect some of these were likely 
degradation products of GP64 with the exception of some high molecular weight bands, 
which were speculated to represent dimeric, trimeric, and tetrameric forms of GP64 
(258, 260). The AcV1 epitope on BV was destroyed when viral proteins were denatured 
in the presence of R-mercaptoethanol. GP64 was (again) shown to be phosphorylated, 
and reported to have an isoelectric point of 3.15 and therefore to be highly acidic. It was 
suggested that the phosphate groups might contribute to the acidity of GP64. 
Unpublished data from our laboratory however suggest that the isoelectric point is 
between 5.6 and 6.0, contradicting the earlier assertion that GP64 might be a highly 
acidic protein (Monsma, unpublished data). 
GP64 and virus exit from the host cell. A study by Volkman (264) was among the 
first to demonstrate the location of GP64 in a baculovirus infected insect cell, and to give 
clues about one of its possible roles in the baculovirus infection cycle. AcV1 was shown 
to react with the surface of infected cells at a stage of the infection cycle prior to 
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FIG. 3. Baculovirus BV budding and presence of 'spike-like' proteins or 'peplomers' on the BV 
phenotype as seen by electron microscopy (from Blissard(7)). In the late phase of the infection cycle, 
progeny NCs migrate from the nucleus and bud through the plasma membrane at sites where GP64 
(indicated by arrows), the major envelope glycoprotein of the BV phenotype, has accumulated. GP64 is 
acquired during the budding process, along with an apparently loosely adhering plasma membrane-derived 
envelope. The resulting virions display 'spike-like' proteins or 'peplomers' at the virion surface. These spike-
like proteins appear to be concentrated at one end of the virion and are believed to be composed of the 
major envelope glycoprotein GP64. 
polyhedra formation, a period of active virus budding. Also, immuno-electron 
microscopy indicated that AcV1 reacted with a protein present at or in the viral 
envelope, more concentrated at one end of the virion with 'peplomers' (264)(Fig. 3). The 
accumulation of 'peplomers' or 'spike' glycoproteins at the plasma membrane 
coincident with budding of virus particles from the cell surface, was a process observed 
with several other enveloped viruses (129). In addition, while NCs were observed 
budding only from the basolateral side of ODV- infected midgut epithelial cells (74, 
249), GP64 was detected in AcMNPV- infected columnar epithelial cells in a polar 
fashion as well (127). Hence, it was suggested that GP64 might be a potentially 
important factor in the budding process of AcMNPV. The role of GP64 in virus exit was 
extensively studied in this thesis, see chapters 4 and 3. 
GP64 and virus entry into the host cell. In an attempt to better understand the 
entry mechanism of BV, the mechanism by which MAb AcV1 neutralized BV infectivity 
was examined (261). Binding of radiolabeled BV to Sf21 cells appeared unaffected 
when BV was pre-incubated with AcV1, showing that the neutralizing capacity of AcV1 
was not at the level of virus binding to cells. In the same study, a valuable insight into 
the mechanism by which the BV phenotype enters its host cell was gained, when the 
effect of lipophilic amines on BV infectivity was examined. These agents (for example 
chloroquine and ammonium chloride, also called lysosomotropic reagents) prevent the 
acidification of the endosome when added to cells (89, 148). As such, these reagents 
identified viruses that enter by endocytosis, such as the enveloped viruses Semliki 
Forest virus (SFV, Togaviridae)(158), Influenza virus (Orthomyxoviridae)(148), and 
Vesicular Stomatitus virus (VSV, Rhabdoviridae)(35). When insect cells were treated 
with these lipophilic amines, BV infectivity was drastically reduced, and it was therefore 
concluded that baculovirus BV also enters its host cell by endocytosis. MAb AcV1 then, 
neutralized BV at a stage of endocytosis beyond binding, possibly in the endosome. In 
the model of entry by endocytosis (see also Fig. 2), virus first binds to cells, and is then 
taken up via clathrin coated pits to follow an endocytic pathway. During uptake through 
the endocytic pathway, the pH of the endosome decreases at least partly as a result of 
vacuolar proton ATPases (83). The lowered pH triggers a conformational change in the 
viral glycoprotein, which in some cases has been shown to expose a hydrophobic 
fusion peptide/domain. Based on recent studies with Influenza virus following a 
comparison of the three-dimensional structure of portions of HA at the physiological and 
low pH conformations (18, 279), some of the important conformational changes 
believed to occur are a) formation of a triple-stranded coiled coil, and b) the transition of 
a loop region within each HA monomer to an alpha-helix structure. These structural 
changes in turn translocate the alpha-helical hydrophobic peptide, and insert the 
peptide into the target membrane. The top of the acid-induced coiled coil is then thought 
to spread apart, thereby bringing the viral and cellular membrane closer together 
('apposition' (20, 285)). This ultimately leads to fusion of the viral and endosomal 
membrane by a process that is poorly understood, and after which the viral NC is 
thought to be released into the cytoplasm. The fact that uptake through an endocytic 
pathway (after binding to the host cell) requires energy and can be prevented by using 
low temperatures, was utilized to further examine the kinetics of viral entry by 
endocytosis and the role of GP64 in viral entry (chapter 5). Adsorption of viruses to the 
surface of cells is generally thought to occur by interaction of the virus and a specific 
receptor, and this has been demonstrated for several virus species. However, 
negatively charged liposomes have also been shown to enter cells by adsorptive 
endocytosis, suggesting that specific receptor interaction may not be necessary (238). 
Alternative to adsorptive endocytosis to enter cells, it is possible that baculoviruses may 
utilize fluid endocytosis, one of the uptake mechanisms for low molecular weight solutes 
and soluble macromolecules such as enzymes, hormones, and antibodies (228), or a 
combination of adsorptive and fluid endocytosis. It may however not seem beneficial 
that a virus would depend on a non-specific interaction such as fluid endocytosis for 
entry into its host cell. 
In another study (262), GP64 was found to be resistant to functional inactivation 
by proteolysis. Protease treatments with proteinase K and trypsin each resulted in a 35 
kD soluble GP64 fragment, and 36 and 37 kD fragments of GP64 that were retained 
with the BV, and the AcV1 epitope was lost by this protease treament. The fragments 
retaining with the BV also appeared to be more sensitive to B-mercaptoethanol, 
however the protease-treated BV proved as infectious as control BV containing the full 
length GP64. Assuming that in this case, GP64 in the viral envelope was effectively and 
quantitatively cleaved, and that consequently the fragments retained with the BV 
represent one side of the GP64 molecule only, this would imply that the necessary, 
biologically relevant domains of GP64 for entry are located in the 36 and 37 kD 
fragments retained with the BV. It may however seem unlikely that ~ half of the GP64 
molecule would be dispensable for its functions within the baculovirus infection cycle. 
DNA and amino acid sequences, and predicted domains of GP64. Molecular 
aspects of GP64 were first addressed, when the coding sequences for OpMNPV and 
AcMNPV GP64 were cloned after locating the genes by using GP64-specific antibodies 
to screen a lambda gt11 expression library (9) and (273). Subsequent sequence 
analyses revealed ORFs with 1527 and 1539 nt respectively for OpMNPV and AcMNPV, 
predicting a protein with a molecular weight of ~ 58. (The difference between predicted 
and observed molecular mass is mostly due to glycosylation.) A high degree of 
nucleotide (74%) and amino acid (78%) identity was observed between these two 
GP64s. Translated ORFs contained 7 and 5 potential N-linked glyosylation sites, for 
OpMNPV and AcMNPV GP64 respectively. The GP64 promoter region contained early 
as well as late transcription consensus motifs, and primer extension analyses showed 
transcription initiation at the early (CAGT) as well as two out of the four late (ATAAG) 
consensus motifs. Western blot analysis and immunofluorescence microscopy of 
infected cells demonstrated that GP64 was expressed in both early and late stages of 
the infection cycle, and was present as diffuse patches in the cytoplasm or at the plasma 
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FIG. 4. Features of AcMNPV GP64. Various domains, antibody epitopes, and hydrophobicity 
profile of AcMNPV GP64 are shown: N (N-terminus), C (C-terminus), SP (signal peptide), TM 
(transmembrane domain), CTD (cytoplasmic tail domain), leu zipper (heptad repeat of leucines, predicting 
an amphipathic alpha-helix), AcV5 (linear epitope of Monoclonal antibody [MAb] AcV5), B12D5 (linear 
epitope of MAb B12D5), F (domain involved in fusion), Tr (domain involved in trimerization), Y (consensus 
N-linked glycosylation sites). Indicated fusion and oligomerization domains are the corresponding locations 
in AcMNPV GP64 to those mapped in the OpMNPV GP64 protein (171). Vertical arrows indicate the 
locations of cysteine residues. The hydrophobicity profile is based on Kyte and Doolittle (142); The vertical 
axis indicates Kyte-Doolittle hydrophobicity values (+ hydrophobic; - hydrophilic) and numbers on the 
horizontal axis represent GP64 amino acid numbers. For the complete 512 amino acid primary sequence of 
AcMNPV GP64, see Fig. 3, chapter 6. (Insert) Classification of integral membrane proteins adapted from 
Von Heijne and Gavel (267). Mature GP64 is a type 1 membrane glycoprotein, with a large N-terminal 
ectodomain, membrane anchoring domain (TM), and a C-terminal cytoplasmic domain. The site where the 
signal peptide is cleaved is indicated by an arrow. 
membrane (9). Hydrophobicity profiles (142) predicted that GP64's topology resembled 
that of a type 1 transmembrane protein (Fig. 4): A signal peptide preceding a large N-
terminal ectodomain and a membrane anchoring (transmembrane, TM) domain at the 
C-terminus followed by a short cytoplasmic tail domain (CTD). A TM domain of a type I 
membrane envelope protein is generally defined as a highly hydrophobic domain near 
the C-terminus, and there are no consensus sequences known that indicate beginning 
or end of a TM domain. Based on hydrophobicity alone, residues Ieu480 to phe483 may 
represent the N-terminal end of the AcMNPV GP64 TM domain. The first charged 
residue beyond the hydrophobic domain, arg506, may represent the C-terminal 
boundary and start of the cytoplasmic tail domain (CTD). With the above considerations, 
the TM domain was predicted to be 23 amino acids long, while the CTD domain was 
predicted to be only 7 amino acids long, of which several residues are positively 
charged. Due to its predicted cytoplasmic location, it was speculated that this CTD might 
be involved in virion assembly (273). A non-protein modification of GP64 that might alter 
the hydrophobicity of the TM domain was reported (207). Palmitic acid was found to be 
the fatty acid responsible for a detected acylation of GP64, and two candidate amino 
acid residues were selected (ser482 and cys503) for this modification. Based on the 
characteristics of chemical release, it was proposed that this modification most likely 
occurs post-translationally through a thio-ester linkage at ser482. Suggested functions 
and location of acylation of GP64 are addressed in the general discussion. 
GP64 mediates low pH-dependent membrane fusion. Enveloped viruses (such 
as Influenza and VSV) that enter their host cells by receptor-mediated endocytosis, 
possess surface glycoproteins which (after endocytosis) fuse the viral envelope with the 
membrane of the endocytic vesicle upon exposure to low pH (see section 'GP64 and 
entry of the host cell'). Entry of baculovirus BV resembled that of the enveloped viruses 
mentioned above ((261), see earlier), and GP64 was implied in the entry process 
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FIG. 5. Low pH-induced membrane fusion assay and model for fusion pore formation (from 
Blissard (5)). On the left: Infected or transfected Sf9 cells which express GP64, are incubated with pH 5 
medium for 5 min. After 5 min, the pH 5 medium is replaced with TNM-FH and cells are further incubated. 
The exposure to low pH triggers GP64 to induce fusion between adjacent membranes, resulting in the 
formation of multi-nucleated syncytia. The low pH-triggered membrane fusion assay can serve as an 
indicator for the capacity of a particular envelope protein to fuse viral and cellular membranes in the 
endosome during viral entry by endocytosis. On the right: Before NCs can enter the cytosol, viral and 
endosomal membrane must fuse, and form a pore (or pores) wide enough to allow passage of the NC. In BV 
entry, membrane fusion is mediated by GP64. In the ODV, a viral protein mediating membrane fusion has 
not yet been identified. A hypothetical model for fusion pore formation shows that opposing membranes 
must first be docked or held in close 'apposition'. Subsequent steps include a merging of outer membrane 
leaflets (membrane mixing), a merging of inner membrane leaflets (pore formation), followed by pore 
enlargement. Small arrows indicate the steps that are presumably catalyzed by viral membrane fusion 
proteins. A step at which lysolipids are able to inhibit membrane fusion is also indicated. 
because AcV1, a MAb that was known to immunoprecipitate a protein of 64 kD, 
neutralized BV infectivity at an entry step beyond binding (see earlier). Moreover, 
GP64's hydrophobicity profile resembled that of type 1 membrane proteins such as 
Influenza HA. Blissard and Wenz (10) examined the capacity of OpMNPV GP64 to 
mediate low pH-triggered membrane fusion by syncytium formation assays. Ability to 
fuse plasma membranes in this assay generally serves as an indicator of the capacity to 
fuse viral and cellular membranes in the endosome during viral entry. When expressed 
alone in Lymantria dispar (Ld) cells (i.e. in the absence of viral infection), and exposed 
to low pH medium, OpMNPV GP64 was capable of inducing membrane fusion, with 
formation of multi-nucleated syncytia (Fig. 5). This suggested that one function of GP64 
was to induce membrane fusion during entry, presumably to release the NC into the 
cytosol. A drop in pH from 6.2 (physiological) to < 5.5 was necessary to induce 
membrane fusion, and as little as 5 seconds exposure to low pH was sufficient for this 
induction. Several studies showed that the neutralization of AcMNPV by MAb AcV1 was 
likely the result of inhibition of fusion between the viral and endosomal membrane: 
Lysis of red blood cells by AcMNPV BV at low pH was inhibited by pre-incubating BV 
with AcV1 (261), and Sf9 cells pre-incubated with AcV1, no longer formed syncytia 
when exposed to low pH (25). In OpMNPV GP64 a domain was identified, involved in or 
responsible for the low pH-dependent membrane fusion, by examining the effect of 
single or multiple amino acid substitutions in predicted hydrophobic domains on low 
pH-triggered membrane fusion (171). The identified domain was one of two small, 
locally hydrophobic domains of GP64 (termed I and II; Fig. 4) that are present in addition 
to the signal peptide and TM domain. Nonconservative substitutions of amino acids 
Ieu226 or Ieu227, which represent the core of hydrophobic domain I (amino acids 223 
to 228), completely abolished fusion while the stability and surface expression of GP64 
were unaffected. Hydrophobic region II was also examined in that study. Region II 
shows characteristics typical of a leucine zipper, a structure with heptad repeats of 
leucine, predicted to be an amphipathic alpha helix with local hydrophobicity along one 
face of the helix. When multiple leucines of the heptad repeats were replaced with 
alanines or prolines (helix destabilizing), GP64 no longer oligomerized, indicating that 
this region is required for oligomerization. In the same study, the epitope for MAb AcV5 
was mapped to 9 amino acids (431 to 439) within GP64. 
Evolution of GP64: A remarkable homology between GP64 and an 
orthomyxovirus glycoprotein. Thogoto (THO) and Dhori (DHO) viruses are tick-
transmitted viruses that replicate in both ticks and mammals. Both are classified as 
THO-like viruses within the Orthomyxoviridae, based on several morphological and 
biochemical similarities, while displaying biological properties divergent from other 
orthomyxoviruses (26). When the sequence of RNA segment 4 of THO virus was 
determined (173), a protein of 512 amino acids was predicted, with a type 1 membrane 
topology. The THO envelope glycoprotein (THO env) has extensive homology with the 
previously published putative envelope glycoprotein of the DHO virus (54), but did not 
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display significant homology with any of the envelope glycoproteins of other 
orthomyxoviruses. Instead a remarkable homology was found between the 
glycoproteins of THO and DHO virus and baculovirus GP64 (173). Overall amino acid 
identity was between 28 and 33%, and clusters of strong homology were present. 
Hydrophobicity profiles were strikingly similar, and some glycosylation sites as well as 
most cysteines were conserved between DHO/THO env, and GP64 from AcMNPV and 
OpMNPV, indicative of a significant conservation. Upon characterization of THO viral 
proteins, Portela (201) found a membrane associated glycoprotein with a molecular 
mass of 75, which likely represents the glycoprotein predicted by Morse (173). In 
addition, the THO virus showed low pH-induced membrane fusion, hemagglutination, 
and hemolytic activity with a pH optimum of 6, when infecting mammalian cells, grown 
at pH 7. The 75 kD protein (THO env) was implicated in these functions because MAbs 
against this protein inhibited these activities. 
We have cloned the THO env coding sequence into an insect and a mammalian 
expression vector and performed transient analysis in insect cells (Ld652Y; at 
physiological pH, 6.2) as well as several mammalian cell lines (NIH3T3, BHK, and 
COS; at physiological pH 7). When exposed to low pH, only minimal syncytium 
formation could be detected in Ld cells, and none in NIH3T3, or BHK cells. However, in 
COS cells, expression of THO env alone was sufficient for robust, low pH-induced 
syncytia formation (Oomens, unpublished data). Together these data indicate that THO 
env and baculovirus GP64 are structurally and functionally similar. Evolutionary 
implications are discussed in the general discussion. 
Scope of the thesis 
The aim of this thesis is to lay out my experimental contribution to understanding 
GP64 structure and function in the baculovirus life cycle, and to put this contribution in 
the perspective of the processes of exit and entry of enveloped viruses in general. 
Previous literature reports (see 'A history of GP64 literature preceding the thesis') 
suggested that GP64 might be involved in two important events in the baculovirus life 
cycle: BV entry into, and exit from the host cell. One function was demonstrated when 
GP64 was shown to induce plasma membrane fusion when expressed alone in insect 
cells, and thus likely to be the protein responsible for fusion between the viral and 
endosomal membrane upon entry by endocytosis (10). However, direct roles in other 
aspects of exit or entry of the baculovirus BV phenotype were suspected but never 
demonstrated. The research presented in this thesis contributes to elucidating the role 
of GP64 in virus exit, viral transmission, and virus entry. 
First I conducted some basic experiments addressing temporal expression, 
oligomerization, and carbohydrate processing of GP64, as well as certain structural 
features of GP64 from the baculovirus OpMNPV (chapter 2). Next, the role of GP64 in 
the infection cycle was addressed by examining AcMNPV infectivity in the complete 
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absence of GP64. This was accomplished by deleting the gene from the viral genome 
and the generation of a gp64null virus, which was complicated by the fact that the GP64 
turned out to be an essential baculovirus protein. An important function of GP64 was 
revealed by this gp64null virus: Without GP64, the virus was unable to transmit infection 
from cell-to-cell in cell culture as well as in insect larvae. Whether this effect was due to 
decreased virus budding or whether the absence of GP64 resulted in defective virions, 
was the next question addressed (chapter 4). When it was shown that this defect in viral 
transmission was caused primarily by a reduction in virus budding in the absence of 
GP64, the focus shifted towards the CTD of GP64. The CTD is predicted to be in a 
position to interact with cytoplasmic viral and/or cellular factors and hence a logical 
target for BV exit/assembly studies. Recombinant viruses carrying deletions or 
modifications in the CTD and/or portions of the TM domain were generated and 
examined for their role in virus budding (chapter 4). Switching direction, the role of 
GP64 in BV entry into host cells was addressed in chapter 5. Data of those studies 
suggest that AcMNPV GP64 is a host cell receptor binding protein, and demonstrate 
half-times of AcMNPV entry, and release from endosomes. In the last experimental 
chapter (chapter 6) we mapped the GP64 homolog in baculovirus Anticarsia 
gemmatalis Multicapsid Nucleopolyhedrovirus (AgMNPV). This virus is extensively 
utilized in the protection of soybean crop in Brazil, and demonstrates well the 
baculovirus potential for insect pest control. To examine the relatedness of AgMNPV to 
other NPVs, a genomic region of AgMNPV, containing the gp64 gene and 18 additional 
ORFs, was analyzed and compared to the corresponding regions in other 
baculoviruses. Finally, because virus budding is a poorly understood area of 
baculovirology, the general discussion includes a review of selected literature 
regarding the role of viral spike proteins in exit of enveloped viruses from host cells. A 
few additional GP64 research areas are also included in the discussion. These are not 
or to a lesser degree addressed experimentally in this thesis, but are touched upon with 
the aim of complementing the experimental contribution towards our understanding of 
GP64 structure and function. The discussion is concluded with a note on current and 
future avenues of GP64 research. 
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Chapter 2 
The baculovirus GP64 envelope fusion protein: 
Synthesis, oligomerization, and processing 
Abstract 
The baculovirus GP64 envelope fusion protein (GP64 EFP) is a class I integral membrane 
protein that enters the secretory pathway, and is oligomerized and extensively processed during 
transport to the plasma membrane. The kinetics of GP64 EFP biosynthesis, oligomerization and 
processing in OpMNPV-infected Lymantria dispar cells, were examined by pulse label, pulse-
chase, and immunoprecipitation experiments. Relative rates of GP64 EFP synthesis in OpMNPV 
infected L dispar cells were examined at various times throughout the infection cycle. Using pulse 
labeling and immunoprecipitation, GP64 EFP synthesis was detected within 2 hr p.i., and the 
maximal rate of synthesis was observed in the period of 24-26 hr p.i., a time coincident with the 
onset of high level production of budded virus in OpMNPV-infected L dispar cells. To determine 
the oligomeric structure of GP64 EFP, a soluble form of Orgyia pseudotsugata Multicapsid Nuclear 
Polyhedrosis virus (OpMNPV) GP64 EFP was produced, and examined by a combination of gel 
filtration chromatography, non-reducing SDS-PAGE, and mass spectrometry. Oligomeric GP64 EFP 
was identified as a trimeric molecule, that migrates as 2 discrete bands on non-reducing SDS-
PAGE. Pulse-chase studies, performed at both early (12 hr p.i.) and late (36 hr p.i.) stages of the 
infection cycle, showed that GP64 EFP oligomerization is complete within 15 min after synthesis. 
Efficiency of oligomerization however was relatively low, with less than 28% of the synthesized 
GP64 EFP converted to trimers. The majority of monomelic GP64 EFP remaining in the cell 
appeared to be degraded within 30 to 45 min after synthesis. Analysis of the kinetics of 
carbohydrate processing at early (12 hr p.i.) and late (36 hr p.i.) times post infection showed that 
for both early and late phases of infection, carbohydrate was rapidly added, and processing 
began within 10 to 20 min after GP64 EFP synthesis. Although carbohydrate processing was 
completed within - 90 min after synthesis during the early phase, the same process required - 150 
min during the late phase. Thus, carbohydrate processing appeared to become less efficient as 
infection progressed. These studies thus show that GP64 EFP undergoes a rapid but inefficient 
oligomerization step that results in a homo-trimeric structure for GP64 EFP. While carbohydrate 
addition is rapid, carbohydrate processing requires prolonged periods of time (with half-times of 45 
to 75 min) and appears to become less efficient during the late phase of the infection. 
This chapter has been published as: 
Oomens, A.G.P., S.A. Monsma, and G.W. Blissard (1995). The Baculovirus GP64 envelope fusion protein: 
Synthesis, oligomerization, and processing. Virology 209, 592-603 
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Introduction 
The Baculoviridae are a family of enveloped animal viruses that are pathogenic 
to invertebrates, primarily insects in the order Lepidoptera. Baculoviruses have large 
circular double-stranded DNA genomes ranging from approximately 80 to 180 kbp. 
Transcription, replication, and nucleocapsid assembly take place in the nuclei of 
infected cells. Baculoviruses are characterized by an infection cycle that produces two 
virion phenotypes that are structurally and functionally distinct (7, 265). The first virion 
phenotype produced in the infection cycle is the budded virus (BV). Production of the 
BV begins when nucleocapsids bud through the plasma membrane into the 
extracellular space. BV is responsible for the systemic infection of insect cells and 
tissues in vivo, and is highly infectious in cell culture systems. Production of the second 
virion phenotype, the occlusion-derived virus (ODV), occurs in the very late phase of the 
infection cycle when nucleocapsids become enveloped within the nucleus. The process 
of ODV envelopment is not well characterized, and is followed by occlusion of ODV 
virions within proteinaceous occlusion bodies (termed polyhedra in the nuclear 
polyhedrosis viruses, and granules in granulosis viruses). Although BV and ODV 
appear to be identical in nucleocapsid structure, they differ in the sources of their 
envelopes. This difference results in differences in biochemical compositions (14), and 
correlates with observed differences in relative infectivities for different tissues within the 
insect and in tissue culture (128, 265). 
Infectivity of BV is dependent on a major BV-specific envelope glycoprotein 
known as the GP64 Envelope Fusion Protein (GP64 EFP). Some monoclonal 
antibodies and polyclonal antisera directed against the GP64 EFP are capable of 
neutralizing infectivity (97, 171, 206, 264). Transcription of the gp64 efp gene is 
regulated by both early and late promoters, which results in the appearance of GP64 
EFP in infected cells at both early and late times post infection. This temporal pattern of 
gp64 efp transcriptional expression has been demonstrated in both OpMNPV (8, 9, 13) 
and Autographa californica multicapsid nuclear polyhedrosis virus (AcMNPV) (112, 
273). Similarities in regulatory sequence arrangements between the gp64 efp genes of 
OpMNPV, AcMNPV and Choristoneura fumiferana multicapsid nuclear polyhedrosis 
virus (CfMNPV) suggest that transcriptional regulation is similar in these three 
baculoviruses (9, 112, 273). Regulation of early transcription has been studied in detail 
for the OpMNPV gp64 efp gene (8-10, 132, 133). After viral DNA replication and late 
gene expression, nucleocapsids assemble in the nucleus. Nucleocapsids then migrate 
through the cytoplasm, and bud through the plasma membrane at sites where GP64 
EFP appears to be concentrated (264). A number of biochemical properties of the GP64 
EFP protein of AcMNPV have been described: GP64 EFP is a phosphorylated, acylated, 
and glycosylated homo-oligomer with subunits that are covalently linked by disulfide 
bonds (207, 260, 264). The OpMNPV, AcMNPV and CfMNPV GP64 EFP's have very 
similar hydrophobicity profiles, and show an high degree of amino acid sequence 
similarity (9, 93) with the predicted ectodomains showing at least 82% identity across all 
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three baculovirus GP64 EFP proteins. The OpMNPV and CfMNPV proteins have 7 
potential sites for N-linked glycosylation, whereas AcMNPV has 5. The locations of the 5 
potential glycosylation sites in AcMNPV are conserved in both OpMNPV and CfMNPV 
(9, 93, 273). Recent studies of the AcMNPV GP64 EFP show that at least some of the N-
linked glycosylation sites contain carbohydrates that are Endo H resistant (112) and 
thus may be processed into complex sugars. 
Previous studies utilizing a neutralizing monoclonal antibody (MAb), AcV1, and 
the lipophilic amine chloroquine, showed that GP64 EFP is required for viral entry by 
endocytosis (97, 261). Later, it was demonstrated that GP64 EFP expressed on the 
surface of uninfected cells is sufficient to mediate membrane fusion in a pH dependent 
manner (10). These studies showed that GP64 EFP is necessary and sufficient for low 
pH activated membrane fusion activity, consistent with the role of GP64 EFP in viral 
entry through the low pH environment of the endosome. Recent studies of GP64 EFP 
mediated membrane fusion have identified a hydrophobic 'fusion domain' which is 
required for pH-dependent membrane fusion activity (171). 
Although the kinetics of folding, oligomerization, and transport have been 
characterized for a diverse group of animal and viral membrane proteins (43), little is 
known about similar kinetics of baculovirus membrane proteins. Here, we report a study 
of the kinetics of production, oligomerization and processing of OpMNPV GP64 EFP in 
infected L. dispar cells. Because GP64 EFP is a highly processed viral protein that 
enters the secretory pathway, studies of the kinetics of GP64 EFP biosynthesis, 
oligomerization, and processing will aid our understanding of baculovirus infection 
mechanisms, and may also yield insights into the use of recombinant baculoviruses to 
express secreted or membrane proteins that are highly processed. 
Materials and methods 
Anti-GP64 EFP polyclonal antiserum. To generate a polyclonal antiserum (PAs) 
directed against the GP64 EFP, we cloned the OpMNPV gp64 efp open reading frame 
in the pMalcRI plasmid vector (New England Biolabs), and expressed GP64 EFP as a 
protein fusion in E. coll. For cloning, pMalcRI was digested with Hind\\\, repaired with 
Klenow polymerase, then digested with Psft. A 1685 bp Pst\-Sma\ fragment (containing 
the gp64 efp gene) was excised from plasmid p64-166 (10), and ligated into the 
pMalcRI vector. The resulting plasmid, pMalcR1-EFP, encodes a protein fusion 
consisting of amino acids 1-384 of the E. coll maltose binding protein (MBP) fused to 
amino acids 45-509 of OpMNPV GP64 EFP. This resulted in a protein of 857 amino 
acids with a predicted size of approximately 92 kDa. E. coll expressing the MBP-EFP 
protein were sonicated, then centrifuged for 20 min at 1500 x g. The MBP-EFP protein 
was purified from the supernatant by affinity chromatography on amylose columns, 
followed by size fractionation on preparative 6% SDS-PAGE, and electroelution from 
gel purified bands. The MBP-EFP protein was concentrated in Centricon-30 micro-
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concentrators (Amicon, Inc.) and used for injections into a Flemish Giant/Chinchilla 
rabbit. Prior to use, anti-GP64 EFP PAs was preadsorbed with an MBP extract prepared 
from E. coli cells. To prepare the MBP extract, E. coli cells expressing MBP were 
sonicated, cleared by centrifugation (20 min at 1500 x g), and supematants were stored 
at -20°C. The anti-GP64 EFP PAs was preadsorbed by adding 5 JLLI MBP extract 
(approximately 3 mg MBP/ml extract) to 250 ^l of a 1:100 dilution of the anti-GP64 EFP 
PAs, and incubating at 4°C for 1 hr, followed by ultra centrifugation at 84,000 x g for 30 
min to remove insoluble complexes. 
Cell culture, infections, and virus purification. L dispar cells (IPLB-LD-652Y) 
were propagated in TNM-FH medium (95) and infected with OpMNPV at a multiplicity of 
infection (m.o.i.) of 20. The time defined as 0 hr p.i. corresponds to the timepoint at the 
end of a 1 hr viral absorption period. Mock-infected cells were treated similar to infected 
cells but no virus was added. BV virions were collected at 7 days post infection from the 
medium of cells infected at a low m.o.i. (0.01). Debris were removed by low speed 
centrifugation at 3000 x g for 1 hr, and BV virions were purified by sucrose density 
gradient centrifugation (177). 
Metabolic labeling and immunoprecipitation. An EXPRESS protein labeling mix 
(containing 72% L-35S-methionine and small amounts of L-35S-cysteine; DuPont NEN) 
was used for metabolic labeling of protein. Prior to labeling, L. dispar cells (5x105 per 
well in a 24 well plate) were starved by incubation in Graces without methionine 
(Graces™1) for 30 min (pulse labeling experiments) or 60 min (pulse-chase 
experiments), then labeled by incubation in Graces"™' supplemented with EXPRESS 
protein labeling mix, at a final concentration of 75 ju.Ci (pulse label experiments) or 100 
|j.Ci (pulse-chase experiments) of EXPRESS per 250 \i\ labeling medium. For 
immunoprecipitation of GP64 EFP, pulse labeled L. dispar cells (5x105 cells) were 
lysed in 300 u.l RIPA buffer (150 mM NaCI, 1% NP-40, 0.5% deoxycholic acid, 0.1% 
SDS, and 50 mM Tris, pH 8) for 1 hr at 4°C with agitation. Insoluble material was 
cleared from the lysate by centrifugation for 10 min at 16,000 x g , followed by a 30 min 
centrifugation at 84,000 x g at 4°C. To 250 |il of the cleared supernatant, 250 u.l of 
preadsorbed anti-GP64 EFP PAs (1:100 in RIPA buffer) was added and incubated for 
40 min at 4°C. Insoluble protein A (Staph A, in 40 mM sodium phosphate buffer, pH 7.2) 
was added (25 \i\ 1250 \i\ lysate), and incubated at 4°C for 45 min with agitation. The 
Staph A complexes were then pelleted, washed 3x in 0.7 ml RIPA buffer, and boiled in 
disruption buffer. For electrophoresis under non-reducing conditions (6% 
polyacrylamide) the disruption buffer contained 8% SDS, 37.5 mM iodoacetamide (IA), 
and no B-mercaptoethanol. For electrophoresis under reducing conditions (9% 
polyacrylamide) the disruption buffer contained 2% SDS and 5% B-mercaptoethanol. 
Oligomeric structure of GP64 EFP. For studies of the oligomeric structure of GP64 
EFP, a soluble form of OpMNPV GP64 EFP (GP64 EFP50') was prepared and purified. 
Full details of expression vector construction and GP64 EFP80' purification will be 
published elsewhere (87). Briefly, a recombinant virus expressing GP64 EFP80' was 
constructed as follows. A stop codon was engineered into the OpMNPV gp64 efp gene 
18 
in plasmid p64-166 (10), immediately upstream of the predicted transmembrane 
domain. The Tyr478 codon (TAC) was converted to TGA using the long-primer unique 
site elimination protocol (171, 203) to create plasmid p64-166STOP. Next, a BglU 
restriction site was created 10 nt upstream of the translation initiation codon of the gp64 
e/pgene in plasmid p64-166STOP, to create plasmid p64-166BglATG-STOP. To place 
the gp64 EFP501 gene under control of the polyhedrin promoter, the 1820 bp Bgl\\-BamH\ 
restriction fragment of plasmid p64-166BglATG-STOP was ligated into the Ba/nHI site of 
tr EFPSQ| nsfer vector pAcDZI (177, 295) to create transfer plasmid pAc-OpEFPso1. A 
recombinant AcMNPV virus was then generated by standard methods (177) using 
linearized AcMNPV viral genomic DNA (BacPak6, Clontech Inc.). A recombinant virus 
(EFPSQ| C2) was purified by three rounds of cloning by end point dilution. 
GP64 EFPso1 was expressed and purified from supernatants of EFPS0|C2 infected 
BTI-Tn-5B1-4 cells (75), grown in spinner cultures. Cells were grown in serum-free 
Excell 405 liquid medium (JRH Bioscience) at 27°C to a density of 1x106 cells/ml, then 
infected at m.o.i. 10. Infected cells were maintained at 27°C, and media was harvested 
at 48 hr p.L GP64 EFPSD| was purified from the media by a combination of lectin-binding, 
anion-exchange, hydrophobic interaction, and gel filtration chromatography. Purity as 
assessed on silver-stained SDS-PAGE gels typically exceeded 95%. 
For analysis of the oligomeric structure of GP64 EFPSQ|, purified GP64 EFPso1 was 
examined by both gel filtration and mass spectrometry. For gel filtration, purified GP64 
EFPso1 was loaded onto a 70 cm x 1.6 cm Sephacryl S400-HR column (Pharmacia) 
equilibrated with 200 mM NaCI, 20 mM Sodium phosphate, 0.02% azide (pH 7.0) and 
run at a flow rate of 20 ml/hr. For molecular weight estimates, the following gel filtration 
standards were used to calibrate the column: Carbonic anhydrase (29 kDa), albumin 
(66 kDa), alcohol dehydrogenase (150 kDa), (3-amylase (200 kDa), apoferritin (443 
kDa), and blue dextran (2000 kDa). The protein concentration was monitored by 
spectrophotometry (UV-absorption at 280 nm). Column fractions of 3 ml each were 
collected, and aliquots were denatured in non-reducing lysis buffer and examined on 
6% SDS-PAGE gels by Coomassie blue staining. Molecular weight markers, run in 
parallel on the non-reducing SDS-PAGE gels, included myosin (200 kDa), 13-
galactosidase (116.25 kDa), and phosphorylase b (97.4 kDa). Although bovine serum 
albumin (BSA, 66 kDa) was also run, BSA contains disulfide bonds and therefore was 
not utilized for calculations of molecular weight under non-reducing conditions. For 
mass spectrometry, the three peak fractions from the gel filtration indicated in Fig. 3B 
were pooled, dialyzed to distilled H2O, and concentrated. The sample (approximately 
20 pmol) was prepared in sinnapinic acid and analyzed on a Finnegan-Matt matrix-
assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometer at the 
Cornell Biotechnology service facility, using BSA (66,431 MW) for calibration. 
Analysis of carbohydrate processing. For studies of N-linked glycosylation, 
addition of N-linked carbohydrates was inhibited by adding tunicamycin (TM, 
Boehringer) to the medium to a final concentration of 10 ng/ml. TM containing medium 
was added to cells 1 hr prior to pulse labeling and was maintained throughout the 
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experiment. For endoglycosidase treatments, immunoprecipitated 35S-labeled GP64 
EFP samples were first boiled for 4 min in the presence of 0.5% SDS and then for 4 min 
in the presence of 0.75% n-octylglucoside and 0.1% SDS. For each immunoprecipitate 
(from 4x105 cells), 0.5 units of endoglycosidase F/N-glycanase F (endo F, Boehringer) 
or 10 milliunits of endoglycosidase H (endo H, Boehringer) were added and incubated 
for 24 hr at 37°C. After endoglycosidase treatments, samples were mixed with an equal 
volume of 2x disruption buffer (0.25 M Tris, pH 6.8; 4% SDS; 20% glycerol; 0.002% 
bromophenol blue; 10% R-mercaptoethanol), boiled for 5 min, and run on a 9 or 10% 
SDS-polyacrylamide gel. 
Analysis of immunoprecipitated GP64 EFP. For analysis of GP64 EFP labeling, 
SDS-PAGE gels were fixed in 25% isopropanol, 10% acetic acid for 30 min, then 
treated with a fluorographic reagent (Amplify, Amersham) for 30 min before drying 
under vacuum. Dried gels were used to expose both x-ray film and phosphorimager 
screens. For phosphorimager analysis, screens were exposed for times ranging from 
0.5 - 3 days and scanned on a Molecular Dynamics phosphorimager. Analysis of SDS-
PAGE images and quantification of individual bands were performed with the 
Imagequant software package (Molecular Dynamics, Inc.). 
Results 
Anti-GP64 EFP antiserum. To examine the relative rates of synthesis and the 
kinetics of oligomerization and processing of GP64 EFP in OpMNPV infected L. dispar 
cells, we generated a PAs specific for GP64 EFP. Preliminary studies showed that the 
available MAbs to GP64 EFP varied in cross-reactivity and their capacities to recognize 
native and denatured forms of the protein. To generate a PAs with broad specificity for 
GP64 EFP, a protein fusion of MBP and GP64 EFP, MBP-EFP, was expressed in E. coli, 
purified, and used to produce rabbit anti-GP64 EFP antibodies. Specificity of the anti-
GP64 EFP PAs was examined by Western blot analysis and immunoprecipitation of 
GP64 EFP from OpMNPV infected L. dispar cells and purified OpMNPV BV (Fig. 1). On 
Western blots treated with pre-immune serum, no proteins of 64 kDa were detected from 
BV, infected cells, or uninfected cells, although two minor cross-reacting proteins of 
lower molecular weight were detected in infected cells (Fig. 1, lane 1). In Western blots 
treated with the anti-GP64 EFP PAs, a 64 kDa protein corresponding to the 64 kDa 
GP64 EFP was detected in infected cells and from purified BV (Fig. 1, lanes 4 and 5). 
The identity of the reactive band was confirmed on parallel blots using the well-
characterized anti-GP64 EFP MAb, AcV5 (9, 97) (data not shown). The anti-GP64 EFP 
PAs was also used to immunoprecipitate native GP64 EFP. Uninfected and infected L. 
dispar cells were metabolically labeled with 35S-methionine for 14 hours, and proteins 
were immunoprecipitated with either the anti-GP64 EFP PAs or pre-immune serum. A 
64 kDa protein was immunoprecipitated from infected L. dispar cells (Fig. 1, lane 11), 
but not from uninfected cells or when pre-immune serum was used (Fig. 1, lanes 8 and 
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FIG. 1. Specificity of the anti-GP64 EFP polyclonal antiserum. An anti-GP64 EFP polyclonal 
antiserum (anti-GP64) was generated from a MBP-EFP fusion expressed in E. coli (see Materials and 
Methods). Specificity of the anti-GP64 EFP PAs was examined by Western blot analysis (panel A) and 
immunoprecipitation (panel B). (A) Western blot analysis of protein from uninfected and infected L dispar 
cells, and purified budded virions (BV). Sources of proteins are indicated immediately above each lane. The 
left panel (lanes 1 to 3) shows reactivity of pre-immune serum (pre-lmm.) and the right panel (lanes 4 to 6) 
shows reactivity of anti-GP64 EFP polyclonal antiserum (anti-GP64). The location of GP64 EFP, as 
determined by incubation of similar blots with monoclonal antibody AcV5, is indicated by an arrowhead on 
the left of each blot. (B) Immunoprecipitation analysis of anti-GP64 EFP antiserum. Uninfected and infected 
L. dispar cells were metabolically labeled with 35S-methionine for 14 hr, then lysed and immunoprecipitated 
with either anti-GP64 EFP polyclonal antiserum (anti-GP64; lanes 8 and 11), pre-immune serum (pre-lmm.; 
lanes 7 and 10), or with no serum (Staph A; lanes 9 and 12). Infected cells were prepared at 40 hr p.i. The 
location of GP64 EFP is indicated by an arrowhead on the left. The positions and sizes of marker proteins 
(M) are indicate on the right. 
10, respectively). Because the anti-GP64 EFP PAs reacted with denatured and reduced 
forms of GP64 EFP on Western blots, and also immunoprecipitated non-denatured 
GP64 EFP from infected cells, these data indicate that the anti-GP64 EFP PAs has a 
broad specificity for both native and denatured forms of the protein. 
GP64 EFP synthesis early and late in infection. To examine the relative rate of 
GP64 EFP synthesis during various periods of the infection cycle, L. dispar cells were 
infected at an m.o.i. of 20, then metabolically labeled with 35S for 2-hr periods between 0 
and 120 hr p.i. At the end of each 2-hr labeling period, GP64 EFP was 
immunoprecipitated from cell lysates with anti-GP64 EFP PAs (Fig. 2). GP64 EFP was 
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detected at a relatively low level during the first time period examined (Fig. 2A, 0-2 hr 
p.i.), indicating either a low level of synthesis over the entire 2 hr period or the onset of 
synthesis within this period. However, by 6 hr p.i., GP64 EFP synthesis had increased 
dramatically, as evidenced by a more than 6-fold increase in the quantity of GP64 EFP 
detected during that period (Fig. 2A, 2B; 0-2 vs. 6-8 hr p.i.). Peak rates of early phase 
expression were observed in the periods of 12-14 and 18-20 hr p.i.. The highest overall 
rate of synthesis was detected in the 24-26 hr p.i. period, a time immediately after late 
transcription of the GP64 EFP begins (9). The rate of GP64 EFP synthesis decreased 
gradually between 36 and 72 hr p.i. and low but detectable GP64 EFP synthesis was 
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FIG. 2. Relative rate of GP64 EFP synthesis in infected L. dispar cells. (A) L. dispar cells were 
infected with OpMNPV at an m.o.i. of 20, and metabolically labeled with 35S-methionine for 2-hr periods 
(indicated above the lanes) between 0 and 122 hr p.i. At the end of each 2-hr labeling period, GP64 EFP 
was immunoprecipitated, denatured in the presence of 6-mercaptoethanol and electrophoresed on a 9% 
SDS-PAGE gel. A control immunoprecipitation from uninfected 2-hr pulse labeled cells is shown in the first 
lane (mock). The location of GP64 EFP is indicated by a bar on the left of the panel. Closed circles indicate 
the different size classes of immunoprecipitated GP64 EFP. (B) Quantitative analysis of 
immunoprecipitated GP64 EFP. Relative band intensities, as measured by phosphorimager analysis 
(Molecular Dynamics, Inc) are indicated as a percentage of the maximal rate of GP64 EFP synthesis (Y-axis) 
and are plotted as a function of the 2-hr labeling periods (X-axis). Early, late, and very late phases of the 
infection cycle are indicated above the graph. 
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observed in the 72-74 and 96-98 hr p.i. periods. The extremely low levels of GP64 EFP 
synthesis detected at 120 hr p.i. may result from cellular lysis at this late stage of 
infection. Some cellular lysis was observed by light microscopy at 120 hr p.i., but not at 
the earlier time periods examined (data not shown). With a plateau in the early phase 
and a peak observed after the late phase begins (Fig. 2B), the rates of OpMNPV GP64 
EFP synthesis correlate well with the known transcriptional regulation of the gp64 efp 
gene. It is likely that the plateau in rate of GP64 EFP synthesis between the 12-14 and 
18-20 hr p.i. periods results from maximal steady state levels of accumulated GP64 EFP 
early mRNAs. The further increase in the rate of GP64 EFP synthesis observed between 
the 18-20 and 24-26 hr p.i. periods likely results from increased levels of GP64 EFP 
mRNA produced from the late promoter, as late transcripts are first detected at 24 hr p.i. 
(9). In most 2-hr periods examined, the detected GP64 EFP consisted of 3-4 distinct size 
classes (Fig. 2A, filled circles). Because the labeling periods were long (2 hr), the 
multiple sizes of GP64 EFP detected may likely represent GP64 EFP in various states of 
glycosylation and processing (see below). 
Oligomeric structure. Like many other viral membrane proteins, the baculovirus 
GP64 EFP is present in the virion and functions as an oligomer. However, little 
information is available on the oligomeric structure of GP64 EFP. GP64 EFP forms 
disulfide-bonded oligomers that migrate at positions equivalent to approximately 172 
and 229 kDa (based on linear non-disulfide bonded marker proteins) on non-reducing 
SDS-PAGE gels (260). Because these sizes correspond approximately to homotrimers 
and homotetramers of GP64 EFP, and the presence of both forms would be unusual, we 
used a soluble form of GP64 EFP to more closely examine its oligomeric structure. For 
these studies, we produced a recombinant AcMNPV baculovirus (EFPS0|C2) that 
expresses a soluble form of the OpMNPV GP64 EFP (GP64 EFP30'). A stop codon was 
inserted after codon 477 (of the OpMNPV gp64 efp ORF), which is immediately 
upstream of the predicted transmembrane domain and predicted acylation site. GP64 
EFP50' was collected from supernatants of cells infected with EFPsolC2 and purified as 
described (see Materials and Methods). In reduced samples, the size of secreted GP64 
EFPso1 corresponded to the predicted size of mature GP64 EFP without the C-terminal 
32 amino acids (data not shown). On non-reducing gels, GP64 EFPso1 showed a 
migration pattern similar to native GP64 EFP from purified OpMNPV BV, appearing as 
two major high molecular weight bands (Fig. 3C). To examine a possible difference 
between the two observed bands in more detail, purified GP64 EFPso1 was fractionated 
by gel filtration chromatography, and fractions were analyzed by electrophoresis on 
non-reducing SDS-PAGE gels. On S400 gel filtration columns, GP64 EFPso1 eluted as a 
single peak centered at an estimated mass of approximately 200 kDa (Fig. 3A). Analysis 
of multiple fractions across the single peak by non-reducing gel electrophoresis and 
Coomassie blue staining showed that both high molecular weight bands of GP64 EFPso1 
were represented in all fractions from this peak (Fig. 3B). In addition, the ratio of protein 
in the 2 bands (quantitated by densitometric scanning) did not vary significantly across 
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FIG. 3. Physical analysis of the oligomeric structure of a purified, soluble form of GP64 EFP (GP64 
EFPso1). A soluble form of OpMNPV GP64 EFP, expressed from a recombinant baculovirus, was used for 
physical studies of the oligomeric state of GP64 EFP using gel filtration chromatography, non-reducing 
SDS-PAGE, and mass spectrometry. (A) The elution profile of GP64 EFPst" obtained from S400 gel filtration 
chromatography is illustrated. Absorbance at 280 nm is shown on the Y-axis, and 14 fractions collected from 
the single broad GP64 EFPscl peak are indicated on the X-axis. Three peak fractions selected and pooled for 
further analysis are indicated by a thick line above and below the peak. (B) Fourteen fractions (lanes 1-14) 
from the major peak of GP64 EFP50' isolated by S400 column chromatography (panel A) were 
electrophoresed on a non-reducing SDS-PAGE and stained with Coomassie blue. Three fractions selected 
and pooled for analysis by mass spectrometry are indicated by a thick line above lanes 4-6, and correspond 
to peak fractions indicated in panel A. The two protein bands are identified as I and II. (C) The S400 purified 
GP64 EFPso1 and wt GP64 EFP were compared on non-reducing SDS-PAGE. GP64 EFP was identified by 
Western blot analysis, using monoclonal antibody AcV5. The two major GP64 EFP bands are identified as I 
and II. The migrations of reduced protein markers on the same gel are shown on the right. (D) Matrix-
assisted laser desorption/ionization mass spectrum of a >98% pure preparation of oligomeric GP64 EFPso1. 
The measured molecular mass of 175.933 kDa represents the mass of oligomeric GP64 EFP50' with one 
attached proton ([GP64 EFPS°']+) and corresponds to a trimeric species. A second peak (88.860 kDa, 
[GP64 EFPsol]2+) represents a doubly protonated form of the trimer. Mass-to-charge ratios (m/z) x 10"3 are 
indicated along the X-axis and signal intensity is indicated on the Y-axis. 
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the peak (data not shown). Analysis by gel filtration therefore suggested that the two 
bands detected on non-reducing SDS-PAGE do not differ in molecular mass. To 
determine whether the two bands observed on non-reducing SDS-PAGE corresponded 
to oligomeric proteins composed of different numbers of subunits, a >98% pure 
preparation of GP64 EFPso1, containing both bands (Fig. 3B, lanes 4 to 6, pooled), was 
analyzed by MALDI-TOF mass spectrometry. Data from the mass spectrometry analysis 
showed that the largest singly-charged species of GP64 EFPso1 has an approximate 
molecular mass of 175.9 kDa (Fig. 3D, [GP64 EFPsol]+, filled arrowhead). The mass-to-
charge (m/z) ratio of the doubly-protonated species (Fig. 3D, [GP64 EFPS0|]2+, open 
arrowhead) also agrees closely, (within approximately 1%) with this mass 
measurement. Because N-terminal amino acid sequencing of GP64 EFPS°' showed that 
the mature peptide backbone begins at amino acid 18 (Ala18, (87)), the molecular mass 
of monomeric, unglycosylated GP64 EFPso1 is predicted (from the amino acid sequence) 
to be 52.525 kDa. Since mature GP64 EFP801 contains approximately 6-8 kDa of 
carbohydrate per monomer (determined by endoglycosidase treatment, data not 
shown), the mass determination by mass spectrometry corresponds to a homo-trimeric 
form of GP64 EFPso1 (3x[52.525+6] = 175.6 kDa). As no larger species were detected by 
mass spectrometry, there is no evidence for the presence of a tetrameric form in this 
preparation. Thus, the analysis of oligomeric GP64 EFP50' by gel filtration and mass 
spectrometry indicates that the largest oligomeric form of GP64 EFP50' is trimeric. Based 
on these data, the two major forms of GP64 EFP and GP64 EFP80' detected on non-
reducing SDS-PAGE gels (Fig. 3C) are designated trimer I and trimer II. 
Oligomerization and processing in infected cells. To examine oligomerization 
and processing of GP64 EFP in different phases of the infection cycle, pulse-chase 
experiments were performed at both early (12 hr p.i.) and late (36 hr p.i.) times post 
infection. Infected cells were pulse labeled for 5 min with 35S-methionine, and chased 
with unlabeled amino acids for times ranging from 0 to 300 min. To examine the 
oligomerization state, GP64 EFP was immunoprecipitated after pulse-chase and 
examined on SDS-PAGE gels under reducing and non-reducing conditions. 
Oligomeric forms of GP64 EFP consisted primarily of the two trimer forms (Fig. 
4A, trimer I, II). Based on migration in non-reducing gels, a small amount of apparently 
dimeric GP64 EFP was also detected (Fig. 4A, dimer). Oligomeric GP64 EFP was 
detected immediately after the 5 min pulse period, indicating that oligomerization occurs 
very rapidly (Fig. 4, lane 2, trimer I, II). At this time (0 min chase), the monomeric form 
accounted for approximately 74% of the total GP64 EFP detected (Fig. 4A, lane 2, trimer 
I, II vs. monomer). Levels of oligomeric GP64 EFP increased slightly with extended 
chase times, and the largest quantity of oligomeric GP64 EFP was detected after a 10 
min chase (Fig. 4A, lane 3, trimer I, II). Between 0 and 45 min chase the amount of total 
detectable GP64 EFP decreased substantially (approximately 67%) (Fig. 4A and 4B, 
lanes 2 vs. 6). Because DNA replication and budding of progeny virus have not yet 
occurred at 12 hr p.i. (13), this approximately 67% decrease in detection of GP64 EFP 
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FIG. 4. Oligomerization and processing of GP64 EFP in OpMNPV infected L. dispar cells at 12 hr 
p.L L cfepar cells were infected at an m.o.i. of 20. At 12 hr p.i. cells were pulse labeled for 5 min with 3 5 S -
methionine, then chased with unlabeled medium. GP64 EFP was immunoprecipitated at various time points 
between 0 and 300 min chase. Immunoprecipitates were divided into equal portions and examined under 
non-reducing (Panel A) and reducing (Panel B) conditions. (A) Analysis of GP64 EFP under non-reducing 
conditions. Immunoprecipitated GP64 EFP was boiled in the presence of 37.5 mM IAA and 
electrophoresed on a 6% SDS-polyacrylamide gel. Numbers above the lanes represent chase times (min) at 
which GP64 EFP was immunoprecipitated. Lane 1 and 14 (mock) are immunoprecipitates from uninfected 
cells, pulse labeled and chased for 0 and 300 min, respectively. The positions and sizes of linear (reduced) 
protein markers are indicated on the right. On the left the positions of different oligomerization products of 
GP64 EFP are indicated (Trimer I, Trimer II, Dimer, Monomer). The two closed circles in Panel A indicate the 
migrations of pre-processed and processed forms of GP64 EFP Trimer II. (B) Analysis of GP64 EFP under 
reducing conditions. Immunoprecipitated GP64 EFP was boiled in the presence of 5% G-mercaptoethanol 
and electrophoresed on a 9% SDS-polyacrylamide gel. The lanes correspond to those directly above on 
the non-reducing gel, and the position of a marker protein is indicated on the right. 
was not due to loss of surface GP64 EFP through viral budding. On non-reducing gels, 
the decrease in total GP64 EFP detected between 0 and 45 min chase was due 
primarily to a loss of monomeric, not oligomeric GP64 EFP (Fig. 4A, lanes 2-6, 
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monomer). An approximately 86% decrease in monomeric GP64 EFP was detected 
between 0 and 45 min chase. Surprisingly, no equivalent increase in oligomeric GP64 
EFP was observed during the same time, indicating that monomeric GP64 EFP was not 
chased into the oligomeric form. These data therefore suggest that a large proportion of 
the newly synthesized monomeric GP64 EFP is degraded within 30 to 45 min after 
synthesis. Together, these data indicate that, while oligomerization occurs very rapidly 
and is completed in less than 15 min, the efficiency of oligomerization appears to be 
relatively low. Less than 28% of the synthesized GP64 EFP is converted to the trimer 
forms, and the majority of monomeric GP64 EFP appears to be degraded within the cell. 
A change in the migration of the oligomeric forms was observed from 30 to 90 
min chase (Fig. 4A, lanes 5-8, trimer II). A slower migrating trimer II form was 
predominant from 0 to 30 min, whereas a faster migrating form appeared at 45 to 60 min 
and was the primary form at 90 min chase and beyond. This reduction in size was 
observed for all oligomeric forms on non-reducing gels (Fig. 4A, lanes 5-8), and also for 
denatured GP64 EFP on reducing gels (Fig. 4B, lanes 5-8). Mature OpMNPV GP64 EFP 
contains 7 potential sites for N-linked glycosylation in the ectodomain. To determine if 
the observed reduction in size resulted from carbohydrate processing, we examined 
GP64 EFP before the change in migration (15 min chase) and after the change (120 
min chase), using either a) treatments that prevented carbohydrate addition 
(tunicamycin, TM), or b) treatments that removed N-linked carbohydrates 
(endoglycosidase F/N-glycanase F [Endo F], or endoglycosidase H [Endo H]). For 
carbohydrate analysis at 12 hr p.i., cells were pulse labeled for 10 min with 35§. 
methionine, then chased for either 15 min (pre-transition) or 120 min (post-transition), 
Control TM EndoF EndoH 
ChaM(min) 15 120 15 120 15 120 15 120 M 
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FIG. 5. Carbohydrate processing on GP64 EFP. The N-linked carbohydrate content of GP64 EFP 
was examined by pulse chase analysis in combination with an inhibitor (Tunicamycin, TM) and two 
endoglycosidases. OpMNPV infected L. disparcells, at 12 hr p.i., were pulse labeled for 10 min with 35S-
methionine, and subsequently chased in unlabeled medium for 15 or 120 min. After the chase, GP64 EFP 
was immunoprecipitated, reduced by boiling in B-mercaptoethanol, and electrophoresed on a 9% SDS-
polyacrylamide gel. The closed circles in lanes 1 and 2 (control) indicate a shift in size of GP64 EFP between 
15 and 120 min chase. Lanes 3 and 4 represent samples in which tunicamycin (TM) was added to the cells 
before and during the experiment. Lanes 5-8 represent samples treated with either endoglycosidase F/N-
glycanase F (endo F, lanes 5 and 6), or endoglycosidase H (endo H, lanes 7 and 8). Chase times (min) and 
treatments are indicated above the lanes. The migration of a protein size marker (M) is indicated on the right. 
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and immunoprecipitated. Samples were reduced in disruption buffer containing 5% 13-
mercaptoethanol and visualized on an SDS-PAGE gel. At 15 min chase with no 
inhibitors (Fig. 5, lane 1), 3 bands were detected. The majority of the labeled protein 
was present in a central band of approximately 67 kDa (Fig. 5, lane 1, filled circle). By 
120 min chase, the migration of labeled GP64 EFP had changed significantly: the 
majority of labeled GP64 EFP was detected as a faster migrating band of 64 kDa (Fig. 5, 
lane 2, filled circle). This is consistent with earlier observations on reducing gels (Fig. 
4B, lane 4 vs. 9). To compare the molecular weight of reduced GP64 EFP at 15 and 120 
min chase in the absence of N-linked sugars, GP64 EFP proteins were either treated 
with endo F or endo H; or synthesized in the presence of TM. While the sizes of 
untreated GP64 EFP at 15 and 120 min chase differed (Fig. 5, compare lanes 1 and 2), 
treatment with either TM (Fig. 5, lanes 3 and 4) or endo F (Fig. 5, lane 5 and 6) resulted 
in proteins of equal size (approximately 56 kDa for TM, and 58 kDa for endo F 
treatments) at both chase times. Thus, the differences in the size of GP64 EFP at 15 and 
120 min chase resulted from changes in the carbohydrate portions of the glycoprotein. 
The increased mobility at 120 min is therefore likely caused by the processing of 
carbohydrates during the process of transport through the Golgi complex. The 
difference of approximately 2 kDa in GP64 EFP mass between endo F and TM 
treatments presumably results from the fact that TM prevents the transfer of 
oligosaccharides (linked to dolichol phosphate) to protein, whereas endo F cleavage 
results in a residual N-acetyl-D-glucosamine molecule at each glycosylation site. Endo 
H treatment showed results similar to endo F treatment, although a slightly slower 
migrating and more diffuse GP64 EFP band was observed at 120 min chase. This 
indicates that between 15 and 120 min chase, at least a portion of the 7 potential re-
linked carbohydrates are processed to a more complex endo H-resistant form. 
Extensive cellular modifications are associated with viral infection and the 
transition between early and late stages of infection. Therefore, we also examined 
GP64 EFP oligomerization and processing during the late phase of the infection cycle 
(36 hr p.i., Fig. 6), after the initiation of viral DNA replication and late transcription. 
Similar to observations at 12 hr p.i., biosynthesis of GP64 EFP at 36 hr p.i. was followed 
by rapid oligomerization (Fig. 6, lane 2), and degradation of the majority of the 
monomeric GP64 EFP between 0 and 45 min chase (Fig. 6A, monomer, lanes 2-6). 
Carbohydrate processing was also examined at early and late times post infection. In 
contrast to the observations at 12 hr p.i., the period during which processing occurred 
was significantly extended. At 36 hr p.i., processing was extended through 
approximately 150 min chase, when the majority of oligomeric GP64 EFP was detected 
in a more discrete and faster migrating band (Fig. 6A, lanes 5-11, trimer II). To compare 
the kinetics of GP64 EFP carbohydrate processing at 12 and 36 hr p.i., the pre-
processed and processed forms of the GP64 EFP trimer II bands shown in Figures 4A 
and 6A were quantified, and plotted as a function of chase times (Fig. 7). For both 12 
and 36 hr p.i. a decrease in the pre-processed form began between 10 and 20 min 
chase. Thus, the initiation of carbohydrate processing was similar at early and late times 
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FIG. 6. Oligomerization and processing of GP64 EFP in OpMNPV infected L. dispar cells at 36 hr 
p.L L. disparceWs were infected at an m.o.i. of 20. At 36 hr p.i. cells were pulse labeled for 5 min with ^5$. 
methionine, then chased with unlabeled medium. GP64 EFP was immunoprecipitated at various time points 
between 0 and 300 min chase. Immunoprecipitates were divided into equal portions and examined under 
non-reducing (Panel A) and reducing (Panel B) conditions. (A) Analysis of GP64 EFP under non-reducing 
conditions. Immunoprecipitated GP64 EFP was boiled in the presence of 37.5 mM IAA and 
electrophoresed on a 6% SDS-polyacrylamide gel. Numbers above the lanes represent chase times (min) at 
which GP64 EFP was immunoprecipitated. Lane 1 and 14 (mock) are immunoprecipitates from uninfected 
cells, pulse labeled and chased for 0 and 300 min, respectively. The positions and sizes of linear (reduced) 
protein markers are indicated on the right. On the left the positions of different oligomerization products of 
GP64 EFP are indicated (Trimer I, Trimer II, Dimer, Monomer). The two closed circles in Panel A indicate the 
migrations of pre-processed and processed forms of GP64 EFP Trimer II. (B) Analysis of GP64 EFP under 
reducing conditions. Immunoprecipitated GP64 EFP was boiled in the presence of 5% R-mercaptoethanol 
and electrophoresed on a 9% SDS-polyacrylamide gel. Lanes correspond to those directly above on the 
non-reducing gel, and the position of a marker protein is indicated on the right. 
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FIG. 7. Processing of GP64 EFP at early (12 hr p.i., upper panel) and late (36 hr p.i., lower panel) 
times post infection. The quantities of pre-processed and processed forms of GP64 EFP trimer II, as 
detected in Fig. 4A and 6A (12 hr p.i. and 36 hr p.i., respectively) by phosphorimager analysis, are 
graphically illustrated. Relative band intensities (Intensity) are indicated on the Y-axis, and chase times (min) 
are indicated on the X-axis. The slower migrating pre-processed form of GP64 EFP Trimer II is indicated by a 
solid line and the processed form is indicated by a dashed line in each graph. 
post infection. However, early and late phases differed with respect to how rapidly 
processing was completed. In the early phase (12 hr p.i.), maximal levels of processed 
GP64 EFP were detected by 90 min chase, indicating that the half-time for carbohydrate 
processing was approximately 45 min. In the late phase (36 hr p.i.), near maximal levels 
of processed GP64 EFP were observed only after 150 min, indicating that the half-time 
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for processing was approximately 75 min. This increase in the half-time required for 
carbohydrate processing suggests that processing of carbohydrates may become less 
efficient in the late phase of the infection cycle. 
Discussion 
Synthesis. GP64 EFP is critical for infectivity of the BV, which mediates the 
systemic portion of baculovirus infections in insects. Although it has been shown that 
GP64 EFP is expressed early in infection (Fig. 2) (9, 13, 112), the precise role of GP64 
EFP expressed during the first few hours after infection is not known. Studies showing 
BV budding from the basal side of midgut epithelial cells within 0.5 hr of infection (74, 
76) suggest that one possible role of early GP64 EFP expression may be the rapid 
production of BV from midgut cells prior to DNA replication. Thus, early expression of 
GP64 EFP may support rapid movement of the virus through the midgut epithelium. 
Expression of GP64 EFP is driven by both early and late promoters. In combination with 
transcription data from a previous study (9), data from pulse labeling experiments (Fig. 
2) show that early gp64 efp transcription results in increasing rates of GP64 EFP 
synthesis between 0 and 12 hr p.i., and a plateau in the rate of synthesis between 12 
and 18 hr p.i.. This early phase plateau in the rate of GP64 EFP synthesis is followed by 
a further increase in synthesis between 18 and 24 hr p.i.. Transcription from gp64 efp 
late promoters is first detected at approximately 24 hr p.i. (9) and this correlates well 
with data showing that the maximal rate of GP64 EFP synthesis is observed at 
approximately 24-26 hr p.i. (Fig. 2). The initiation of late transcription also marks the 
beginning of BV production. GP64 EFP synthesis decreased substantially by 48 hr p.i., 
and this likely resulted from lower steady state levels of GP64 EFP mRNA at that time 
(9). Preliminary experiments utilizing long (4 hr) pulse labeling periods, followed by 
GP64 EFP immunoprecipitation from culture supematants (data not shown) indicate that 
decreased synthesis and not virion budding is responsible for decreased levels of 
GP64 EFP detected in the late phase in the experiment in Fig. 2. GP64 EFP synthesis 
decreases further between 48-72 hr p.i. and remains at a relatively low level throughout 
the remainder of the infection cycle. The decreased synthesis of GP64 EFP at 48 hr p.i. 
appears to be coordinated with the onset of the very late phase of infection, which is 
characterized by high level synthesis of structural proteins of the occlusion body. In a 
previous study of OpMNPV infected L. dispar cells, capsid protein (P39, a late gene 
product) was first detected at 36 hr p.i., while polyhedrin (a very late gene product) was 
first detected at 48 hr p.i. (13). Thus, GP64 EFP synthesis is highest in the late phase, 
and decreases but does not cease in the very late phase. These observations of GP64 
EFP synthesis correlate well with the observation that in OpMNPV infected L. dispar 
cells, BV production reaches maximal levels between 24 and 48 hr p.i. and remains 
high between 48 and 96 hr p.i. (13). 
31 
Oligomeric structure. Previous studies demonstrated that GP64 EFP of AcMNPV 
was present in the BV envelope as homo-oligomers in which the subunits were 
associated by disulfide bonds (260). Similar to the AcMNPV protein, oligomers of 
OpMNPV GP64 EFP show resistance to boiling in 8% SDS (Fig. 4, upper panel), but 
dissociate into monomers in the presence of a reducing agent (5% 13-mercaptoethanol) 
(Fig. 4B). These data demonstrate that, in addition to very high conservation of primary 
amino acid sequence, the AcMNPV and OpMNPV GP64 EFP proteins oligomerize in a 
similar, if not identical, manner. Based on migrations in non-reducing gels, it was 
initially proposed that GP64 EFP oligomers might consist of trimers and tetramers (260). 
In order to study the oligomeric structure of GP64 EFP, we produced a highly purified 
soluble form of OpMNPV GP64 EFP (GP64 EFPso1), and showed that GP64 EFPso1 was 
oligomerized in a manner similar to native GP64 EFP. On non-reducing SDS-PAGE, 
migration patterns of GP64 EFPso1 were identical to those of GP64 EFP from budded 
virions (Fig. 3C). Physical analysis of purified, oligomeric GP64 EFPso1 by gel filtration 
and mass spectrometry (Fig. 3) showed that its mass corresponds to a trimeric form. 
Thus, the two high molecular weight bands detected on non-reducing gels (Fig. 3C, 4A, 
6A) both represent trimeric GP64 EFP. One possible explanation for the migration of 
trimeric GP64 EFP as two species on non-reducing gels is the presence of disulfide 
isomers. Since the OpMNPV GP64 EFP contains 16 cysteine residues and may be 
extensively disulfide bonded, differential migrations in non-reducing gels may result 
from differential patterns of disulfide bonding during synthesis or folding of the 
individual GP64 EFP chains, or during oligomerization. 
Kinetics of oligomerization. Protein folding is an event that typically occurs 
cotranslationally. In contrast, the process of oligomerization commonly takes place 
posttranslationally inside the ER (106). The kinetics of oligomerization can differ 
significantly between various membrane proteins (43, 106). Pulse-chase analysis of 
GP64 EFP shows that oligomerization is complete or near-complete within 15 min, a 
timing that is relatively rapid and similar to that of the hemagglutinin protein of Influenza 
virus and VSV-G protein (29, 42), other homo-trimeric fusion proteins. Subunit 
concentration and complexity are factors that may influence the rate of oligomerization 
(107). GP64 EFP can be considered non-complex with respect to assembly, since 
trimers of GP64 EFP are assembled from identical subunits. While GP64 EFP is 
oligomerized rapidly, the efficiency of this process is very low. Less than 28% of the 
synthesized GP64 EFP reaches the trimeric state. In most cases, oligomeric membrane 
proteins must assemble in order to become transport-competent (106). Although the 
requirement of oligomerization for transport is not universal, monomers of oligomeric 
viral membrane proteins are often restricted to the ER (30). In the case of GP64 EFP, it is 
likely that monomeric forms are not transported to the cell surface. Evidence for this 
includes the fact that GP64 EFP found in the virion is predominantly, if not exclusively, in 
the trimeric form. In addition, recent studies of GP64 EFP proteins containing mutations 
that interfere with oligomerization showed that these mutant proteins failed to 
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accumulate normally at the cell surface (171), indicating that oligomerization deficient 
GP64 EFP proteins were also transport deficient. It is therefore likely that the majority of 
monomeric GP64 EFP detected in pulse chase experiments, represents a fraction that is 
either misfolded or unable to oligomerize and is subsequently degraded within the cell. 
Thus GP64 EFP appears to be highly sensitive to misfolding and/or oligomerization 
defects and the low natural efficiency of oligomerization results in a low efficiency of 
synthesis of the mature, functional protein. 
Glycosylation and carbohydrate processing. Glycosylation of GP64 EFP appears 
to occur cotranslationally, since proteins migrating at the size of unglycosylated (TM 
treated) GP64 EFP were not detected in pulse-chase experiments (Fig. 4, 5, and 6). 
Processing of carbohydrates was detected as a change in the mobility of oligomerized 
GP64 EFP, beginning within 10 to 20 min after synthesis (Fig. 4 and 6). This 
carbohydrate processing probably occurs within the Golgi compartment, since most 
carbohydrate processing events are mediated by Golgi-associated enzymes (136). 
Changes in carbohydrate presence or content may affect the stability or conformation of 
glycoproteins, and thus may be a possible explanation for the diffuse nature of the 
GP64 EFP-oligomer bands in non-reducing gels during the period of carbohydrate 
processing (Fig 4, lanes 6 and 7; Fig. 6, lanes 5-10). At both 12 and 36 hr p.i., the 
amount of the pre-processed trimer II begins to decrease within 10-20 min chase, and 
thus the beginning of carbohydrate processing does not appear to be affected by the 
phase of infection. However, early and late phases differ with respect to how rapidly 
processing is completed. At 12 hr p.i. near maximal quantities of processed GP64 EFP 
were detected at 90 min chase, whereas at 36 hr p.i., near maximal levels of processed 
GP64 EFP were not observed until 150 min chase. This difference in the time required 
to complete processing suggests that processing of carbohydrates is more efficient at 
12 hr than at 36 hr p.i., possibly reflecting a reduction in the cell's capacity to process 
carbohydrates at later times post infection. We do not know when, in the process of 
maturation, GP64 EFP appears on the surface of a cell, or which factors determine the 
speed and efficiency of this process. However, relative to carbohydrate addition and 
oligomerization of subunits, carbohydrate processing appears to be a slow process and 
may be the rate-limiting step in the process of GP64 EFP maturation and transport. 
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Chapter 3 
The GP64 envelope fusion protein is an essential baculovirus 
protein required for cell to cell transmission of infection 
Abstract 
To demonstrate the essential nature of the baculovirus GP64 Envelope Fusion Protein 
(GP64 EFP), and to further examine the role of this protein in infection, we inactivated the gp64 
gene of Autographa californica Multicapsid Nuclear Polyhedrosis virus (AcMNPV), and examined 
the biological properties of this virus In vivo. To provide GP64 EFP during construction of the 
recombinant GP64 EFP-null AcMNPV baculovirus, we first generated a stably transfected insect 
cell line (Sf90p646) that constitutively expressed the GP64 EFP of Orgyia pseudotsugata MNPV 
(OpMNPV). The AcMNPV gp64 gene was inactivated by inserting the bacterial lacZ gene in frame 
after codon 131 of the gp64 gene. The inactivated gp64 gene was cloned into the AcMNPV viral 
genome by replacement of the wild-type gp64 locus. When propagated in the stably transfected 
insect cells (Sf90p64~6), budded virions produced by the recombinant AcMNPV GP64 EFP-null virus 
(vAc64Z) contained OpMNPV GP64 EFP supplied by the Sf90p64"6 cells. Virions propagated in 
Sfgop646 ce||s w e r e ^pal-jig 0f jnfecting wild-type Sf9 cells, and cells infected by vAc64Z exhibited a 
blue phenotype in the presence of X-gal. Using cytochemical staining to detect vAc64Z infected 
cells, we demonstrate that this GP64 EFP-null virus is defective for cell to cell propagation in cell 
culture. Although defective for cell to cell propagation, vAc64Z produces occlusion bodies and 
infectious occlusion derived virions within the nucleus. Occlusion bodies collected from cells 
infected by vAc64Z were infectious to midgut epithelial cells of Trichoplusia ni larvae. However, in 
contrast to a control virus, infection by vAc64Z did not proceed into the hemocoel. Analysis of vAc64Z 
occlusion bodies in a standard neonate droplet feeding assay showed no viral-induced mortality, 
indicating that occluded virions produced from vAc64Z could not initiate a productive (lethal) infection 
in neonate larvae. Thus, GP64 EFP is an essential virion structural protein that is required for 
propagation of the budded virus from cell to cell and for systemic infection of the host insect. 
This chapter has been published as: 
Monsma, Scott A., A.G.P. Oomens and Gary W. Blissard (1996). The GP64 envelope fusion protein is an 
essential baculovirus protein required for cell to cell transmission of infection. Journal of Virology 70 (7), 
4607-4616 
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Introduction 
Baculoviruses are large double stranded DNA viruses that are pathogens of 
insects. Infection of the host begins when insect larvae acquire the virus orally. Infection 
is first observed in the epithelial cells of the midgut and is followed in most cases by 
systemic infection. One hallmark of the baculovirus infection cycle is the production of 
two structurally and functionally distinct virion phenotypes. One virion phenotype, the 
occlusion derived virus (ODV), is found within the protective "occlusion bodies". Once 
released from the occlusion body by the alkaline pH of the gut, the ODV initiates 
infection of the animal by infecting epithelial cells of the midgut. A second virion 
phenotype, the budded virus (BV), is produced by budding from the surface of infected 
cells. The BV is initially produced from infected midgut epithelial cells (74, 127) and is 
believed to be essential for systemic infection, mediating movement of the virus from 
midgut to other tissues and propagating the infection from cell to cell within the infected 
animal. BV are highly infectious to tissues of the hemocoel and to cultured cells, 
whereas ODV appear to be less infectious in cell culture or when injected into the 
hemocoel (265, 266). The two virion phenotypes also differ in entry mechanisms, as the 
BV enter cells via endocytosis (261), while the ODV appear to fuse directly with the 
plasma membrane at the cell surface (74, 99). 
The major envelope protein of the BV is the GP64 Envelope Fusion Protein 
(GP64 EFP, also known as GP67), which is an extensively processed type I integral 
membrane glycoprotein that has been studied in some detail (10, 25, 112, 171, 184, 
206, 207, 260, 262, 273). Densely packed peplomers found on the surface of BV are 
believed to be composed of the GP64 EFP protein (264) and these peplomers are 
acquired by the virion during budding. Recent studies of a soluble form of GP64 EFP 
indicate that the native form of GP64 EFP is trimeric (184) and thus, each peplomer is 
likely comprised of a single trimer of GP64 EFP. The important role of GP64 EFP in BV 
infectivity BV is demonstrated by the neutralization of BV infectivity with antibodies 
specific to GP64 EFP (97, 171, 206, 264). Using syncytium formation assays and cells 
expressing GP64 EFP, it was shown that the GP64 EFP protein is both necessary and 
sufficient for low pH activated membrane fusion activity (10, 171). In addition, two 
functional domains have been identified in GP64 EFP: an oligomerization domain 
necessary for trimerization and transport, and a small internal hydrophobic membrane 
fusion domain (171). Thus, functional studies of GP64 EFP show that GP64 EFP 
mediates membrane fusion in a pH dependent manner, consistent with an essential 
role for GP64 EFP during viral entry by endocytosis. 
While indirect data on the role of GP64 EFP in the infection cycle strongly 
suggest that GP64 EFP is essential for infectivity of the BV, conclusive data have been 
lacking. No temperature sensitive mutants in the GP64 EFP gene are known, and 
previous attempts to generate a helper-independent virus containing a GP64 EFP 
deletion were unsuccessful (J. Kuzio, personal communication). To demonstrate the 
essential nature of GP64 EFP and to further characterize the role of GP64 EFP in 
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infection, we generated a stably-transfected cell line that constitutively expresses the 
GP64 EFP of OpMNPV, and used the cell line to generate a recombinant GP64 EFP-
null AcMNPV baculovirus. We then examined the effect of the GP64 EFP-null mutation 
on viral transmission in both cell culture and insect larvae. 
Materials and methods 
Cells, insects and antibodies. For production of stably transfected cell lines and 
propagation of AcMNPV, Spodoptera frugiperda Sf9 cells were cultured in TNM-FH 
complete medium containing 10% fetal bovine serum at 27° C (95, 244). For neonate 
and larval bioassays, larvae of Trichoplusia ni were reared as described previously 
(105). Monoclonal antibody AcV5 (97) was used to detect GP64 EFP of both AcMNPV 
and OpMNPV. Monoclonal antibody OpE4A was raised against a purified soluble form 
of OpMNPV GP64 EFP (184). Because OpE4A recognizes both native and denatured 
forms of OpMNPV GP64 EFP, and does not cross react with GP64 EFP of AcMNPV, 
OpE4A was used to distinguish between OpMNPV and AcMNPV GP64 EFP. 
Monoclonal antibody MAb 39 (274) was used to detect the AcMNPV capsid protein, 
P39. A commercially available anti-B-galactosidase monoclonal antibody (Promega) 
was used to detect the GP64-(3-galactosidase fusion protein. A rabbit polyclonal 
antiserum was generated against a soluble form of OpMNPV GP64 EFP (GP64 EFPso1) 
that was expressed and purified as previously described (184). The anti-GP64 EFPso1 
antiserum reacts with both SDS-denatured and native GP64 EFPs of both OpMNPV 
and AcMNPV. 
Virus preparation. Viral DNA used for the generation of recombinant viruses was 
prepared from the E2 strain of AcMNPV (232) by standard methods (177). For 
production of budded virus (BV) stocks and occlusion bodies of the wild type and 
recombinant viruses, cells (Sf9 or Sf9 , see below) were infected at a multiplicity of 
infection (MOI) of 0.1 and incubated at 27° C for 5 to 7 days. Supernatants were 
harvested and titered by end-point dilution. The recombinant AcMNPV virus lacking 
gp64 expression was titered on the Sf9 cells, and the wild type AcMNPV virus and 
recombinant virus vAc s were titered on Sf9 cells. Occlusion bodies were purified from 
infected cells by sequential washing with 0.5 % SDS, 0.5 M NaCI and distilled water as 
described previously (177). For analysis of budded virion structural proteins, budded 
virions were isolated from viral stocks by pelleting through a 25% sucrose pad followed 
by centrifugation on 25%-60% sucrose gradients (177). The budded virus band was 
collected, diluted in PBS pH 6.2, pelleted and resuspended in SDS lysis buffer for 
SDS-PAGE on 10% acrylamide gels. 
Isolation of stably transfected insect cell lines expressing OpMNPV GP64 EFP. 
To generate stably transfected insect cells, Sf9 cells were transfected with two plasmids. 
One plasmid (p64-166, (10)) encodes the OpMNPV gp64 efp OFF under the control of 
its own 166 bp promoter. The second plasmid (pAc ie1-Neo) encodes a bacterial 
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neomycin resistance gene under the control of the AcMNPV ie1 promoter, and was 
constructed using the approach described by Jarvis et al. (111). Transfection and G418 
selection were performed essentially as described previously (113, 233). Briefly, Sf9 
cells were plated at a density of 1 x 10 cells per well (34 mm diameter). The cells were 
transfected with 2 |xg p64-166 plasmid plus 1 (xg pAc ie1-Neo using calcium phosphate 
precipitation (244). One day after transfection, the cells were replated at low density in 
75 cm2 flasks and maintained for 2 weeks in TNM-FH complete media containing 1 
mg/ml G418 (Geneticin, GIBCO-BRL). During this period, mock-transfected Sf9 control 
cells died due to the G418 selection. The G418-resistant transfected cells were replated 
in TNM-FH complete medium (lacking G418) at low density. Single colonies were 
isolated and transferred to individual wells of a 24 well plate. Isolated lines were 
screened for GP64 EFP expression by cell-surface staining of paraformaldehyde-fixed 
cells using MAb AcV5 and an alkaline phosphatase-conjugated goat-anti-mouse 
secondary antibody. Isolated lines were also screened for GP64 EFP fusion activity 
using a syncytium formation assay (10, 171). 
Quantification and analysis of GP64 EFP expression in stably transfected cell 
lines. To analyze GP64 EFP expression in stably transfected cell lines, we quantified 
the levels of GP64 EFP expressed in stably transfected Sf9 cells, transiently transfected 
Sf9 cells, and AcMNPV infected Sf9 cells, using quantitative enhanced 
chemiluminescence (ECL) Western blots, cell-surface ELISA, and flow cytometry. For all 
three assays, the following cells were analyzed under the following conditions: a) two 
OP64-6 OP64-2 
cell lines (Sf9 and Sf9 ) constitutively expressing OpMNPV GP64 EFP were 
plated at passage number 39, and analyzed at 44 h after plating, b) Sf9 cells 
transfected with plasmid p64-166 (encoding OpMNPV GP64 EFP) at 3.75 u.g plasmid/3 
x 105 cells were analyzed at 44 h post-transfection, c) Sf9 cells infected with AcMNPV 
(MOI 10) were analyzed at 24 h post-infection (pi), and d) Sf9 cells were analyzed at 44 
h after plating as a negative control. Values for this negative control were subracted as 
background in quantitative analysis of CELISA and ECL-Western blots. 
Quantitative ECL-Western blot analyses were performed by comparison of cell 
lysates to a standard dilution series of purified GP64 EFPso1, using MAb AcV5 to detect 
GP64 EFP and GP64 EFPso1. A preparation of GP64 EFPso1 (purity >95% as judged by 
SDS-PAGE and coomassie blue staining) was quantified by absorption at 280 nm. The 
predicted molar extinction coefficient of pure, native GP64 EFPso1 at 280 nm was 
calculated as 77,510 M"1 cm'1 , based on the predicted amino acid content of 14 Cys, 11 
Trp and 11 Tyr residues per molecule (65). The molecular weight of mature GP64 EFP501 
predicted from the amino acid sequence is 52,519 Da (amino acids 18-477 of OpMNPV 
GP64 EFP). To prepare a standard curve, purified GP64 EFP30' was added to Sf9 cell 
lysates in SDS lysis buffer (30,960 cells/20 [i\ lysate) at concentrations of 0.1 ng to 40 
ng GP64 EFPsol/20 u.l lysate (equivalent to 1.3 x 104 to 5 x 106 trimers of GP64 
EFPsol/cell). Triplicate cell samples and standard curve samples were electrophoresed 
on SDS-PAGE gels, blotted to PVDF membranes, and GP64 EFP was detected with 
MAb AcV5 by ECL (Amersham). For quantification of films by densitometry, ECL 
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exposure times were chosen to avoid film saturation. Exposed films were digitized on a 
flat-bed scanner and the ECL signals (below saturation) were quantified using 
Imagequant software (Molecular Dynamics). Quantitative measurements of GP64 EFP 
expression from the samples of infected, transiently transfected, or stably transfected 
cells were performed by comparison of the mean ECL signal to the GP64 EFPS°' 
standard curve. The mean ECL signal from each triplicate cell sample was divided by 
the estimated number of cells in the sample, determined by counting the cells present in 
triplicate wells of an identically treated replicate plate. Conversion from ng GP64 
EFPsol/cell to trimers/cell used the predicted mass of GP64 EFPso1: (52,519 g/mole)/(6.02 
x 1023 molecules/mole) = 8.72 x 10"20 g/molecule of GP64 EFP30' = 2.62 x 1019 g/trimer of 
GP64 EFP30'. Because both GP64 EFPso1 and GP64 EFP were detected using a 
monoclonal antibody that recognizes a single defined epitope (171) the ECL signal is 
proportional to the number of molecules rather than the mass. 
Relative levels of GP64 EFP localized on the cell surface were determined by a 
previously described whole cell ELISA (CELISA) technique (171) with minor 
modifications. Cells were fixed for 10 minutes at room temperature with 0.5% 
gluteraldehyde in PBS pH 7.4, and surface GP64 EFP was detected using MAb AcV5. 
The mean CELISA signal from each triplicate cell sample was normalized to the 
estimated number of cells per well, as determined above for quantitative ECL analysis. 
To examine variation of GP64 EFP surface density in populations of cells, 
uninfected Sf9 cells, AcMNPV infected Sf9 cells, the stably transfected cell lines, and 
transiently transfected Sf9 cells were analyzed by flow cytometry using anti-GP64 EFPso1 
antiserum. For flow cytometry, cells were gently suspended in TNM-FH complete 
medium containing 0.02% w/v sodium azide (NaN3) and incubated for 20 min at RT. 
Cells (1 x 106 cells/250 uJ) were incubated with anti-GP64 EFP50' antiserum (diluted 
1:20,000 in binding buffer; binding buffer is PBS pH 7.0 containing 1% w/v gelatin and 
0.02% NaN3) for 40 min at RT. After washing twice with PBS-NaN3 (PBS pH 7.0 
containing 0.02% NaN3), the cells were incubated with FITC-conjugated goat-anti-rabbit 
secondary antibody (diluted 1:100 in binding buffer; Pierce). Cells were washed four 
times in PBS-NaN3, and resuspended in 350 |xl PBS-NaN3 for flow cytometry. For each 
cell type, control samples were incubated without antibodies, or with only secondary 
antibody. Fluorescence was analyzed by flow cytometry (EPICS, Coulter Corp.), and 
fluorescence data were collected for 1 x 104 cells from each sample. Dead cells were 
excluded from analysis by gating of the live cell population based on the ratio of forward 
to side scatter. 
Generation of a GP64 EFP-null AcMNPV baculovirus. To construct a transfer 
vector for allelic replacement of the gp64 efp locus of the AcMNPV genome, the 4718 
bp EcoRI-Smal fragment (corresponding to nucleotides 107,326 to 112,043 from the 
EcoRI H fragment (2)) of AcMNPV strain E2 was cloned into the pBS vector 
(Stratagene) to generate the plasmid pAcEcoHASma. This plasmid contains 2327 bp 
upstream of the gp64 efp ORF, the gp64 efp ORF, and 853 bp downstream of the gp64 
efp ORF. To disrupt the AcMNPV gp64 efp gene by insertional mutagenesis, we 
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generated an in-frame fusion between GP64 EFP and and the Escherichia coli lacZ 
gene in an AcMNPV GP64 EFP expression plasmid pAcNru(BKH). The pAcNru(BKH) 
expression plasmid contains an 18 bp in-frame linker encoding unique Bgl\\, Kpn\ and 
Hind\\\ restriction sites, inserted at the Nru\ restriction site within the gp64 efp ORF of 
plasmid p166B+1 Ac Spe/Bgl (171). A 3072 bp BamH\ fragment containing the lacZ 
ORF (derived from pMC1871, (22) was subcloned into BglU digested pAcNru(BKH). The 
resulting construct (pAcNru(lacZ)) contains a GP64-lacZ fusion after codon 131 of gp64 
efp (4, 43), and the fusion gene open reading frame terminates at the end of the lacZ 
insertion. The 3447 bp Bsml/Sacll fragment of pAcNru(lacZ) (containing the lacZ 
cassette and the flanking portions of gp64 efp) was subcloned into Bsml/Sacll digested 
pAcEcoHASma, to generate plasmid pAcGP64Z (Fig. 2A). Finally, to ensure inactivation 
of the gp64 efp gene, the downstream portion of the gp64 efp ORF was truncated by 
digesting pAcGP64Z with A/col, removing the resulting 54 bp Nco\-Nco\ fragment, then 
blunting and religating to generate pAcGP64ZANco. This deletion results in a frame shift 
mutation and terminates the gp64 efp open reading frame after codon 452, 30 codons 
upstream of the predicted transmembrane domain. Recombinant viruses were 
generated using standard protocols (177), by cotransfecting viral DNA from wild-type 
AcMNPV strain E2 and pAcGP64ZANco plasmid DNA into the GP64 EFP expressing 
Sf9 cells. A recombinant virus (vAc ) was isolated from culture supernatant by 
plaque purification on Sf9 cells, using X-gal in the agarose overlay to identify the 
recombinant plaques. 
64Z 
The structure of the gp64 efp locus in vAc was analyzed by PCR amplification 
and restriction mapping. DNA was extracted from infected Sf9 cells at 24 h pi, or viral 
DNA was isolated from BV pelleted through a 25% sucrose cushion (177). For PCR 
analysis, the following primers homologous to the 5' and 3' ends of the gp64 efp ORF 
were used (Fig. 2A): GB111, 5'-GAGCTGATCGACCGTTGGGG-3' and GB152, 5'-
CGGTTTCTGATCATACAGTACA-3'. To verify the presence of the Ncol deletion in 
64Z 
vAc , PCR amplification was performed using primers flanking the deletion site (Fig. 
2A; GB53, 5'-CCAGCGGCTGGTCGTTTATCGCCC-3' and GB152). 
hsZ For comparisons of infection in Sf9 cells and T. ni larvae, a control virus (vAc ; 
hsZ 
kindly provided by Dr. P. Roelvink) was used. vAc contains the bacterial lacZ gene 
(under the control of the Drosophila hsp70 promoter) in the p10 locus, and lacks a 
functional p 10 gene (vAc s is identical to recombinant virus AcNPV/As3 (256). 
Assays: 
Cell-cell transmission in cell culture. To monitor the cell to cell transmission of 
infection in cell culture, Sf9 cells were infected at MOI 0.1 with vAc or vAc s . After a 1 
h incubation at room temperature, the innoculum was removed and the cells were 
rinsed twice with complete TNM-FH media, then placed in complete TNM-FH media and 
incubated at 27° C. At 20, 48, and 72 h pi, the cells were fixed and stained for B-
galactosidase activity to detect cells infected by the lacZ-marked viruses (247). 
Larval feeding assays. Neonate bioassays were performed by the droplet 
feeding assay (105), using occlusion bodies prepared from either wild type AcMNPV-
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infected Sf9 cells or from vAc -infected Sf9 cells. Occlusion bodies were 
suspended in distilled water, counted in a hemacytometer, then diluted to the indicated 
concentrations in distilled water containing blue food coloring. After droplet feeding, 
larvae that had imbibed were identified by their blue color, and were placed in 
individual cups with artificial diet and maintained at 29° C in darkness. Because a low 
level of non-viral neonate mortality is sometimes observed, larvae that died within the 
first 24 h post-feeding were discarded from analysis. Viral-induced mortality was scored 
at 4 d post-feeding. For late larval bioassays, newly molted 4th instar T. ni larvae were 
starved for 1.5-2 h after molting, then fed occlusion bodies prepared from either vAc 
infected Sf9 cells, or from vAc s infected Sf9 cells. Each larva was fed 1 u1 of a 
suspension containing 1000 occlusion bodies/uJ, 5% w/v sucrose and blue food 
coloring. Larvae were kept in empty cups for 2 h after feeding, then were placed in 
individual cups with artificial diet and maintained at 27° C in darkness. At the indicated 
times post-feeding, larvae were dissected in PBS (pH 7.4) by a single longitudinal 
incision through the dorsal cuticle and pinned to expose the gut and hemocoel. 
Dissected larvae were fixed for 30 min at RT by immersion in 0.01% w/v gluteraldehyde 
and 2% w/v paraformaldehyde in PBS pH 7.4. After fixation, larvae were rinsed 3 times 
for 5 min in PBS (pH 7.4), and stained with X-gal (1 mg/ml) in PBS (pH 7.4) containing 3 
mM K3Fe(CN)6 and 3 mM K4Fe(CN)6 (51). Staining times were typically 2 h at RT (Fig. 5 
panels A, C and D), but were extended to 18 h at RT to verify the lack of systemic 
64Z 
infection with vAc (Fig. 5 panel B). 
Results 
Generation of stably transfected cell lines. Because previous studies using anti-
GP64 EFP antibodies suggested that GP64 EFP might be an essential component of 
budded virions, we used a strategy in which the GP64 EFP protein was provided in 
trans, to complement the inactivation of the gp64 efp gene in the virus. To provide GP64 
EFP in trans, a stably transfected cell line that constitutively expresses the OpMNPV 
GP64 EFP protein was generated by transfection with plasmids encoding GP64 EFP 
and the bacterial neomycin resistance gene, followed by selection for G418 resistance. 
To express the OpMNPV GP64 EFP, we used a GP64 EFP expression plasmid (p64-
166) that contains the OpMNPV gp64 efp ORF under control of an OpMNPV gp64 efp 
early promoter construct that has been studied in detail (6, 8, 132, 133). Transfected Sf9 
cells that were resistant to G418 were selected, and isolated cell lines were established. 
Quantitative analysis of GP64 EFP expression in stably transfected cell line. 
Expression of GP64 EFP from two stably transfected cell lines (Sf9 and Sf9 ) 
was compared to AcMNPV infected Sf9 cells (at 24 h pi), and to transient GP64 EFP 
expression from Sf9 cells transfected with plasmid p64-166 (at 44 h post-transfection) 
(5). For these analyses, we used several quantitative techniques to determine absolute 
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FIG. 1. Expression of GP64 EFP by transiently transfected Sf9 cells (transfected), AcMNPV 
infected Sf9 cells (infected), and two stably transfected Sf9 cell lines (Sf9 and Sf9 ). For analysis of 
infected cells, Sf9 cells were infected with wild type AcMNPV at an MOI of 10 and analyzed at 24 h pi. 
Transiently transfected cells were transfected with plasmid p64-166 (encoding OpMNPV GP64 EFP) and 
analyzed at 44 h post transfection. Stably transfected cell lines Sf9 and Sf9 were analyzed at 44 h 
after plating. (A) ECL-Westem blot quantification of total GP64 EFP. Cell lysates were prepared from 
triplicate samples of each cell type and analyzed by Western blot with enhanced chemiluminescence 
detection using MAb AcV5. Two exposures of the triplicate samples of each cell type are shown below the 
graph. Absolute quantities of GP64 EFP per cell were determined by densitometry and extrapolation from a 
standard curve prepared with purified GP64 EFPS°' (inset). The inset shows two exposures of a series of 
standard concentrations (ng/20 |il) of GP64 EFPso1. Each bar in the graph represents the calculated mean 
number of GP64 EFP trimers per cell; error bars represent the standard deviations of triplicate samples for 
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and relative levels of GP64 EFP: a) absolute levels of GP64 EFP from whole cells were 
determined by quantitative ECL-Westem blots, b) relative surface levels of GP64 EFP 
were determined by CELISA, and c) variation in average surface density of GP64 EFP 
was determined by flow cytometry (Figure 1). 
A soluble secreted form of GP64 EFP (GP64 EFPso1) was used to generate a 
standard curve for quantitative ECL analysis (see Methods; Fig. 1A inset). Comparisons 
of GP64 EFP present in the whole cell extracts from transiently transfected Sf9 cells, 
AcMNPV infected Sf9 cells, and two stably transfected cell lines are indicated in Figure 
1A. The quantity of GP64 EFP detected in AcMNPV infected Sf9 cells at 24 h pi 
corresponds to approximately 1.3 x 10 trimers of GP64 EFP per cell. The quantity of 
GP64 EFP detected from stably transfected line Sf9°P64'6 (2.5 x 105 trimers/cell) was 
approximately 19% of that detected from AcMNPV infected cells at 24 h pi. Total GP64 
EFP levels from line Sf9°P64'2 were lower (1.6 x 105 trimers/cell), corresponding to 
approximately 12% of that detected from AcMNPV infected cells. Interestingly, 
transiently transfected Sf9 cells assayed at 44 h post-transfection (included as a control) 
showed the highest average levels of GP64 EFP expression, approximately 3.2 x 10 
trimers/cell, or 2.5 times that detected from AcMNPV infected Sf9 cells. 
Detection and quantification (by CELISA) of average relative levels of surface-
localized GP64 EFP (Figure 1B) showed that the level of surface-localized GP64 EFP 
from Sf9 cells was similar to that detected at the surface of AcMNPV infected Sf9 
cells at 24 h pi, a time when virion budding is occurring. Average surface levels of GP64 
EFP on Sf9 cells were lower, corresponding to approximately 70% of that detected 
from AcMNPV infected Sf9 cells or Sf9°P64'6 cells. Transiently transfected Sf9 cells 
assayed at 44 h post-transfection expressed the highest average levels of surface GP64 
EFP, corresponding to approximately 2.7 times that detected from AcMNPV infected Sf9 
cells at 24 h pi. 
Because GP64 EFP expression levels may vary between individual cells in a 
population, we also used flow cytometry to determine the degree of variation. The 
degree of variation (of GP64 EFP surface densities) within populations was compared 
each indicated cell type. All data were normalized to Sf9 cells analyzed at 44 h after plating. (B) CELISA of 
surface-localized GP64 EFP. Relative levels of surface localized GP64 EFP were determined by CELISA of 
gluteraldehyde fixed cells using MAb AcV5. Each bar in the graph represents the mean CELISA signal of 
triplicate samples, normalized to the estimated mean number of cells present in each sample. Error bars 
represent the standard deviations of triplicate samples for each indicated cell type. All data were normalized 
to Sf9 cells analyzed at 44 h after plating. (C-G) Flow cytometry analysis of surface-localized GP64 EFP on 
individual cells. Unfixed cells from each indicated population were incubated with an anti-GP64 EFPS0 ' 
polyclonal serum in the presence of sodium azide. Bound antibodies were detected with an FITC-
conjugated secondary antibody. Each graph plots the cell count (y axis) versus relative fluorescence level 
(x-axis). For each population, samples analyzed included cells incubated without antibodies (solid black 
line), cells incubated with secondary antibody only (fine dotted line), and cells incubated with both primary 
and secondary antibodies (dashed line). For reference, the mean fluorescence intensity for the negative 
control (Sf9 cells incubated with anti-GP64 EFP primary antibody and FITC-conjugated secondary antibody) 
is indicated by the vertical dashed line. 
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FIG. 2. Insertional mutagenesis of the AcMNPV gp64 efp gene. (A) Construction of the GP64-lacZ 
transfer vector pAcGP64zANco. Plasmid names are indicated for each construct (diagrams not to scale). The 
lacZORF is shaded gray, the gp64 efp ORF is indicated in white, and AcMNPV sequences flanking the 
gp64 efp ORF are indicated in black. Small arrows below the bottom diagram indicate the locations of 
primers (GB111, GB53, GB152) used for PCR analysis. (B) Map of the GP64-lacZ transfer vector 
pAcGP64zANco. The transfer vector contains 2327 bp of flanking sequences upstream of the gp64 efp 
ORF, and 853 bp of flanking sequences downstream of the wild type gp64 efp stop codon. Also indicated 
are the locations and orientations of genes flanking the gp64 efp locus (vcath, p24, gp16 and pp34 (pep)). 
(C) PCR amplification of the gp64 efp locus of wild type AcMNPV or vAc . Primers flanking the lacZ 
insertion (GB111 and GB152, indicated in panel A) were used to amplify the gp64 efp locus. The templates 
used for PCR amplification were: plasmid DNA containing a wild type AcMNPV gp64 efp gene (P; lane 1); 
DNA extracted from Sf9 cells infected with wild type AcMNPV (WT; lane 3); DNA extracted from Sf9 cells 
infected with vAc (Z; lane 4); and plasmid DNA from the transfer vector pAcGP64zANco (TV; lane 6). The 
intact gp64 efp ORF is predicted to yield a 1.17 kb PCR product, while the disrupted gp64 efp ORF 
resulting from lacZ insertion and the Nco\ deletion is predicted to yield a 4.22 kb product. Lanes 2 and 5 
contain molecular weight standards (M), indicated in kb on the right. 
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OP64-6 between AcMNPV infected Sf9 cells at 24 h pi, stably transfected cell lines Sf9 and 
OP64-2 
Sf9 , and transiently transfected cells at 44 h post-transfection (Fig. 1C-G). Analysis 
of cells from each population showed that both stably transfected cell lines (Sf9 and 
Sf9 ) and transiently transfected Sf9 cells contain a significantly wider variation in 
GP64 EFP surface densities than do AcMNPV infected Sf9 cells, as indicated by the 
broader peaks (Fig. 1, compare panels E, F and G to panel D). A small proportion of 
cells in both of the stably transfected cell populations and in the transiently transfected 
cell population showed higher levels of surface GP64 EFP (relative fluorescence 
intensities of approximately 200-300) than did infected Sf9 cells (maximum 
fluorescence intensity of approximately 150). 
Thus by several measurements, the average surface density of GP64 EFP on 
stably transfected Sf9 cells appears to be comparable to that on AcMNPV infected 
Sf9 cells at 24 h pi, a time at which active budding of virions is occurring. Therefore, the 
level of GP64 EFP expressed by Sf9 cells was judged to be sufficient to 
complement inactivation of the gp64 efp gene in the AcMNPV viral genome. 
64Z 
Generation of vAc To inactivate the gp64 efp gene in AcMNPV, we used 
insertional mutagenesis. The AcMNPV gp64 efp gene was inactivated by inserting the 
bacterial lacZORF (in frame) into the gp64 efp ORF after codon 131 (Fig. 2A). Although 
the lacZ ORF contains a translation termination codon, we also created a frame-shift 
mutation after codon 452 of gp64 efp, by removing a 54 bp A/col restriction fragment. 
This frame shift resulted in a translation termination codon immediately upstream of the 
GP64 EFP transmembrane domain and insured inactivation of the gp64 efp gene. The 
gp64-lacZ fusion gene was then cloned into a transfer vector containing sequences 
flanking the gp64 efp locus in AcMNPV (Fig. 2B; pAcGP64ZANco). Recombination of 
this transfer vector into the gp64 efp locus of wild type AcMNPV results in a virus wild 
type for all genes except gp64 efp. To generate recombinant viruses defective for GP64 
EFP, transfections, recombination and viral growth were carried out in the Sf9 cell 
line. A recombinant virus (vAc ) was isolated by plaque purification on Sf9 cells, 
using X-gal in the plaque overlay to detect B-galactosidase expression. Although the 
gp64 efp promoter is active in both early and late phases of infection, B-galactosidase 
activity was not detectable before 5-7 days pi, unless the plaque assay plates were 
subjected to a freeze-thaw cycle to disrupt the infected cells. This result suggested that 
active GP64-B-galactosidase fusion protein was not secreted into the medium, despite 
the presence of the GP64 EFP signal peptide in the GP64-B-galactosidase fusion 
protein. 
64Z To confirm the location of the gp64-lacZ insertion in vAc , the gp64 efp locus of 
64Z 
the vAc recombinant virus was examined by PCR amplification using primers 
complementary to the 5' and 3' ends of the gp64 efp gene (Fig. 2A; GB111, GB152). As 
control templates for PCR, we used a plasmid containing the wild-type AcMNPV gp64 
efp gene (negative control), DNA from cells infected with wild type AcMNPV, or plasmid 
DNA of the transfer vector pAcGP64ZANco (positive control). Amplification from the 
45 
plasmid containing the wild type gp64 efp gene or AcMNPV viral DNA resulted in a 1.17 
kb product, as predicted from the sequence (Fig. 2C, lanes 1 and 3). Amplification from 
the pAcGP64ZANco transfer vector or DNA from cells infected by vAc resulted in a 
single 4.22 kb product, as predicted from allelic replacement of the gp64 efp locus by 
the gp64-lacZfusion gene (Fig. 2C, lanes 4 and 6). PCR analysis (using primers GB53 
64Z 
and GB152; Fig. 2A) was also used to verify that the recombinant virus vAc lacked the 
Ncol fragment deleted from the downstream region of the gp64 efp ORF (data not 
64Z 
shown). The structure of the recombinant virus vAc was also examined by restriction 
enzyme digestion of viral genomic DNA. As expected, the EcoRI and BamVW restriction 
64Z 
profile of vAc differed from wild type AcMNPV only in the EcoRI H and BamH\ G 
fragments, confirming replacement of the gp64 efp locus (data not shown). Thus, PCR 
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analysis, restriction mapping and 13-galactosidase activity indicate that the recombinant 
64Z 
virus vAc contains only the gp64-lacZ fusion gene in the gp64 efp locus, and cells 
64Z infected with vAc express B-galactosidase activity. 
64Z 
To verify that the gp64 efp gene was inactivated, vAc infected Sf9 cells were 
examined by ECL-Western blot analysis (Fig. 3A). Cells were infected with either vAc 
or wild type AcMNPV, and cell lysates were prepared at 24 and 48 h pi. Replicate blots 
were probed with monoclonal antibodies specific to (3-galactosidase (Fig. 3A, lanes 1-
5), GP64 EFP (Fig. 3A, lanes 6-10), or P39 capsid protein (Fig 3A, lanes 11-15). A 
replicate blot was also probed with a mixture of all three antibodies (Fig. 3A, lanes 16-
20). Expression of R-galactosidase was detected only in cells infected with vAc (Fig. 
3A, lanes 1 and 2) and not in cells infected with wild type AcMNPV (Fig. 3A, lanes 4, 5). 
64Z 
GP64 EFP expression was not detectable in cells infected with vAc (Fig. 3A, lanes 6, 
7). However, expression of the capsid protein P39 was detected in cells infected with 
64Z 
either vAc or wild type AcMNPV (Fig. 3A, lanes 11, 12, 14 and 15). 
To demonstrate the presence of OpMNPV GP64 EFP on budded virions 
produced by vAc64 infected Sf9 cells, budded virions were purified from tissue 
culture supernatants by sucrose gradient centrifugation and examined by Western blot 
analysis (Fig. 3B, lanes 2, 4 and 6). As a control, budded virions were also purified from 
tissue culture supernatants of AcMNPV infected Sf9 cells (Fig. 3B, lanes 1, 3 and 5). 
Replicate blots were probed with either a) a monoclonal antibody that reacts only with 
FIG. 3. Analysis of GP64 EFP in infected Sf9 cells (panel A) and purified budded virions (panel B), 
and protein synthesis in infected Sf9 cells (panel C). (A) Western blot analysis of expression of GP64-B-
galactosidase fusion protein (R-gal), GP64 EFP (GP64), and the major capsid protein (P39) in Sf9 cells 
infected with either vAc642 (Z) or wild type AcMNPV (WT). Sf9 cells were infected at MOI 10 with vAc (Z; 
lanes 1, 2, 6, 7, 11, 12, 16, 17) or with wild type AcMNPV (WT; lanes 4, 5, 9, 10, 14, 15, 19, 20); mock 
infected cells were included as a negative control (M, lanes 3, 8, 13 and 18). Cell lysates were prepared for 
SDS-PAGE and Western blot analysis at 24 h pi (24; lanes 1, 4, 6, 9, 11, 14, 16, 19) or 48 h pi (48; lanes 2, 
5, 7, 10, 12, 15, 17, 20). Replicate blots were probed with either a MAb directed against E. coli R-
galactosidase (B-gal; lanes 1-5), MAb AcV5 which is directed against GP64 EFP (GP64; lanes 6-10), or MAb 
39 which is directed against P39 Capsid protein (P39; lanes 11-15). Lanes 16-20 were probed with a 
mixture of all three MAbs. Bound antibodies were detected by ECL. Positions of protein size standards are 
indicated along the left in kDa. (B) Detection of OpMNPV GP64 EFP on vAc budded virions. Budded 
virions were purified from supernatants of AcMNPV infected Sf9 cells (lanes 1, 3 and 5) or vAc infected 
Sf9 cells (lanes 2, 4 and 6) by centrifugation on 25-60% sucrose gradients. The budded virion bands 
were collected and analyzed by SDS-PAGE and Western blot. Duplicate blots were probed with MAb 
OpE4A, which recognizes only the GP64 EFP of OpMNPV (lanes 1 and 2); with MAb AcV5 (lanes 3 and 4) 
which recognizes the GP64 EFPs of both AcMNPV and OpMNPV; or with MAb 39 which recognizes the 
P39 capsid protein (lanes 5 and 6). Bound antibodies were detected by ECL. Positions of protein size 
standards are indicated along the left in kDa. (C) Kinetics of infection-specific protein expression. Sf9 cells 
were infected at MOI 20 with either vAc6"Z (Z; lanes 3, 5, 7, 9,11) or wild type AcMNPV (WT; lanes 2, 4, 6, 8, 
10). At the indicated times pi, the cells were pulse-labeled for 2 h with 35S-methionine. As a negative 
control, mock-infected cells were labeled at the first time point (M; lane 1). After the labeling period, the cells 
were lysed and labeled proteins were analyzed by SDS-PAGE and Phosphorimager analysis. Positions of 
protein size standards are indicated along the left in kDa. 
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the OpMNPV GP64 EFP (Fig. 3B, lanes 1 and 2; OpE4A), b) a monoclonal antibody that 
reacts with GP64 EFPs of both OpMNPV and AcMNPV (Fig. 3B, lanes 3 and 4; AcV5), or 
c) a monoclonal antibody that reacts with the P39 capsid protein (Fig. 3B, lanes 5 and 
642 
6). GP64 EFP was detected in purified budded virions of both AcMNPV and vAc by 
monoclonal antibody AcV5 (which cross reacts with GP64 EFPs of both AcMNPV and 
OpMNPV), and capsid protein P39 was also detected in both budded virion 
preparations (Fig. 3B, lanes 3-6). Using the OpMNPV GP64 EFP-specific monoclonal 
antibody (OpE4A), we detected the OpMNPV GP64 EFP in purified budded virions of 
64Z 
vAc (Fig. 3B lane 2), but not in budded virions of AcMNPV (Fig. 3B lane 1). Thus 
vAc budded virions produced from Sf9 cells contained the OpMNPV GP64 EFP 
protein. 
64Z 
To verify that the infection cycle proceeds normally in vAc infected cells, the 
kinetics of the infection cycle were examined by pulse-labelling of proteins (Fig. 3C). In 
64Z 
vAc infected Sf9 cells, the overall pattern of protein synthesis was similar to that from 
Sf9 cells infected with wt AcMNPV. At 24 h pi, a labeled band of approximately 64 kD 
64Z 
was observed in wt AcMNPV infected cells but not in vAc infected cells (Fig. 3C, 
compare lanes 6 and 7). Because 24 h pi is the time of maximal GP64 EFP synthesis in 
AcMNPV infected Sf9 cells (112) this 64 kD band is likely GP64 EFP. Comparison of the 
temporal progression of infection 
confirms progression into the late phase between 6 and 12 h pi and therefore suggests 
64Z 
that the viral infection cycle of vAc is not significantly affected by the lack of GP64 EFP 
expression. 
Because sequences flanking the gp64 efp genes of AcMNPV and OpMNPV are 
present in the recombinant virus vAc and in the Sf9 cell line, respectively, and the 
two genes are highly similar (9), the formal possibility exists that recombination between 
the heterologous genes in the virus and cell line might result in replacement of the 
gp64-lacZ fusion gene with a functional (OpMNPV) gp64 EFP gene. In addition, 
selection pressure might force integration of the OpMNPV gp64 EFP gene at random 
sites within the genome. Such recombination products were not detected in DNA from 
64Z 
the vAc viral stocks, using PCR amplification with primers specific for the OpMNPV 
gp64 efp gene (data not shown). In control experiments, OpMNPV viral DNA was 
detectable with the OpMNPV specific primers when mixed with AcMNPV DNA at a 
molar ratio of 1 part OpMNPV to 10" parts AcMNPV DNA, but was not detectable at 
1:10s. Our inability to detect OpMNPV gp64 efp in vAc viral stocks therefore indicates 
that if any recombinant viruses carrying the OpMNPV gp64 efp gene were present, they 
occurred at a frequency of less than 1 in 104 particles. Because the most likely 
recombination events that might restore the gp64 efp gene would also remove the lacZ 
gene, expression of the lacZ marker gene was used as the indicator of infection in 
subsequent analyses of vAc infectivity. 
48 
Cell to cell transmission. To determine if GP64 EFP is required for the production 
of infectious virions and cell to cell transmission of the virus, Sf9 cells were infected at a 
low MOI (MOI 0.1) with vAc or with a /acZ-marked control virus (vAc s ) . At various 
times post-infection, the cells were fixed and stained with X-gal to detect spread of the 
/acZ-marked viruses from the initially infected cells (Fig. 4). At 20 h pi, single infected 
642 
cells were detected in the cultures infected with vAc (Fig. 4A) or with the control virus 
(Fig. 4D). At 48 h pi, the control virus had spread from the initially infected cells resulting 
in large clusters of infected cells (Fig. 4E), and by 72 h pi the control virus had infected 
most or all cells in the culture (Fig. 4F). In contrast, cultures infected with vAc showed 
no evidence of cell to cell movement, with only single infected cells detected at 48 and 
72 h pi (Fig. 4B and C). Thus these data indicate that GP64 EFP is required for the 
production of infectious virions, and for cell to cell movement in cell culture. 
64Z 
To examine the role of GP64 EFP during infection in the animal, vAc occlusion 
bodies were purified from infected Sf9 cells and fed to early 4th instar T. ni larvae 
(1.5-2 h post-molt). As a control, a second group of larvae was fed occlusion bodies 
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FIG. 4. GP64 EFP role in cell to cell transmission in cell culture. Sf9 cells were infected at a low MOI 
64Z 
(0.1) with either virus containing an inactivated gp64 efp gene (vAc ; panels A, B and C) or a control virus 
expressing R-galactosidase from the hsp70 promoter (vAc ; panels D, E and F). To identify infected cells, 
(3-galactosidase activity was detected. Cells were fixed with gluteraldehyde and stained with X-gal at 20 h pi 
(panels A and D), 48 h pi (panels B and E) or 72 h pi (panels C and F). 
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FIG. 5. GP64 EFP role in systemic infection in the insect host. Newly molted 4th instar T. ni larvae 
were fed a suspension of occlusion bodies (1000 occlusion bodies/|il) from either the GP64 EFP-null virus 
(vAc ; panels A and B) or the control virus (vAc s ; panels C and D). The larvae were dissected, fixed and 
stained with X-gal to detect (3-galactosidase expression in infected cells at either 1 day postfeeding (panels 
A and C), or 4 days postfeeding (panels B and D). Infected midgut epithelial cells were observed as blue 
cells in the midut at 1 d postfeeding in larvae fed either the GP64 EFP-null virus (vAc ; panel A) or the 
control virus (vAc ; panel C). By 4 d postfeeding, larvae fed vAc appeared healthy, and only occasional 
infected cells were detected in the midgut epithelium (panel B, inset is higher magnification). The larvae fed 
the control virus vAc s (panel D) exhibited widespread systemic infection of many tissues and this was 
consistent with their moribund state. 
from the /acZ-marked control virus (vAc ). At various times post-feeding, animals were 
dissected and fixed, and infected cells were identified by whole mount X-gal staining 
(Fig. 5). Infected cells in the midgut epithelium were detected at 4 h postfeeding in 5 of 6 
64Z hsZ 
animals fed vAc occlusion bodies and in 5 of 6 animals fed vAc occlusion bodies 
(data not shown). By 24 h postfeeding, many midgut cells contained B-galactosidase 
activity in animals fed either vAc occlusion bodies (Fig. 5A, 3 of 5 animals) or vAc 
occlusion bodies (Fig. 5C, 4 of 5 animals), indicating infection. By 4 d postfeeding, all 
animals fed the control virus vAc s were quiescent and moribund (5 of 5 animals). After 
X-gal staining, these animals exhibited extensive 13-galactosidase staining in many 
tissues, indicating systemic infection (Fig. 5D). In parallel experiments, all animals fed 
vAc s occlusion bodies underwent tissue liquification (typical of late stage infection by 
64Z 
NPVs) by 5 days postfeeding. In contrast, animals fed vAc occlusion bodies appeared 
healthy at 5 days postfeeding and continued to develop normally. When examined at 4 
days postfeeding by X-gal staining, these animals did not exhibit infection in any 
tissues, except for occasional isolated midgut cells containing R-galactosidase activity 
64Z 
(Fig. 5B, inset). Thus, occluded virions of vAc were infectious to midgut cells and 
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Table I. Comparative mortalities of neonates fed vAc64Z 
and AcMNPV in droplet feeding assays 
Exp 
1 
II 
Virus 
AcMNPV 
vAc64Z 
Control 
AcMNPV 
vAc64Z 
Dose 
(OBsa/10nl) 
1 
5 
10 
1 
5 
10 
0 
0.1 
1 
10 
10 
100 
1,000 
n 
30 
30 
30 
30 
30 
30 
57 
57 
58 
57 
53 
55 
52 
% Mortality 
30.0 
80.0 
93.3 
0 
0 
(3.3)b 
0 
1.8 
20.7 
65.0 
0 
0 
0 
OB, occlusion body 
b
 One animal died, but not because of polyhedrosis 
64Z 
established a primary infection, but the infection by vAc failed to escape the midgut. 
Thus GP64 EFP was not required for infection by occlusion derived virions (ODV), but 
was essential for the escape of the infection from the midgut into the hemocoel. 
To further assess the biological effects of GP64 EFP inactivation, we used a 
642 
sensitive neonate droplet feeding assay to determine the lethality of vAc to neonate 
larvae (Table I). T. ni neonates were allowed to feed on a suspension of occlusion 
64Z 
bodies of either vAc or wild type AcMNPV. Because each larva typically consumes a 
volume of 8-13 nl (104, 105), occlusion bodies were diluted to a concentration of 1, 5 or 
10 occlusion bodies per 10 nl, and neonate larvae were allowed to feed for estimated 
doses of 1, 5 or 10 occlusion bodies per larva. By 4 d pi, neonates fed 5 or 10 occlusion 
bodies of wild type AcMNPV exhibited 80% and 93% mortality respectively, while larvae 
fed an average of 1 occlusion body of wild type AcMNPV exhibited 30% mortality (Table 
I Experiment I). These observations are consistent with previously published data from 
wild type AcMNPV in the droplet feeding assay (78). In contrast, larvae fed vAc64Z 
occlusion bodies at doses of 1 or 5 occlusion bodies per 10 nl exhibited no viral 
induced mortality. In the group of larvae fed 10 vAc64Z occlusion bodies, one animal died 
but upon microscopic examination, no evidence of polyhedrosis was found. In a second 
experiment, doses of 10 occlusion bodies of wild type AcMNPV per 10 nl resulted in 
65% mortality (Table I Experiment II). However, doses of vAc64Z as high as 1000 
51 
occlusion bodies per 10 nl (100x the measured LD65 of wt AcMNPV in this experiment) 
64Z 
resulted in no viral induced mortality by 4 d pi. Thus, the vAc virus was not lethal to T. 
ni neonate larvae at any dose tested. 
Discussion 
Generation of a virus lacking GP64 EFP. To study the role of the baculovirus 
GP64 EFP protein in the context of a viral infection, we generated a recombinant 
baculovirus that contains an insertionally inactivated gp64 efp gene and examined the 
effects of that mutation on viral infectivity, and propagation of the virus in cell culture and 
in animals. Previous studies of the GP64 EFP protein demonstrated that some anti-
GP64 antibodies are capable of neutralizing infectivity of the virus (97, 171, 206, 264). 
Because of the likelihood that inactivation of the gp64 efp gene would be difficult, we 
chose to supply the GP64 EFP protein in trans, from a stably transfected cell line, and to 
then use homologous recombination for generating an inactivated gp64 efp gene in the 
context of an otherwise wild type AcMNPV baculovirus. 
One disadvantage of this approach is that if the gp64 efp gene is essential, a very 
strong selection pressure for regenerating a GP64 EFP+ virus may result in 
recombination between the virus and the gp64 efp gene within the cell line. To reduce 
this possibility and insure that we examined only virus containing the inactivated gp64 
efp gene, we used the following strategies: a) For generating the stably transfected cell 
line, we selected a heterologous gp64 efp gene (derived from a different baculovirus, 
64Z 
OpMNPV), b) Recombinant vAc virus stocks were screened by restriction analysis, 
Western blots and PCR for significant levels of any revertant virus, c) A lacZ marker 
gene was fused in-frame with the wt AcMNPV gp64 efp gene, and analyses of the "loss-
of-function" phenotype of the recombinant virus relied on detection of the 3-
galactosidase marker. Thus, the analysis of only cells expressing the lacZ marker gene 
insured that we exclusively analyzed viruses carrying the inactivated gp64 efp gene. 
Constitutive expression of GP64 EFP on Sf9 cells. The first step in the above 
strategy involved the production of cell lines that constitutively expressed the GP64 EFP 
protein from OpMNPV. In addition to facilitating the construction of the recombinant 
virus, the use of a heterologous gp64 efp gene also allowed us to determine whether 
the highly conserved (but not identical) OpMNPV GP64 EFP could functionally replace 
the AcMNPV GP64 EFP protein. After constructing the OpMNPV GP64 EFP expressing 
cell lines, we performed several quantitative studies to compare GP64 EFP expression 
from AcMNPV infected cells, stably transfected cells and transiently transfected cells. 
For one aspect of these studies, we measured the quantities of GP64 EFP expressed on 
a per cell basis. At 24 h pi, AcMNPV infected Sf9 cells contained on average 
approximately 3.9 x 106 molecules of GP64 EFP per cell (equivalent to 1.3 x 106 
trimers). Stably transfected Sf9°P64"6 cells contained only approximately 7.6 x 105 
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molecules (equivalent to 2.5 x 105 trimers) of GP64 EFP per cell. While the total quantity 
of GP64 EFP per infected cell was approximately 5 times higher than the quantity 
detected per Sf9 6 cell, a further (CELISA) analysis of the average levels of GP64 
EFP at the surface of these cells indicated that the level of GP64 EFP at the surface of 
the Sf9 cells was similar to that of infected cells. Flow cytometry analysis of surface 
GP64 EFP levels on individual cells in each population indicated that there was less 
cell to cell variability among AcMNPV infected cells than among Sf9 cells. Greater 
variability of GP64 EFP surface density appeared to be a general feature of transfected 
cells, since both the Sf9 cell line and transiently transfected cells also exhibited 
wider variations in GP64 EFP surface levels. The narrower range of GP64 EFP surface 
levels in infected Sf9 cells is likely due to the synchronization of GP64 EFP expression 
during infection, since at 24 hours postinfection, GP64 EFP expression is primarily from 
the late promoter. In contrast, GP64 EFP in transfected cells results from constitutive 
expression by the early promoter and accumulation of the protein in a population of 
asynchronously dividing cells. In transient transfections, variable levels of GP64 EFP 
expression may also arise from cell to cell variations in DNA uptake during transfection. 
Because cell surface levels of GP64 EFP from infected and Sf9 cells were 
similar, yet an approximately 5 fold difference was detected in the total quantity of GP64 
EFP, these data suggest that no more than 20% of the total GP64 EFP protein detected 
from AcMNPV infected Sf9 cells (at 24 h pi) is found at the cell surface. Using this 
estimate of surface localization (20%) in combination with quantitative ECL data derived 
from whole cell measurements of GP64 EFP, we estimate that AcMNPV infected Sf9 
cells (MOI 10, 24 h pi) contain an average surface density of 2.6 x 105 trimers of GP64 
OP64-6 
EFP per cell, at most. These preliminary studies suggested that the Sf9 cell line 
produces sufficient quantities of surface localized GP64 EFP to yield reasonable titers of 
budded virions when infected by a virus lacking a gp64 efp gene. Production of 
infectious vAc budded virus from Sf9 cells was on the order of 2-3 x 10^ 
infectious units/ml (determined by TCID50 on Sf9 cells). The presence of GP64 
EFP on the surface of the Sf9 cells apparently did not interfere with infection, since 
the TCID50 titer of the wild type AcMNPV stock determined on the Sf9 cells was 
approximately 1.3 fold higher than the titer determined on Sf9 cells. In addition to 
production of recombinant baculoviruses containing deletions or mutations in GP64 
EFP, these stably transfected cell lines constitutively expressing GP64 EFP will also be 
useful for studies of GP64 EFP mediated membrane fusion. 
gp64 efp is an essential baculovirus gene. The production of infectious budded 
virions by vAc infected Sf9 646 cells demonstrates that the OpMNPV GP64 EFP can 
functionally substitute for the AcMNPV GP64 EFP in the production of budded virions. In 
addition, vAc virions (produced in Sf9 cells) were infectious to Sf9 cells indicating 
that this aspect of host range was apparently unaffected. Thus the GP64 EFP protein 
from these two related baculoviruses appears to be interchangeable. Of particular 
64 Z OP64-6 
importance, we demonstrate that vAc budded virions produced in Sf9 cells are 
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able to enter and infect Sf9 cells, but in the absence of the gp64 efp gene, the vAc 
virus is unable to transmit the infection to uninfected neighboring cells. Thus gp64 efp is 
an essential baculovirus gene, and the GP64 EFP protein is required for the cell to cell 
transmission of the infection. Studies are now in progress to identify the cause of the 
defect in viral transmission. Preliminary studies suggest that virion budding is defective 
in the absence of GP64 EFP. 
GP64 EFP is not essential for infectivity of occluded virions. In previous studies, 
the transmission of virus from the midgut to hemocoel has been studied using marker 
genes to follow the progression of tissues infected (47, 51). Virions have been observed 
budding from the basal side of the midgut epithelial cells (74) and virion budding is 
believed to serve as the primary mode of viral movement from midgut epithelium to 
hemocoel. Hemocytes (127) cells of the tracheal system (47), and basal lamina 
associated muscle and tracheal cells (51) have been proposed as the primary cells 
infected after the first round of replication in midgut epithelial cells. It has also recently 
been suggested that the tracheal system may serve as a "conduit" for budded virus 
transmission across the basal lamina of the midgut epithelium to other tissues within the 
hemocoel (47). 
In the current study, we examined the role of GP64 EFP during infection in the 
64Z 
animal by feeding occlusion bodies prepared from vAc infected cells to either 
neonate or early 4th instar T. ni larvae. Using whole mount histological staining of 4th 
64Z instar T. ni larvae to detect infection, we found that the vAc occlusion derived virions 
64Z 
were capable of infecting cells of the midgut epithelium, but infection by vAc did not 
64Z 
move beyond the midgut. The ability of vAc to produce infectious occluded virions in 
the absence of GP64 EFP expression is consistent with previous studies that found no 
detectable GP64 EFP protein associated with the occluded virus (14, 97) and clearly 
demonstrates the virion phenotype specificity of the GP64 EFP protein. 
As perhaps the most sensitive indicator of systemic propagation of viral infection, 
64Z 
we examined mortality in neonate larvae fed occlusion bodies of vAc . At doses of up 
64Z to 100x the LD65 of AcMNPV, the vAc virus was non-lethal to T. ni neonates. The lack 
64Z 
of vAc induced mortality in T. ni neonate larvae thus confirms the observations in 
64Z 
tissues of whole 4th instar larvae, and demonstrates that the inability of the vAc virus 
to escape from the midgut epithelium results in a non-lethal phenotype in the animal. 
These results therefore demonstrate an absolute requirement for GP64 EFP in the 
progression of the infection from the midgut epithelium to the systemic form of the 
disease in tissues of the hemocoel. 
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Chapter 4 
Requirement for GP64 to drive efficient budding of 
Autographa californica Multicapsid Nucleopolyhedrovirus 
Abstract 
Budded virions (BV) of Autographa californica Multicapsid Nucleopolyhedrovirus (AcMNPV) 
contain a major envelope glycoprotein (GP64) that is present on the plasma membrane of infected 
cells. GP64 is acquired by virions during budding from the plasma membrane, the final step in 
assembly of the budded virion at the cell surface. Previous studies (172) showed that insertional 
inactivation of the AcMNPV gp64 gene resulted in a virus unable to move from cell to cell and non-
lethal to orally infected Trichoplusia ni larvae. To determine if GP64 is involved in virion budding, 
we measured BV production from Sf9 cells infected with a gp64null virus. Sf9 cells infected with 
gp64null virus vAc64' were pulse labeled and progeny BV were isolated on equilibrium sucrose 
gradients and quantified. BV production from vAc64" was reduced to - 2% of that from wild-type 
AcMNPV. Thus, the GP64 protein is important for efficient virion budding. To determine if the highly 
charged 7 amino acid cytoplasmic tail domain (CTD) of GP64 was required for virion production, we 
generated a series of GP64 constructs containing C-terminal truncations or substitutions. Modified 
forms of GP64 were analyzed in transfected cells, and in recombinant viruses in which the wild-
type gp64 gene was replaced with a modified gp64. Deletion of 1 to 7 amino acids from the CTD 
did not affect GP64 trimerization, protein transport to the cell surface, or membrane fusion activity. 
However, deletions of 11 or 14 amino acids, which removed the CTD and portions of the predicted 
TM domain, were trimerized but were present at lower levels on the cell surface due to shedding of 
these truncated proteins. Comparisons of growth curves and quantitative measurements of labeled 
progeny BV production from recombinant viruses expressing either wild-type or mutant GP64 
proteins showed that deletion of the 7 residue CTD only moderately reduced the production of 
infectious virions (~ 50%). However, deletions of the C-terminal 11 or 14 amino acids had more 
substantial effects. Removal of the C-terminal 11 amino acids reduced titers of infectious virus b y 
78-96% and labeled progeny virions were reduced by 91-92%. Removal of 14 amino acids from 
the C-terminus resulted in an - 98% reduction in progeny BV and a virus that was apparently 
incapable of efficient propagation in cell culture. Thus, the GP64 CTD is not essential for production 
of infectious BV, but removal of the CTD results in a measurable reduction in budding efficiency. 
Deletion of the CTD plus small portions of the TM domain resulted in shedding of GP64, reduced 
surface levels, and a dramatic reduction in the production of BV. Together, these data indicate that 
GP64 is an important and limiting factor in BV production. 
This chapter has been published as: 
Oomens, A.G.P., and G.W. Blissard (1999). Requirement for GP64 to drive efficient budding of Autographa 
californica Multicapsid Nucleopolyhedrovirus. Virology25A, 297-314. 
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Introduction 
During the infection cycle, baculoviruses such as the Autographs califomica 
Multicapsid Nucleopolyhedrovirus (AcMNPV) and the Orgyia pseudotsugata MNPV 
(OpMNPV) produce two types of infectious virus particles which are referred to as virion 
phenotypes (reviewed in (5, 167, 209)). The two virion phenotypes are termed Budded 
Virus (BV) and Occlusion Derived Virus (ODV). Each consists of enveloped 
nucleocapsids, but the envelopes differ in source and composition (14). BV and ODV 
serve distinctly different roles in the life cycle of the virus and are assembled by different 
mechanisms and at different sites in the infected cell. BV are assembled at the cell 
surface as nucleocapsids bud through the plasma membrane. In contrast, ODV are 
assembled within the nucleus when nucleocapsids are enveloped within membranes 
that appear to be derived from the nuclear membrane (52, 98). Very late in infection, 
ODV become embedded within an abundantly expressed viral protein, polyhedrin, to 
form highly stable occlusion bodies. Animal-to-animal transmission of baculovirus 
infections is typically by the oral route and is mediated by ODV which are highly 
infectious to the epithelial cells of the midgut (265). ODV enter and infect host midgut 
epithelial cells and infection results in assembly and budding of BV from the basal side 
of these polarized cells (74, 127). BV is highly infectious to tissues within the hemocoel 
and in cell culture (266) and mediates the spread of infection from cell to cell within the 
animal. BV from viruses such as AcMNPV and OpMNPV have a loosely adhering 
envelope that contains a major spike protein known as GP64. On the surface of infected 
cells and in the BV envelope, GP64 is present as a homotrimer (184). GP64 is thought 
to serve critical roles during viral entry into host cells. After binding, BV enter cells by 
endocytosis (261) and previous studies have demonstrated that GP64 is necessary and 
sufficient for low pH triggered membrane fusion, a process that is required for release of 
nucleocapsids from endosomes (10, 25, 147, 171, 172). During budding and assembly 
of BV, GP64 concentrates in discrete areas on the plasma membrane (9) and these 
sites appear to represent the sites of BV budding (260). In many cases, viral envelope 
proteins are important in budding and assembly of progeny virions at the cell surface 
(236). However, the role of the envelope proteins in virion budding may differ 
substantially in different virus groups. Recent studies of virion budding in two 
rhabdovirus systems showed that virion budding is severely reduced (approximately 30 
fold) in the absence of the major envelope glycoprotein, G protein (163, 223). In 
contrast, the budding of some retroviruses is independent of the major envelope protein 
(Env), requiring only the gag protein for budding (64, 72, 215, 226). 
In a previous study, we generated a gp64null AcMNPV baculovirus using a 
stably transfected cell line to provide the GP64 protein during construction and 
propagation of the virus (172). Using the gp64null virus, it was demonstrated that GP64 
is necessary for cell-to-cell transmission of infection in cell culture, and for movement of 
infection from the insect midgut into the hemocoel. However, the precise mechanism of 
this defect in the gp64null virus was not known. Possible explanations included: a) a 
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defect in production of BV, or b) production of BV that were not infectious. To address 
these possibilities in the current study, we used a biochemical approach to examine BV 
production from a gp64null virus. We show that virion production is almost completely 
eliminated in the absence of GP64. Our results indicate that GP64 plays an important 
role in virion budding from the plasma membrane, and that the observed defect in cell-
to-cell transmission by the gp64null virus results primarily from a defect in virion 
budding. We also examined the role of the predicted cytoplasmic tail domain (CTD) of 
GP64 in virion budding from the plasma membrane. A series of GP64 constructs 
containing deletions or substitutions within the CTD region was generated, analyzed, 
and used for constructing recombinant viruses in which the wild type gp64 gene was 
replaced with modified forms of gp64. We found that the GP64 CTD was not required for 
either transport to the cell surface, trimerization, low pH-triggered membrane fusion 
activity, budding of progeny virions, or infectivity of BV. However, deletions of the CTD 
and portions of the transmembrane domain resulted in less efficient anchoring of GP64 
in the plasma membrane, which was accompanied by a decrease in virion assembly at 
the cell surface. 
Results 
GP64null virus construction. In a previous study (172) we generated a gp64null 
baculovirus (vAc64Z) in which the gp64 gene was inactivated by insertion of a lacZ 
cassette into the AcMNPV gp64 ORF. The vAc64Z virus was generated and propagated 
in a cell line (Sf9OP646) that constitutively expresses the OpMNPV GP64 protein. We 
found that upon prolonged passage of vAc64Z in Sf9OP64e cells, low frequency 
homologous recombination of the virus with the OpMNPV gp64 gene in the cell line 
resulted in rescue and generation of a low level of virus expressing a functional GP64 
protein. To avoid the potential problem of gp64null rescue by homologous 
recombination, we generated a second recombinant AcMNPV, in which the entire gp64 
ORF was removed. To remove the gp64 ORF, we generated a transfer vector plasmid 
containing a lacZ cassette (under the control of the OpMNPV IE1 promoter), flanked by 
sequences found upstream and downstream of the AcMNPV gp64 ORF (Fig. 1). 
Cotransfection of the transfer vector and wild type AcMNPV DNA in stably transfected 
cells that express OpMNPV GP64 (Sf90p1D), resulted in discrete removal of the AcMNPV 
gp64 ORF plus a small amount of flanking sequence, and replacement with the lacZ 
cassette (Fig. 1). The resulting virus (vAc64), lacking the gp64 gene and containing a 
lacZ cassette in the gp64 locus, was confirmed by PCR and restriction enzyme analysis 
as described earlier (172). Following extensive passaging of vAc64" in Sf90p1D cells, we 
did not detect production of GP64 when Sf9 cells were subsequently infected with vAc64' 
(data not shown). 
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FIG. 1. Construction and analysis of vAc64', agp64null virus containing a complete deletion of the 
AcMNPV op64 ORF. (A) Construction of gp64null virus vAc64". The top line represents the 4718 bp EcoRI-
Smal fragment (corresponding to nt 107325 to 112049) from plasmid pAcEcoHASma. This fragment 
contains the AcMNPV gp64 locus plus flanking genes (open arrows indicate AcMNPV ORFs). The gp64 
ORF was removed from pAcEcoHASma as a 1722 bp Spel-Bglll fragment (dashed horizontal line), and 
replaced with a 4195 bp cassette containing the E. coli lacZ ORF under the control of the OpMNPV IE1 
early promoter (lower line). The resulting transfer vector as named pAcEcoHASmaSpe(Opie1Z+)Bgl and 
was used to generate gp64null virus vAc64" by cotransfection and homologous recombination with wild type 
AcMNPV E2 DNA in Sf90p1D cells. vAc64" contains a discrete deletion of the AcMNPV gp64 gene between nt 
108,039 and 109,761, and replacement with the 4195 bp lacZ expression cassette. (B) Restriction enzyme 
analysis of genomic DNAs from wild type and recombinant baculoviruses. Lanes 2-4 compare BamHI 
restriction enzyme profiles of genomic DNA's from wt AcMNPV E2 (Lane 2), vAc64" (Lane 3), and vAc-Con 
(Lane 4). The fragments containing portions of the GP64 ORF are indicated on the left of lane 2. Fragments 
containing the replacement gp64 gene and GUS gene are indicated on the left of lane 4. Lane 1 contains a 
DNA ladder (M). 
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Studies of a previous gp64null virus (vAc64Z) showed that the absence of GP64 
expression resulted in a virus unable to move from cell to cell. However, the nature of 
the defect was not known. Possible explanations included: a) a defect in virion budding, 
or b) production of virions that were not infectious. To determine if GP64 was involved in 
BV budding or assembly, we used a biochemical approach to compare relative 
quantities of BV production in Sf9 cells infected with either wild type AcMNPV or the 
gp64null recombinant virus, vAc64". Since vAc64' is propagated in Sf90p1D cells, the 
virions carry OpMNPV GP64 in their envelope and are therefore infectious in cell 
culture. However, after infection of Sf9 cells, vAc64' is unable to produce GP64. As an 
internal control to confirm infection of Sf9 cells by each virus, cell extracts were 
examined by Western blot analysis, using a combination of anti-VP39 and anti-GP64 
antibodies (Fig. 2, Lower panels, lanes W). Polyhedra formation in infected cells was 
also monitored (not shown) as a control for productive infection. As expected, the major 
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FIG. 2. Quantitative analysis of 35S-methionine labeled BV production from wild type AcMNPV (A) 
and vAc64" (B) infected Sf9 cells. Sf9 cells infected with each virus were pulse labeled with 35S-methionine 
from 16 to 30 h pi and labeled progeny virions were isolated from supernatants by purification through a 
sucrose cushion, followed by separation on equilibrium sucrose density gradients. Gradients were 
fractionated and the density of each gradient fraction was measured. Equal amounts of gradient fractions 
were analyzed by electrophoresis on SDS-PAGE gels and proteins were quantified by phosphorimager 
analysis (bottom panels, left). To confirm infection in each experiment, infected cell extracts were examined 
by Western blot analysis using anti-GP64 and anti-VP39 antibodies (lane W). In each panel (A and B) the top 
panels show the measured density (g/ml, dashed line) and the relative quantity of VP39 (solid line, 
determined by phosphorimager analysis) in each fraction. 
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capsid protein, VP39, was detected from cells infected with both viruses, and GP64 was 
not detected from Sf9 cells infected with vAc64", confirming the GP64null virus 
phenotype. Because the antibody used for these experiments cross reacts with 
OpMNPV GP64, these data also show that we could not detect any remaining OpMNPV 
GP64 from the inoculum. 
To distinguish between the virions used to infect cells and potential progeny 
virions, infected Sf9 cells were pulse labeled with 35S-methionine from 16 to 30 h post 
infection (p.i.) and supplemented with unlabeled methionine as a chase at 22 h p.L 
Supernatants harvested at 30 h p.i. were used for virion isolation, fractionation, and 
quantitative analysis. Virions present in supernatants from cells infected with wild type 
AcMNPV or vAc64" were pelleted through a 25% sucrose cushion, resuspended, then 
layered onto a linear 25-60% sucrose gradient and centrifuged to equilibrium. Equal 
fractions were collected from the gradient, the densities were measured, and proteins 
were analyzed on SDS-PAGE gels. Relative quantities of labeled virion proteins in 
each fraction were determined by phosphorimager analysis, using the characteristic 
polypeptide profile to identify virion fractions. The VP39 capsid protein in virion fractions 
was used as an internal indicator of the relative number of virions. Figure 2 shows the 
results of this analysis. Virion fractions isolated from the supernatants of Sf9 cells 
infected with wild type AcMNPV were identified by the presence of GP64 and VP39 in 
standard virion profiles (Fig. 2A; fractions 8-13). Wild type AcMNPV virions were 
identified at a peak density of approximately 1.18 g/ml. Although abundant virion 
production was detected from wild type AcMNPV, only trace amounts of the VP39 
protein were detected at similar densities when supernatants from vAc64" infected Sf9 
cells were similarly analyzed (Fig. 2B, fractions 9-11). Long exposures of the gel in the 
lower panel of Figure 2B showed that other virion proteins were also present in fractions 
FIG. 3. Construction and analysis of plasmid constructs expressing GP64 proteins with truncations 
or substitutions in the cytoplasmic tail domain (CTD) and the transmembrane (TM) domain. (A) A schematic 
representation of the GP64 protein shows the locations of the signal peptide (SP), fusion domain (F), 
B12D5 and AcV5 epitopes, trimerization domain (TR), transmembrane domain (TM), and cytoplasmic tail 
domain (CTD). The various deletions and substitutions in the CTD and TM domain used in this study, and 
their names, are indicated. The indicated constructs were generated in plasmids, examined in transient 
expression assays, and used to generate recombinant viruses (see Fig. 5). A summary of the properties of 
each GP64 construct is shown on the left of each construct (see Fig. 5). (B) Expression and trimerization of 
representative GP64 constructs. Sf9 cells were transfected with plasmids expressing either wild type GP64 
(Wt) or modified GP64 (C-1, C-7, C-11, C-14, and C-37), and expression and trimerization of GP64 were 
examined by Western blot analysis of cell extracts on reducing SDS-PAGE (top panel) or non-reducing 
SDS-PAGE (bottom panel). The positions of GP64 and oligomeric forms (Trimer, Dimer, Monomer) are 
indicated on the right. (C) Detection of modified GP64 proteins from the supernatants of Sf9 cells 
transfected with plasmids expressing either wild type GP64 (Wt) or modified GP64 (C-1, C-7, C-11, C-14, 
and C-37). Supernatants were collected from transfected Sf9 cells examined in panel B, and GP64 was 
immunoprecipitated using an anti-GP64sol antiserum. Plasmid pACIa-C-37, which expresses a secreted 
soluble form of AcMNPV GP64 (C-37), was used as a positive control for secretion. All constructs were 
expressed from the wild type AcMNPV GP64 early promoter, except C-37 in plasmid pACIa-C-37, which 
contains a truncated early promoter. 
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9-11 (not shown) confirming that the VP39 detected in these fractions resulted from BV. 
As expected, no labeled GP64 was detected from these progeny virions as the gp64 
gene was deleted from vAc64" (Fig. 2B). Quantitative measurements of VP39 in all virion-
containing fractions indicated that virion production from the vAc64" virus was 
approximately 2 % of that detected from wild type AcMNPV. This dramatic reduction in 
virion production in the absence of GP64 indicates that GP64 is necessary for efficient 
virion budding. However, the detection of small quantitites of labeled VP39 in virion 
fractions from vAc64 supematants also indicates that a very low level of budding 
occured even in the absence of GP64. 
Construction and analysis of GP64 CTD mutations. The predicted structure of the 
AcMNPV GP64 protein includes a 20 amino acid hydrophobic N-terminal signal peptide 
(SP), a large ectodomain of 459 amino acids (present on the cell or virion surface), a 
hydrophobic transmembrane (TM) domain of 23 residues, and a short hydrophilic 
cytoplasmic tail domain (CTD) of 7 amino acids (Fig. 3A). By convention, the TM and 
CTD are defined as follows: the TM is defined as the highly hydrophobic domain near 
the C-terminus, and the CTD is defined as the hydrophilic domain which begins with the 
first charged residue following the hydrophobic TM domain. Because the cytoplasmic 
tail of GP64 is the only domain thought to be in direct contact with the cytoplasm, and 
was considered most likely to interact with other viral or cellular proteins during 
budding, we examined the functional role of the predicted 7 amino acid AcMNPV GP64 
CTD. To examine the function of the AcMNPV GP64 CTD, we generated a series of 
constructs in which amino acid residues were sequentially deleted from the C-terminus, 
with deletions extending through the CTD and into the predicted TM domain (Fig. 3A, C-
1 to C-14). For constructs designated C-1 through C-37, numbers represent the number 
of amino acids removed from the C-terminus of AcMNPV GP64. To examine the 
potential role of a cluster of basic residues within the CTD, we also generated a 
construct in which each of the 3 arginine residues was replaced with alanine (Fig. 3A, 
CA3Ra). 
Because previous studies showed that a number of GP64 ectodomain 
modifications resulted in unstable proteins, representative constructs containing CTD 
and TM mutations were initially examined by transient expression in transfected cells. 
Expression and trimerization of mutant constructs were compared to that of wild type 
GP64 (Fig. 3B; wt vs C-1, C-7, C-11, C-14). The two characteristic trimeric forms (Trimer 
I and II) were identified in the extract of cells transfected with each construct (Fig. 3B, 
bottom panels) when examined under non-reducing conditions. All constructs except C-
37 were transiently expressed under the control of the wild type AcMNPV gp64 early 
promoter region. Control construct (C-37), which contains a complete deletion of the 
CTD and TM, was expressed from a truncated promoter and was expressed in higher 
quantities. Because deletions of the CTD and portions of the predicted TM domain 
might affect protein anchoring, supematants from transfected cells were also examined 
for the presence of GP64 that may be shed from the cell surface. Control construct C-37 
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contains a deletion of the complete CTD and TM and therefore represents a secreted 
soluble form of GP64 and served as a positive control for secretion or shedding. 
Supernatants from transfected cells were collected at 48 h post transfection and GP64 
was immunoprecipitated with an anti-GP64sol polyclonal antiserum. The wt, C-1, and 
C-7 GP64 proteins were detected in abundance in cell extracts (Fig. 3B, lanes 1-3), and 
in only trace amounts from supernatants (Fig. 3C, lanes 1-3). In contrast, the GP64 C-11 
and C-14 proteins were detected in the supernatants of transfected cells at much higher 
levels than wt, C-1 or C-7 proteins, suggesting that C-11 and C-14 were shed from the 
cell surface (Fig. 3C, lanes 4-5). Thus, initial analyses of AcMNPV GP64 with CTD and 
TM truncations showed that the modified proteins were expressed and trimerized in a 
manner similar to wild type GP64, and that truncations into the TM domain resulted in 
less stable anchoring in the membrane. 
Construction of recombinant viruses with GP64 CTD mutations. To generate 
recombinant AcMNPV viruses in which modified forms of gp64 replaced the wild type 
gp64 gene, viral DNA derived from the gp64null virus vAc64" was cotransfected into Sf9 
or Sf90p1D cells with transfer vectors containing the modified gp64 genes and sequences 
flanking the gp64 locus. A wild type gp64 gene was also included for parallel 
construction of a control virus. Each transfer vector also contained a GUS marker gene 
under the control of the AcMNPV p6.9 promoter, inserted downstream of the gp64 gene 
(Fig. 4A). Because the gp64null virus contains a lacZ gene in the gp64 locus, double 
recombination events resulted in viruses in which the lacZ gene was replaced with the 
modified gp64 gene and GUS gene, and exhibiting a lacZ7GUS+ phenotype. Virus 
isolates were identified and plaque purified based on this phenotype and were 
subsequently examined by PCR analysis, restriction enzyme profiles of genomic DNA's 
(Fig. 1, lane 4), and sequencing to confirm correct insertion of the wild type or modified 
gp64 gene. Sf9 cells were used to generate viruses containing all constructs shown in 
Figure 3A, except the C-14 construct. This construct apparently did not produce 
infectious virions in suffcient quantities to sustain a multiple-round plaque purification 
procedure. Therefore, Sf90p1D cells (a line that constitutively expresses wild type 
OpMNPV GP64) were used for generation and propagation of the vAc-C-14 virus. 
To confirm that the infection cycle proceeded normally in each of the recombinant 
viruses, viral infections were analyzed by pulse labeling. Sf9 cells were infected with 
each virus at an m.o.i. of 10, then pulse labeled with 35S-Methionine for 1.5 hours 
preceding the indicated times (Fig. 4B, 18 and 36 h p.i.). Cell lysates were then 
examined for the presence and relative intensities of infected cell specific proteins 
(ICSPs). Profiles of ICSPs from viruses carrying modified gp64 genes were similar to 
those from a control virus (Fig. 4B, lanes Con) in which the wild type gp64 gene was 
inserted in the same manner as modified gp64 constructs (Fig. 4A). 
65 
vAc 64-
Spel AcMNPVflpW pgg GUS Cassette 
promoter 
pASmaA-GUS 
B 18hrp. 36 hr p. 
116-
97-
66' 
45' 
31 
21-
^ DC ££ 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 6 0 6 6 6 0 
U * I H « M iiiwu tt rji #1 ilitilillliili^iaiii 
* # # « » < * & « » 4»1 
"A •*•• - t • 44 - w. a> w -.• v ' • * • # 
* 1 
:: * ft -. 
• - - « # • ^ * k (ft ^6 ^ 
66 
Analysis of mutant GP64 proteins in recombinant viruses. The expression, 
localization, and function of wild type and modified GP64 proteins were examined in 
infected Sf9 cells. To compare relative quantities of each GP64 protein construct at the 
cell surface, Sf9 cells infected with each recombinant virus were examined by cell 
surface ELISA (CELISA) using an anti-GP64 Mab, AcV5. Data from CELISA at 30 h p.i. 
are shown in Figure 5A. GP64 levels at the surface of cells infected with viruses 
expressing constructs C-1 through C-7 and CA3Ra were similar to that of wild type 
GP64 from either a control virus (Con) or wild type AcMNPV. The surface levels of GP64 
among these constructs ranged from approximately 80 - 130% of that observed from 
wild type GP64 in the control virus, vAc-Con. In contrast, the C-11 and C-14 proteins 
were detected at substantially lower levels, approximately 19 and 24%, respectively, 
relative to the level of wild type GP64 from the control virus. This is consistent with the 
earlier data demonstrating increased levels of GP64 in the supernatants of transfected 
cells expressing the C-11 and C-14 (Fig. 3C). Thus, CELISA and immunoprecipitation 
data indicate that the C-11 and C-14 truncations affected anchoring of these protein 
constructs to the cell membrane. 
To confirm that truncated and modified GP64 proteins were trimerized in Sf9 cells 
infected with recombinant viruses, infected cell extracts were examined under reducing 
and non-reducing conditions (Fig. 5B). Previous studies showed that trimer forms I and 
II both represent homotrimeric forms of GP64 (184) although the physical differences 
that result in different electrophoretic mobilities are not understood. All constructs were 
detected from infected cells at levels similar to those observed in the control virus 
expressing wild type GP64 and all constructs were trimerized (Fig. 5B, right panel). 
We also asked whether low pH triggered membrane fusion was affected by the 
C-terminal truncations or substitutions. Sf9 cells were infected with each of the 
recombinant viruses, then assayed at 36 h p.i. for membrane fusion activity using a 
FIG. 4. Construction and analysis of recombinant AcMNPV viruses expressing modified forms of 
the GP64 protein and GUS. (A) To generate recombinant AcMNPV viruses expressing modified GP64 
proteins, gp64null virus DNA (vAc64", shown as a circle; not drawn to scale) was linearized with unique site 
Bsu36l (located in the lacZ ORF), and cotransfected with transfer vectors containing inserts as indicated 
below. Each transfer vector contained an AcMNPV gp64 gene with modifications of the cytoplasmic tail 
domain (CTD) and/or transmembrane (TM) domain, a GUS gene cassette containing the GUS gene under 
the control of the AcMNPV p6.9 promoter, and flanking sequences for recombination into the gp64 locus 
(nt 107,325 to 111,042). Dashed lines represent the boundaries of the area exchanged between vAc64' 
and transfer vector pASmaA-GUS by double homologous recombination. This results in replacement of the 
lacZ cassette of vAc64" with the modified gp64 and GUS marker gene. Sequences in the transfer vector 
derived from the gp64 locus of the AcMNPV genome are represented as a solid line whereas sequences 
associated with the GUS cassette are represented by a dashed line. Numbers indicated above the 
sequence represent the standard nomenclature for AcMNPV (2). (B) Pulse labeling of proteins from Sf9 
cells infected with viruses expressing wild type or modified forms of GP64. Cells were infected (m.o.i. 10) 
and labeled with 35S-methionine at 18 and 36 h p.i. Extracts from infected cells were electrophoresed on 
SDS-PAGE gels and examined by phosphorimager analysis. (M, mock infection; Con, Control virus vAc-
Con; C-1 to CA3Ra, recombinant viruses expressing modified forms of GP64). 
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FIG. 5. Expression and functional analysis of wild type and modified forms of GP64 in infected Sf9 
cells. (A) Quantitation of GP64 on the cell surface of Sf9 cells infected with recombinant viruses expressing 
modified forms of GP64 (C-1 to C-14, and CA3Ra) at 30 h p.i. by CELISA. The background CELISA signal 
from uninfected Sf9 cells is indicated on the left (Sf9); Positive controls are a control virus that expresses 
the wild type GP64 protein (Con) and wt AcMNPV. (B) Expression and trimerization of modified forms of 
GP64 in Sf9 cells infected with the recombinant viruses listed in A. Western blots of cell extracts (48 h pi ) 
electrophoresed under reducing (left) and non-reducing (right) conditions, and detected with Mab AcV5. 
(C) Syncytium formation assays with recombinant viruses listed in A. Sf9 cells were infected at m.o.i. 10. At 
36 h pi, medium was removed and replaced for 5 minutes with PBS adjusted to a range of pH values from 
5.2 to 6.2, then fresh medium was added and incubated for 2 h prior to scoring for syncytium formation. 
Syncytium formation requires > 5 nuclei in each syncytial mass. (++ syncytia abundant; + syncytia present 
but not abundant; +/- syncytia rare but present; - no syncytia observed.) 
syncytium formation assay. Triggering of fusion was examined over a range of pH 
values (Fig. 5C). The pH required to trigger membrane fusion activity in the syncytium 
formation assays was between 5.4 and 5.6 and was similar for constructs C-1 through 
C-7 and the wt GP64 protein (Con). Interestingly, membrane fusion activity was 
detected from construct C-11 only at pH 5.2 and no activity was detected from construct 
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C-14. While this effect may be partially explained by lower levels of C-11 and C-14 at 
the cell surface (Fig. 5A), the levels of cell surface GP64 C-11 and C-14 were similar in 
CELISA experiments that were performed in parallel (Fig. 5A,C). Thus, the truncation of 
additional amino acids in the TM domain in construct C-14 may specifically affect the 
ability of the protein to mediate fusion. Further studies will be necessary to confirm this 
preliminary result. 
Effects of CTD mutations on infectious BV production. The GP64 protein is 
necessary for virion entry into host cells by receptor-mediated endocytosis, and studies 
of a GP64 deletion virus showed that GP64 was important for efficient virion budding. To 
study the role of the cytoplasmic tail domain (CTD) on production of infectious progeny 
virus, we examined yields of infectious virions from cells infected with virus constructs 
containing the truncated or modified GP64 CTDs described above. Except for virus vAc-
C-14 (which was propagated in Sf90p1D cells) relatively high levels of virus production 
were observed from all other constructs, even when the CTD was truncated by 11 
amino acids (Fig. 6A). These data provided an initial but clear indication that the GP64 
CTD was not essential for viral propagation in cell culture. To examine potential 
differences in virion production in more detail, we generated viral growth curves for 
selected viruses (vAc-Con, vAc-C-7, vAc-C-11, and vAc-CA3Ra). For these studies, BV 
production was measured during 6 hour periods throughout the course of infection. Sf9 
cells were infected with each virus (m.o.i. 10) and cells were washed 6 hours prior to 
each indicated time point and fresh medium was added. Supernatants containing 
infectious virions that accumulated in the supernatant (during the subsequent 6 hour 
period) were collected and infectious BV quantified by TCID50 assay. BV production 
curves were similar for viruses vAc-Con, and vAc-CA3Ra (Fig. 6B). The production of 
infectious BV from vAc-C-7 infected cells was also high but was lower than the control 
virus (vAc-Con). Significantly lower titers were recorded from vAc-C-7 at a number of 
time points (18, 36, 48, and 60 h p i ) . Thus, growth curve data suggested that 
production of infectious BV from vAc-C-7 was slightly reduced from that of the control 
virus that expresses a wild type GP64 protein. Production of infectious BV from virus 
vAc-C-11 was further reduced and was consistently 78 to 96% lower than that 
measured from the control virus (vAc-Con) at 18-60 h p.i. (Fig. 6B). These reductions in 
yield of infectious BV are correlated with the deletions from the C-terminus of GP64, and 
the lower levels of the C-11 construct detected at the surface of vAc-C-11 infected Sf9 
cells (Fig. 5A). 
Biochemical analysis of virion production. The reduction in virus titers from cells 
infected with vAcC-7, vAcC-11, and vAc-C-14 could result from either a) normal 
production of virion particles but reduced infectivity per virion; or b) a reduction in the 
quantity of virions budded from the cell surface. To determine if the observed effects of 
GP64 truncations C-7, C-11, and C-14 were due to a reduction in the quantity of 
progeny virions, we pulse labeled infected cells, then purified and measured the 
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FIG. 6. Production of infectious virions by recombinant viruses expressing wild type or C-terminally 
modified forms of GP64. (A) Comparison of virus stock titers. All viruses except vAc-C-14 were titered in Sf9 
cells. Virus vAc-C-14 was titered in Sf90p1D cells which constitutively express OpMNPV GP64. (B) 
Comparison of virus growth curves for selected recombinant viruses with C-terminal modifications. Viruses 
expressed either a wt GP64 (vAc-Con), a complete deletion of the GP64 CTD (vAc-C-7), a deletion of the 
complete CTD plus 4 amino acids of the TM domain (vAc-C-11), or substitutions of all three arginines within 
the CTD with alanine (vAc-CA3Ra). Each data point represents virion production in the preceding 6 hour 
period. Data points represent triplicate infections and titrations and error bars represent standard deviation 
from the mean. 
relative quantities of labeled virions that accumulated in cell culture supernatants as 
described earlier (see also Materials and Methods). The control virus (vAc-Con) used 
for these studies was generated in parallel with other GP64 replacement viruses, and 
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contains a GUS marker gene and a wild type gp64 gene inserted into the gp64 locus. 
Infection and the expression of the GP64 construct from each recombinant virus was 
confirmed by western blot analysis of infected cell supernatants (Fig. 7; lower panels, 
lanes W). As before, VP39 in virion fractions was used as an indicator of relative virion 
quantity. Phosphorimager analysis and comparisons of virion fractions from vAc-C-7 
and vAc-Con infected cells indicated that vAc-C-7 virion production was approximately 
53% of that detected from vAc-Con (Fig. 7A,B). These findings parallel the data from 
growth curves where a small but notable reduction in infectious virus yield was 
measured for virus vAc-C-7 (Fig. 6B). This indicates that the 7 amino acid GP64 CTD 
plays a significant role in virion production, although relatively high titers of infectious 
virions are still produced in its absence (Fig. 6B, vAc-C-7). A more substantial reduction 
in infectious BV production was observed from growth curve data for virus vAc-C-11, 
which expresses a more severely truncated GP64 protein. Biochemical analysis of BV 
production (Fig. 7C) showed that vAc-C-11 produced only approximately 8-9% of the 
BV generated from the control virus that expresses wild type GP64 (Fig. 7C vs. 7A). 
Thus, the measured reduction by quantitative analysis of virion proteins (91-92%) 
closely parallels the reduction in infectious BV observed from growth curves (78-96%). 
We also examined potential virion production from vAc-C-14 which expressed a 
C-terminal truncation of 14 amino acids. In our studies, insertion of this GP64 mutant 
into the AcMNPV genome was not sufficient for propagation of a recombinant virus in 
Sf9 cells (vAc-C-14 was generated and propagated in Sf90p1D cells). Analysis of virions 
prepared from supernatants from vAc-C-14 infected Sf9 cells resulted in detection of 
only trace quantities of BV, approximately 2% of that detected from the control virus, 
vAc-Con (Fig. 7D vs. 7A). These data were similar to earlier results from the gp64null 
virus which contained a complete deletion of GP64 (Fig. 2). Long exposures of gels 
containing virion fractions from vAc-C-14 revealed that these virions contained the 
mutant C-14 GP64 protein, albeit in very low quantities. 
Effects of GP64 mutations on GP64 incorporation into BV. In addition to the 
effects of GP64 and the GP64 CTD on virion production, we also analyzed the effects of 
the CTD and TM truncations on the incorporation of GP64 into virions. As a measure of 
the concentration of GP64 in each virion, we examined the ratio of GP64 to the major 
capsid protein, VP39, in virion fractions (Fig. 7; Table I). The ratio of GP64:VP39 in the 
peak fraction of the control virus (vAc-Con; Fig. 7, fraction 12) that expresses the wild 
type GP64 protein was 0.762 (Table 1). Comparison of this ratio to that from the peak 
BV factions from viruses vAc-C-7, vAc-C-11, and vAc-C-14 indicated that the 
GP64:VP39 ratio was substantially lower for each of the viruses containing C-terminal 
truncations (Table 1, column 3). When data from all fractions containing BV were 
similarly analyzed, similar results were obtained (Table 1, column 4). Because the 
mature GP64 protein and the VP39 protein contain different numbers of methionine 
residues (16 and 9 residues, respectively), and the amount of incorporated label is 
proportional to the number of methionine residues, protein labeling data were adjusted 
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FIG. 7. Quantitative analysis of 35S-methionine labeled progeny BV production from recombinant 
baculoviruses expressing wild type (vAc-Con) or C-terminal truncations of GP64 (vAc-C-7, vAc-C-11, vAc-C-
14). Sf9 cells infected with each virus were pulse labeled with 35S-methionine from 15 to 40 h p.i. and 
labeled progeny virions were isolated from supernatants by centrifugation through a sucrose cushion, 
followed by separation on equilibrium sucrose density gradients, and fractionation. Gradients were 
fractionated and the density of each gradient fraction was measured. Equal amounts of gradient fractions 
were analyzed by electrophoresis on SDS-PAGE gels and proteins were quantified by phosphorimager 
analysis (bottom panels, left). To confirm infection in each experiment, infected cell extracts were examined 
by Western blot analysis using anti-GP64 and anti-VP39 antibodies (lane W). In each panel (A, B, C, and D) 
the top panels show the measured density (g/ml; dashed line) and the relative quantity of VP39 (solid line, 
determined by phosphorimager analysis) in each fraction. 
to represent relative molar quantities of the two proteins (Table 1, column 5). In all 
cases, truncation of the GP64 CTD resulted in a reduction (50-63%) in the concentration 
of GP64 in virions. In the case of C-11 and C-14, reduced quantities of GP64 on the cell 
surface may account for this difference since cell surface levels of GP64 were reduced 
by approximately 81 and 76% respectively (Fig. 5A). However, in the case of the C-7 
protein, cell surface GP64 levels were similar to that from wt GP64 (Fig. 5A), yet the 
GP64 concentration in the virion was decreased by approximately 63%. Thus, the 
absence of C-terminal residues and not reduced cell surface levels, appear to result in 
Table 1 
GP64:VP39 Ratio 
Virus 
vAc-Con 
vAc-C-7 
vAc-C-11 
vAc-C-14 
Percent 
Budding 
100.0% 
52.5% 
8.6% 
1.4% 
Peak Virion 
Fraction 
0.762 
0.233 
0.233 
0.256 
All Virion 
Fractions 
0.684 
0.255 
0.354 
0.256 
Molar 
Ratios 
0.129 
0.048 
0.068 
0.051 
Percent Budding represents a comparison of the S-Met 
labeled VP39 capsid protein present in virion fractions from 
each virus construct (Fig. 7). GP64:VP39 ratios were calculated 
from phosphorimager data (GP64 and VP39 bands) from 
either the "Peak Virion Fraction" or "All Virion Fractions" for 
each virus. Molar ratios of GP64:VP39 were calculated for 
virions of each virus (using data from All Virion Fractions) 
based on 16 methionine residues (mature wtGP64), 15 
methionine residues (constructs vAc-C-11 and vAc-C-14), or 
9 methionine residues (VP39). 
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a reduction in the concentration of GP64 in the virions of vAc-C-7. Together, these data 
suggest that the CTD influences the incorporation of GP64 into the virion, but is not 
essential for GP64 incorporation. 
TM CTD 
OpMNPV- GGHTTSLSDIADMAKGELNATLYE FMLGHGFTFVLIVGVILFLVCML RNRPSH-Y 
CfMNPV- GGHTTSLSDITDMAKGELNAKLWEFMLGHAFSFMLTVGVIIFLFCMVRNR-SRAY 
AcMNPV- GGVGTSLSDITSMAEGELAAKLTSFMFGHWNFVIILIVILFLYCMIRNRN-RQY 
BmNPV - GGVGTSLNDITSMAEGELAAKLTEFMFGHVATFVIVFIVILFLYCMVRNRNSRQY 
DHO- GGKGTSLEDVLGYPSGWINGKLQG LLLNGAISWVWIGWLVGVCLN RRVF 
FIG. 8. Alignment of the C-terminal regions of baculovirus GP64 proteins and Dhori virus GP75 of 
the Orthomyxoviridae. The hydrophobic predicted transmembrane (TM) domain of each protein is indicated 
by the box and the cytoplasmic tail domains are aligned to demonstrate the conservation of charged 
arginine residues and prevalence of the terminal tyrosine residue in baculovirus proteins. (CfMNPV, 
Choristoneura fumiferama MNPV; BmNPV, Bombyx mori NPV; DHO, Dhori virus). 
Discussion 
Using recombinant AcMNPV baculoviruses containing either a deletion of the 
gp64 gene, or modified forms of gp64, we examined the role of the GP64 protein in 
virion budding. By labeling and quantifying progeny virions from cells infected with 
either wild type AcMNPV or a gp64null virus, we showed that GP64 is necessary for 
efficient production of BV. Therefore, the previously observed defect in cell-to-cell 
transmission in a gp64null virus (172) is caused primarily by a defect in virus budding. 
In the current study, we detected only very low quantities of BV in the absence of the 
gp64 gene, and this result may be explained by one of two possible mechanisms. One 
possibility is that GP64 is not absolutely required for budding and a low level of budding 
may occur in the absence of GP64. A second possible explanation is that GP64 is 
essential for budding and the low level of progeny BV observed in these experiments 
results from recycling of GP64 present on infecting gp64null virus particles of the 
inoculum. Because we were unable to detect recycled GP64 (by Western blots), we 
currently favor the former explanation. It is not known whether GP64 is recycled or 
whether it is degraded after virion dissassembly during entry. Our observation that the 
major AcMNPV BV envelope protein is required for efficient budding is similar to results 
from recent studies of the rhabdovirus G protein. In those studies, virion budding by 
VSV and Rabies viruses was reduced approximately 30 fold in the absence of G-protein 
(163, 223). 
In several cases, it has been proposed that virion budding is driven by 
interactions between the cytoplasmic domains of viral envelope proteins and capsid or 
matrix proteins . We therefore examined the role and function of the GP64 cytoplasmic 
tail domain (CTD) in this process. The predicted CTD of the AcMNPV GP64 protein 
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consists of only 7 amino acids. In comparison, the predicted CTDs of membrane 
proteins such as Influenza HA and NA, VSV G-protein, and human CD4 are 10 and 6, 
29, and 38 amino acids in length, respectively. The small size of the GP64 CTD may be 
an important characteristic since the small size (7-8 amino acids) is conserved in GP64 
proteins identified from Bombyx mori NPV (BmNPV), Choristoneura fumiferama MNPV 
(CfMNPV), and OpMNPV (Fig. 8). In addition, the closely related GP75 protein from an 
arthropod vectored orthomyxovirus (Dhori virus) contains a predicted CTD of only 4 
amino acids. In each of these proteins (baculovirus and Dhori virus), the very short CTD 
contains 2-3 arginine residues which confer a basic charge on the CTD. To examine the 
role of the AcMNPV GP64 CTD, we generated alanine substitutions for the 3 arginine 
residues in the CTD, and generated a series of sequential deletions through the CTD 
and into the TM domain. An initial concern was that the modified GP64 constructs might 
be unstable. In a previous study, a number of GP64 constructs containing insertions and 
deletions in the AcMNPV and OpMNPV GP64 ectodomain were analyzed and in many 
cases, changes in the internal spacing of the ectodomain rendered the protein unstable 
(171). In the current study, representative GP64 mutants were examined using assays 
for transport, anchoring, and membrane fusion. We observed no significant differences 
in expression or stability of GP64 constructs containing deletions or substitutions of the 
CTD and TM, when compared with wild type GP64 (Fig. 3 and 5). Studies of protein 
transport and accumulation at the cell surface, and membrane fusion identified no 
apparent effect of the three arginine to alanine substitutions (CA3Ra) or the deletions of 
the CTD (C-1 to C-7). Because previous studies have shown that deletions or 
modifications of the Influenza HA CTD can result in modified membrane fusion activity 
(164, 180), we therefore asked whether the AcMNPV GP64 CTD mutations affected 
triggering of membrane fusion by low pH. No apparent changes were observed for 
GP64 constructs that were present on the cell surface at or near wild type levels (C-1 to 
C-7 and CA3Ra). Because we examined only the pH requirement for triggering, we 
cannot exclude the possibility that the kinetics or magnitude of GP64 mediated pore 
formation may be affected by changes in the CTD. Whether the GP64 CTD plays a role 
in fusion pore formation after triggering remains unknown and awaits further more 
detailed analyses of these constructs. Anchoring of GP64 to the cell membrane did not 
appear to be substantially affected by the deletion of the 7 amino acid CTD or by 
alanine substitutions for three arginine residues in the CTD, as little GP64 was detected 
in the supernatants of cells transfected with plasmids expressing those constructs. In 
contrast, cells transfected with constructs C-11 and C-14, which contain deletions of the 
7 amino acid CTD plus removal of 4 or 7 additional amino acids from the predicted TM 
domain, had significantly lower levels of cell surface GP64 (Fig. 3A, C-11 and C-14), 
and increased levels of GP64 in the supernatants (Fig. 3B; C-11 and C-14). These data 
support the predicted locations of the boundaries of the TM and CTD. Relatively short 
deletions into the predicted TM domain (C-11) resulted in rather dramatic effects on 
anchoring of the protein in the membrane. Thus, these data show that the region 
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immediately upstream of amino acid 506 clearly serves as an anchoring domain for the 
GP64 protein. 
We next examined the effects of these C-terminally modified GP64 proteins in the 
context of viral infection. To accomplish this, we retained wild type AcMNPV gp64 
transcriptional and translational regulatory control for mutant GP64 constructs, and used 
a gp64null virus to insert genes encoding these modified GP64 proteins into the gp64 
locus of the AcMNPV genome (Fig. 4). To examine the ability of modified GP64 
constructs to facilitate virion assembly and budding, we analyzed the recombinant 
baculoviruses for production of infectious virions in growth curve experiments (Fig. 6), 
and by quantitative analysis of labeled BV production (Fig. 7). The virus carrying the 
three arginine-to-alanine substitutions in the GP64 CTD (vAc-CA3Ra) showed no 
detectable change in production of infectious virions in growth curve experiments. 
Virion production was however, affected when the entire CTD was removed. Separate 
assays for infectious virions and labeled progeny virions both showed an approximately 
50% decrease in virion production in the absence of the GP64 CTD (Fig. 6,7; vAc-C-7). 
These data indicate that the CTD is important for efficient virus budding, but not 
indispensable. Similar studies have examined the roles of CTDs from the Influenza 
virus HA and NA proteins, and the VSV G protein. Deletion of the CTD of either HA or 
NA does not cause substantial effects on budding and assembly, although altered 
morphology of virions was observed when the NA CTD was deleted (116, 118, 170). An 
Influenza virus in which the CTDs were deleted from both the HA and NA proteins, 
resulted in altered particle morphology, and budding was substantially reduced but 
remained at approximately 10% of wild type virus (117). Deletion of the majority of the 
VSV G protein CTD (28 of 29 residues) also results in a severe reduction in virion 
budding, with virion production reduced to approximately 11% of that from wt VSV 
(221). Interestingly, when the VSV G protein CTD and TM domains were replaced with 
the CTD and TM domains from a heterologous cellular membrane protein (Human 
CD4), virion production recovered to approximately 50% of wild type levels. Although 
the AcMNPV GP64 protein is necessary for efficient budding, the CTD does not appear 
to play a critical role in budding since deletion of the entire predicted CTD resulted in 
only a 50% reduction in budding. The role of the TM domain in virion budding remains 
unclear since deletion of the CTD plus small portions of the predicted TM resulted in 
poorly anchored GP64. The correlation of reduced budding with a reduction in cell 
surface levels of GP64 suggests that cell surface GP64 serves as a limiting factor in 
budding. However differences in BV production between vAc-C-11 and vAc-C-14 (Fig. 
7C,D) cannot be explained by differences in surface levels and therefore suggest a 
possibly specific role for sequences within the TM. More definitive studies of the function 
of the TM in virion budding will require replacement of the GP64 TM domain with TM 
domains from heterologous membrane proteins. 
In addition to examining the effect of the CTD on production of infectious BV, we 
also asked whether The GP64 CTD affected GP64 incorporation into virions. We 
therefore compared viruses expressing wild type and truncated GP64 proteins. The 
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GP64:VP39 ratio in virus vAc-C-7 was reduced in comparison to the contol virus 
expressing wild type GP64 (Table 1, vAc-Con vs. vAc-C-7) indicating a lower level of 
GP64 in each virion. Reduced GP64 in vAc-C-7 virions did not appear to result from a 
limitation in available GP64 since the level of GP64 measured at the cell surface was 
similar for vAc-C-7 and the control virus, vAc-Con (Fig. 5A). Therefore, the absence of 
the CTD in vAc-C-7 resulted in both a reduced efficiency of budding and a decreased 
incorporation of GP64 into progeny virions. These data suggest that the GP64 CTD 
promotes efficient budding and is involved in concentrating GP64 within the particle. 
In combination, the data presented in this study show that the GP64 protein is 
necessary for efficient budding of progeny virions. Because we detected low levels of 
virions containing no labeled GP64 in the absence of a gp64 gene, we cannot rule out 
the possibility that incoming GP64 is recycled in these experiments. Therefore, it is not 
known whether the requirement for GP64 in the budding process is absolute. However 
quantitative measurements of BV progeny showed a 98-99% decrease in budding in 
the absence of GP64. We also found that the CTD was not required for budding, but 
appears to moderately affect the efficiency of budding. In comparison, removing the 
CTD plus small portions of the TM domain resulted in dramatic reductions in budding 
efficiency and this appears to result primarily from a limitation in the available GP64 due 
to the poor retention of these truncated proteins in the membrane. Because GP64 is 
required for efficient budding, yet removal of the CTD did not reduce budding 
dramatically, these data suggest that the GP64 protein contains an additional domain 
that facilitates efficient virion budding and that the domain is located either within the 
transmembrane portion of the protein or within the ectodomain. 
The AcMNPV baculovirus has been developed and used extensively as an 
expression vector for heterologous proteins, as a biological control agent, and as a 
model virus system. Recent studies have also suggested that it may be possible to 
utilize AcMNPV in human gene therapy applications. If such applications are to be 
realized and developed, further studies of the function of the GP64 envelope protein will 
be necessary in order to understand the requirements for virion entry into host and non-
host cells, and the role of this protein in the production of budded virions. For the current 
studies, we developed and used a recombinant baculovirus system for replacing the 
essential gp64 gene with genes expressing modified forms of the GP64 protein. This 
system permits the insertion of modified GP64 proteins that would otherwise produce a 
lethal phenotype. The development of this system for examining mutant envelope 
proteins in the context of the virion and the infection cycle will allow us to address a 
number of important questions on virus entry, assembly, budding, and infection. 
Baculoviruses produce two virion phenotypes utilizing what appears to be the same 
nucleocapsid structure to generate virions in two quite different processes. Although 
little is known of the process and mechanisms of baculovirus BV assembly and 
budding, the identification of GP64 as a key component in the process of BV assembly 
will allow us to further examine and dissect the interactions that occur during this critical 
process. 
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Materials and Methods 
Cells, transfections, and infections. Spodoptera frugiperda (Sf9) cells were used 
to propagate wild type (wt) AcMNPV virus as well as most recombinant viruses. Cells 
were cultured at 27°C in TNM-FH medium (95) containing 10% fetal bovine serum. 
Viruses without a functional copy of GP64 (vAc64' and vAc-C-14, see below) were 
propagated in a cell line (Sf90p1D) that constitutively expresses the OpMNPV GP64 
protein. Cloning and characterization of cell line Sf90p1D were described previously 
(195). Wild type virus used in these studies was AcMNPV strain E2. AcMNPV nucleotide 
numbers listed in this study are according to the nomenclature of Ayres et al. (1994). For 
transient transfections, 6 |ig of DNA was introduced into 0.6 x 106 cells by CaP04 
precipitation as described earlier (8). For viral infections, virus was incubated on cells 
for a 1 hr viral adsorption period. Times post infection (p.i.) were calculated from the 
time the viral inoculum was added. 
Generation of gp64null virus vAc64'. For studies of virion production from a 
gp64null virus, the gp64 gene was deleted from the AcMNPV genome using a 
modification of a previously described method (172). A transfer vector for recombination 
into the gp64 locus was constructed as follows: Plasmid pOplE1-3gal-Sal (provided by 
Dr. D. Theilmann) contains a cassette consisting of a lacZ gene driven by an OpMNPV 
IE1 promotor, and flanked by Sail sites. Linkers (Spel/Sse83871/Sall and 
Sall/sse83781/Bglll) were inserted into each of the Sail sites to create an Spel site 
upstream, and a Bglll site downstream of the cassette. The Spel/Bglll lacZ cassette was 
excised and used to replace the wild type gp64 ORF in Spel/Bglll digested plasmid 
pAcEcoHASma (172), creating transfer vector pAcEcoHASmaSpe(Opie1Z+)Bgl. This 
transfer vector contains 2325 bp (nt 109761 to 112049) of sequence from the region 
immediately upstream of the AcMNPV gp64 ORF , and 851 bp (nt 107325 to 108039) of 
sequence from the region immediately downstream. Wild type AcMNPV viral DNA (1 
u.g) and pAcEcoHASmaSpe(Opie1Z+)Bgl (2 |ig) were cotransfected into 1 x 106 Sf90p1D 
cells, and overlayed with agarose in TNM-FH. Plaques were picked 3 days after 
transfection. In sequential plaque assays, plaques were generated in the presence of 
120 ng/ml 5-bromo-4-chloro-3-indolyl-(3-D-galactopyranoside (Xgal, Labscientific, Inc.), 
and blue plaques were selected from infected Sf90p1D cells. A plaque purified viral 
isolate was named vAc64". In vAc64", the complete gp64 ORF plus an additional 43 bp of 
upstream and 140 bp of downstream sequence (nt 108039 to 109760) are removed 
and replaced by the 4195 bp OplE1-lacZ cassette, with the lacZ ORF in the same 
orientation as grp64. Homologous recombination into the gp64 locus, replacing the 
gp64 gene, was confirmed by PCR analysis as described earlier (172) and restriction 
enzyme profiles of genomic DNA's. 
Generation of GP64 CTD mutations. To generate GP64 proteins containing 
truncations or single amino acid substitutions near the C-terminus, plasmid 
pAcEcoHACIa (172), containing the wild type gp64 gene, was used for site-directed 
mutagenesis with the MORPH mutagenesis kit (5 prime->3prime, Inc.). Substitution of nt 
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1514 of the gp64 ORF (T) with C created a unique Bell site at the C-terminal end of the 
predicted TM domain (conserving isoleucine 505); Substitution of nt 1538 to 1543 
(relative to the start of gp64 ORF) with CCCGGG created a unique Smal/Xmal site at the 
gpQA ORF stop codon, resulting in plasmid pACIa-Bcl/Sma. This modified gp64 gene 
was then used to replace the wild type gp64 gene in plasmid pASmaA (a pBS plasmid, 
containing the gp64 locus, AcMNPV nt 107341 to 111046), creating pASmaA-Bcl/Sma. 
Oligonucleotide linkers corresponding to the various C-terminal deletions or 
substitutions were then synthesized and cloned into Bcll/Xmal digested pASmaA-
Bcl/Sma. The resulting plasmids were used to generate transfer vectors for the 
construction of recombinant viruses (see below). 
Budding assay. For a comparison of virion budding from cells infected with either 
wild type AcMNPV or vAc64", Sf9 cells (5 x 106) were infected at m.o.i. 5 for 1 hr at 27°C, 
washed once with TNM-FH, and further incubated at 27°C. At 14 hr p.i., cells were 
washed once and starved by incubation in Graces without methionine (Graces™1) for 2 
hr. At 16 hr p.i., the medium was replaced with 2.2 ml of Graces'™' containing 1 mCi of 
EXPRESS protein labeling mix (Dupont, NEN). At 22 hr p.i., 0.8 ml of TNM-FH was 
added. Cells and supernatants were harvested for analysis at 30 hr p.i. Cells (5 x 106) 
were washed once in PBS, then lysed and boiled in 2 ml Laemmli buffer containing a 
cocktail of protease inhibitors (0.7 |ig/ml pepstatin; 1 mg/ml pefabloc; 10 ng/ml 
leupeptin). Supernatants were cleared of cell debris by brief centrifugation (15 min at 
2000 x g, 4°C), then loaded onto a 25% sucrose cushion and centrifuged at 80,000 x g 
for 80 min at 4°C in a SW60 rotor. Virus pellets were resuspended in 300 \i\ PBS (pH 
6.2; incubation at 4°C for 10 min on a shaker platform at low speed). Resuspended 
virions were loaded onto pre-chilled 12 ml, 25 to 60% linear sucrose gradients and 
centrifuged to equilibrium at 96,000 x g for 16 hr at 4°C. Gradients were fractionated at 
4°C in a Model 640 Density Gradient Fractionator (Isco), in 0.6 ml fractions at 1 ml/min. 
A 35 |il sample was removed from each 0.6 ml fraction for density measurements 
(ABBE-3L refractometer, Spectronic Instruments). The remainder of each fraction was 
diluted to 1.5 ml with cold PBS pH 6.2, and virions were pelleted by centrifugation at 
36,200 x g for 1.5 hr at 4°C. Pelleted virus was resuspended in 30 |j.l Laemmli buffer 
containing a cocktail of protease inhibitors (see above), and incubated at 100°C for 5 
min. Samples from cell lysates and sucrose gradient fractions were electrophoresed 
simultaneously on 10% polyacrylamide gels. For cell lysates, approximately 1.9% 
(equivalent to approximately 93,000 cells) of the total sample was loaded per lane. For 
samples derived from sucrose gradient fractions, the entire sample was loaded in each 
lane. The portion of the gel containing the cell lysates was transferred to Immobilon-P 
(Millipore) membrane, and blots were incubated simultaneously with monoclonal 
antibody (Mab) AcV5 (97, 171) and Mab 39 (274) for simultaneous detection of GP64 
and VP39 respectively. The portion of the gel containing gradient fractions was dried, 
exposed on a phosphorimager screen, and scanned on a Molecular Dynamics 
phosphorimager. Quantification of individual bands was performed with the Imagequant 
software package (Molecular Dynamics, Inc.). 
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For a comparison of virion budding from cells infected with recombinant viruses 
containing C-terminal truncations and substitutions, the following modifications to the 
above protocol were used: For metabolic labeling, infected cells were washed in 
Graces"161, and label was added at 15 hr p.i. TNM-FH was added at 30 hr p.i., and cells 
and supernatants were harvested for analysis at 40 hr p.i. 
CELISA, Western blots, and fusion assays. Western blots and fusion assays were 
carried out as described previously (10). For detection and quantification of GP64 
surface levels, a modified cell ELISA (CELISA) protocol was used: Cells were fixed in 
0.5% glutaraldehyde for 10 min at RT, washed once with phosphate buffered saline 
(PBS pH 7.4) and blocked by incubation in PBS + 1% gelatin for 2 hr at 27°C. Cells 
were then incubated for 45 min at 27°C in Mab AcV5 tissue culture supernatant diluted 
1:25 in PBS + 0.5% gelatin. Cells were washed once in PBS for 2 min, followed by 
incubation for 45 min at 27°C in a secondary goat-anti-mouse antibody conjugated to (3-
galactosidase (GAM-Bgal, Fisher) diluted 1:750 in PBS + 0.5% gelatin. Cells were then 
washed four times (5 min/wash) in PBS, then incubated in 1 mM o-nitrophenyl-B-d-
galactopyranoside (oNPG) in oNPG substrate buffer (0.01 M of each of the following: 
Tris base, sodium chloride, magnesium chloride, R-mercaptoethanol) at 37°C. After 
addition of the substrate, the OD405 was determined at several timepoints using an 
ELISA plate reader. Immunoprecipitations were performed as described previously 
using a polyclonal antiserum prepared against a purified soluble form of OpMNPV 
GP64(184). 
Generation of CTD recombinant viruses. Plasmids containing genes encoding 
GP64 C-terminal truncations or substitutions (described above) were used to generate 
transfer vectors for construction of AcMNPV recombinant viruses by recombination into 
the GP64 locus of the GP64null virus vAc64'. For that purpose a cassette, containing the 
3-glucuronidase (GUS) gene driven by the AcMNPV p6.9 promoter and followed by the 
AcMNPV polyhedrin polyA signal, was cloned as a Bglll fragment downstream of the 
modified gp64 gene, into each of the pASmaA plasmids (described above). The 
resulting transfer vectors (see Fig. 4) contain 1325 bp (AcMNPV nt 109717 to 111042) 
of sequence from the region immediately upstream of the AcMNPV gp64 ORF, and 705 
bp (AcMNPV nt 107330 to 108035) of sequence from the region immediately 
downstream. For each recombinant virus, vAc64" viral DNA (1|Kj, linearized by Bsu36l 
digestion) and transfer vector (2 |ig) were cotransfected into 1.5 x 106 Sf9 cells, and 
supernatants were harvested 3 days after transfection. In sequential plaque assays, 
plaques were selected by blue color in the presence of 120 ug/ml 5-bromo-4-chloro-3-
indolyl-B-D-glucuronide (XGluc, Labscientific, Inc.), and viral isolates were named vAc-
C-1 to -14, and vAc-CA3Ra. Homologous recombination into the gp64 locus and 
replacement of the lacZ cassette was confirmed by PCR analysis and restriction enzyme 
profiles of genomic DNA's. The mutations in the C-terminal region were confirmed by 
sequencing the PCR amplified C-terminal region of each recombinant virus. 
Pulse labeling. Sf9 cells infected with the CTD recombinant viruses at m.o.i 10 
were analyzed by pulse labeling proteins at 18 and 36 hr p.i. Two hr before each of 
80 
these timepoints, cells were washed once and starved by incubation in Graces without 
methionine (Graces™1) for 30 min, followed by metabolic labeling in Graces"™' 
containing 25 uCi of EXPRESS protein labeling mix (Dupont, NEN) per 0.6 x 106 cells, 
for 1.5 hr at 27°C. At the end of the labeling period, cells were washed once in PBS, 
then lysed and boiled in 350 JLXI Laemmli buffer containing a cocktail of protease 
inhibitors (see above). Each sample (45 |xl) was electrophoresed on a 12% 
polyacrylamide gel, dried, exposed to a phosphorimager screen, and scanned on a 
Molecular Dynamics phosphorimager. 
Growthcurves. To measure infectious BV production from four of the CTD 
recombinant viruses, viral growth curves were generated by collecting infected cell 
supernatants at 6 hour intervals at various times post infection. Sf9 cells (0.65 x 106 
cells per well; 12 well plates) were infected at m.o.i. 10 for 1 hr at 27°C. For each 
timepoint post infection, and each virus, triplicate samples were generated, and all wells 
were infected simultaneously to minimize variability. After infection, cells were washed 
once with 0.8 ml TNM-FH, and incubated in 0.9 ml TNM-FH. At 6 hr before each 
timepoint (except timepoint '0'), cells were washed once, and incubated in fresh TNM-
FH for six hours, followed by harvesting of the supernatant. All data therefore represent 
BV produced during the 6 hr time period preceeding the indicated timepoint. 
Supernatants were carefully removed from the infected cells, centrifuged at 20,800 x g 
for 5 min to remove debris, and titered by TCID50(177, 244). X-Gluc, the substrate for the 
GUS marker gene present in these viruses, was included in the TCID50 assay at 120 
ng/ml, and cells were examined 8 days p.i. for blue color and polyhedra formation. 
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Chapter 5 
Host cell receptor binding by baculovirus GP64 
and kinetics of virion entry. 
Abstract 
GP64 is the major envelope glycoprotein from budded virions of the baculoviruses 
Autographa californica Multicapsid Nucleopolyhedrovirus (AcMNPV) and Orgyia pseudotsugata 
Multicapsid Nucleopolyhedrovirus (OpMNPV). To examine the potential role of GP64 in host cell 
receptor binding, we generated, overexpressed, and characterized a soluble form of the OpMNPV 
GP64 protein, GP64sol0p. Assays for trimerization, sensitivity to Proteinase K, and reduction by 
DTT suggested that GP64sol0p was indistinguishable from the ectodomain of the wild-type 
OpMNPV GP64 protein. Virion binding to host cells was analyzed by incubating virions with cells 
at 4e in the presence or absence of competitors, in a single cell infectivity assay. Purified soluble 
GP64 (GP64sol0p) competed for binding of a recombinant AcMNPV marker virus (vAchsZ) to host 
cells, similar to control competition with psoralen-inactivated wild-type AcMNPV and OpMNPV 
virions. A non-specific competitor protein did not similarly inhibit virion binding. Thus, specific 
competition by GP64sol0p for virion binding suggests that the GP64 protein is a host cell receptor 
binding protein. We also examined the kinetics of virion internalization into endosomes and virion 
release from endosomes by acid-triggered membrane fusion. Using a protease sensitivity assay to 
measure internalization of bound virions, we found that virions entered Spodoptera frugiperda 
(Sf9) cells between 10 and 20 minutes after binding, with a half-time of ~ 12.5 min. We used the 
lysosomotropic reagent ammonium chloride to examine the kinetics of membrane fusion and 
nucleocapsid release from endosomes after membrane fusion. An ammonium chloride inhibition 
assay indicated that AcMNPV BV were released from endosomes between 15 and 30 min after 
binding, with a half-time of - 25 min. 
This chapter has been published as: 
Hefferon, K.L., A.G.P. Oomens, S.A. Monsma, CM. Finnerty, and G.W. Blissard (1999). Host cell receptor 
binding by baculovirus GP64 and kinetics of virion entry. Virology 258, 455-468 
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Introduction 
Baculoviruses are enveloped viruses that contain large circular double-stranded 
DNA genomes ranging in size from ~ 80-180 kbp (259). Transcription, DNA replication 
and nucleocapsid assembly occur within the nuclei of infected host cells. Baculoviruses 
are characterized by an infection cycle that produces two virion phenotypes which are 
structurally and functionally distinct (reviewed in (5, 167, 209)). Budded virus (BV) is 
highly infectious in cell culture and mediates cell-to-cell transmission in the infected 
animal. Virions of the second phenotype, occlusion-derived virus (ODV), are embedded 
within large proteinaceous occlusion bodies that are produced in the very late phase of 
the infection cycle. Structurally, BV and ODV differ by the origin and composition of their 
envelopes (14). They also differ in the mechanisms by which they enter host cells. BV 
enter cells through the endocytic pathway (261), whereas ODV appear to enter the 
midgut epithelial cells by direct membrane fusion at the cell surface (73, 243). Although 
several studies have examined binding properties of the two virion phenotypes (99, 
270, 276), the viral receptor-binding proteins and host cell receptors have not been 
identified for either ODV or BV. 
The BV envelopes of AcMNPV and OpMNPV contain an abundant viral-encoded 
glycoprotein, GP64, that is not found in the ODV envelope (9, 14, 49, 84, 273). BV 
examined by EM contain characteristic spike-like peplomers within the envelope and 
these spike proteins appear to be concentrated at the end of the virion that is associated 
with virion budding. Immuno-electron microscopic studies of virions budding from 
AcMNPV infected cells suggest that spikes are composed of the GP64 protein (258) and 
it was recently shown that GP64 is necessary for efficient production of BV (183). Each 
spike or peplomer is believed to represent a single homotrimer of the GP64 protein 
(184) and antibodies directed against GP64 have been shown to neutralize infectivity of 
the BV (97, 264). However, the single neutralizing monoclonal antibody (MAb AcV1) 
that has been characterized in detail was shown to neutralize virion entry by inhibition 
of membrane fusion, a step after virion binding (25, 261). Monoclonal antibodies that 
inhibit virion binding have not been reported. Previous studies showed that the GP64 
protein is necessary and sufficient for low pH-triggered membrane fusion activity, the 
process that occurs during virion entry by endocytosis (10, 147, 171). In addition, a 
small hydrophobic domain necessary for membrane fusion was identified and 
characterized by site-directed mutagenesis (171). By generating and examining a 
Gp64null virus containing a gp64 knockout, it was demonstrated that GP64 is an 
essential viral structural protein of AcMNPV (172). In animals fed occlusion bodies from 
the gp64null virus (vAc64Z), midgut cells were efficiently infected by ODV but the 
infection was unable to move from the midgut epithelium into cells and tissues of the 
hemocoel. Similarly, infection by vAc64Z did not spread from cell to cell in tissue 
culture. 
Envelope proteins from animal viruses mediate entry into host cells by facilitating 
two critical functions: binding to host cell receptors and fusion of the viral envelope with 
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the host cell plasma membrane. In some cases such as the well studied Influenza 
hemagglutinin (HA) protein, both functions are provided by a single protein. In other 
cases such as the parainfluenza viruses, these two functions are segregated into two 
proteins: hemagglutinin/neuraminidase (HN) and fusion (F) proteins. Viral binding to a 
host cell receptor may serve two major functions. First, adhesion of the virus particle to 
the cell may be a necessary prerequisite for subsequent endocytosis. Second, the viral 
envelope and host plasma membrane must be closely apposed in order to fuse. For 
example, in some parainfluenza viruses it has been demonstrated that the receptor 
binding activity of the HN protein is necessary for fusion induced by the F protein (143). 
In the case of the baculoviruses OpMNPV and AcMNPV, the GP64 protein was 
previously demonstrated to encode a low-pH activated membrane fusion activity (10, 
184). However, host cell receptor binding has not been previously assigned to GP64 or 
any other BV envelope protein. A recent study of GP64 glycosylation mutants showed 
that decreased infectivity was observed when some glycosylation sites were eliminated, 
suggesting that the GP64 glycosylation state may affect virion binding (115). Perhaps 
most compelling is the observation that a closely related orthomyxovirus homolog of 
GP64 (the GP75 protein of the Thogoto virus) has hemagglutinating activity(173, 201). 
Because the GP64 protein contains primary sequence similarities across the entire 
predicted ectodomain of GP75, this suggests that the GP64 protein may also encode a 
host receptor binding function. In the present study, we examined the role of GP64 in 
virion binding at the cell surface. To determine whether GP64 was involved in virion 
binding to host cell receptors, we first generated, purified, and characterized a secreted 
soluble form of the GP64 protein, GP64sol0p. We previously showed that GP64sol0p was 
trimerized in a manner indistinguishable from native membrane-bound GP64 protein. In 
the current study, we used N-terminal sequencing, limited proteolysis, and DTT 
sensitivity assays to further demonstrate that GP64sol0p is indistinguishable from the 
predicted ectodomain of native GP64. Using purified GP64sol0p as a competitor for 
virion binding to Sf9 cells, we show that GP64sol0p competes for binding of AcMNPV BV 
at the surface. To further characterize virion entry, we also examined the kinetics of BV 
entry by measuring the timing of BV internalization into endosomes and release of 
nucleocapsids from endosomes. 
Results 
Production of a secreted soluble form of GP64. A secreted soluble form of the 
OpMNPV GP64 protein was produced in an AcMNPV baculovirus expression vector 
system, by inserting a modified gp64 ORF into the polyhedrin locus of AcMNPV. Site 
directed mutagenesis was used to insert a stop codon after Leu477, which is located 
immediately upstream of the predicted transmembrane domain of the OpMNPV gp64 
ORF (Fig. 1A). The resulting construct was placed under the control of the polyhedrin 
promoter in transfer vector pAcDZI (109) and a recombinant baculovirus was 
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FIG. 1. (A) Construction of GP64sol0p. The OpMNPV GP64 open reading frame is represented as 
an open bar with protein domains indicated on and below the bar. The gene encoding the secreted soluble 
form of GP64 (GP64sol0p) contains a stop codon (*, Stop) introduced at Tyr 478, immediately upstream of 
the transmembrane domain (TM). The N-terminal sequence determined from the mature secreted soluble 
GP64 protein is indicated below the nucleotide sequence and the predicted N-terminal sequence. The 
signal peptide cleavage site is indicated by an arrowhead. SP, signal peptide; F, fusion domain; Helix, 
predicted amphipathic alpha-helical region; AcV5, monoclonal antibody epitope; CTD, cytoplasmic tail 
domain. (B) Highly purified GP64sol0p (purified as described in Materials and Methods) was compared with 
GP64 from OpMNPV budded virions (BV) by SDS-PAGE and Coomassie blue staining. Lane 1, Protein 
markers; lane 2, OpMNPV BV; lane 3, Highly purified GP64sol0p. (C) GP64sol0p glycosylate. Purified 
GP64sol0p (undigested, U) was compared with endoglycosidase F (F) or endoglycosidase H (H) digested 
GP64sol0p on SDS-PAGE gels stained with Coomassie blue. The positions of protein markers and the 
mature GP64sol0p (arrowhead) is indicated on the left and positions of major products of each digest are 
indicated on the right. 
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generated from BacPAK6 viral DNA. The secreted soluble form of GP64 (GP64sol0p) 
was purified from supernatant collected from infected Tn5B1-4 cells at 48 h pi as 
described in the Materials and Methods section. Quantity and purity of GP64sol0p were 
assessed by Bradford protein assay and by Coomassie blue and silver staining of 
GP64sol0p electrophoresed on SDS-PAGE gels, followed by densitometric scanning of 
stained gels (Fig. 1B). Extensive purification of GP64sol0p resulted in a preparation 
exceeding (93-95%) purity, which was used for all competition studies. A partially 
purified preparation of GP64sol0p was used for protease resistance and oligomerization 
studies. We previously showed that this secreted soluble GP64sol0p was trimerized in a 
manner indistinguishable from native OpMNPV GP64, suggesting that GP64sol0p was 
identical to the ectodomain of native GP64 (184). To further confirm the native structure 
and processing of GP64sol0p, we examined GP64sol0p by N-terminal sequencing, 
endoglycosidase treatment, partial reduction with DTT, and protease treatment (below). 
For these studies GP64sol0p was compared to GP64 derived from OpMNPV virions (Fig. 
1,2). 
Posttranslational modifications. The N-termini of baculovirus GP64 proteins are 
highly hydrophobic, although not well conserved in primary sequence (9, 93, 273). This 
is consistent with the presence of a signal peptide which is cleaved during entry into the 
secretory pathway. In a previous study (9), the signal peptide cleavage sites for the 
OpMNPV GP64 protein was predicted at a position between amino acids 17 and 18 
(Fig. 1 A) and this corresponds to a similar position (between amino acids 20 and 21) in 
the AcMNPV GP64 protein. N-terminal sequencing of highly purified GP64sol0p resulted 
in the following N-terminal sequence, N-Ala-Glu-His-Xxx-Asn-Ala-GIn, demonstrating 
that the predicted peptide cleavage site is correct (Fig. 1 A, arrowhead). 
The native AcMNPV and OpMNPV GP64 proteins contain 5 and 7 potential sites 
for N-linked glycosylation, respectively, and previous studies have shown that the native 
proteins contain ~ 6 to 8 kDa of N-linked carbohydrate per monomer (9, 112, 184, 273). 
Digestion of purified GP64sol0p with endoglycosidase F or endoglycosidase H resulted 
in increased mobility consistent with that reported from native OpMNPV GP64 (Fig. 
1C)(184). 
Proteinase K digestion and DTT reduction. To determine whether the secreted 
soluble form of GP64 retained a native conformation, GP64sol0p was compared directly 
to GP64 from OpMNPV BV in Proteinase K resistance assays and DTT reduction assays 
(Fig. 2). Previous studies of GP64 from AcMNPV virions showed that Proteinase K 
digestion of native GP64 resulted in protease resistant peptides of ~ 34 to 37 kDa (262). 
To examine protease resistance, we used a monoclonal antibody (AcV5) that 
recognizes a defined, conserved linear epitope near the C-terminus of the GP64 
ectodomain (171). When digested with proteinase K, an - 34 kDa protease resistant 
peptide (that encompasses the C-terminal portion of GP64) was identified from both 
wild-type OpMNPV GP64 and GP64sol0p (Fig. 2A, lanes 2 and 4, respectively). These 
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FIG. 2. (A) Protease resistance of OpMNPV GP64 and GP64sol0p. GP64sol0p (0.5 |ig) and 
OpMNPV budded virions (1 \ig) were digested with 0.1 mg/ml Proteinase K (Prot.K) for 10 min at 56s, then 
examined by Western blot analysis using monoclonal antibody AcV5. Lane 1: Undigested OpMNPV BV; 
lane 2: OpMNPV BV digested with Proteinase K; lane 3, Undigested GP64sol0p; lane 4, GP64sol0p 
digested with Proteinase K. The position of the protease resistant C-terminal fragment of GP64 is indicated 
by the arrowhead. (B) DTT sensitivity of OpMNPV GP64 and GP64sol0p. Purified GP64sol0p and wild-type 
GP64 (wild-type GP64) from OpMNPV budded virions were reduced in various concentrations of DTT at 37Q 
for 5 min, then prepared under non-reducing conditions and electrophoresed on SDS-PAGE gels. 
Samples of GP64sol0p (0.5 ug) and OpMNPV BV (1 |ig) were treated with increasing concentrations of DTT 
(0-10 mM). GP64 proteins were identified by Western blot analysis using MAb AcV5. Lanes 1-5, OpMNPV 
BV; lanes 6-10, GP64sol0p. Concentrations of DTT (mM) are indicated above each lane of the gel. 
Oligomericforms of GP64 (Trimer land II, Dimer, Monomer) which were characterized previously (184) are 
indicated on the left. 
proteinase resistance data strongly suggest that analogous portions of both proteins are 
exposed to cleavage by proteinase K and that GP64sol0p is found in the same 
conformation as native GP64 from BV. 
GP64 is present in BV as disulfide linked homotrimers and a previous study 
demonstrated that two electrophoretic forms of trimeric GP64 are observed on 
nonreducing SDS-PAGE gels (184). The two trimer forms were designated Trimer I and 
Trimer II. Trimer I and II were also detected from GP64sol0p. Thus trimers of GP64sol0p 
were indistinguishable from those of wild-type GP64 derived from virions (see also Fig. 
2B, lanes 1 vs. 6). To confirm the similarities and further examine GP64 trimerization, 
both GP64sol0p and wild-type OpMNPV GP64 from BV were incubated in increasing 
concentrations of the reducing agent DTT, from 2 to 10 mM. In both cases, increasing 
concentrations of DTT resulted in a gradual loss of trimeric forms. At low DTT 
concentrations (2-4 mM), Trimer I appears to be more susceptible to reduction than 
Trimer II. This was observed for both GP64sol0p and GP64 from OpMNPV BV (Fig. 2B 
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lanes 2-3 and 7-8). At higher concentrations of DTT (10 mM), both GP64s were almost 
completely reduced to monomers (Fig. 2B, lanes 5, 10). These similarities in sensitivity 
to DTT suggest that GP64sol0p and wild-type OpMNPV GP64 are similar in structure. 
Baculovirus BV binding and infectivity. To examine virion binding and entry in 
subsequent experiments, we used a recombinant AcMNPV virus containing a lacZ gene 
under the control of a promoter (Drosophila hsp70) that is active early in the infection 
cycle. The virus vAchsZ (172, 256) was used in a single cell infectivity assay to measure 
changes in virion binding. To generate a dose-response curve and identify assay 
conditions in which changes in virion binding could be detected and quantified, Sf9 
cells (3x105) were infected with increasing concentrations of vAchsZ virions (MOIs 
ranging from 0.015 to 0.2), by binding BV at 49 for 1 hour. This resulted in a proportional 
linear increase in the number of single infected cells detected by staining for (3-
galactosidase at 24 hours pi (Fig. 3A). Thus, within this range of virion concentrations 
and under these conditions, virions are not present in saturating concentrations. 
Competition for virion binding can therefore be more readily detected by this method. 
Virion concentrations within the linear range of this assay were used in all subsequent 
experiments. 
In these studies, virion entry was synchronized by binding BV to cells at 4sfor 1 h, 
then shifting the temperature to 27s to permit endocytosis of virions. To confirm that the 
vAchsZ BV that were bound at 4s remained at the cell surface at the end of the 1 h 
binding period, virions were bound to cells at 4s for 1 h, then cells were washed and 
treated with the protease subtilysin (2 mg/ml) to inactivate or release virions at the cell 
surface. As a control, virions were bound at A- for 1 hour, washed in TNM-FH medium, 
then incubated at 272 for one hour (allowing bound virions to internalize), and 
subsequently treated with subtilysin. Treatment of cells with subtilysin immediately after 
the 4s binding step resulted in a dramatic decrease in numbers of infected cells 
detected (Fig. 3B, column 2). In contrast, when virions were bound at 4s, then allowed to 
enter endosomes by incubating at 279 for one hour before protease treatment, no 
detectable decrease in infectivity was observed (column 3). A control pretreatment of BV 
with subtilysin prior to binding (column 4) resulted in little binding and infectivity, as 
expected. These data indicate that during the 4s incubation period, virions remain at the 
cell surface, and that bound virions enter within one hour after the shift from 49 to 27s. 
Thus, entry by endocytosis (after binding) is efficiently synchronized in this manner. 
Virion and GP64sol°p competition. Because GP64 is the major envelope protein 
of the BV, we hypothesized that BV binding to the host cell receptor may be mediated by 
GP64. The OpMNPV and AcMNPV GP64 proteins are highly conserved, showing 84% 
sequence identity in the ectodomains. In addition, in previous studies (unpublished) we 
found that OpMNPV BV appear to bind and enter Sf9 cells, although Sf9 cells are not 
permissive for OpMNPV replication. Thus, if the GP64 protein encodes the host cell 
receptor binding activity, the OpMNPV GP64 protein may compete for the same 
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FIG. 3. (A) Dose-response curve for a single cell infectivity assay with virus vAchsZ. To develop a 
rapid single cell infectivity assay for detecting changes in virion binding, a range of virion concentrations 
were examined in a 1 hour viral binding assay. To identify a range of virion concentrations in which the 
response to increasing virion concentrations was linear, Sf9 cells (3 x 105) were incubated with increasing 
concentrations of vAchsZ (MOIs of 0.0125 to 0.2) for 1 hour at 4s C, then washed in TNM-FH, and 
incubated for 24 h in TNM-FH at 27g. Single cells were scored for expression of B-galactosidase as 
described in the Materials and Methods. In the dose-response curve, each data point represents the 
averaged results from three wells and bars represent standard deviation. (B) Protease sensitivity of virions 
bound at the cell surface. To determine whether virions remained at the cell surface at the end of a 1 h 
binding period at 49, the sensitivity of surface bound virions to inactivation or release by treatment with the 
protease subtilysin was examined in a single cell infection assay. Virions of vAchsZ were bound to Sf9 cells 
at 4Q for one hour, then cells were washed 3x with TNM-FH at 4s and either not treated (Lane 1), or treated 
with 2 mg/ml subtilysin (Lane 2) prior to shifting to 279 C and incubating for 24 hours. As a control, virions 
were bound at 4s, cells were washed as above, then virions were allowed to internalize by shifting to 27s for 
1 hour prior to treatment with subtilysin (Lane 3). Pretreatment of vAchsZ virions with subtilysin prior to 
binding was sufficient to inactivate virions in the same single cell infection assay (Lane 4). Each data point 
represents average data from three wells and bars represent standard deviation. 
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binding sites used by AcMNPV or the AcMNPV recombinant, vAchsZ. To determine 
whether OpMNPV virions compete for the same binding sites used by AcMNPV, 
psoralen-inactivated virions of AcMNPV and OpMNPV were used as competitors in the 
virion binding assay described above. For these competition assays, Sf9 cells were 
incubated for 1.5 h at 49 with various concentrations of psoralen-inactivated AcMNPV or 
OpMNPV virions prior to addition and binding of vAchsZ at 4s for one hour. Prebinding 
of psoralen-inactivated AcMNPV or OpMNPV virions at 4e resulted in a dramatic 
decrease in the number of cells infected by vAchsZ, as detected in the single cell 
infection assay (Fig. 4). Results of these competition assays suggest that both AcMNPV 
and OpMNPV virions competed with vAchsZ for binding sites on Sf9 cells. 
Competition studies with a soluble GP64 protein. Because both AcMNPV and 
OpMNPV appeared to compete for the same host cell receptor sites, we next asked 
whether secreted soluble GP64 (GP64sol0p) would similarly compete for binding to the 
host cell receptor. To address this question, various concentrations of GP64sol0p were 
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FIG. 4. Competition for virion binding by inactivated AcMNPV and OpMNPV BV. To determine 
whether OpMNPV and AcMNPV BV utilize the same host receptor binding sites on Sf9 cells, psoralen-
inactivated BV of AcMNPV and OpMNPV were used as competitors for binding of BV from vAchsZ. Sf9 
cells were preincubated with increasing concentrations of psoralen-treated AcMNPV and OpMNPV BV (X-
axis, MOI) at 4° for 1 h, then vAchsZ (MO11) was added and allowed to bind for 1 h at 4s. Cells were washed 
in TNM-FH, fresh medium was added, and infection was allowed to proceed for 20 h. Numbers of infected 
cells were determined as described in Materials and Methods. Each data point represents average data from 
three wells and bars represent standard deviation. 
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FIG. 5. GP64sol0p competition for AcMNPV binding. GP64sol0p was used as a competitor for virion 
binding in a single cell infectivity assay as described earlier. Sf9 cells were preincubated with increasing 
concentrations (X-axis) of either GP64sol0p (solid line) or BSA (dashed line) at 4° for 1.5 h, then vAchsZ 
virions were added and bound for 1 h at 4°. Cells were washed at 49 in PBS, then incubated at 279 for 22 h. 
Numbers of infected cells (Y-axis) were quantified as described in Materials and Methods. Each data point 
represents average data from two wells and bars represent standard deviation. 
incubated with Sf9 cells at A- for 1.5 hours, then vAchsZ was added and bound to cells 
for an additional hour at 4s. As a control, identical molar concentrations of BSA were 
included in a parallel competition assay. Incubation of cells with increasing 
concentrations of GP64sol0p resulted in a dramatic decrease in the number of infected 
cells (Fig. 5). Inhibition of virion binding was first detected at a GP64sol0p concentration 
of 50 nM, and increasing concentrations of GP64sol0p (100 and 200 nM) resulted in 
additional decreases in virion binding. Only a minor reduction in numbers of infected 
cells was observed when equivalent concentrations of BSA were used as a non-
specific competitor (Fig. 5, dashed line). Competition by GP64sol0p for virion binding 
was observed in at least 6 separate experiments. To determine whether native 
GP64sol0p trimers were required for efficient binding, and as a further control to confirm 
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the role of GP64, purified GP64sol0p trimers were reduced by treatment in 10 mM DTT 
prior to competition assays. Previous studies showed that these conditions were 
sufficient to reduce trimeric GP64sol0p to monomers (Fig. 2B). For these experiments 
concentrated GP64sol0p was reduced in 10 mM DTT, then diluted to a final 
concentration of 50 nM GP64sol0p and 0.1 mM DTT for use as a competitor. Treatment 
of GP64sol0p with 10 mM DTT resulted in a loss of competition by GP64sol0p (Fig. 6). In 
a mock experiment, the same final dilution of DTT (0.1 mM DTT) added alone to cells 
did not affect infection in the absence of the competitor (not shown). The inability of 
reduced GP64sol0p to effectively compete for virion binding sites suggests that disulfide 
bonds may be necessary for maintenance of a receptor binding domain of GP64 or that 
native trimeric GP64 is necessary for efficient receptor binding by GP64 (Fig. 6). As an 
additional control, GP64sol0p was also pretreated with chymotrypsin, followed by 
addition of protease inhibitors, prior to use in competition assays. Protease treated 
GP64sol0p did not compete for binding by vAchsZ (Fig. 6). 
2500 
GP64sol°P BSA No Competitor 
Competitor 
FIG. 6. Reduction in specific competition by GP64sol0p after treatment with protease or reducing 
agent. GP64sol0p was treated with either 1 mg/ml chymotrypsin (hatched bars) or 10 mM DTT (open bars) 
prior to use as a competitor in a virion binding assay, as in Figure 5. Competitor (GP64sol0p or BSA) 
concentrations were 50 nM. Bovine serum albumin (BSA) was similarly treated. Treated and untreated 
protein competitors were preincubated with Sf9 cells at A- for 1.5 h prior to incubation with BV of vAchsZ, as 
described in Figure 5. Numbers of infected cells were determined as described above. Each bar represents 
the average data from three wells and bars represent standard deviation. 
Kinetics of virion entry. The timing of BV entry into endosomes was measured by 
first synchronizing BV binding at the cell surface at 4° incubating for various periods at 
275 to permit endocytosis, inactivating or releasing BV remaining at the cell surface with 
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subtilysin treatment, then measuring the virus that was internalized and therefore 
protected from subtilysin treatment. For these studies we used virus vAchsZ and the 
single cell infectivity assay described above. vAchsZ was bound to cells for 1 hr at 4s, 
then the temperature was shifted to 27 s for increasing intervals of time from 0-120 min. 
At the end of each time interval, cells were treated with 2 mg/ml subtilysin to inactivate 
or release BV remaining at the cell surface. Cells were washed and then incubated at 
27s for 24 hours, and numbers of infected cells were determined as described earlier. 
The protease resistance curve shown in Fig. 7A (solid line) shows that between 0 and 
10 min at 279, BV were highly sensitive to inactivation by exogenously applied 
subtilysin. Resistance to inactivation by subtilysin increased dramatically between 10 
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FIG. 7. (A) Kinetics of virion internalization into endosomes. The kinetics of virion internalization 
into endosomes were examined by synchronously binding virions to the cell surface at A- for 1 h, then 
shifting to 279 for various periods of time, and treating with subtilysin. Resistance of internalized BV to 
inactivation by subtilysin was measured by the single cell infectivity assay described earlier. Synchronously 
bound virions of vAchsZ were incubated at 27s for time periods ranging from 5-120 minutes. At the end of 
each time period, cells were treated with subtilysin, washed, and incubated at 27g for 20 h. Numbers of 
infected cells were determined as described above and each data point represents the average of three 
wells. Error bars represent standard deviation. Subtilysin treated cells (solid line, solid diamonds); Untreated 
control cells (dashed line, solid squares). (B) Kinetics of virion release from the endosome. The kinetics of 
virion release from the endosome were examined by measuring the time after binding, required for 
acquisition of resistance to inhibitors of endosomal membrane fusion. Virions of vAchsZ were 
synchronously bound to Sf9 cells for 1 h at 4Q, then the temperature was shifted to 27° for increasing time 
periods (2-120 min). At the end of each period, medium was replaced with medium containing 25 mM 
ammonium chloride or 0.75 mM chloroquine for the remainder of the assay (20 h). The numbers of infected 
cells were determined as described above. The inset shows an identical experiment in which chloroquine 
was added at 2 min intervals between 0 and 40 minutes. 
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and 20 min of incubation at 27s. As shown in Figure 7A the measured half-time for 
internalization of virions into endosomes was ~ 12.5 min. 
Release of BV nucleocapsids from the endosome occurs when the BV envelope 
fuses with the membrane of the endosome, an event catalyzed by the pH triggered 
fusion activity of GP64. Studies using a syncytium formation assay indicate that 
AcMNPV and OpMNPV GP64s are triggered at pH values of - 5.5 - 5.7(10, 147). 
Lipophilic amines such as ammonium chloride or chloroquine buffer the endosomal pH 
and can be used to inhibit membrane fusion during endocytosis. For precise studies of 
timing, ammonium chloride appears to be the reagent of choice since ammonium 
chloride can buffer the pH of the endosome within 1 min after its addition to cells (77). 
To measure the timing of baculovirus nucleocapsid release from the endosome, we 
used ammonium chloride inhibition in combination with the single cell infectivity assay. 
vAchsZ BV binding at the cell surface was synchronized by binding virions at 4s for 1 
hour, then shifting the cells to 27s. After various intervals at 27s (0-120 min), ammonium 
chloride was added to a final concentration of 25 mM and cells were incubated for up to 
24 hours. At 24 h after shifting to 279, plates were scored for infected cells. When 
ammonium chloride was added immediately after the 4s BV binding period, an ~ 98% 
inhibition of virion infectivity was observed. With increasing intervals of incubation at 27s 
prior to ammonium chloride addition, the numbers of infected cells detected increased 
(Fig. 7B). Escape from ammonium chloride inhibition was first detected after 16 minutes 
and was near maximal levels after ~ 28 minutes of incubation at 27e. Within 30 min at 
279, infectivity had increased to ~ 90% of that from cells in which no ammonium chloride 
was added. Thus, after binding of BV at the cell surface, the estimated half-time for 
triggering of membrane fusion and release of BV nucleocapsids from the endosome in 
Sf9 cells was ~ 25 min (Fig. 7B). 
Discussion 
The process of baculovirus entry by receptor-mediated endocytosis may be 
subdivided into several discrete steps: virion binding at the cell surface, formation of 
clathrin coated pits and uptake of the virion into a vesicle (endosome), triggering of 
membrane fusion by low pH, and release of the nucleocapsid into the cytoplasm. 
Although the role of GP64 in membrane fusion has been examined in some detail (10, 
25, 171, 172, 195, 196), its role as a potential host cell receptor binding protein has not 
been previously explored. Several lines of indirect evidence suggested that GP64 might 
represent the viral encoded host cell receptor binding protein. First, the GP64 protein 
represents the most abundant viral protein identified from the BV envelope, and BV-
neutralizing antibodies recognize the GP64 protein (97, 206). Recent studies of GP64 
glycosylation also suggested that the glycosylation state of GP64 may affect virion 
binding to host cells (115). Second, GP64 homologs (known as GP75) from a small 
group of arboviruses within the Orthomyxoviridae appear to be involved in receptor 
95 
binding. The GP75 proteins from the Thogoto and Dhori viruses show remarkable 
primary amino acid sequence identity with baculovirus GP64 proteins, and Thogoto 
virus hemagglutination is inhibited by a monoclonal antibody directed against GP75 
(146, 173, 201). Finally, the GP64 protein expressed on the surface of transfected insect 
cells is capable of mediating low pH-triggered membrane fusion (10). Since prior 
receptor binding (docking) is usually a requirement for membrane fusion, this final 
observation strongly suggested that GP64 may also function as the host cell receptor 
binding protein. 
In the current study, we examined the role of GP64 in host cell receptor binding 
by using a soluble form of OpMNPV GP64 as a competitor for virion binding. To 
examine competition for virion binding to the host cell, we developed a competition 
assay in which a recombinant baculovirus (vAchsZ) carrying a marker gene was bound 
to the cell surface by incubation at 4° in the presence of competitor proteins. Unbound 
virions were removed by washing cells prior to shifting the temperature to 27°. 
Successful virus binding was scored by analysis of single ceil expression of (3-
galactosidase from the recombinant virus. In competition experiments, we showed that 
both AcMNPV and OpMNPV competed with vAchsZ for binding, suggesting that both 
OpMNPV and AcMNPV utilize the same cellular receptor(s). To examine the role of 
GP64 in virion binding to host cells, we used a highly purified soluble form of GP64 as a 
direct competitor for virion binding. The purified soluble GP64 (GP64sol0p) was 
determined to be structurally indistinguishable from the ectodomain of native GP64 from 
budded virions, based on oligomerization patterns and their comparative sensitivities to 
glycosidase, protease cleavage, and reducing agent DTT. Because the soluble form of 
GP64 specifically competed for vAchsZ binding to Sf9 cells, these data directly implicate 
GP64 as a host cell receptor binding protein. In addition, reduced GP64sol0p did not 
exhibit any significant competition in this assay suggesting that disulfide bonds may be 
required to maintain a structure capable of binding the receptor. Although we did not 
attempt to measure the affinity of GP64sol0p binding to host cells in the current study, it is 
likely that GP64sol0p binds to host cells with a lower overall affinity than virions, which 
contain local concentrations of GP64. Such differences in affinity may explain why we 
were not able to eliminate virion binding completely in this very sensitive assay. 
However, our demonstration that GP64sol0p competes for virion binding in this assay 
provides the best data to date that GP64 serves as a baculovirus virion binding protein. 
gp64 genes from several baculoviruses (AcMNPV, BmNPV, OpMNPV, CfMNPV, 
AfMNPV {Anagraphs falcifera), and EpNPV (Epiphyas postvittana)) have been 
identified and these proteins are highly conserved, showing ~ 80% amino acid 
sequence identity within the predicted ectodomains(9, 93, 155, 273). Because both 
AcMNPV and OpMNPV are able to enter Spodoptera frugiperda cell lines yet are 
distinctly different viruses with distinct host ranges, the differences in host range may be 
explained by factors other than virion binding. Indeed, our previous studies have shown 
that two OpMNPV late promoters are not fully functional in the AcMNPV genome (62). 
Studies of host range determinants in AcMNPV and other baculoviruses have identified 
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critical host range factors that do not appear to be associated with virion entry into the 
host cell (32, 44, 125, 152, 154, 168). Those studies indicate that baculovirus host 
specificity can be determined at levels other than virion binding at the cell surface. 
However, identification of the host receptor for AcMNPV BV will be important for 
understanding whether viral entry may influence tissue specificity within the infected 
host and for applications of AcMNPV BV for gene delivery in biotechnological 
applications such as gene therapy. BV from AcMNPV are infectious to cells of many 
insect tissues and are highly infectious in insect cell culture. Several early studies 
showed that BV entered cells of diverse organisms that were non-permissive for viral 
replication (16, 19), although the mechanisms of entry were not examined. Recent 
studies of several mammalian cell types showed that AcMNPV BV efficiently entered 
primary cultures of human hepatocytes and cell lines derived from hepatocytes (3, 12, 
96, 218). Other recent studies have reported BV entry into a broad range of mammalian 
cell lines (227). The apparently wide array of potential cell types that AcMNPV BV can 
enter suggests that the BV interaction with the host cell may involve recognition of a 
host receptor molecule that is highly conserved and present on many cell types, or that 
the interaction may be relatively non-specific. 
In the current studies, we also examined the kinetics of two successive steps in 
baculovirus BV entry by receptor-mediated endocytosis: 1) uptake into the endosome 
and 2) release from the endosome by membrane fusion. vAchsZ entry was analyzed by 
synchronizing BV entry by binding virions to cells at 4°, then using a protease resistance 
assay to measure virions internalized after various periods of incubation at 27s C. The 
measured half-time required for virus uptake was 12.5 minutes. This rate of entry is 
similar to those reported from adenovirus, Influenza virus and SFV, which have uptake 
half-times of 12.5, 10 and 3-5 min, respectively (69, 77, 160). Release of baculovirus 
virions from endosomes was measured using inhibitors of low pH-triggered membrane 
fusion. The measured half-time for nucleocapsid release from the endosome was 25 
minutes. This is similar to release times reported from several enveloped viruses, 
including Influenza, VSV, Reovirus and West Nile Virus (159, 162, 240). In an earlier 
study (261), it was estimated that significantly longer times (half-times of 1-1.5 hours) 
were necessary for AcMNPV BV release from the endosome. The differences may result 
from differences in the assay techniques used in the two studies. In the current study, 
we used a sensitive single cell infectivity assay that detects viral entry and early gene 
expression in single cells, thus isolating virion entry from subsequent steps such as late 
gene expression, viral replication, and plaque formation. The current data on BV entry 
and nucleocapsid release correspond well with data reported from other enveloped 
viruses. 
In summary, we identified GP64 as a protein involved in AcMNPV binding to host 
cell receptors and we characterized two steps in AcMNPV entry into host cells: 
internalization into and release from endosomes. Because the GP64 proteins are highly 
conserved in several baculoviruses, and share a common ancestry with the GP75 
envelope proteins from several orthomyxoviruses that are transmitted by ticks, it is 
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possible that a common entry mechanism is shared by these disparate groups that both 
infect arthropods. Future studies that identify and characterize the host cell receptor for 
baculovirus binding will be important for understanding how these very different viruses 
are adapted to their invertebrate hosts. 
Materials and methods 
Cells, viruses, and recombinant virus construction. Spodoptera frugiperda (Sf9) 
and Lymantria dispar (Ld652Y) cells were cultured at 27s in TNM-FH complete medium 
(95) containing 10% FBS. Viruses AcMNPV (strain E2) and vAchsZ (172, 256), were 
titered on Sf9 cells, and OpMNPV was titered on Ld652Y cells as described previously 
(9). To construct a recombinant virus expressing soluble GP64, a stop codon was 
engineered into the OpMNPV gp64 gene in plasmid p64-166 (10) immediately 
upstream of the predicted transmembrane domain. A synthetic oligonucleotide 
(5'CTCAACGCCACGCTCTgaTCATTTATGCTGGGGCAC-3') was used to convert the 
codon for Tyr478 (TAC) to TGA, using site directed mutagenesis (39, 203). Next, the 
synthetic antisense oligonucleotide 5'-ACCATCTGTAGATCTTGTAGTGTT-3' was used 
for site directed mutagenesis to introduce a Bglll restriction site just upstream of the 
gp64 ATG, and the resulting plasmid was named p64-BglATG-STOP. The -1700 bp 
Bglll/Spel fragment containing the gp64 ORF from p64-BglATG-STOP was cloned into 
BamHI/Xbal digested transfer vector pAcDZI, replacing the lacZ ORF and placing the 
modified gp64 ORF under control of the very late polyhedrin promoter. The resulting 
plasmid was named (pAcGP64STOP). A recombinant virus was generated by co-
transfection of Sf9 cells with pAcGP64STOP and Bsu36l-digested BacPAK6 viral 
genomic DNA (Clontech) and the virus was named vAcGP64sol0p. Recombinant viruses 
were isolated by 3 rounds of limiting-dilution cloning. Recombinant viral genomes were 
confirmed by restriction enzyme analysis and by PCR using primers homologous to the 
polyhedrin promoter and the OpMNPV gp64 gene. 
Purification of GP64soPp. For biochemical studies requiring high purity GP64sol0p 
and to confirm biological assays, a highly purified preparation of GP64sol0p was 
prepared. A four step protocol was developed to purify GP64sol0p from tissue culture 
supematants of vAcGP64sol0p-infected cells. Insect cells (Tn5B1-4) were grown in 
serum-free media (Excell 405; JRH Biosciences), and infected at an MOI of 10 with 
vAcGP64sol0p. After infection, the cells were diluted to a density of 1 x 106 cells/ml and 
maintained in spinner culture at 27s for 48 h. Cells and debris were removed by low 
speed centrifugation, supematants were collected, and sodium azide was added to 
0.02% w/v. Sodium azide was present at all times throughout the purification, except for 
ion-exchange loading, wash and elution. ConA-agarose beads (Sigma) equilibrated in 
ConA wash buffer (150 mM NaCI, 20 mm NaPi pH 7.0) were added to the supernatant 
(~ 143 mg beads/liter) and mixed gently overnight at ~ 4 rpm at 7s in a roller bottle. The 
beads were collected in a large buchner funnel, transferred to a glass column (3 cm 
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diameter), and washed extensively with ConA wash buffer. Bound glycoproteins were 
eluted with two bed volumes of 0.5 M glucose, 0.5 M methyl -D-mannopyranoside, 20 
mM NaPi pH 7.0, followed by three bed volumes of ConA wash buffer. The eluate and 
first bed volume of wash were pooled and dialyzed overnight against 200 mM NaCI, 20 
mM NaPi pH 7.0. The dialyzed pool was centrifuged (27,000 x g for 30 min at 4° C) to 
remove precipitated material. For hydrophobic interaction chromatography, the 
supernatant was applied to a column composed of phenyl-Sepharose CL-4B 
equilibrated with 200 mM NaCI, 20 mM NaPi, pH 7.0. After sample application the 
column was washed with one bed volume of 200 mM NaCI, 20 mM NaPi, pH 7.0 
followed by one bed volume of 20 mM Tris-HCI, pH 8.0. The bound proteins were eluted 
by washing with two bed volumes of distilled H20. The bound GP64sol0p eluted as a 
major peak at the 20 mM Tris-HCI-dH20 transition, followed by a very broad tail. The 
fractions were analyzed on SDS-PAGE gels and the fractions containing GP64sol0p 
were pooled and dialyzed against 20 mM Tris-HCI, pH 8.0. For anion-exchange 
chromatography, the pooled fractions were applied to a DEAE-Memsep cartridge 
(Millipore) equilibrated with 20 mM Tris-HCI, pH 8.0. After sample application, the 
cartridge was washed with 20 mM Tris-HCI, pH 8.0. Bound proteins were eluted with a 
linear salt gradient (0 to 250 mM NaCI) in 20 mM Tris-HCI, pH 8.0. GP64sol°p eluted as 
several peaks at salt concentrations from 75 to 150 mM NaCI. The fractions containing 
GP64sol0p were pooled, and Tween 20 was added to 0.1% vol/vol and sodium azide 
was added to 0.02% wild-type/vol. The pooled fractions were concentrated with 
Centriprep 30k MWCO ultrafiltration units. For gel filtration chromatography, the 
concentrated fractions were applied to a 94 cm x 2 cm column of Sephacryl S400HR 
equilibrated with 200 mM NaCI, 20 mM NaPi, pH 7.0. The peak fractions containing 
GP64sol0p were pooled and concentrated as above, and aliquots of GP64sol0p were 
stored at -809. The final purity of GP64sol0p was > 95% as judged by densitometric 
quantification of Coomassie-blue stained SDS-PAGE gels. For protease resistance 
assays, a partially purified preparation of GP64sol0p was prepared and used. 
Supernatants of cells infected with vAcGP64sol0p were collected as before and 
incubated with ConA beads as described above, then protein was precipitated in 10% 
ammonium sulfate. GP64sol0p was further purified by gel filtration chromatography as 
described above. Purity of partially purified GP64sol0p was estimated at ~ 60% by 
Bradford assay and Coomassie stained SDS-PAGE gels, and confirmed by Western 
blot analysis. 
Glycosidase treatment, protease resistance, and reduction of GP64soPp. For 
glycosidase digestions, 2 ux| of purified GP64sol0p was digested with either 0.5 units of 
Endo F (Boehringer) or 0.01 units of Endo H (Boehringer) for 1 hour in 10 mM sodium 
phosphate buffer pH 7.0 at 37 s, then electrophoresed on 6% SDS-PAGE gels. 
To compare the protease resistance profiles of GP64sol°p and native OpMNPV 
GP64, 0.5 ng of secreted soluble GP64 (GP64sol°p) and 1.0 |ig of OpMNPV budded 
virions were each treated with 0.1 mg/ml proteinase K for 10 min at 56e. Digestion 
products were examined by electrophoresis on SDS-PAGE gels and Western blot 
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analysis with MAb AcV5 (97). For comparisons of oligomerization and the susceptibility 
of oligomers to reduction by DTT, purified GP64sol0p (0.5 |ig) or OpMNPV budded 
virions (1.0 u.g) were incubated with increasing concentrations of DTT at 37s for 5 min. 
Trimerization and reduction were examined by preparing proteins in 37.5 mM 
lodoacetamide, 2% SDS (no (3-mercaptoethanol) and electrophoresing proteins on a 
6% nonreducing polyacrylamide gel as described earlier (184), followed by Western 
blot analysis using MAb AcV5. 
Binding, infectivity, and competition assays. To measure the effects of GP64sol0p 
competition on BV binding, we used recombinant virus vAchsZ (which constitutively 
expresses (3-galactosidase in the early phase) for a sensitive single cell infection assay. 
To demonstrate the linearity of the assay, Sf9 cells (3 X 105) were infected with various 
concentrations of vAchsZ virions (MOIs ranging from 0.0125 to 0.2) by incubating virus 
with cells for 1 hour at 4s. Cells were washed three times in complete TNM-FH medium 
at 4°, then incubated for 24 h in complete TNM-FH medium at 27s, fixed 10 min in 0.5% 
gluteraldehyde in PBS at RT, and stained for (3-galactosidase activity using 1 mg/ml X-
gal in PBS + 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1mM 
MgS04 (247). For each virus dilution, three wells of cells were infected and the number 
of stained cells in each well were counted. Data presented (Fig. 3) represent the 
average and standard deviation (error bars) of data from three wells. For competition 
assays, Sf9 cells (3 or 6 x 105) were preincubated with various concentrations of 
competitors for 1.5 h at 4s, then BV of vAchsZ were added and incubated with agitation 
for 1 h at 4s, and cells were processed and assayed as described above. For some 
experiments, higher or lower MOIs of vAchsZ were used but in all cases, MOIs fell within 
the linear range of the assay (as established above, Fig. 3A). Viruses (AcMNPV and 
OpMNPV) used as competitors in binding assays were inactivated by addition of 
psoralen (4'-aminomethyl-Triosalen, Sigma) to a final concentration of 1 mg/ml followed 
by crosslinking for 10 minutes with a UV transilluminator (312 nm). Inactivation of viral 
infectivity was confirmed by examining infectivity on Sf9 or Ld652Y cells as described 
above. 
For competition assays, protein competitors consisted of highly purified 
GP64sol0p and a negative control, Bovine Serum Albumin (BSA; Sigma Chemicals). As 
additional controls, protein competitors were also treated with chymotrypsin (2 mg/ml) at 
37s for 30 min. Reactions were terminated with 1 (iM Leupeptin, 1 uM Pepstatin A and 4 
u.M Pefabloc. Complete proteolysis of GP64sol0pwas assessed by electrophoresis and 
examination on 8% polyacrylamide gels. As an additional control, DTT was added to a 
final concentration of 10 mM, and samples were incubated at 959 for 20 min. After 
treatment in DTT, protein samples were diluted 100x to a final concentration of 0.1 mM 
DTT and applied to cells as competitors. To confirm that this concentration of DTT did 
not interfere with infection, cells were also preincubated with 0.1 mM DTT prior to 
infection with vAchsZ in the absence of competition. 
BV binding, entry, and endocytosis assays. For analysis of virion binding at the 
cell surface and entry after binding, BV of virus vAchsZ was bound to Sf9 cells at 4s for 1 
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h, and cells were washed in complete TNM-FH at 4°. In initial experiments, subtilysin 
was added to a final concentration of 2 mg/ml either before, or after shifting cells to 27s 
and incubating 1 h. As controls, BV were also pretreated with subtilysin (2 mg/ml) prior 
to binding BV to Sf9 cells. For studies of virion entry, BV of vAchsZ were bound to Sf9 
cells at 4s for 1 h, then the temperature was shifted to 27s for increasing periods of time. 
At the end of each time interval at 279, cells were treated with 2 mg/ml subtilysin for 15 
min at 379 to inactivate or remove virions remaining at the cell surface. This 
concentration of subtilysin was previously determined to inactivate BV when BV were 
treated prior to binding to host cells (not shown). Cells were then washed three times 
with complete TNM-FH medium, incubated for 20 h at 27a in TNM-FH complete medium, 
then fixed and stained as described above, and scored for single infected cells. To 
examine the kinetics of virion release from the endosome, virions were bound to cells 
for 1 h at 4°. The temperature was then shifted to 27° for increasing time intervals as 
described above. At the end of each interval, media was exchanged for TNM-FH 
containing 25 mM ammonium chloride or 0.75 mM chloroquine, then incubated 20 h at 
27a and assessed for single cells expressing (3-galactosidase activity. 
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Chapter 6 
Characterization of the ORF119-gp64-p74 locus of Anticarsia 
gemmatalis Multicapsid Nucleopolyhedrovirus 
Abstract 
The Anticarsia gemmatalis Multicapsid Nucleopolyhedrovirus (AgMNPV) is succesfully 
utilized in biological insect pest control but little is known of its molecular biology and its relatedness 
to other better characterized baculoviruses. In this study, we examined a 12.5 kbp area of the 
AgMNPV genome which contains homologs to the lef-7, gp64, p24, gp16, pp34, alkaline 
exonuclease, p26, p10, and p74 genes of Autographa californica Multicapsid 
Nucleopolyhedrovirus (AcMNPV). Comparison of AgMNPV genes to homologs from four other 
Nucleopolyhedroviruses (AcMNPV, Bombyx mori MNPV (BmNPV), Orgyia pseudotsugata MNPV 
(OpMNPV), and Choristoneura fumiferana MNPV (CfMNPV)), suggests that AgMNPV is most 
closely related to OpMNPV and CfMNPV. Gene organization in the Ief7-gp64-p74 region was 
generally similar with several notable differences. Among these differences were the absence of 
homologs to the chitinase, cathepsin, and p35 genes of AcMNPV, the presence of a small ORF 
with homology to the 3' end of the AcMNPV p94 gene, and the presence of a 195 nt hr-\\ke repeat 
region between the homologs of AcMNPV ORF119 and 120. This repeat region was unable to 
support plasmid replication in a transient replication assay. Comparison of AgMNPV GP64 to six 
other baculovirus GP64s showed that a) the ectodomain is highly conserved (~ 77 to 82% amino 
acid identity between the various GP64s), b) the AgMNPV GP64 transmembrane (TM) domain is 
the least conserved among the various GP64 TM domains, and c) the cytoplasmic tail domain 
(CTD) of AgMNPV is truncated, consisting of only two arginines. To examine functional similarities 
between the AgMNPV GP64 protein and other baculovirus GP64s, we examined the pH 
requirements for triggering membrane fusion in syncytium formation assays. The maximum pH 
required for triggering AgMNPV GP64-mediated membrane fusion was identical to that determined 
for OpMNPV GP64, and similar to that for AcMNPV GP64. Implications of these observations are 
discussed. 
Manuscript in preparation: 
Oomens, A.G.P., M. Lobo de Souza, J.M. Slack, B.M. Ribeiro, and Gary W. Blissard. Characterization of the 
ORF119-gp64-p74 locus of Anticarsia gemmatalis Multicapsid Nucleopolyhedrovirus. 
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Introduction 
Baculoviruses are large double stranded DNA viruses of invertebrates that have 
been used as biological control agents and as vectors for eukaryotic gene expression 
and protein production. Most detailed studies of baculovirus molecular biology have 
focussed on the following baculoviruses: Autographa californica Multicapsid 
Nucleopolyhedrovirus (AcMNPV), Bombyx mori NPV (BmNPV), Orgyia pseudotsugata 
MNPV (OpMNPV), and Lymantria dispar MNPV (LdMNPV), of which the complete 
genomic sequences are now available ((2); Accession number L33180; (1, 141)). 
Because in most cases, wild-type AcMNPV is not sufficient for effective biological 
control in commercial agricultural settings, many studies have attempted to improve its 
properties as a biological control agent by adding foreign genes. In contrast, a related 
baculovirus, Anticarsia gemmatalis MNPV (AgMNPV), has been highly succesful as a 
biological control agent in agriculture and is currently used for insect control on over 
one million hectares of soybeans in Brazil. Thus, AgMNPV may represent the most 
successfully used baculovirus in agriculture worldwide. Unlike AcMNPV, little is known 
of the molecular biology of AgMNPV and its degree of relatedness to other better 
characterized baculoviruses. 
AgMNPV is classified as a member of the Nucleopolyhedroviruses (NPVs), one 
of two genera within the family Baculoviridae. Because of a lack of extensive sequence 
data outside the few well studied viruses above, the degree of relatedness of viruses 
within the NPVs is not well understood. Studies of the AgMNPV genome to date have 
focused on restriction enzyme mapping (120), examination of repeated sequences 
homologous to the AcMNPV and OpMNPV hr regions (33, 59), and physical mapping 
and characterization of the polyhedrin gene (287). Comparison of polyhedrin gene 
sequences suggested that within the Lepidopteran NPVs, at least two evolutionary 
divergent groups exist, and that AgMNPV clustered with AcMNPV, OpMNPV, and 
BmNPV, designated NPV group I (286). Those studies also showed that AgMNPV 
appears more distantly related to baculoviruses of designated NPV group II, such as 
Mamestra brassicae MNPV (MbMNPV), Panolis flammea MNPV (PfMNPV), Spodoptera 
frugiperda MNPV (SfMNPV), and Spodoptera exigua MNPV (SeMNPV). The division of 
the NPVs into groups I and II, and the placement of AgMNPV within the group I viruses 
was supported by a recent phylogenetic study (17), in which PCR amplified sequences 
based on polyhedrin and DNA polymerase genes were examined. 
All previous phylogenetic studies were based on the comparison of a single 
AgMNPV gene with that of other baculoviruses. In the study presented here, we 
examine a continuous 12.5 kbp region of the AgMNPV genome, which contains the 
gp64 gene, plus homologs to the ORF119, ORF120, ORF121, lef-7, gp64, p24, gp16, 
pp34, alkaline exonuclease, p26, p10, and p74 genes of AcMNPV. This region is 
compared to four other NPVs, AcMNPV, BmNPV, OpMNPV, and Choristoneura 
fumiferana (CfMNPV), generating a view of the comparative gene organization of this 
genomic region. One observed difference was the presence of a short sequence with 
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homology to various baculovirus hrs. This sequence was subcloned and analysed in a 
transient replication assay (134). Other observed differences include the absence of 
chitinase, cathepsin, and p35 genes, the presence of a short sequence encoding a 
protein with homology to the C-terminus of AcMNPV P94, and the presence of a 
homolog to (CfMNPV) hypothetical protein P22.2. Hypothetical translation products of 
the AgMNPV ORFs were subjected to Blast searches, and sequence alignments 
between the putative AgMNPV proteins and homologs from other baculoviruses 
revealed that the highest average degree of amino acid identity occurred between 
AgMNPV, OpMNPV, and CfMNPV proteins. Among all the putative AgMNPV protein 
homologs examined, GP64 displayed the highest amino acid identity between the 
different viruses. Analysis of AgMNPV virion-associated GP64 revealed that its 
molecular weight is similar to GP64 of AcMNPV and OpMNPV, and syncytium formation 
assays based on transient expression of the AgMNPV gp64 gene show that the pH 
requirement for GP64-induced membrane fusion is identical to that of OpMNPV GP64 
and similar to that of AcMNPV GP64, despite significant differences in the TM and CTD 
domains. A multiple sequence alignment with all known baculovirus GP64s and two 
distant GP64 homologs in Thogoto-like orthomyxoviruses, Thogoto (THO) virus 
envelope protein (THO env; (201)) and Dhori (DHO) virus envelope protein (DHO env; 
(54)), identified seven blocks of high amino acid identity, and displays a general GP64 
structural organization which may yield insight into the structure-function of the GP64 
protein. 
Results 
To address the relatedness between AgMNPV and other, well characterized 
baculoviruses, we selected the highly conserved gp64 gene and flanking regions for 
analysis of gene organization. To locate the gp64 gene, a probe based on three 
overlapping portions of the AcMNPV gp64 gene, was used for moderate-stringency 
Southern blot hybridizations. Using this technique, a 5.4 kb Hindlll fragment of the 
AgMNPV genome was identified. Because preliminary analysis showed that the Hindlll-
I fragment contained only a portion of the gp64 ORF (3' end), a larger AgMNPV 
fragment (12.5 kb, BamHI-D) containing the entire gp64 ORF was subcloned from the 
AgMNPV genome. This 12.5 kb BamHI-D fragment was subsequently sequenced. 
Gene organization in the ORF119-gp64-p74 region. The arrangement of genes 
in the selected 12.5 kb genomic segment of AgMNPV was compared to corresponding 
regions of OpMNPV, CfMNPV, AcMNPV, and BmNPV in Fig. 1. The complete 
corresponding loci are available from complete genomic sequences for OpMNPV, 
AcMNPV, and BmNPV. For CfMNPV, the majority of the corresponding locus was 
assembled from overlapping sequences available in the GenBank database(see 
Materials and Methods), resulting in a genomic segment from gp64 to p74. While in 
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general the region was found to be similar in gene order and orientation, several 
striking differences were observed: 
- Chitinase and cathepsin genes are absent from this region of the AgMNPV genome. 
In AcMNPV, BmNPV, OpMNPV, and CfMNPV, GP64, chitinase, and cathepsin are 
highly conserved baculovirus proteins, and the genes encoding these proteins are 
found clustered together. In the corresponding location of the AgMNPV genome 
however, chitinase and cathepsin genes are absent. In addition, attempts to locate a 
cathepsin gene homolog in the AgMNPV genome using an AcMNPVv-cath probe in 
Southern blot hybridization assays, identified no cross-hybridizing DNA fragments (data 
not shown). Because like gp64, the cathepsin gene is highly conserved between 
AcMNPV, BmNPV, OpMNPV, and CfMNPV, and stringency hybridization conditions 
were used similar to those used to locate the gp64 gene, these data suggest that the 
cathepsin gene may not be present in the AgMNPV genome. Attempts to detect 
cathepsin activity from AgMNPV-infected cells were also negative (J. Slack, personal 
communication). 
- A small ORF encoding a protein with similarity to the C-terminus of AcMNPV p94 is 
located immediately upstream of the p26 gene. This is particularly interesting because 
the presence of p94 varies considerably between AcMNPV, BmNPV and OpMNPV. 
While the AcMNPV genome contains two major ORFs (p35 and p94) between the alk-
exo and p26 ORFs, the OpMNPV genome contains neither the p35 nor p94 ORF, and 
the BmNPV genome contains the p35 ORF and a small portion of the p94 ORF (Fig. 1). 
Like AgMNPV, the BmNPV p94 portion maps to the C-terminus of the AcMNPV P94 
homolog, however to a different location than the BmNPV p94 portion. Unlike AcMNPV 
p94, the ATG codon of the small AgMNPV ORF does not conform to Kozak's rules and 
an early (or late) consensus transcription motif (TATA; CAGT) is not present, suggesting 
that it may not be transcribed. A larger (and perhaps functional) AcMNPV P94 homolog 
has been identified only in Leucania separata NPV (LsNPV)(119), but this p94 homolog 
is located in a different locus since it is found adjacent to AcMNPV ORF61, 60, and 59 
(Ief8 locus) homologs from LsNPV. The presence of p94 in AcMNPV and LsNPV, the 
absence of p94 in OpMNPV, and the presence of portions of p94 in AgMNPV and 
BmNPV suggests the possibility that the AcMNPV or LsNPV genome may more closely 
FIG. 1 . Genomic heterogeneity in the ORF119-gp64-p74 genomic region of five distinct 
Nucleopolyhedroviruses. The 12.5 kb BamHI-D fragment of AgMNPV (Isolate 2D) was sequenced and 
compared to the corresponding region in OpMNPV (1), AcMNPV (2), BmNPV (GenBank accession number 
L33180) and CfMNPV (see Materials and Methods). Positions indicated at the beginning and end of each 
genomic fragment are the positions within the complete genomes, except for AgMNPV and CfMNPV. At 
the bottom, a bar indicates the scale (basepairs). Large differences between the genomic regions are 
illustrated by shaded areas. (Insert) Two regions (represented by horizontal bars) with significant 
sequence similarity to a previously identified AgMNPV tandem repeat region ((59), are present between 
ORF119 and 120 (boxed area within AgMNPV sequence), and are designated repeat-1 and repeat-2. Both 
repeat regions display significant nucleotide identity with various baculovirus hrs (see text). Numbers 
indicated represent the position of these repeat regions within the 12.5 kb AgMNPV genomic fragment. 
The positions of two imperfect palindromes, located within these repeat regions, are indicated. 
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resemble an ancestral state in which the large p94 gene was present. Subsequently, 
p94 may have been relocated or partially or completely lost as these viruses diverged. 
- AgMNPV contains a homolog to hypothetical protein p22.2 of CfMNPV, while a P22.2 
homologous ORF is absent from OpMNPV and AcMNPV (Fig. 1). The AgMNPV 
homolog encodes a predicted protein of 211 amino acids displaying 61.6% identity with 
CfMNPV P22.2. The functional relevance of p22.2 is not known. 
- Putative hr sequences. AgMNPV contains a sequence, located between ORF119 and 
120 homologs, with similarity to various baculovirus hr regions. This area displays two 
regions, (nt 891 to 992 and 1005 to 1084), with a high degree of nt identity to each 
other, each containing an ~ 40 nt imperfect palindrome (Fig. 1). Both regions show 
similarity to nt 488-564 of a previously published AgMNPV genomic repeat region (59), 
and are designated repeat-1 (102 nt) and repeat-2 (80 nt). In addition, Blast searches 
reveal homology of repeat-1 to an OpMNPV enhancer region downstream of the IE2 
gene (250), and to the 3' end of the CfMNPV IE2 ORF (GenBank accession number 
U72030). AgMNPV repeat-2 shows homology to the same OpMNPV enhancer region, 
CfMNPV /E7-enhancer region (GenBank accession number L04945), CfMNPV hr\ 
region (282), BmNPV hr\ region (156), and AcMNPV hrA region (80). It has been 
speculated that hrs may serve as hot spots for genomic rearrangements (167), and they 
can serve as enhancers of transcription (81, 250) and putative origins of replication 
(135). Although this region is small in comparison to characterized hr sequences from 
AcMNPV and other repeats in AgMNPV, we examined whether the short AgMNPV 
repeat sequences could serve as an origin of replication in an infection-dependent, 
transient replication assay (135). Both AgMNPV repeat-1 and -2 were examined 
separately as well as combined (as present within the AgMNPV 12.5 kb sequence). 
Repeats were PCR amplified and cloned into pGEM-T vector plasmids. A known 
AcMNPV hr (hro) was cloned into the same plasmid as a positive control. Unlike the 
AcMNPV /7/5-containing plasmid which displayed substantial replication, neither of the 
plasmids containing AgMNPV repeats was able to support plasmid replication in the 
context of AgMNPV or AcMNPV viral infection (data not shown). It is possible that 
additional factors are necessary to allow replication of the AgMNPV repeat regions in a 
transient assay, but the above result suggests that these small regions alone do not 
serve as origins for AgMNPV viral replication. 
Amino acid identities show that AgMNPV is closely related to OpMNPV and 
CfMNPV, and confirm the proposed phylogenetic placement of AgMNPV within one 
NPV subgroup. Figure 2A shows amino acid sequence identities between all proteins 
(50 amino acids or longer) predicted by the ORFs in the AgMNPV 12.5 kb sequence 
and their homologs in other baculoviruses. Protein homologs were identified from the 
GenBank database by Advanced Blast searches. ORF119 and p74 from the AgMNPV 
sequence are incomplete: The protein predicted by AgMNPV ORF119 constitutes -
50% (the C-terminal half) of its AcMNPV homolog, whereas AgMNPV P74 represents 
the C-terminal ~ 29% of AcMNPV P74. Figure 2B graphically displays percent identity 
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FIG. 2. (A) Amino acid identities between translated putative ORFs of AgMNPV and other 
baculoviruses. Positions of the putative ORFs within the 12.5 kb sequence are indicated in column 1. In 
column 2 (hAc ORF) the AcMNPV homologs to the AgMNPV ORFs are indicated according to Ayres (2), 
except position 10563-9928 (homolog to CfMNPV hypothetical 22.2kD protein), and three ORFs (U1, 2 
and 3) with no observed homologies. Column 3 shows commonly used names of some of the proteins. 
Column 4 shows the length of the predicted AgMNPV proteins in amino acids. Displayed percentages are 
the number of identical amino acids between AgMNPV and a homolog/total number of amino acids of the 
AgMNPV protein x 100%. Where homologies were to partial proteins only, the percentage is followed by *, 
see specific comments in 'Results' section. (B) Graphic representation of selected amino acid identities of 
Figure 2A, with amino acid identities on the Y-axis and selected viral proteins of five different viruses 
(OpMNPV [1], CfMNPV [2], AcMNPV [3], BmNPV[4], LdMNPV [5]) on the X-axis. A possible CfMNPV 
homolog to ORF119 is indicated by '?', as the ORF119-genomic region of CfMNPV is not available from the 
GenBank database. 
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for a selection of proteins from Figure 2A, and demonstrated that AgMNPV is closely 
related to OpMNPV and CfMNPV: Except for P10 and ORF132, all identities are higher 
than 64%. Between AgMNPV and two other proposed NPV group I viruses, AcMNPV 
and BmNPV, amino acid identities are also high (ranging from 28.4 to 77%), but lower 
than the identities between AgMNPV and OpMNPV or CfMNPV. Analysis of the 
complete LdMNPV genome sequence (141) revealed homologs to 95 AcMNPV ORFs, 
although there was only limited similarity in the organization and order of genes. Out of 
the 19 selected ORFs within the AgMNPV sequence, homologs for only five (ORF119, 
p24, pp34, alk-exo., and p74) were found in LdMNPV, with identities ranging from 29.4 
to 49.5%. Relatively low identities with LdMNPV support the conclusion that LdMNPV is 
phylogenetically relatively distant from the proposed group I NPVs (141). Relatively low 
amino acid identities are also observed between proteins of AgMNPV and group II 
NPVs (Buzura suppressaria SNPV [BsNPV], SeMNPV, Spodoptera litura MNPV 
[SpltNPV], Spodoptera littoralis MNPV [SpliNPV]). This, combined with the high identity 
between AgMNPV and OpMNPV/CfMNPV/AcMNPV/BmNPV correlates well with the 
placement of the latter viruses within one subgroup (I) of the NPVs. 
Specific comments on amino acid identities of selected individual proteins: 
ORF129/p24: Only a partial AgMNPV P24 protein (C-terminal amino acids 125 to 
192) showed significant homology to a hypothetical LdMNPV 11k protein with unknown 
function. 
ORF131/pp34: Protein alignments revealed an unusually large difference in the C-
terminus between AcMNPV and BmNPV, two viruses that otherwise display a very high 
degree of amino acid identity. AcMNPV PP34 appeared truncated at cys249, compared 
to other PP34 proteins. Screening for alternate reading frames in the C-terminus of this 
AcMNPV PP34 coding sequence revealed that possibly a frame shift was introduced 
due to a one bp deletion at position 111647 (2). Introduction of one nt (arbitrarily an 'A') 
at that position increased the length of AcMNPV PP34 from 252 to 322 amino acids 
(similar to BmNPV PP34: 315 amino acids) and amino acid identity from 36.9 to 61.9%. 
In Gombart et al. (70), a frame shift-corrected version of AcMNPV PP34 was used for 
alignments with OpMNPV PP34; However, the source of AcMNPV PP34 however was 
reportedly the same as the one used in the complete genome of (2, 178), with no 
mention of the discrepancy in the C-terminus. Because we consider the frameshift-
corrected version (322 amino acids) more likely than the shorter version of 252 amino 
acids, the data reported in Fig. 2 reflect identity with an AcMNPV PP34 protein of 322 
amino acids (61.9%). The BsNPV PP34 sequence (102) lacked an N-terminal 
methionine and aligned with the AgMNPV PP34 sequence starting at amino acid 86. 
The BsNPV PP34 sequence therefore appeared incomplete and was aligned with a 
partial AgMNPV PP34 protein only (amino acid 86 to 293). 
ORF133/alk-exo: In addition to the baculovirus homologies, alignments showed 
similarities with two different herpesvirus proteins: a bovine herpes virus 1 DNAse 
protein (257) and the pseudoRabies UL12 gene product (with alkaline exonuclease 
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function; (40)). Although average amino acid identities (22.4% and 18.6% for bovine 
herpes 1 and Pseudorabies respectively, not shown in Fig. 2A) were relatively low, a 
cluster of amino acids with high identity was found in the same region of the putative 
AgMNPV alk-exo protein: amino acids 55 to 89. These amino acids may represent a 
conserved domain in AgMNPV ORF133 involved in its putative function. 
hCf p22.2: and ORF134/p94: See earlier. 
ORF137/p10: Sizes of P10 proteins of the various NPVs are uniform (~ 90 amino 
acids). One exception is BmNPV, of which P10 (from complete genome (100, 155)) is a 
truncated version with a length of 70 amino acids. This truncation is the result of a stop 
codon introduced by a frameshift ~ 20 amino acids before the C-terminus. This 
truncation was found in several natural isolates and does not seem to be a cloning 
artefact (100), perhaps most convincingly shown by the fact that a one bp change in the 
downstream sequence creates a putative polyA signal, conserving well the spacing 
between stop codon and polyA signal (90 nt compared to ~ 88 nt for AcMNPV). 
Therefore, the truncated P10 version from the complete BmNPV genome was used for 
the alignments in Fig. 2. There are however reports of full length BmNPV P10 proteins 
(189, 289). It is possible that the P10 C-terminus (which is involved in the formation of 
fibrillar structures) is not essential for the survival of the virus or that the truncation is an 
adaptation to a particular environment. 
ORF138/p74: Homologs to the partial sequence of AgMNPV P74 were found through 
Blast searches in 9 different baculoviruses, belonging to both postulated NPV groups (I 
and II). Across NPV group I and II, P74 is the most conserved protein of the examined 
AgMNPV sequence, with identities ranging from 49.5 to 88.8%. 
ORF128/gp64: Fig. 2B shows amino acid identities ranging from 74.5 to 78.6% 
between AgMNPV and four other GP64s, however in contrast to P74, GP64 has been 
found within proposed group I of the NPVs only. The fact that GP64 is so highly 
conserved between the different baculoviruses, (all known GP64s display between 70 
and 80% amino acid identity), suggests that GP64 is either a extremely critical factor in 
their life cycles, or that the acquisition of GP64 is a relatively recent event in baculovirus 
evolution. GP64 is a key factor in systemic spread of the virus within the insect host 
(172). The absence of gp64 from the genome of the evolutionary distant LdMNPV 
suggests that GP64 may be an attribute specific to one subgroup (I) only, and raises the 
question of whether all baculoviruses have common strategies for cell-to-cell 
transmission or whether alternate mechanisms exist for these important steps in the 
baculovirus life cycle. Previous data indicate that GP64 structure and function is 
conserved not only between the group I NPVs but also between baculoviruses and a 
Thogoto-like genus within the Orthomyxoviridae. A remarkable similarity (-32% overall 
amino acid identity, local clusters of strong amino acid identity, conserved cysteine 
residues and hydrophobicity profiles; (173)) between GP64 and the envelope protein of 
two tick-transmitted orthomyxoviruses: Thogoto (THO) and Dhori (DHO) virus. This 
homology strongly suggests a common ancestry for GP64 and the THO and DHO 
envelope proteins. 
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Comparison of GP64 homologs from different baculoviruses and THO-like 
orthomyxoviruses. Among baculovirus GP64s, amino acid identity is exceptionally high 
throughout the ectodomain. The multiple sequence alignment (Fig. 3) demonstrates that 
this is also the case for AgMNPV GP64, with ectodomain amino acid identities ranging 
from 77.5 to 81.9% between AgMNPV and other GP64s. In contrast, among all GP64 
proteins, the AgMNPV GP64 transmembrane (TM) domain is the least conserved, with 
only -22% identity with other GP64s, although most substitutions are of a conservative 
nature, retaining the overall hydrobicity of the domain. In addition, the AgMNPV CTD is 
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FIG. 3. (A) Multiple amino acid sequence alignment (Clustal method with PAM250 weight residue 
table) of seven different baculovirus GP64s (AgMNPV, OpMNPV, CfMNPV, AcMNPV, BmNPV, EpNPV, 
and AfNPV) and envelope proteins from two THO-like orthomyxoviruses (Thogoto [THO] and Dhori [DHO] 
virus). The display of identities is based on comparison with AcMNPV GP64 (center sequence). Amino 
acids differing from those of AcMNPV GP64 are indicated as shaded boxes. Numbered boxes represent 
areas of high amino acid identity (area 1 to 7). Boxes named 'fusion' and 'trimerization' represent a predicted 
hydrophobic domain of OpMNPV GP64 involved in membrane fusion (171), and a predicted hydrophobic 
domain of OpMNPV GP64 involved in trimerization (171). Signal peptide of AcMNPV GP64 (chapter 5) and 
predicted AcMNPV GP64 TM domain are also indicated. (B) Percentages similarity and divergence 
between the GP64 homologs based on the alignment of Fig. 3A. Similarity is calculated as 100x sum of the 
matches/length - individual gap residues. Divergence is calculated as 100x the distance of individual 
sequences divided by the total distance (see Materials and Methods). (C) GP64 phylogenetic tree based 
on similarities and divergence of Fig. 3B. The length of a pair of branches represents the relative distance 
between a pair of sequences. The scale beneath the tree indicates the relative distance between all 
sequences involved. 
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truncated, consisting of only two arginines. The CTD truncation correlates well with our 
previous demonstration that, although the CTD increases budding efficiency, this 
domain is dispensable for propagation of the virus in cell culture. The functional 
homology and sequence conservation between baculovirus GP64 and THO and DHO 
envelope proteins can be used as a tool to identify functional domains within GP64. At 
least seven clusters of relatively high amino acid sequence identity can be identified 
among baculovirus GP64 and THO/DHO env proteins. Based on amino acid numbers 
from the AcMNPV GP64 protein, these are designated: region 1 (aa 21-33), region 2 
(aa 66-86), region 3 (aa 102-128), region 4 (aa 142-165), region 5 (aa 340-372), region 
6 (aa 381-402), and region 7 (aa 438-465). A region that contains a predicted coiled-
coil motif (amino acids 301-337) displays lower amino acid sequence identity, but 
leucine and methionine residues predicted to constitute the hydrophobic face of the 
alpha helix, are conserved. Notably also throughout the GP64 ectodomain is the 
conservation of the location of cysteine residues. This conservation is 
also evident in the THO and DHO env proteins, and suggests conserved locations of 
disulfide bridges. The strong conservation in the ectodomain does not include a 
membrane fusion and oligomerization domain previously characterized in OpMNPV 
GP64 (171). Although these two functional domains (corresponding to AcMNPV amino 
acids 229/230 and 330-338 respectively) are well conserved among baculoviruses, 
they are only poorly to moderately conserved between GP64 and the envelope proteins 
of the THO-like viruses. 
The phylogenetic tree in Fig. 3C, projects large evolutionary distances between 
the baculovirus GP64s as a group and DHO/THO envelope proteins. The THO and 
DHO envelope proteins also appear to be diverged significantly. In comparing and 
interpreting these projected distances, one should keep in mind the fact that THO and 
DHO virus are segmented ssRNA viruses. Their mutation and recombination 
frequencies may differ substantially from the ds DNA baculoviruses. Thus evolutionary 
rates may differ and divergence may be difficult to compare between these two groups. 
While the remaining conservation between envelope proteins of two such distant virus 
families suggests an essential nature and/or a relatively high intolerance for amino acid 
substitutions, recently completed baculovirus genomes demonstrate that at least some 
baculoviruses do not possess a gp64 gene. 
Molecular mass of AgMNPV GP64 from virions and pH requirement for 
membrane fusion of AgMNPV-gp64 transfected Sf9 cells. To compare the size of virion-
associated AgMNPV GP64 to that of AcMNPV and OpMNPV, partially purified budded 
virions were electrophoresed on SDS-PAGE, transferred to membranes (Western blot), 
and incubated with MAb AcV5. The epitope recognized by MAb AcV5 (SWKDASGWS) 
is conserved between AgMNPV, AcMNPV, and OpMNPV, and resulted in detection of 
an AgMNPV GP64 protein band of ~ 60 kD, slightly smaller than the AcMNPV and 
OpMNPV GP64 proteins. The predicted AgMNPV GP64 protein is 13 amino acids 
shorter than AcMNPV GP64. In addition, carbohydrate modifications or phosphorylation 
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FIG. 4. (A) Detection of GP64 from budded virions of AcMNPV, OpMNPV, and AgMNPV. Sf9 cells 
(AcMNPV, AgMNPV), or Ld cells (OpMNPV) were infected at low moi and supernatants harvested at 4 days 
pi. Virions were isolated by centrifugation through a 20% sucrose cushion, resuspended in Laemli buffer 
and electrophoresed on 10% SDS-PAGE gels. Gels were stained with Coomassie blue (lanes 1, 3, 5, 7, 
and 8), or transferred to membranes, incubated with MAb AcV5 and visualized with an anti-mouse AP 
conjugate (lanes 2, 4, and 6). Lane 1 and 2: AcMNPV GP64; Lane 3 and 4: OpMNPV GP64; Lane 5 and 6: 
AgMNPV GP64. Lanes 7 and 8 are Coomassie stained uninfected Sf9 and Ld cell lysates respectively. (B) 
Syncytium formation after transient expression of AcMNPV, OpMNPV, and AgMNPV gp64 in Sf9 cells. 
AcMNPV and AgMNPV gp64 gene expression was driven by their respective wild-type promoters; 
OpMNPV gp64 by a truncated OpMNPV gp64 promoter construct. Amounts of GP64 on the cell surface for 
each construct were monitored by CELISA and adjusted to similar levels. At 36 h post transfection, cells 
were exposed to a range of pH values (4.5 to 6) for 5 min, further incubated in TNM-FH for 2 h, fixed, and 
scored for syncytium formation. Syncytium formation required > 5 nuclei in each syncytial mass (++ syncytia 
abundant; + syncytia present but not abundant; +/- syncytia rare but present; - no syncytia observed). 
may also cause variability in the molecular mass measured by SDS-PAGE 
electrophoresis. Low pH-induced membrane fusion is a function of GP64 necessary for 
its mechanism of entry by adsorptive endocytosis. Because truncations in the CTDs of 
some viral envelope proteins can modulate the ability to fuse membranes (174, 205, 
235), the fusogenic capacity of AgMNPV GP64 and the pH value at which fusion is 
triggered, were compared to that of OpMNPV and AcMNPV GP64. First, AgMNPV GP64 
was subcloned in a pBS-based plasmid vector with 392 nt of upstream sequence 
corresponding to nt 4037 to 6168 in the 12.5kb AgMNPV sequence (pBS-AgGP64). 
Because the level of GP64 expressed at the cell surface may be a factor in whether 
membrane fusion can be induced, MAb AcV5 was used in a modified cell ELISA assay 
(CELISA; (171)) to monitor the amount of each GP64 at the cell surface (data not 
shown). Based on the CELISA data, plasmid concentrations for cell transfections were 
adjusted, so that very similar levels of the various GP64s were present at the plasma 
membrane. AgMNPV, OpMNPV, or AcMNPV GP64-transfected cells were then exposed 
to a range of pH values (4.5-6.0) at 36 h. post transfection for 5 min, incubated in TNM-
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FH for 2 hrs, and fixed with 0.5% glutaraldehyde in PBS (Fig. 4B). Syncytium formation 
was scored based on > 5 nuclei per syncytial mass. The range of pH values at which 
AgMNPV GP64 induced membrane fusion was identical to that of OpMNPV and similar 
to that of AcMNPV. For AgMNPV and OpMNPV GP64s, the maximum pH at which 
syncytia were formed was 5.8, whereas for AcMNPV GP64 no membrane fusion was 
observed above pH 5.6. It is possible that the identical range of pH values at which 
AgMNPV and OpMNPV GP64 induced fusion, is a reflection of their high level of amino 
acid identity. 
Discussion 
Identities and similarities based on single proteins or genes are a useful tool to 
study phylogeny of baculoviruses. However these need to be considered jointly with 
other approaches for a broader view of baculovirus evolution. Analysis of multiple 
genes within a large genomic segment represents a more powerful approach, because 
it combines conservation between individual homologous genes and conservation of 
gene organization. Comparative analysis of the genomic structure of the 12.5 kb region 
of AgMNPV to OpMNPV, CfMNPV, AcMNPV, and BmNPV, may yield additional insight 
into the relatedness of the above NPVs and the potential relative importance of 
individual genes. Our study agrees well with the proposed placement of AgMNPV within 
one group of the NPVs. Within this subgroup, our data strongly indicates that AgMNPV 
is most closely related to OpMNPV, to which AgMNPV proteins revealed a high level of 
amino acid identity. Between AgMNPV and CfMNPV, almost equally high amino acid 
identities were observed, and (unlike any other NPV of this subgroup) these two viruses 
both possessed a gene encoding hypothetical protein P22.2. Of the more distantly 
related baculoviruses, most protein homologs were found among BsNPV and LdMNPV, 
but this likely reflects the large amount of sequence available from these viruses. For 
LdMNPV, a virus considered evolutionary distant from the proposed group I NPVs, 
homologs were found for ORF119, P24, PP34, alk-exo., and P74. Of these, P74 
displayed the highest percentage of amino acid identity. Thus, not only is P74 present 
across a wide variety of baculoviruses, it is also relatively well conserved. Such 
characteristics may yield clues to what some of the most conserved and critical 
functions and processess may be of the baculovirus life cycle. While comparison of the 
LdMNPV genome to that of AcMNPV revealed an average amino acid identity between 
homologs of ~ 41%, LdMNPV- and AcMNPV P74 were 61% identical (141). The most 
conserved proteins were those predicted by the polyhedrin and ORF2 genes, while 
several other well conserved genes included: lef 8, Ief9, chitinase, cathepsin, ubiquitin, 
sod, and ctl. Such proteins were likely acquired in an early evolutionary stage and were 
perhaps present in an ancestral baculovirus. 
The absence of cathepsin and chitinase genes from this AgMNPV locus is 
interesting because the location of these genes, adjacent to the gp64 gene, is very well 
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conserved in all other NPVs of this subgroup sequenced to date. Chitinase and 
cathepsin are widespread among the kingdoms and are present in all examined 
baculoviruses so far, albeit in sometimes different locations in different subgroups. They 
are known to be involved in viral directed liquefaction of the host, as cathepsin and 
chitinase deletion mutants each fail to liquefy infected caterpillars (179, 231) in an 
otherwise normal infection. Liquefaction is a result of degradation of cuticle and internal 
insect tissues, which require the synergistic action of cathepsin and chitinase and is 
thought to enhance the horizontal spread of the virus by increasing availability of 
polyhedra to feeding caterpillars. While the cathepsin gene is highly conserved among 
baculoviruses, Southern hybridization under moderate stringency conditions failed to 
detected a cathepsin homolog elsewhere in the AgMNPV genome. Absence or 
presence of cathepsin and chitinase genes can be conclusively demonstrated only by 
sequencing of the entire AgMNPV genome, and a baculovirus lacking chitinase and 
cathepsin would be exceptional. A possible absence of the chitinase and cathepsin 
genes from the AgMNPV genome might indicate that an unrelated functional homolog 
exists in AgMNPV or that cathepsin and chitinase-like enzymes may not be necessary 
for efficient propagation of AgMNPV through an insect population. It has been 
suggested that the chitinase gene may have been inserted into an ancestral 
baculovirus gene containing a signal sequence and a KDEL (ER retention) signal (167). 
The speculated absence of chitinase and cathepsin then might suggest that this 
acquisition occurred after the divergence of the AgMNPV lineage, or that the AgMNPV 
lineage lost the cathepsin/chitinase genomic region. Considering that AgMNPV is 
highly similar to OpMNPV (which like AcMNPV, BmNPV and CfMNPV, possesses both 
chitinase and cathepsin genes), the divergence of AgMNPV before acquisition of these 
genes would seem unlikely. 
In several baculoviruses, tandem repeat sequences (hrs) have been 
demonstrated at various locations within the baculovirus genomes. Sequences with 
similarities to hrs have been demonstrated in AgMNPV as well. Past studies of plaque-
purified AgMNPV isolates from field samples collected over different years in Brazil, 
identified repeat regions at four locations throughout the AgMNPV genome, one of 
which was located immediately upstream of the p74 gene (map units 88.6 to 90.1, (59, 
120)) This region contained repeats of 127 bp sequences each harboring two 30 bp 
imperfect palindromes and showed homology to hrs of AcMNPV and OpMNPV. One of 
the field isolates (AgMNPV-D7) had developed increased virulence for an alternate host 
(Diatraea saccharalis) after serial passage in this host, without affecting its virulence for 
Anticarsia gemmatalis (192). Upon characterization, a deletion was found consisting of 
3 repeats in the p74 repeat region, compared to prototype AgMNPV-2D (59). 
Approximately the same region (map units 88.7 to 94.3) had previously been identified 
as a region associated with genotypic variation (33). Although the deletion in AgMNPV-
D7 may or may not be responsible for its increased virulence, the AgMNPV hrs may 
serve a similar role as proposed for other baculoviruses: to serve as prime areas for 
genomic rearrangements. In the AgMNPV GP64 genomic region examined in this study, 
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we also identified two short sequences with similarities to various baculovirus hrs. The 
two repeat regions also show strong nucleotide identity with the previously identified 
sequence within the p74 repeat region identified in AgMNPV (161). The presence of a 
region with homology to the hrs in this AgMNPV locus may not be too surprising, as 
between baculoviruses only some hrs are conserved in location. In our transient 
replication assays we could not detect replication from the repeat regions identified in 
the 12.5 kb AgMNPV genomic segment. This may indicate that these repeat regions 
alone do not serve as an origin of replication. This does however not fully exclude an 
origin of replication or other function for this region. LdMNPV hrs for example had to be 
linked to AT-rich sequences before being capable of undergoing replication (194), and 
it is also possible that this region serves an enhancer function, analogous to AcMNPV 
(80) and OpMNPV hrs (250). 
In previous studies, we characterized GP64 proteins of OpMNPV and AcMNPV. 
In this paper we found that the AgMNPV GP64 protein is very similar to the previously 
characterized GP64 proteins, displaying 78.5% amino acid identity with OpMNPV 
GP64, and 76% with AcMNPV GP64. Predicted TM domains and CTDs display less 
amino acid identity than seen with any of the other published GP64 sequences, while 
syncytium formation assays show that the maximum pH at which membrane fusion is 
induced is identical to OpMNPV GP64. Although GP64 is known to be an essential 
baculovirus protein (171), the recently completed LdMNPV genome contains no 
potential protein with homology to GP64. This brings forth the question whether 
LdMNPV (and possible other baculoviruses not containing a gp64 gene) contains a 
functional homolog of GP64, or whether it uses alternate strategies for entry and exit of 
its host cell. It also raises the question of how widespread presence of the gp64 gene is 
within the Baculoviridae. Although extensive sequence data are available for only a few 
baculoviruses, all viruses to date shown to contain a gp64 gene, are phylogenetically 
placed within one proposed subgroup of the NPVs (group I; (286)). It is generally 
believed that MNPVs are not a monophyletic group, except for the proposed group I. If 
GP64 is restricted to the proposed group I baculoviruses only, it is possible that the 
acquisition of the gp64 gene at some point in evolution may be a key factor in the 
existence of this subgroup I as a monophyletic group. The strong conservation between 
GP64 from the various baculoviruses may reflect its essential nature and with it an 
intolerance for amino acid substitutions. It is however also possible that the gp64 gene 
was acquired at a relatively late stage in baculovirus evolution, and insufficient time has 
elapsed to allow divergence of the individual gp64 genes. The latter fits well with 
previous suggestions (101, 286), whose phylogenetic studies indicate distinct 
evolutionary rates for proposed groups I and II, with radiation in group I apparently 
slower than in group II or occurring later. The phylogenetic tree in Fig. 3C suggests that, 
among the viruses in proposed NPV group I, AgMNPV GP64 may have been the first to 
branch from the ancestral GP64 protein. 
A hint towards the evolutionary origin of GP64 was the finding that a GP64 
homolog exists in the THO-like orthomyxoviruses THO, DHO, and Batken virus (only a 
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partial gp64 ORF is available for Batken virus; (55)). A striking structural and functional 
homology between their envelope proteins and baculovirus GP64 points to a common 
ancestor for these proteins (173, 201). In interpreting the phylogenetic tree of Fig. 3C, 
one should keep in mind that the THO and DHO virus are single-stranded RNA viruses, 
with a mutation rate possibly higher than that of the double-stranded DNA 
baculoviruses. This may explain why a large evolutionary distance is projected between 
DHO and THO env in Fig 3C, and why amino acid identity between DHO and THO 
envelope proteins is only 33%, very low compared to the identity between baculovirus 
GP64s. Consequently though, individual amino acids and clusters of amino acids that 
are conserved between DHO/THO envelope proteins and GP64 may represent 
residues or domains that are extremely important to functions conserved between the 
envelope proteins of these two virus families: Fig. 3A demonstrates that the signal 
peptide and TM domain are the least conserved domains between all the shown 
homologs, although most substitutions are of a conservative nature, retaining the 
overall hydrobicity of the domain. Several blocks of strong conservation in the 
ectodomain do not include a membrane fusion and oligomerization domain previously 
characterized in OpMNPV GP64 (171). These two functional domains (corresponding to 
AcMNPV amino acids 229/230 and 330-338 respectively) are well conserved among 
baculoviruses, but only poorly to moderately conserved between GP64 and the 
envelope protein of the THO-like viruses. With regard to the fusion domain, this may 
reflect the capacity of THO-like viruses to function in mammalian cells, at a physiological 
pH different than that from insect cells. Beside the domains demonstrated to be involved 
in OpMNPV GP64 fusion and trimerization, little is known about how and which regions 
of the protein are involved in which functions. Identification of the above clusters of 
amino acids, conserved between baculoviruses and THO-like orthomyxoviruses, may 
be helpful to further unravel the structure/function relationship of the GP64 protein. 
Materials and methods 
Cells, virus, infections, and transfections. Spodoptera frugiperda (Sf9) cells, 
Lymantria dispar (Ld) cells, and Trichoplusia ni (Tn5B1-4) (75) cells were used to 
propagate wild-type AcMNPV (strain E2), OpMNPV, and AgMNPV (isolate 2D) virus. 
Cells were cultured at 27°C in TNM-FH medium (95) containing 10% fetal bovine 
serum. For viral infections, virus was incubated on cells for a 1 hr viral adsorption 
period. For transient transfections, 6 u.g of DNA was introduced into 0.6 x 106 Sf9 cells 
by CaP04 precipitation as described earlier (8). 
Southern blot hybridizations. AgMNPV genomic DNA was used to screen for 
presence of a cathepsin gene homolog. A 1 kb AcMNPV v-cath PCR fragment (400 ng) 
was 32P-labelled using the Rediprime kit (Amersham), and used to probe 1-2 (j.g of 
Hindlll or Pstl-digested viral DNA (AgMNPV isolate 2D and L1). The viral DNA was 
transferred to a nylon blot by vacuum transfer (Hybaid transfer apparatus) and 
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hybridization was done in a Hybaid oven under the following conditions: Pre-
hybridization in 50 ml of 6x SSC, 0.5% SDS, 5x Denhardts solution, 100 u.g/ml 
denatured salmon sperm DNA for 2 h at 60 °C. Hybridization was carried out overnight 
in 20 ml pre-hybridization solution + 0.01 M EDTA. The membrane was washed for 15 
min at 60°C in 50 ml of 2x SSC/0.1%SDS, for another 15 min in 0.1x SSC/0.1%SDS, 
and exposed to X-ray film for 72 hours. Hybridizations to initially locate the gp64 gene 
were carried out similarly, with a probe based on three different but overlapping 
restriction fragments of the AcMNPV gp64 gene. 
Cloning of AgMNPV 5.4 kb genomic (Hindlll-I) fragment. Shotgun cloning was 
used to clone multiple AgMNPV genomic segments: AgMNPV DNA was digested with 
Hindlll-I, precipitated, and cloned into a Hindlll-cut pBS-based plasmid. Clones with 
various size inserts were recovered. A clone with a 5.4 kb insert, containing a partial 
gp64 gene, was named pBS-Ag/Hindlll-l. 
Cloning of AgMNPV 12.5 kb genomic (BamHI-D) fragment. AgMNPV DNA was 
digested with BamHI, precipitated, and cloned into a BamHI-cut pBS-based plasmid. 
Clones with inserts of two different sizes were recovered: A clone with insert size 12.5 
kb was named pBS-Ag/BamHI-D, and a clone with insert size 18.2 kb was called pBS-
Ag/BamHI-C. 
Sequencing, Blast searches, and protein alignments. Sequencing was done of a 
CsCI-purified plasmid prep of pBS-Ag/BamHI-D on a ABI Prism 310 genetic analyzer 
(Perkin Elmer). Both strands were sequenced at least once, and DNASTAR SeqMan 
(Martinez and Needleman-Wunsch algorithms) was used to generate a consensus 
sequence. DNASTAR MAP was used to locate ORFs coding for proteins equal to or 
larger than 50 amino acids. A few small ORFs, 50-100 amino acids in length, which 
overlapped with ORFs with a known function and of which no homologous proteins are 
known, were disregarded in the analysis, resulting in a total of 19 ORFs of > 50 amino 
acids. These selected ORFs were translated and used to find protein homologs through 
'Advanced Blast' searches in the GenBank database. Three ORFs, Unknown 1, 2 and 3 
(U1,2, 3), did not display homology to any baculovirus or other proteins. Blast hits with 
significant homology were aligned individually with the corresponding predicted 
proteins of the AgMNPV sequence by the Clustal method (91) with the use of an identity 
residue weight table and default settings for pairwise alignment: gap penalty 3, window 
5, diagonals saved 5, ktuple 1 (DNASTAR Megalign). Percentage identity was 
calculated as number of identical amino acids/total number of amino acids of the 
AgMNPV protein x 100%, and all baculovirus homologs, as well as other homologs with 
an amino acid identity of > 22.5%, were selected and used for Figure 2. The multiple 
sequence alignment of GP64 (Figure 3) was performed by the Clustal method with a 
PAM 250 residue weight table and default settings for multiple alignments (gap penalty 
10, gap length penalty 10)(DNASTAR Megalign). Percentages similarity and 
divergence between the GP64 homologs were determined based on the alignment of 
Fig. 3A. Similarity is a gross measure of similarity between sequences, and is 
calculated as 100 x sum of the matches/ length - individual gap residues. Divergence is 
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calculated as 100x the distance of individual pairs of sequences divided by the total 
distance of all sequences. Distance between two sequences = sum of the residue 
distances + (gaps x gaps penalty) + (gap residues x gap length penalty). 
Assembly of the genomic segment (chitinase to p74) of CfMNPV. The genomic 
segment around the gp64 gene of CfMNPV was constructed by overlapping of the 
various sequences available in the GenBank database. These overlaps were 
determined through DNA alignments by the Wilbur-Lipman method with default settings, 
and were always larger than 100 nt with 98 to 100% identity. References used for the 
various DNA segments are: gp64 (93); p24/gp16/pp34/ORF132/alk-exo/p22.2/p26 (198, 
199); pro (280); p74 (94). 
Origin of replication assay. AgMNPV repeat regions, as well as AcMNPV hro 
were PCR amplified, and cloned into the pGEM-T vector (Promega). Amplified regions 
from AgMNPV corresponded to nt 808-1024 (217 bp, includes repeat 1), nt 1002-1163 
(162 bp, includes repeat 2), and nt 808-1163 (366 bp, includes repeat 1+2). Infection-
dependent plasmid replication assays were performed as described by (135). Briefly, 
Sf9 cells were transfected with plasmids containing the AgMNPV repeat 1, 2 or a 
combination of 1 and 2, or AcMNPV hr5 as a control, 5 |ig/2x106 cells. Transfected Sf9 
cells were superinfected with AgMNPV or AcMNPV (control) at MOI 10 at 24 h post 
transfection, and further incubated at 27°C. DNA was extracted according to (177) at 48-
72 h post super infection, and 13 (ig of DNA per sample was digested at 37°C for 12 h 
with DpNI, followed by a 12 h digest with Pstl. DNA fragments were transferred to 
Genescreen Plus membrane, and hybridized with a pGEM-T vector-based probe, P32-
labelled with the Prime-It Rmt kit (Stratagene). The following conditions were used for 
hybridization: Pre-hybridization was carried out in a Hybaid oven for 2 h at 65°C in 
prehybridization solution (5x SSC, 0.1% laurylsarcosine, 0.02% SDS, 10% blocking 
reagent [Boehringer Mannheim]). Hybridization was carried out for 14 h at 65°C, in 
prehybridization solution + probe. After hybridization, membranes were washed in 2x 
SSC/0.1% SDS at RT, followed by a wash step in 5x SSC/0.1%SDS at 65°C. 
Membranes were scanned on a phosphorimager and analyzed with the Imagequant 
software (Molecular Dynamics). 
CELISA and Western blots. Western blots were carried out as described 
previously (10). For detection and quantification of GP64 surface levels, a cell ELISA 
(CELISA) protocol was used as previously described (171): Cells were fixed in 0.5% 
glutaraldehyde for 10 min at RT, washed once with phosphate buffered saline (PBS pH 
7.4) and blocked by incubation in PBS + 1% gelatin for 2 h at 27°C. Cells were then 
incubated for 45 min at 27°C in Mab AcV5 tissue culture supernatant diluted 1:25 in 
PBS + 0.5% gelatin. Cells were washed once in PBS for 2 min, followed by incubation 
for 45 min at 27°C in a secondary goat-anti-mouse antibody conjugated to alkaline 
phosphatase (GAM-AP, Promega) diluted 1:7500 in PBS + 0.5% gelatin. Cells were 
then washed four times (5 min/wash) in PBS, and incubated in 1 mM p-nitrophenyl 
phosphate (Boehringer) in alkaline substrate buffer (100 mM Tris; 100 mM NaCI, 5 mM 
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MgCI2 [pH 9.5]) at 37°C. After addition of the substrate, the OD405 was determined at 
several timepoints using an ELISA plate reader. 
Syncytium formation assays. Syncytium formation assays were done as follows: 
Sf9 cells were transfected with p64-166 (OpMNPV GP64 with a truncated wild-type 
promoter), pBS-Ag-Xba/Pst (AgMNPV GP64 with wild-type promoter), or pAcEcoHACIa 
(AcMNPV GP64 with wild-type promoter). Based on the CELISA data, plasmid 
concentrations for cell transfections were adjusted, so that very similar levels of the 
various GP64s were present at the plasma membrane. At 48 hr post transfection, 
supernatant was replaced with PBS-citrate buffer titrated to a range of pHs (4.5 - 6). The 
PBS-citrate buffer was incubated on the cells for 5 min, replaced with TNM-FH, and 
cells were further incubated for 2 h. Cells were then fixed in 0.5% glutaraldehyde (10 
min) and scored for the presence of syncytia. Syncytium formation required > 5 nuclei in 
each syncytial mass (++ syncytia abundant; + syncytia present but not abundant; +/-
syncytia rare but present; - no syncytia observed). 
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Chapter 7 
General discussion 
In addition to the individual discussions of chapters 2 to 6, I will address a few 
selected topics below. A part of these regard aspects of GP64 that have not been 
experimentally addressed in this thesis, and supplement the understanding acquired 
from the previous chapters. The topics are 'Carbohydate and lipid modifications of 
GP64', 'Glycoprotein targeting in polarized epithelial cells', 'Evolution of GP64', and 
'The role of viral spike proteins and their cytoplasmic tail domains in virus budding. In 
the latter section I will review virus budding models and mechanisms and speculate on 
how they may apply to baculovirus BV budding. A list of CTDs and TM domains of spike 
proteins from the virus families addressed in this chapter, can be found in Fig. 2. The 
chapter is concluded with a note on future perspectives of GP64. 
Carbohydate and lipid modifications of GP64 and their role in GP64 
function 
Carbohydrate modifications. With the use of baculoviruses as protein expression 
systems there has been an interest in knowing the capacity of insect cells to glycosylate 
foreign gene products, and in the biological effects of carbohydrate modifications. When 
N-linked oligosaccharides of three insect cell lines were examined, carbohydrate 
modification pathways similar to those of mammalian cells were suggested (138). Insect 
cells are able to glycosylate heterologous proteins but their capacity to process 
carbohydrates to complex forms differs from mammalian cells. Some galactose was 
found on human plasminogen produced in insect cells (37) however most often, 
complex carbohydrate modifications such as sialic acid and galactose, are not found 
(for example (140)). GP64 can serve as a model for studies of the capacity of insect 
cells to produce and modify carbohydrates, and for the role of carbohydrates in structure 
and function of glycoproteins, because GP64 is extensively modified with 
carbohydrates. Characterization of AcMNPV BV glycoproteins by (237) and 
immunoprecipitation of AcMNPV BV proteins, labeled with N-acetyl-D-
[13H]glucosamine, by MAb AcV1 (264) first indicated that GP64 was a glycoprotein. This 
is consistent with the presence of a signal peptide, directing GP64 into the secretory 
pathway where carbohydrate additions and modifications take place. The amino acid 
sequence of AcMNPV GP64 (after signal peptide cleavage) contains five potential re-
linked glycosylate sites (N-X-S/T) (273) whereas the OpMNPV GP64 coding 
sequence contains 7 (9). While O-linked glycosylation clearly takes place in baculovirus 
infected cells (177) and some viral proteins have been reported to contain O-linked 
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sugars (for example ODV structural protein GP41 (271)), no reports on O-linked 
carbohydrate modification of GP64 have been published. Consensus sites for O-linked 
glycosylation are not well defined, and it is therefore difficult to predict whether any 
potential sites on GP64 exist. The site for O-linked glycosylation, similar to the one seen 
in baculovirus GP41 (N-acetyl glucosamine addition), was mapped for a nuclear pore 
protein (34) and found to be attached to a serine residue. In mucins, O-linked N-acetyl 
glucosamine addition is known to occur in proline/serine-rich regions (284). Although 
some of these N-linked glycosylation sites may be critical for GP64 structure or function, 
only moderate conservation is apparent. For DHO env, the locations of two and three 
glycosylation sites are conserved with AcMNPV and OpMNPV respectively. Only one 
site is conserved between THO env and OpMNPV GP64, and none between THO env 
and AcMNPV GP64. Between DHO and THO env, only one putative N-linked 
glycosylation site is conserved. The study presented in chapter 2 (184) indicates that, 
shortly after production, the observed mass of a GP64 subunit is ~ 67. During transport 
to the cell surface, carbohydrate processing shifts the observed molecular weight from 
67 to 64. When a mature, 64 kD, OpMNPV GP64 protein subunit was deglycosylated, 
an approximate 8 kD size shift was observed. Compared to synthesis, folding, 
oligomerization and carbohydrate addition, the carbohydrate processing events are 
relatively slow, and may be rate-limiting steps in GP64 maturation and transport to the 
cell surface, although it was also demonstrated that processing may not be necessary 
for functional maturation (114). Resistance to endoglycosidase H shows that at least 
some of the GP64 carbohydrates are processed to a more complex form (113, 184). In a 
recent report (115) the positions of N-linked glycans on AcMNPV GP64 were mapped, 
showing that 4 out of 5 consensus sites are used for carbohydrate addition (amino acid 
positions 198, 355, 385, and 426). These carbohydrates were processed to various 
degrees (suggested to be partly due to their relative position in GP64) with most 
containing fucose but none containing complex modifications such as R-linked 
galactose or alpha2,6-linked sialic acid. 
Carbohydrate modification of a protein may be necessary for proper progression 
of the folding process. There are several reports on the biological effects of tunicamycin 
on GP64 production and function. For example AcMNPV GP64, produced in the 
presence of tunicamycin, could still be immuno-precipitated by AcV1 (which recognizes 
a conformational epitope that is lost upon exposure to 1% SDS) (264). This would 
indicate that the AcV1 epitope is intact, and that at least some GP64 must be properly 
folded in the absence of carbohydrate addition. In similar experiments, it was 
demonstrated that transport of GP64, its incorporation into BV, and infectious BV 
production, are all dramatically reduced in the presence of tunicamycin (23, 114). 
However the interpretation of these results is complex as tunicamycin may have 
additional effects on cells due to inhibition of glycosylation of all newly synthesized 
glycoproteins. These biological effects were again addressed in a study using site 
directed mutagenesis to knock out individual or combinations of glycosylation sites, and 
generation of recombinant viruses containing these mutant GP64 proteins (115). A very 
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similar study had previously been reported for the Influenza HA protein, in which a 
series of mutants were generated to knock out individual, groups, or all of the 7 N-linked 
glycosylation sites (58). No individual oligosaccharide side chain was necessary or 
sufficient for folding, intracellular transport, or function of HA. At least five of the seven 
oligosaccharide chains were necessary to transport HA through the secretory pathway. 
If less than five sites were glycosylated, intracellular aggregates were formed and HA 
was retained in the ER. When a variety of GP64 glycosylation-recombinant viruses were 
examined, expression of GP64 and transport to the cell surface were unaffected, while 
oligomerization was not addressed. Incorporation of GP64 into BV seemed unaffected, 
but it should be noted that the examined progeny BV was only partially purified. All 
constructs possessed fusogenic activity that could not be distinguished from wild-type 
GP64 by the syncytium formation assay used in this study. However, because this assay 
was not quantitative, one cannot eliminate the possibility of subtle effects on the function 
of the mutant GP64 proteins. These new data indicate that the earlier data (23, 114) in 
which transport and incorporation of GP64 into BV were drastically reduced in the 
presence of tunicamycin, were not an effect caused by absence of carbohydrate on 
GP64. Comparisons of infectivity between GP64 glycosylation-recombinant viruses and 
wild-type virus agreed with earlier data, and indicated reduced infectivity for all mutants. 
Whether this effect is due to reduced binding of virus to cells, or to inhibition of a stage 
of entry between initial binding and fusion of the viral and endosomal membrane, 
remains to be determined. 
Lipid modifications. Many membrane associated viral proteins contain 
modifications consisting of fatty acid chains, or are 'acylated'. Most of these acylations 
occur post-translationally with use of the most abundant cellular fatty acid chains: 
palmitic acid (C16, unsaturated), stearic acid (C18, unsaturated), and oleic acid (C18, 
saturated) via ester or thio-ester bonds with amino acids. A relatively rare acylation is 
the co-translational linkage of the saturated myristic acid (C14) to amino-terminal 
glycine residues by amide bond. It is thought that acylation of membrane proteins may 
be involved in anchoring to membranes, membrane mobility, membrane fusion, or 
regulation of intracellular transport (for example targeting to the plasma membrane). 
The fatty acids are linked to regions of membrane proteins which are in proximity to, or 
inside the lipid bilayer, and as such can supplement or alter the hydrophobicity of a 
membrane spanning domain. It is not known if acylation takes place in a preferred 
cellular compartment, but recent reports on acylated proteins give some insight into the 
process of fatty acid modification of proteins. Because GP64 is a membrane-anchored 
protein involved in membrane fusion, it is not an unlikely candidate for acylation. 
Indeed, it was demonstrated that AcMNPV GP64 is acylated (207). Using 3H-palmitic 
and myristic acid, GP64 was found to be modified with palmitic acid, most likely through 
an ester-type linkage. The N-terminus of GP64 was excluded as a candidate for 
acylation because 1) there is no N-terminal glycine, typical of an amide-bonded 
modification with myristic acid, and 2) there is no block to amino-terminal Edman 
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degradation. Therefore the other major membrane-associated area of GP64, the TM 
domain and surrounding amino acids, was examined for potential acylation sites. Two 
potential acylation sites were found to be conserved between AcMNPV and OpMNPV: 
Ser482, located just outside the predicted TM domain in the ectodomain, and cys503, 
located within the TM domain, near the CTD (Fig. 3, chapter 6). Since fatty acid-derived 
radioactive label was not removed from GP64 by boiling in Laemli buffer, an oxy-ester 
linkage was considered more likely than a thio-ester linkage. Ser482 was therefore the 
preferred candidate for this acylation. Previous reports that associate acylating activity 
to intracellular compartments such as ER and Golgi (225), might also suggest ser482 to 
be a good candidate, as topologically this amino acid residue is located inside the 
secretory pathway compartments during transport to the cell surface. Another study 
(212) however challenges this hypothesis, as VSV-G protein was found to be 
palmitylated on a cysteine residue within its 29 amino acid CTD (see Fig. 2) via a thio-
ester linkage. In a comprehensive study by Ponimaskin (200), a variety of TM domains 
and CTDs from viral glycoproteins of different virus families were compared. Nearly all 
cysteines in the CTD domains and all within the C-terminal 7 amino acids of the TM 
domain (cytoplasmic border region), were acylated. However, cysteines simply placed 
close to the cytoplasmic border region were not sufficient to induce acylation, and 
based on TM and CTD domain swaps, complex conformational signals for palmitylation 
were suggested to reside mainly in the TM domain, but also in the CTD. Cys503 of 
baculovirus GP64 is located in the cytoplasmic border region of the predicted TM 
domain, and is conserved between all known GP64s and DHO env (Orthomyxoviridae). 
While ser482 is also conserved between these viruses, the conservation of location of 
cys503 within the various baculovirus GP64s and the fact that its location is very similar 
to the location of acylated cysteine residues within the TM domains of other viral 
membrane proteins, makes cys503 (through a thio-ester type linkage) another 
candidate for acylation. Some reports on viral spike protein acylation mutants 
demonstrate little effect on spike protein transport to the cell surface (212, 275), while 
others show controversial effects. In part this may be due to the fact that most studies do 
not report quantitative data and may therefore fail to detect more subtle effects. VSV G 
acylation was shown not to be necessary for fusion or incorporation into virions (275). 
(175) demonstrated a similar result for Influenza HA: palmitylation of 3 cytoplasmic 
cysteines of HA was not required for HA biosynthesis, function, or incorporation into 
virions. However, Fischer (50) reported that acylation of Influenza HA does modulate 
fusion activity. Only marginal effects were reported in alphaviruses (216). Substitution of 
cysteines in the TM domain (near the CTD domain) of Sindbis virus E1/E2 glycoproteins 
resulted in non-acylated glycoproteins. Viruses with the mutant E1/E2 glycoprotein grew 
slightly slower in cell culture and the amount of virus particles secreted was about half 
that of wild-type. However at later timepoints and in general, the total effects on the 
infection cycle were marginal. A report by Ivanova (108) somewhat contradicted the 
report by Ryan (216): Substitution of the same cysteines in Sindbis resulted in aberrant 
assembly and particle formation. Possible functions of lipid modification of GP64 are 
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further addressed in section: 'The role of viral spike proteins and their cytoplasmic tail 
domains in virus budding'. 
Glycoprotein targeting in polarized epithelial cells, the initial site of ODV 
infection: a role for GP64? 
Host epithelial cells are one of the first barriers an invading virus will encounter. 
Midgut epithelial cells are the first cells infected by the ODV phenotype (Fig. 1), and 
systemic invasion of the caterpillar hinges on succesful spread of the baculovirus from 
the epithelial cell. The question addressed in this section is whether there might be a 
role for GP64 in asymmetrically directing baculovirus BV budding from infected midgut 
epithelial cells. Such a role might not be unlikely, as it was demonstrated that HIV env is 
capable of redirecting an otherwise random gag-induced budding in MDCK cells to the 
basolateral side exclusively (185), while in chapter 4 it was shown that GP64 is 
necessary to drive efficient virion budding. Although in several cases viral spike 
proteins are not necessary for viral budding, a requirement for spike protein for efficient 
budding, similar to baculovirus BV, was demonstrated for other viruses such as alpha 
and rhabdoviruses as well (163, 246). Depending on the particular virus, it may be 
advantageous and/or necessary for progeny virions to exit towards the luminal or 
basolateral side of the epithelium. For example, VSV (208), type C retroviruses (214), 
and HIV type 1 (48) have been shown to bud predominantly from the basolateral 
membrane wheras Sendai virus, Influenza virus (208), and Rotavirus (122) are 
released exclusively from the apical side. Coronaviruses, for which the final 
envelopment step occurs by budding into the pre-Golgi compartment, sort preferentially 
either to the apical or basolateral side, dependent on the virus and cell type (213). If 
progeny baculoviruses (BV phenotype) were to bud from the apical side of the epithelial 
cells into the gut, little would be gained since BV are not infectious to midgut cells (128, 
265). In this case, selective budding from the basolateral side of midgut epithelial cells 
(where host cells and tissues are highly susceptible to BV), would confer an advantage, 
for example accelerating the systemic infection process. Tanada and Hess (249) were 
one of the first to report baculovirus BV budding through the basal plasma membrane of 
midgut epithelial cells, in the armyworm Pseudoletia unipuncta. Granados and Lawler 
also observed budding through the basal side of midgut epithelial cells after feeding 
high doses of ODV to Lepidopteran larvae (74). In addition, they demonstrated that 
infectious virus could be detected in the hemolymph as early as a few hours after 
infection. This was unusual considering that viral spread was thought to occur only after 
viral DNA replication and progeny virus production within the midgut cells. In a more 
recent report it was shown that apparently, albeit at low frequency, parental NCs are 
transported through columnar cells to underlying regenerative cells before the onset of 
viral replication and progeny production (51), closely matching earlier observations in 
AcMNPV infected- T. ni midgut epithelium. All above observations support a mechanism 
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of rapid traverse through the midgut epithelial cells, which may offer to baculoviruses 
the advantage of viral spread before the onset of viral DNA replication. In consideration 
of a role for GP64 in the suggested rapid viral spread, it should be noted that GP64, 
unlike most other structural protein genes which are expressed from late promoters, has 
a complex promoter region, active both early and late in the infection cycle. By 
histochemical staining of AcMNPV infected- Trichoplusia ni caterpillars, GP64 was 
detected in a polar fashion when it was expressed in columnar epithelial cells, but not 
when expressed in other cells types (127). It is a possibility that this asymmetric 
targeting is mediated by signals residing within the GP64 protein. A domain shown to 
contain such sorting motifs in other viral spike proteins, is the CTD. For example, the 
VSV-G protein CTD possesses a basolateral targeting motif, able to confer basolateral 
targeting to a normally apical protein (251). A tyrosine residue at position 19 of the 29 
amino acid CTD domain, proved essential. A membrane-proximal tyrosine residue in 
the CTD domains of two retroviruses (Human T-cell leukemia virus type 1 (HTLV 1) and 
Moloney murine leukemia virus (MoMuLV)) appeared crucial in conferring basolateral 
targeting in a similar study by (150). This led to suggestions of a consensus motif for 
basolateral targeting present in the CTD domain of type 1 membrane glycoproteins. 
However, except for the presence of a tyrosine residue and its relative location, neither 
a consensus sequence nor a specific structural element of such signals has been 
conclusively determined (139), although some believe that Y-X-X-aliphatic/aromatic 
may represent such a motif (150, 251). (While CTDs are often implicated in targeting of 
type 1 membrane proteins, an example of a targeting domain in a type II membrane 
protein was reported in a study by Huang (103). In type II membrane proteins, the signal 
peptide sequence also represents the membrane-anchoring portion of the protein. The 
signal peptide/anchor region of paramyxovirus SV5 hemagglutinin-neuraminidase (HN) 
appeared to contain independent sorting information for apical specific targeting.) With 
the occlusion bodies harvested from an AcMNPV recombinant virus lacking the 
predicted 7 amino acid CTD (vAc-C-7, see chapter 4), we have performed neonate 
droplet feeding assays (Oomens, unpublished data) to determine whether the absence 
of the GP64 CTD would have an effect on in vivo mortality. No significant differences 
however were observed in mortality of T. ni larvae between the recombinant viruses 
and a control virus containing full length GP64. These data are however by no means 
conclusive, as the assay may not be ideally suited to detect such differences. It is also 
possible that GP64 is targeted to the basolateral side, but the CTD domain is not 
involved in this targeting. Given that the CTD is the only GP64 domain predicted to be in 
direct cytoplasmic contact, this may seem unlikely. However, it cannot be excluded that 
the GP64 ectodomain may interact with targeting factors in the ER lumen or that the TM 
domain of GP64 plays a dominant role. Alternatively, GP64 may not contain any 
targeting signals. For example, one possibility is that NCs or components of NCs 
contain basolateral targeting signals and that GP64 is detected at the basolateral 
membrane by virtue of association with NCs. It is also possible that the basolateral 
membrane may be the default target membrane for proteins entering the secretory 
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pathway in midgut epithelial cells. However, the demonstration of basolateral targeting 
signals in the spike protein CTDs within several virus families, may suggest that the 
default sorting pathway for type 1 membrane glycoproteins in epithelial cells may be 
apical. Unlike in the mammalian systems, where polarized cell lines such as the Madin 
Darby canine kidney (MDCK) cell line are utilized, polarized insect cell lines to address 
this question for baculoviruses are not available. It nevertheless remains plausible that 
GP64 is selectively targeted to the basolateral side of epithelial cells to facilitate efficient 
spread, and that signals determining this selectivity, reside within the GP64 protein. 
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FIG. 1. GP64 and basolateral targeting in the midgut epithelium. The left panel represents a 
longitudinal section of a baculovirus-infected caterpillar. The single enlarged cell on the right represents an 
infected midgut epithelial cell. Frequently, epithelial cells are the first host cells targeted by an invading 
virus. In most cases, depending on the virus, budding occurs preferentially on either the apical or 
basolateral side of the infected epithelial cell. Viral spike proteins, and in particular their CTD and TM 
domains, may aid in driving virus budding to the desired location by being asymmetrically targeted (see 
text). Baculovirus budding has been observed by EM from the basolateral side of insect midgut epithelial 
cells only. GP64 is necessary for efficient BV budding (chapter 4), and in AcMNPV infected- Tn columnar 
epithelial cells GP64 was detected in a polar fashion, appearing at the basolateral side (127). It is possible 
that, within midgut epithelial cells, a selective basolateral targeting mechanism is mediated by signals 
residing within the GP64 protein. 
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The role of viral spike proteins and their cytoplasmic tail domains in virus 
budding 
Due to the size of this section, page numbers of subtitles are shown below: 
page 
- Introduction 132 
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- The role of the spike protein CTD in virus budding 133 
- Budding and spike-NC interaction models for alphaviruses (Togaviridae) 135 
- Budding and spike-NC/matrix interaction models for rhabdoviruses 136 
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- Budding and spike-NC/matrix interaction models for retroviruses 139 
- Incorporation of (heterologous) spike proteins in virus particles 141 
- New concepts in virus budding 142 
- A baculovirus BV budding model? 144 
Introduction. The term 'virus budding', as I have used it throughout this thesis, 
refers to the final envelopment step within the overall assembly of a virion. For 
enveloped viruses, budding as a final envelopment step may be the last step in the 
maturation of a virion, however in some cases additional maturation events (for 
example proteolytic cleavage in retroviruses) occurring after budding, have been 
demonstrated. Enveloped animal viruses may target different host cellular membranes 
for their final envelopment step. With few exceptions, most members of the 
Orthomyxoviridae, Rhabdoviridae, Retroviridae, and Togaviridae have been shown to 
use the plasma membrane, whereas others belonging to the Coronaviridae, 
Bunyaviridae, Herpesviridae, and Flaviviridae seem to utilize intracellular membranes 
for the final envelopment step. There does not appear to be a single budding model that 
fits each member of a virus family, but the majority of viruses within one family often fit 
one model. Sometimes, different viruses within one family display unique budding 
properties; in contrast, certain generic steps of a budding mechanism may be shared by 
relatively unrelated viruses. Below I review budding models for a number of virus 
families. Although these may differ from baculoviruses by complexity, size and nature of 
the viral genome and the type of host they infect, they represent some of the best 
described, and perhaps relatively simple budding mechanisms that can serve as a 
model for baculoviruses. Described are: alphaviruses (Semliki Forest virus [SFV], 
Sindbis virus; Togaviridae), rhabdoviruses (Vesicular Stomatitus virus [VSV], Rabies 
virus), orthomyxoviruses (Influenza virus), and retroviruses (Human Immunodeficiency 
virus type 1 [HIV-1], MoMuLV). Specifically, because GP64 seems to play a major role 
in BV budding, I will compare the roles of the spike proteins and their CTD domains in 
virus budding, with the aim of defining general processes that may help design 
strategies to further address baculovirus budding. Only viral spike protein and spike 
protein CTD functions that pertain to a role in virus budding will be explored. Some 
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other hypothetical roles of the GP64 CTD domain that will not be addressed are: 
Endocytosis for the purpose of degradation or recycling, modulation of the membrane 
fusion capacity upon entry, and modulation of membrane mobility of GP64. 
Requirement for spike proteins in virus budding. The earliest budding models 
were based on SFV, an alphavirus, and derived from the demonstration that observed 
virion spikes were composed of transmembrane proteins (61). Interactions between NC 
and spike proteins were thought to initiate and drive the budding process, and both 
components appeared essential. While this crude model currently still applies to 
alphaviruses and has been further refined among others by cryo-EM observations (24), 
recent genetic studies have clearly shown that various other types of interactions and 
viral components are major players in the viral budding process in general as well. 
Matrix proteins of several virus families (for example retroviruses, rhabdoviruses) have 
been shown to be major organizers in virus budding, and lateral interactions between 
core, matrix, membrane proteins, and lipid bilayer have been proposed to be a major 
force in virus budding in general (60). In some cases (for example retroviruses (64)) it 
has been shown that spike proteins are altogether dispensible for budding; however, 
even in these cases and in general, interactions that involve the spike proteins or spike 
protein complexes facilitate efficient virus budding. In viruses for which spike 
glycoproteins are required for efficient virus budding (such as Rabies virus (163) and 
AcMNPV (chapter 4), the requirement for spike protein may not be absolute, as a low 
level of virus budding was detected in the complete absence of spike protein ((163), 
chapter 4). In the case of AcMNPV, this low level of virus budding could potentially be 
explained by recycled GP64 from the inoculum (see chapter 4). Although GP64 was 
undetectable by Western blot, whether the low level virus budding represents virion 
budding in the complete absence of GP64 versus a strongly reduced plasma 
membrane level of inoculum-derived GP64 remains undetermined. A requirement of 
viral spike proteins for efficient budding may seem beneficial, as it assures spike protein 
incorporation into virions. In most cases, spike protein incorporation is critical as virions 
lacking spike proteins are typically non-infectious. For herpesviruses, this may not 
necessarily be so: Pseudorabies encodes a series of different glycoproteins involved in 
entry and exit processes, and gK for example was shown to be involved in virus release 
but not required for entry (130). Despite the fact that retrovirions lacking the spike 
protein (env) are non-infectious, env is dispensable in virus egress as the gag 
polyprotein (Pr559a9 or gag) itself is sufficient to induce budding of virus-like particles 
(64). By virtue of its matrix protein region at the N-terminus, gag is able to associate with 
the plasma membrane without the need for spike protein (293). Since env is not 
required for budding, additional factors must be in place to ensure env incorporation 
and infectivity of the virion. 
The role of the spike protein CTD domain in virus budding. Particularly (but not 
only) in cases where budding at the plasma membrane relies heavily on the spike 
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ectodomain transmembrane domain cytoplasmic tail domain 
ACMNPVGP64 FMFGH VVNF V I I L I V I LFL YCM I RNBNRQY 
OpMNPVGP64 F M L G H G F T F V L I VGVI LFLYCML RNBPSHY 
AgMNPVGP64 YGSFGSYT I V FC I I AFLAFMMCT RR 
DHOEnv GLLLNGA I S W W V I G W L V G C V L M RRVF 
THOGP75 G G L L Y G N I G V Y L L I AFAFVLL I R L I K S A G L C 
SindbisEI L FGGASSLL I I GLMI FACSMMLTST RR 
SindbisE2 VYT I L AVAS ATVAMM I GVTVAVLCACKA RRECLTPYALAPNA V I PTSL AL LCC VRSANA 
SFVE1 I S G G L G A L F A I G A I L V L V V V T C I G L RR 
SFVE2 A A T V S A V V G M S L L A L I S I F A S C Y M L V A A RSKC LTP YALTPGAA VPWTLGI LCCAPRAHA 
lnfl.HA(H7) V I L W F S F G A S C F L L L A I A M G L V F I C V KNGNMRCTICI 
VSVG S S I A S F F F I I G L I I G L F L V L RVG I H LC I KL KHTK KRQ I YTD I EMNRLGK 
HIVEnv I F I M I V G G L V G L R I V A F V L S I VN RVRQGYSPLSFQ R R I R Q G L E R I L L 
MoMuLVEnv FTTL IST IMGPL I I L L L I LLFGPCI LN RLVQFVKDRI S VVQA L VLTQQYHQLK P I EYEP 
1 
FIG. 2. Cytoplasmic tail domains (CTDs) and transmembrane (TM) domains of viral spike proteins 
described in this chapter. All depicted proteins are type 1 transmembrane proteins (see Fig. 5 of chapter 1). 
ATM domain of a type I membrane envelope protein is generally defined as a highly hydrophobic domain 
near the C-terminus. Whereas definition of its N-and C-termini may be somewhat arbitrary, for AcMNPV 
GP64 (see chapter 6, Fig. 3 for full amino acid sequence), residues Ieu480 to phe483 (1s ' residue depicted) 
may represent the N-terminal end, whereas the first charged residue beyond the hydrophobic domain, 
arg506, likely represents the C-terminal boundary and start of the cytoplasmic tail domain (CTD)(chapter 4). 
Of the CTD of HIV env. (150 amino acids long), only the N- and C-terminal 12 amino acids are depicted. For 
full virus names, see page 'abbreviations'. References: GP64s and DHO/THO env, see elsewhere; Sindbis 
and Semliki forest virus (SFV) E1 and E2, (204); Influenza HA, (200); VSV G, (121, 200); HIV env, (269); 
Moloney Murine Leukemia virus env [MoMuLV], (110). 
protein, the spike protein CTD may constitute one of the most critical domains. Figure 2 
displays spike protein CTD and TM domains of viruses addressed in this chapter. 
Because the CTD seems to occupy a strategic position with regard to interactions 
between spike proteins and other viral components, several studies have examined the 
effect of deletion of the spike protein CTD on virus budding. Often, the rate of transport 
to the surface of non-polarized cells is not or only marginally affected by deletion of the 
CTD domain, hence these deletions are considered suitable for studies on the effect on 
virus budding from the plasma membrane or intracellular membranes. In the study in 
chapter 4, AcMNPV budding was found to be reduced by ~ 50% in the absence of the 
GP64 CTD, whereas in a similar study for Rabies virus this reduction was 84% (163), 
and for VSV 90% (221). These results confirm that the CTDs can be major contributors 
to efficient virus budding, but how these domains exert their effect on budding efficiency 
is not well understood. It may appear that budding efficiency is determined by the 
efficiency of membrane anchoring, however in most cases subtle differences raise 
additional questions. For example, AcMNPV GP64 surface expression and growth 
characteristics of the vAc-C-7 virus (chapter 4) are near wild-type levels, however 
budding is reduced by 50% and GP64 incorporation into the virion by 63 to 70%. This 
indicates that, in addition to possible involvement in membrane anchoring, the CTD 
plays other, yet undefined roles in budding and incorporation of GP64 into the virion. It 
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also implicates that the CTD may not be the only domain necessary for efficient 
budding. Fuel to this fire is added by the differences observed in virus budding between 
the vAc-C-11 and vAc-C-14 CTD mutants in chapter 4. The fact that they are equally 
represented on the surface (Fig. 5, chapter 4) yet exhibit remarkably different growth 
characteristics (Fig. 6, chapter 4), cannot be explained by effects on membrane-
anchoring only, and suggests a possible specific role for sequences within the TM 
domain. Another demonstration that the CTD may not be the only determinant in 
efficiency of budding, is that budding in the total absence of the spike protein is more 
strongly reduced (98% for AcMNPV GP64 and 97% for Rabies virus) than budding in 
the presence of CTD-less spike proteins (50 and 84% for AcMNPV and Rabies virus 
respectively). Based on these numbers also, the relative importance of the CTD in 
budding seems to vary between different viruses. For Rabies virus, the reduction by 
spikeless versus CTD-less spike proteins differs by 13%, whereas for AcMNPV, the 
difference in budding in the absence of GP64 (2%) and in the presence of tailless GP64 
(50%) is much larger. 
Budding and spike-NC interaction models for alphaviruses (Togaviridae). For 
GP64, no studies to date have experimentally addressed the role of domains other than 
the CTD in virus budding, and any imaginable interactions between individual viral or 
cellular components have yet to be demonstrated. For a number of other virus families, 
elaborate budding models have been proposed. One of the first described and best 
understood budding mechanisms is that of alphaviruses. In alphaviruses, the spike 
glycoprotein consists of three heterodimers of E1 and E2 proteins. E2 is produced by 
cleavage from a precursor protein p62. This cleavage is not necessary for particle 
formation or release but is important for infectivity (252). The E2/E1 spikes form a rigid 
protein lattice of which the E1 subunits reorganize into more labile fusogenic 
homotrimers upon exposure to low pH (268). An early hypothetical model based on 
SFV (61), in which interactions between two essential components, NC and spike 
proteins, initiate and drive the budding process, has been confirmed and further 
elaborated on for alphaviruses by several important observations. For example it was 
convincingly demonstrated that NC-spike interactions drive the budding process (246), 
and such an interaction was mapped to the CTD of the spike protein E2 (165). A 
tyrosine based motif within that CTD was shown to be essential for budding (292). In the 
absence of capsid protein, spike protein was produced and localized to the plasma 
membrane normally, but unexpectedly, instead of accumulating at the plasma 
membrane, spike protein was degraded rapidly with characteristic degradation products 
(291). Since in wild-type virus, degradation products of the spike protein are never 
found, it was suggested that the spike protein is very efficiently captured by NCs into 
budding complexes. In a study on another alphavirus, Sindbis virus, an interaction 
between the spike protein and the viral capsid was also demonstrated (283). Mutants or 
recombinant viruses were obtained in which interaction between NC and spike protein 
was compromised due to the nature of modified E2. Revertants of this 
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assembly/budding-compromised phenotype were then selected and when analysed, all 
revertants displayed mutations in the capsid protein. In particular, the mutations were 
localized near a hydrophobic pocket of the capsid, postulated to be the site for docking 
of amino acids of the E2 cytoplasmic domain. (The E1 cytoplasmic tail plays no 
sigificant role in SFV multiplication in cell culture (4)). Another big step towards the 
understanding of interactions necessary for budding was taken when the first detailed 
structure of a complete enveloped virion (Ross River virus, an alphavirus) was revealed 
by a combination of cryo-EM and image processing (24). This structure revealed an 
elaborate pattern of interactions between the capsid and spike proteins stabilizing the 
connections between the capsomers. Interestingly, the skirt regions of the spike proteins 
(i.e. the regions close to the lipid bilayer) were shown to entertain extensive lateral 
interactions. These lateral interactions are conceptually interesting and form the basis of 
one of the most recent alphavirus budding model (60). In this hypothetical model, lateral 
interactions between the spike proteins facilitate budding in two ways: 1) the 
interactions form of a larger membrane protein unit with a polyvalent NC-binding site. (A 
few studies indirectly support this hypothesis, for example (46)), 2) the interactions 
assist in formation of a so-called protein 'lattice' or 'cage', and may thereby provide a 
force for membrane bending. Budding then is initiated by binding of the NC to a cluster 
of heterodimers at the PM. The cluster could be a trimer or multimer through lateral 
interactions in the skirt region of the spikes. The multivalent nature of this initial protein-
NC interaction is strong enough to maintain a complex, and additional spike clusters 
bind by cooperative spike-spike and spike-capsid interactions. It is likely that formation 
of the spike protein icosahedral lattice directly promotes membrane bending, but NC-
spike interaction cooperate and are necessary in the formation of the lattice. 
Alphaviruses have a wide host range and replicate in a variety of different 
species ranging from mammals to insects. Interestingly, in a report on Sindbis virus 
replication in mosquito cells, the final envelopment step occurred intracellularly rather 
than at the plasma membrane, and virus was subsequently secreted via vesicles of the 
secretory pathway (169). The basis of the difference in cell compartments in which final 
budding takes place, is not known. 
Budding and spike-NC/matrix interaction models for rhabdoviruses and 
orthomyxoviruses. The negative-stranded RNA viruses rhabdoviruses, 
orthomyxoviruses and paramyxoviruses all encode multi-functional matrix proteins 
which form a dense layer tightly associated with the inner leaflet of the lipid bilayer. 
These matrix proteins also bind to liposomes, and have a tendency to polymerize (63, 
88, 290). These similarities may indicate that these viruses have similar budding 
mechanisms, which so far have been found to differ significantly from the earlier 
described alphavirus model. The basis for this difference lies in the fact that for some 
well studied viruses of this group (for example VSV (123)), the encoded matrix proteins 
were shown to independently (i.e. expressed alone in host cells and without the 
presence of envelope G protein!) bind to the plasma membrane, and induce slow but 
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efficient release of M protein containing vesicles. Expression of deletion and 
substitution recombinants suggested that an N-terminal binding site may be necessary, 
and that a specific structural conformation was required for vesicle budding. 
Interestingly, when G protein was coexpressed with matrix protein, it was not included in 
the budding vesicles, suggesting that the nucleocapsid may be necessary to organize 
matrix-G collaboration. Rhabdovirus budding in the absence of spike protein had been 
previously demonstrated in a study using temperature-sensitive mutants of VSV (131, 
224), however subsequent work (166) showed that the temperature sensitive mutants of 
VSV still contained the C-terminal fragment of VSV G including the cytoplasmic tail. The 
development of reverse genetics systems for negative-stranded RNA viruses enabled 
researchers to generate recombinant viruses completely lacking G protein. For Rabies 
virus, another rhabdovirus, virus budding in the complete absence of spike protein was 
found to be reduced 30-fold (163). When only the CTD of Rabies spike protein was 
absent, budding was reduced 6-fold, indicating a role in budding for this domain. The 
observed difference in reduction (30-fold versus 6-fold) suggests that, beside the CTD, 
other domains of G protein are involved in budding as well. For VSV, remaining 
budding was detected in the absence of G protein (221), however G protein had been 
replaced by a heterologous protein (CD4). Therefore efficiency of budding in the 
complete absence of spike protein (i.e. without the co-expression of a heterologous 
membrane protein) has not yet been conclusively determined. The importance of the 
VSV G protein CTD was also addressed, and demonstrated to be necessary for efficient 
budding and spike protein incorporation (221): While the wild-type CTD of VSV G 
protein is 29 amino acids, a mutant 1 amino acid tail did not support VSV budding, 
whereas a 9 amino acid VSV G tail did. In addition, a VSV G protein in which the CTD 
was replaced with the CTD from CD4 (of approximately equal length) supported 
efficient virus budding, and Respiratory Syncytial virus (RS virus, a paramyxovirus) G 
and F proteins were also succesfully incorporated into VSV virions (124). With regards 
to a rhabdovirus budding model, the above mentioned capacity of matrix protein to 
induce independent budding (123) and the strategic position of the matrix protein within 
the virion, might suggest that the matrix protein plays a central role in rhabdovirus 
budding, and that it may form a protein 'lattice' similar to that described for alphaviruses. 
Based on the CTD studies by Schnell (221), a relatively non-specific interaction 
between the spike protein CTD and a pocket or groove in the viral NC/matrix structure 
was proposed and is thought to generate a glycoprotein array that promotes viral 
budding (Fig. 4). Optimal budding efficiency and G protein incorporation is achieved by 
a concerted action of G, matrix protein, and/or nucleocapsid. An interesting twist to this 
hypothetical model was a study by Rolls (211). The VSV-G protein gene was 
engineered into an SFV-based replicon, possessing no structural proteins genes other 
than the introduced G protein. Not only was G protein expressed in cells transfected 
with this replicon, but infectious virus-like particles were produced capable of 
propagating in cell culture. While these results seem significant, another study (60) 
suggested that the produced particles may have resulted from a generic cellular 
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viral envelope 'spike' 
glycoprotein 
FIG. 3. Virus budding model for Vesicular Stomatitus virus (VSV), a rhabdovirus, by Schnell (221). 
A relatively non-specific interaction between the spike protein cytoplasmic tail domain (CTD) and a pocket or 
groove in the viral nucleocapsid or matrix protein is thought to generate a glycoprotein array that promotes 
viral budding. In this model, VSV matrix protein is not depicted separately, however matrix protein has the 
capacity to induce budding independent of G or other viral proteins, and a tendency to polymerize (see 
text). It has therefore been proposed that matrix protein, in cooperation with G protein and/or nucleocapsid, 
may form a protein 'lattice' as proposed for the alphaviruses, which may aid in inducing membrane curvature 
during budding (60). Optimal budding efficiency and G protein incorporation is achieved by a concerted 
action of G protein, matrix protein, and nucleocapsid. 
process called membrane vesiculation, blebbing, or ectocytosis, thereby perhaps 
leaving a proposed independent vesicle budding capacity for the G protein 
inconclusive. 
Similar to rhabdoviruses, for Influenza viruses it is known that matrix protein M1 
can associate with the lipid bilayer. The role of the spike proteins, though thoroughly 
examined, remains somewhat controversial. Influenza A virus envelopes contain two 
major envelope glycoproteins, neuraminidase (NA, a type 2 membrane protein) and 
hemagglutinin (HA, a type 1 membrane protein), and a much less abundant non-
glycosylated small membrane protein with ion-channel activity (M2). With its 
neuraminidase actvity, NA is important for the release of virus particles from the cell 
surface but its role in budding and assembly is not well understood. Early studies were 
compromised due to lack of a suitable genetics system: Virus budding of NA-minus 
mutants appeared to take place (149, 188), however these mutants apparently still 
possessed the capacity to express the NA TM domain and CTD, (149). According to Jin 
(116), the same potential problem applied to a study of temperature-sensitive mutants of 
the HA protein, in which efficient assembly and budding were observed at the non-
permissive temperature (191). In 1989, a reverse genetics system for Influenza virus 
greatly improved (153) the possibilities to introduce a cDNA derived RNA gene segment 
into an infectious genome. With this improved technology it was shown that deletion of 
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the CTD of the NA protein resulted in 86% less incorporation of NA into virions and 
large aggregates of progeny virions (probably due to insufficient cleavage of sialic acid 
by NA), while the amount of budding did not seem drastically affected (170). In Influenza 
HA, five residues of the 10 to 11 amino acid CTD of HA are well conserved between 
most subtypes (230), among which two cysteines which are post-translationally 
modified by covalent linkage of palmitate. This conservation was thought to be 
indicative of an important function of the HA tail. Simpson and Lamb (230) examined 
alterations of the HA tail, and found that HA proteins with substitutions or deletions in 
the CTD were still incorporated into the virion, and all altered HAs were also biologically 
active in hemadsorption and fusion assays. However, deletion of residues within the 
CTD resulted in delayed cell-surface expression, and no infectivity could be detected 
from virions containing these HA CTD deletions. In another study however, tailless-HA 
viruses assembled and replicated almost as efficiently as viruses containing a wild-type 
HA, contradicting the necessity of the HA CTD for viral infectivity (116). For the above 
studies, it should be noted that most assays in these studies were not quantitative and 
may not be sensitive enough to reveal subtle but perhaps significant differences. An 
importance for the HA CTD in virus propagation may be reflected in the fact that in the 
tailless-HA studies by Jin (116) a revertant virus was recovered, suggesting that 
possession of a cytoplasmic tail does indeed confer an advantage. When the CTDs of 
HA and NA were both absent, particle production was reduced ~ 10-fold. However, 
particles were no longer spherical but displayed an elongated irregular shape (117), 
indicating a role in virion morphology for HA and NA CTDs. 
Budding and spike-NC/matrix interaction models for retroviruses. A very clear 
deviation from the earliest alphavirus-based budding models was demonstrated 
through retrovirus studies, in which it was shown that polyprotein Pr559ag (gag) 
constitutes the budding apparatus. A basic domain in conjunction with several other 
basic residues throughout gag is thought to promote membrane binding by interacting 
with acidic phospholipids on the inner face of the lipid bilayer (182, 294). A myristate 
moiety at the N-terminus (with a proposed myristyl switch mechanism (187, 234)) is also 
necessary for membrane binding (64). Matrix protein seems to form an icosahedral 
'lattice' (176) (which may initiate virus budding), and also appears to have the capacity 
to direct virus budding (53): Mutations between amino acids 84 and 88 of matrix protein 
redirected HIV-1 assembly to an intracellular compartment. The capacity for env protein 
to direct virus budding was addressed by Salzwedel (217) who expressed an HIV-1 
mutant env protein that was strictly retained in the ER. In the presence of this mutant 
env, HIV-1 budding was not redirected to the ER but was still only observed at the 
plasma membrane, which might argue that matrix and not env is the major determinant 
in directing virus budding. Contrary to this data however, it was previously shown that 
env was capable of concentrating HIV-1 budding to the basolateral side in polarized 
epithelial cells (185). Moreover, this capacity to redirect was lost when the env CTD was 
deleted (and also by certain mutations in the matrix protein) suggesting a role for env 
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CTD-gag interaction in budding (151). Other studies have shown equally contradicting 
data for env incorporation into the retrovirus. For example, the CTD of GP41 (which, with 
150 amino acids is unusually long for a viral spike protein; see Fig. 2) was not required 
for the incorporation of the HIV-1 envelope glycoprotein into virions (57, 277) whereas 
for Moloney Murine Leukemia Virus (MoMuLV) the opposite was found (110). Although 
a direct interaction between HIV-1 matrix and GP41 was detected in vitro (31) this has 
not yet been demonstrated in infected cells. Taken together, specific interactions 
between the env CTD and gag may occur, but may not be critical in all retroviruses. In 
one retrovirus model (based on (110)), and other available data, the capsid is 
assembled at the plasma membrane concomitant with, or prior to (for the B- and D-type 
viruses), budding from the cell plasma membrane. The matrix region of the gag 
precursor polyprotein locates to the plasma membrane by virtue of a specific interaction 
with the plasma membrane, and may form a protein 'lattice'. Depending on the virus, 
glycoproteins may or may not interact with the matrix region of gag and accumulate at 
the plasma membrane. Based on x-ray crystal structures (92, 202), SIV and HIV matrix 
protein were determined to be trimeric proteins, and an interaction was proposed 
between the long cytoplasmic tail of GP41 and holes present in the 'lattice'-like structure 
formed upon matrix trimerization (92). The timing of this interaction and the relative 
importance of env and gag in driving budding remains somewhat controversial yet may 
be critical for efficient incorporation of env into the budding virion. A report by Egan (45) 
may help find explanations of some of the observed data. HIV-1 env was found to be 
endocytosed from the plasma membrane in the absence of other viral proteins by 
means of an intrinsic signal in the CTD domain. However, in the presence of gag, 
endocytosis of env was not observed. It is possible that, since env is not required for 
retrovirus budding, early gag-env interaction is an additional factor to assure env 
incorporation into the virion. Should this interaction not occur, then env is not 
incorporated into the virion and is endocytosed for either degradation or recycling for 
another opportunity to interact with gag. This observed endocytosis of unincorporated 
env may also serve to evade detection by the immune system. An exception to the 
above retrovirus model are the foamy viruses. The env proteins contain ER retention 
signals in their CTD which drive maturation to intracellular membranes (67). Because 
spike protein is not required for budding of retrovirus-like particles, retroviruses are well 
suited to study the effect of spike protein absence on virion morphology. For HIV-1, the 
lack of env in the virion had no morphological consequences. Virus particles were 
indistinguishable from wild-type virions, and thus env may not be involved in the 
structural integrity of the virion. In addition to retroviruses, effects of deletion of the spike 
protein or the spike protein CTD on virion morphology have only been examined for 
Influenza viruses (see earlier). EM studies on a gp64null virus might reveal possible 
effects of GP64 deletion on baculovirus morphology, however these particles are far 
less abundant as budding in the absence of GP64 is drastically reduced. If GP64 is 
directly or indirectly (via interaction with the envelope or other viral proteins) involved in 
the integrity or stability of the BV virion, the isolation of properly enveloped GP64-
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lacking virions may prove difficult. The budding studies in chapter 4 do indicate that 
small amounts of virus particles with a density similar to that of wild-type AcMNPV can 
be purified in the absence of GP64 or with strongly reduced amounts of GP64 
incorporated per virion. 
Incorporation of (heterologous) spike proteins in virus particles. The stringency at 
which viruses sort host and viral proteins at membranes, in preparation for budding, 
differs. For Sindbis, cellular proteins are almost completely displaced by viral proteins 
(239), whereas retro- or rhabdoviruses appear less selective (see below). Little is 
understood with regard to these differences, but available space within the viral 
envelope during or after budding may be a factor. For VSV, foreign viral glycoproteins 
as well as a cellular glycoproteins can be incorporated into virions in the absence of 
specific incorporation signals (222). In contrast, the HN protein of the paramyxovirus 
Newcastle Disease virus (NDV) was not incorporated into Sendai virus (another 
paramyxovirus), unless its cytoplasmic domain was replaced with that of Sendai virus 
(248). An example of selective exclusion of homologous virus-encoded proteins is 
Influenza M2 protein. Although expressed at the plasma membrane at levels fourfold 
higher than HA, M2 is greatly underrepresented in the virion (145, 288). When Influenza 
HA and NA genes were added to the VSV genome, they were expressed at high levels 
in infected cells but there was a preference for incorporation of VSV G protein over HA 
and NA (137), also indicating that certain specific signals may be required for efficient 
incorporation. A similar conclusion was drawn for a retrovirus when it was found that 
homologous proteins were incorporated efficiently into MoMuLV virions even when 
present at a relatively low density at the plasma membrane, whereas heterologous 
proteins were incorporated only when expressed at high densities (245). One possible 
mechanism for selective exclusion or inclusion of spike proteins was suggested by 
Johnson era/. (121), who examined why HIV1 env protein could not be incorporated 
into VSV virions unless its cytoplasmic tail was replaced with that of VSV G (186). They 
found that amino acids between position 3 and 10 in the HIV env tail were responsible 
for an inhibition of incorporation into VSV. By confocal microscopy, the authors 
concluded that this inhibition occurred because the HIV env CTD signal directed the 
protein to plasma membrane locations distinct from the sites where VSV proteins were 
concentrated for budding. The data may be explained by their conclusion but the 
evidence for the existence of distict microdomains was however not compelling, and 
their conclusion therefore appears somewhat speculative. Nevertheless, the 
implications of this study are interesting: Within the plasma membrane, distinct domains 
may exist, and specific incorporation signals in the CTD and /or TM domain of viral 
spike proteins may target spike proteins to such microdomains to possibly enhance the 
rate of incorporation. For Influenza, a perhaps related membrane-distribution effect was 
observed. HA appeared to be diffusely distributed over the surface, whereas M2 and NA 
seemed to cluster in patches (144). With regard to the existence of membrane 
microdomains, a very novel and interesting concept has emerged in protein targeting, 
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involving so-called 'rafts' (15, 229). Rafts are dense lipid complexes that are resistant to 
solubilization at 4°C in triton X-100. They represent tightly-packed, cholesterol- and 
sphingomyelin-enriched membrane microdomains. Certain viral glycoproteins (for 
example GPI-anchored proteins and Influenza HA) have been shown to be associated 
with raft domains during transport to the cell surface, and Influenza HA and NA are 
recovered in rafts after entering the Golgi complex, and from the plasma membrane 
(220). The current hypothesis is that raft-domains are formed in the trans Golgi network 
from lipids with preferentially saturated acyl chains, and are dependent on, and 
interspersed with cholesterol. These rafts are less fluid due to the tight lipid packing, 
and function as platforms for intracellular protein sorting and signal transduction events 
(Simons and Ikonen, 1997). Viral spike proteins that pass through the secretory 
pathway may be selectively associated with rafts or forming rafts, and therefore end up 
selectively within or outside of raft domains in the plasma membrane. The significance 
for viral spike protein incorporation may be in the fact that the raft domains at the plasma 
membrane, depending on the virus, may represent preferred or non-preferred sites of 
viral budding and thus influence which membrane-associated proteins are 
incorporated. For example, Influenza HA proteins from purified virions were associated 
with raft domains, whereas SFV and VSV spike proteins were not (219). It has also 
been suggested that acyl modifications of proteins may influence their affinity for raft 
domains. It was for example reported that the acyl groups of HA, a protein that 
associates with rafts, are highly ordered, whereas those of VSV G, a spike protein that 
does not associate with rafts, were more mobile (219). Although lipid modifications (or 
protein-lipid interactions) were implicated as a possible factor in the raft concept, they 
may also modulate the efficiency of the budding process in different ways. Lipid 
modifications may be involved in the positioning of envelope proteins in a budding-
favorable conformation, or preparing the plasma membrane for budding by altering 
plasma membrane curvature (necessary for viral envelopment), for example by 
changing protein-to-lipid ratio or overall lipid content. Lipid content and the amount of 
protein influence the fluidity of a membrane, and significant differences in the lipid 
content of BV and ODV phenotypes of baculoviruses have already been demonstrated 
(14). Fig. 1 of chapter 1 shows the percentages of the various fatty acids found in the BV 
membrane, and it is thought that the BV membrane is more fluid than the ODV 
membrane. AcMNPV GP64 is acylated (207) and this acylation may influence the 
overall fluidity of the BV membrane. One of the proposed candidate residues for GP64 
acylation, cys503, was deleted in AcMNPV-viruses vAc-C-11 and vAc-C-14, described 
in chapter 4). Both of these recombinant viruses display strongly reduced amounts of 
surface-anchored GP64 and a drop in virus budding to below 10% of that of wild-type, 
however vAc-C-11 still propagated efficiently in Sf9 cell culture. 
New concepts in virus budding (see also 'Requirement for spike proteins in virus 
budding1, page 132). Since the early alphavirus budding models, in which spike-
nucleocapsid interactions were proposed to be the major force in driving the budding 
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process, new concepts in budding have emerged. In particular, the role of spike 
proteins as generic promoters of virus budding has been called into question, as in 
several cases viral matrix proteins (as separate proteins or within gag) have been 
shown to independently induce vesicle budding. For the alphaviruses, the early 
budding hypotheses still seem to hold but have been further refined, giving indications 
that extensive lateral interactions between spike proteins may play a significant role. 
These lateral interactions may be partly responsible for, and organize the formation of a 
protein 'lattice' or 'cage' seen in the icosahedral high resolution structure of a mature 
alphavirus virion (24). Because similar protein 'lattices' are seen in retroviruses, and 
because matrix proteins of retroviruses and several negative-stranded RNA viruses 
bind to membranes and have a tendency to polymerize (see earlier), the formation of a 
protein 'cage' has been proposed as a generic mechanism for virus budding (60). This 
'cage' would be organized through extensive interactions between integral or 
peripheral membrane proteins. Interactions between capsid or nucleocapsid and spike 
proteins cooperate in this process, but matrix proteins may be the central organizers in 
this process. Also hypothetical is the idea that these 'lattices' or 'cages' may structurally 
alter/prepare the host plasma membrane for the budding process by sorting host and 
viral proteins via protein-protein or other interactions with stringencies that differ 
depending on the virus. In the cage-formation process, the membrane may adopt the 
curvature of the 'cage' and initiate the movement of the nucleocapsid outward. In 
contrast to the proposed roles for matrix proteins in budding, for coronaviruses 
coexpression of the envelope proteins alone resulted in the release of membrane 
particles indistinguishable from authentic virions (254), thus demonstrating that viral 
budding mechanisms may vary substantially between different virus families. 
Recent research highlights additional potential components of the budding 
machinery: the use of host membrane proteins in pinching off the budding virion, and 
the involvement of the host cytoskeleton in budding and morphogenesis. Pinching off 
constitutes the final step in the dissociation of the virion from the host cell. Very little is 
known about the process of pinching off, but a few interesting observations have been 
reported. One of these observations regards the mapping of a late assembly domain in 
the p2b region of the Rous Sarcoma virus gag protein (278, 281). Mutations in this 
region caused a block in pinching off and the mutant virions remain attached to the 
plasma membrane by a thin membrane stalk. The identified domain contains a 
sequence motif PPPY, which is found in gag proteins of many retroviruses. In HIV, a 
similar pro-rich domain with late assembly function has been identified in a different 
location within gag (71, 190). Most interestingly, the pro-rich sequence motif is similar to 
a consensus motif required to interact with WW domains of cellular proteins. The WW 
domain is a highly structured domain that mediates protein-protein interactions in a 
wide range of cellular proteins with unrelated functions (241). Indeed, the late domain of 
Rous Sarcoma virus gag has been shown to interact with the WW domain of a 
signalling molecule associated with the plasma membrane called YAP (Yes-kinase 
associated protein) (242). In addition, a very similar motif (PPxY) with similar functional 
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characteristics has been demonstrated in VSV and Rabies matrix proteins (86). 
Mutations in this motif abolish binding to WW domains and interfere with the release of 
VSV M protein in a functional budding assay. It is therefore conceivable that both 
retroviruses and rhabdoviruses utilize host cellular proteins for parts of the budding 
process. Other studies have been performed that indicate the participation of the host 
cytoskeleton in virus budding: Both paramyxovirus matrix protein and gag form 
complexes with actin in vitro (36, 66), actin filaments have been seen by EM in 
association with budding virions (11), and purified virus particles have been found to 
contain actin. In brief, there is good evidence to suggest that host cytoskeletal 
components are indeed involved in virus budding, however the mechanisms underlying 
these involvements are not understood. 
A baculovirus BV budding model? Because so little is known about baculovirus 
budding, it is difficult to relate the above described virus budding concepts to 
baculoviruses. Early observations (90, 249, 258, 260) show NCs lining up and budding 
through the plasma membrane of insect cells, and a seemingly independent transport to 
the cell surface and membrane fusion capacity of GP64 (Fig. 4)(9, 10). One can only 
speculate as to what constitutes the driving force in baculovirus BV budding. A 
baculovirus protein with a matrix-like function has not yet been identified, but given its 
abundance, VP39 might be a candidate. In the absence of GP64, budding is 
significantly (but not completely (98%)) reduced, suggesting that budding is either 
critically dependent on GP64 (and the remaining 2% budding is artefactual) or that 
other viral components are capable of inducing budding but efficiency is greatly 
enhanced in the presence of GP64. It is possible that baculoviruses form a protein 
structure, 'lattice' or 'cage', in or near the plasma membrane, analogous to the models 
described for alpha- and retroviruses. If so, it is likely that GP64 would be a constituent 
of the 'lattice', and interactions between GP64 and other components might initiate such 
a structure. No such interactions have been demonstrated to date, but the data in 
chapter 4 indirectly indicate that the CTD may play an interactive role. Despite being 
present at the surface at wild type levels, deletion of the CTD leads to an -63 to 70% 
decrease in the number of GP64 molecules per virion, suggestive of specific 
interactions for preferential incorporation of membrane proteins. The GP64 C-terminal 
residues between -11 and -14 may also be involved in interactions, as vAc-C-14 (see 
chapter 4) was unable to efficiently propagate in Sf9 cells, whereas vAc-C-11, while 
present in equivalent amounts on the cell surface, did efficiently propagate. One of the 
current hypotheses for the initiation of membrane deformation in preparation for viral 
budding is that the membrane follows the curvature induced by the proposed protein 
'lattice'. An interesting phenomena in that regard may be the apparent asymmetrical 
distribution of GP64 within the BV phenotype. If induction of membrane curvature would 
be a function of GP64, presence of GP64 on one side of the virion only might be 
explained by the fact that GP64, after interaction with the NC and induction of the initial 
membrane curvature, would no longer be needed until the end of the virion structure 
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Infected 
insect cell 
FIG. 4. Baculovirus BV budding. In the figure, observed phenomena involving budding are 
depicted: 1) In an infected cell, nucleocapsids (NCs) are seen in the nucleus, cytoplasm, and lining up along 
the plasma membrane, 2) In infected cells, but also when expressed in the absence of viral infection, GP64 
follows the secretory pathway and accumulates at the plasma membrane, 3) NCs bud through the plasma 
membrane at sites where GP64 has accumulated, and acquire an envelope in the process, 4) Spike-like 
structures are seen at one end of the resulting BV virions, and are thought to be composed of GP64. 
Few experimental data are available to understand what constitutes the driving force in baculovirus 
BV budding. Two hypothetical phenomena (boxed; with ?) that may be involved in driving virus budding are 
shown. The top scenario depicts budding of GP64-enriched lipid vesicles. Such a phenomenon has been 
demonstrated for Mouse Hepatitus virus, a coronavirus, in which envelope proteins M and E are together 
capable of inducing budding of virus-like particles (254). It is not known whether GP64 alone has the 
capacity to induce vesicle budding, however this would be an inefficient process as only trace quantities of 
GP64 are detected from the supernatant of GP64 transfected cells. One study (263) suggests that GP64, 
in cooperation with other viral proteins, may be able to induce budding in the absence of the viral 
nucleocapsid. The bottom (boxed) scenario depicts budding in the absence of GP64, resulting in GP64-
lacking virions. Chapter 4 demonstrated that GP64 is necessary for efficient budding, but it is possible that a 
low level of virus budding occurs in the absence of GP64. This would however also be a highly inefficient 
process. In addition to the two depicted phenomena, matrix-like proteins have been demonstrated in other 
viruses such as rhabdo- and retroviruses, with the capacity to induce vesicle budding independent of other 
viral spike proteins. Similar matrix-like proteins have not yet been demonstrated in baculoviruses. 
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due to the virion's rod shape. Pinching off then might then be accomplished in 
cooperation with host cellular proteins, analogous to the proposed utilization of host 
membrane proteins for pinching off of retro- and rhabdovirions (278, 281). It is possible 
that baculoviruses utilize host cellular proteins for additional steps of the budding 
process, such as the interactions described between matrix proteins and actin for retro-
and paramyxoviruses (36, 66). The involvement of the cytoskeleton in virus maturation 
has been addressed for baculovirus AcMNPV (263). In those studies, the effects of 
cytochalasins B and D (CB and CD) were determined. These compounds are inhibitors 
of microfilament elongation, and have been shown to interfere with budding for a 
number of viruses (for example (11, 193) but not for others (for example Sindbis, (28)). 
When added to cells infected with AcMNPV, particles lacking nucleocapsids are 
observed budding from the plasma membrane by EM. Conclusions from these studies 
included that budding remained unaffected by cytochalasin, whereas the inhibitory 
effect was likely on the synthesis, transport and/or assembly of viral components. 
Although these results may hold some very interesting implications for baculovirus BV 
budding, their interpretation is not straight forward. CD has been shown to cause 
secundary effects, not directly related to transport or budding (41, 79), and significant 
quantitative effects may not be easily detected by EM. Also, the absence of 
nucleocapsid at the plasma membrane due to the presence of CB or CD may lead to an 
artefactual overrepresentation of budded empty particles. Nevertheless, the apparent 
budding of core-less particles may hold interesting implications, in particular that the 
baculovirus nucleocapsid may not be essential for budding. The most abundant protein 
detected in the particles produced in the presence of CD is GP64, suggesting that GP64 
may be involved in nucleocapsid-independent virus budding. While I have never 
detected large amounts of GP64 in supernatants from GP64-transfected cells, and 
consider it therefore unlikely that vesicle budding induced by GP64 alone is a 
significant mechanism, it is possible that GP64, in cooperation with other viral or cellular 
proteins, may be capable of inducing budding without the need for nucleocapsid. It has 
been reported that, even in a normal infection, empty particles bud to a limited extent 
(126, 263). However, whether these represent an insignificant minority within the total 
population of budded particles, or whether this is a significant mechanism in 
baculovirus propagation remains to be determined. 
Finally, a recent publication (181) identified a baculovirus protein that is 
necessary for a different step in the assembly process: egress of NC from the nucleus. 
At the non-permissive temperature, NCs of a temperature sensitive mutant of AcMNPV 
were found to be retained in the nucleus and, contrary to wild-type, no interaction with 
the nuclear membrane was observed by EM. This mutation was mapped to GP41, an O-
linked protein previously suspected to reside in the space between the NC and viral 
envelope (defined as the 'tegument') of the ODV phenotype exclusively (272). Studies 
using highly purified rat liver subcellular fractions demonstrated that the majority of 
proteins with O-linked sugars similar to GP41 (O-linked N acetyl-glucosamine) are 
found in the nucleus, with the highest density associated with the nuclear membrane 
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(e.g. nuclear pore proteins; (85)). GP41 is found in the nucleus and in the ODV 
phenotype, but did not fractionate with viral membrane fractions (272). It is however 
possible that GP41 is loosely associated with the nuclear membrane but that membrane 
association was lost in the procedure of fractionation, or that the presence of GP41 in 
ODV is a consequence of its presence in the nucleoplasm when NC are assembled. 
Several functions for GP41 were postulated: GP41 may be involved in movement of 
NCs from the virogenic stroma to the nuclear membrane, or in facilitating movement of 
NCs through the nuclear membrane. GP41 may also be directly involved in assembly of 
NCs, as the EM resolution may not have been sensitive enough to detect possible 
aberrations in the formed NCs in its absence. It is not known whether baculovirus NCs 
use the nuclear pores to migrate from the nucleus to the cytoplasm. Because 
sometimes, enveloped NCs are seen within the cytoplasm, and this envelope is lost 
before reaching the plasma membrane (52), it is possible that baculovirus NCs bud 
through the nuclear membrane. Herpesviruses are an example of how egress from the 
nucleus may occur. Although herpesvirus assembly differs significantly from baculovirus 
assembly, both have a need to transport newly assembled NCs from the nucleus, and 
herpes simplex virus NCs are thought to bud through the inner nuclear lamella and then 
deenvelop by budding through the outer nuclear lamella. Because several findings 
support this process of nuclear exit yet it is only rarely seen in herpesvirus infected cells, 
it is suggested to be a process much more rapid than some other envelopment 
processes (210). Since baculovirus NCs are usually seen naked in the cytoplasm of 
infected cells, and if the process is similarly rapid and difficult to observe, the same 
mechanism might apply to baculoviruses. 
Evolution of GP64, and current and future avenues of GP64 research 
A gp64 gene has been identified in the genomes of a number of baculoviruses 
that taxonomically fall within proposed group I of the genus Nucleopolyhedrovirus: 
AcMNPV, BmNPV, OpMNPV, CfMNPV, AfMNPV, EpNPV, and AgMNPV. These GP64s 
display an ~ 77 to 82 % amino acid identity within the predicted ectodomain. Besides 
baculoviruses, genes with homology to baculovirus GP64 were demonstrated only in 
the genomes of three related arboviruses of the family Orthomyxoviridae (see 
introduction, and chapter 6). It is extremely interesting to find the homology of a viral 
envelope gene between viruses of two so profoundly different groups. A factor that 
possibly links the two is the fact that both baculoviruses and the THO/DHO viruses 
replicate in invertebrate hosts (THO/DHO viruses also replicate in mammalian cells). 
Because of the remarkable sequence similarity, a common ancestor for the GP64 
homologs has been suggested and seems likely. Several schemes of acquiring the 
gene are possible, but at this point one can only speculate as to which virus first 
possessed the gene. Certain considerations may be helpful in understanding how the 
two virus families can share this envelope gene. For example, other orthomyxoviruses 
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such as the Influenza viruses are notorious for their capacity to acquire genes by 
reassortment when multiple viruses infect one host. Although this is described between 
two segmented RNA viruses, it may be possible that the segmented THO/DHO virus 
acquired GP64 (presumably as an mRNA) from a baculovirus by a mechanism similar to 
RNA-RNA reassortment, while sharing the same host. Alternatively, DHO/THO virus may 
have first acquired the gene or both viruses may have independently acquired the gene 
from an ancestor, to which mechanisms such as recombination may have contributed. 
Sharing the same host is not unlikely since they both infect invertebrate cells, and since 
AcMNPV for example has a relatively broad host range. Although only a speculation, is 
it possible that the acquisition of GP64 may have been a contributing factor to 
expanding AcMNPV's host range? And because a large group of baculoviruses may 
not possess a gp64 gene, is it possible that the primordial baculovirus was gut 
(epithelium)-limited and radiated in different directions perhaps upon acquisitions of 
different envelope genes that permitted systemic infection? If this would be the case, 
one would expect the existence of phylogenetic subgroups based on the various 
acquired envelope genes. 
In the determination of what (evolutionary) the most critical domains in GP64 
function may be, conservations between the baculovirus and THO/DHO genes are likely 
to be a good indicator. After the gp64 ancestral gene was acquired, it may have 
diverged within baculoviruses and THO/DHO viruses at different rates. Considering that 
THO/DHO are RNA viruses, their mutation/evolutionary rates may differ from that of the 
double-stranded DNA baculoviruses. A consequence of this may be that the level of 
amino acid identity between the GP64 homologs of DHO and THO viruses is relatively 
low (33%) compared to the high level of conservation (70-80% amino acid identity) 
between baculovirus GP64s. It is altogether likely that those residues that are 
unchanged between baculovirus GP64 and THO/DHO env, represent key amino acids 
in the most conserved functions. Of course, functions may have diverged based on 
requirements of the different viruses or adaptations to a particular host, however the 
structural similarities between them suggest remaining functional conservation. For 
both, induction of low-pH membrane fusion and involvement in receptor binding have 
been demonstrated ((10, 201) Chapter 5). We do not know whether GP64 or THO/DHO 
env are important for the structural integrity of the virion in the extracellular environment, 
however baculovirus virions could be isolated carrying only 30 to 37% of the level of 
GP64 in the envelope of a wild-type virion (Chapter 4). In any case, GP64 and 
THO/DHO envelope proteins appear to share a common ancestry, and both proteins 
play critical roles in the respective infection cycles of their viruses. 
What is the evolutionary significance of the GP64 CTD? The basic character (due 
mainly to arginine residues) and small size of 2 to 8 amino acids, may be important 
characteristics of the GP64 CTD domain since this is conserved between baculovirus 
GP64s and the related orthomyxovirus DHO virus. Based on a statistical analysis of 
membrane protein topology and the role of TM domains and their flanking regions 
(267), a 'positive inside' rule was proposed. This rule says that the transmembrane 
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orientation of an apolar segment is not determined by the apolar region itself, but by the 
charge content of the flanking regions. Positively charged residues were almost always 
found on the non-translocated side of the apolar segment, with a majority of these 
residues being arginines and lysines. This was true for membrane proteins of different 
organisms and a variety of cellular locations: bacterial inner-membrane proteins, and 
eukaryotic proteins from the ER, plasma membrane, mitochondrial and chloroplast 
membrane. These findings suggest that an apolar segment followed by polar and 
charged residues (mostly arginines) is a generic signal for membrane anchoring rather 
than a specific signal for other processes. In that regard, the overall charge of the viral 
spike protein tail or the charge at the cytoplasmic border region (arg506) may aid in 
effective membrane anchoring of GP64. In addition, it is possible that the basic charge 
of the CTD has an undetermined function in the infection process of larvae, however the 
observation that the recombinant virus vAc-CA3Ra (in which all arginines were replaced 
with alanines, see chapter 4) was in all measurable aspects indistinguishable from virus 
carrying a wild-type GP64, demonstrates that the charge is not necessary for viability of 
AcMNPV in cell culture. Not only the charge, but the complete predicted CTD was 
shown to be dispensable for survival of the virus in cell culture. Nevertheless in the 
presence of the CTD domain, despite GP64 surface levels equivalent to those in the 
absence of the CTD, the amount of budding and incorporation of GP64 into virions are 
significantly higher, indicative of a role for the CTD beyond membrane anchoring. 
Because incorporation of GP64 into the virion is important for subsequent entry, the 
CTD thus seems to confer an advantage to AcMNPV. In conclusion, the size and charge 
of the CTD may represent a domain involved in evolutionary conserved functions that 
confer a significant advantage to the virus, or may be a domain with only a marginal 
impact on overall survival. 
Current and future avenues of GP64 research. Most of the GP64 research in the 
past decade has addressed, directly or indirectly, the role of GP64 in the baculovirus 
infection cycle. This is an area that still needs considerable attention, particularly in 
determining the role of GP64 in BV assembly and the mechanism of BV host cell 
receptor binding. Determination of the 3-dimensional structure of GP64 would be 
extremely valuable, especially in the area of receptor binding and structural 
requirements for budding. Attempts to crystallize the soluble form of OpMNPV GP64 that 
was described in chapter 2 and 5, have not yet been succesful. Another fundamental 
line of GP64 research that has developed in recent years and which is not addressed in 
this thesis, concerns the bio-physical aspects of GP64 membrane fusion. Because of 
the robust fusion mediated by GP64, baculovirus GP64 is becoming a model for studies 
of fusion pore formation during the process of membrane fusion. Typically, BV-infected 
insect cells are used in electrophysiological experiments of membrane fusion with the 
use of so-called 'patch-clamping' technique. This resulted in reports on the role of lipid 
composition in fusion pore formation (25), and how size, timing and reversibility ('pore-
flickering') of the initial fusion pore induced by AcMNPV GP64, compares to Influenza 
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HA (197). The stably transfected cell line Sf90p1D, designed to complement GP64 in the 
gp64null virus system (chapter 4), has proved useful in these studies. Upon 
characterization, these uninfected cells showed a relatively uniform distribution of GP64 
at the plasma membrane, and were succesfully used in additional fusion pore studies 
(195), and also in studies examining the multimeric requirements for GP64-induced 
fusion (157). 
There are other, more applied, potential avenues for GP64. Among them is the 
possibility to utilize AcMNPV in human gene therapy-related applications. AcMNPV is 
nonpathogenic to humans, but the BV can enter a large variety of cell types including 
mammalian cells (12, 16, 19, 96, 227) and can efficiently deliver genes (12, 27, 227). A 
very recent example of the use of baculoviruses for gene delivery is a study by Delaney 
and Isom (38). Insertion of the entire hepatitus B virus (HBV) genome into AcMNPV, 
followed by 'infection/transfection' of this recombinant virus, drastically improved the 
very low efficiency of HBV infection of liver cells in vitro. Despite efficient gene delivery 
in some cell types, expression of the genes in mammalian cells from mammalian 
promoters in a recombinant virus, has been more challenging. A recent study (27) 
applied two novel ideas to the baculovirus gene delivery concept: 1) treatment of certain 
mammalian cells with trichostatin A, a selective histone deacetylase inhibitor, 
significantlty increased expression levels of a foreign gene from a mammalian promoter 
in recombinant baculovirus infected cells, 2) incorporation of a selectable marker 
{neomycin resistance gene) into a recombinant virus followed by incubation with G418, 
selected transformed lines incorporating a portion of the baculovirus genome and still 
expressing a gene of interest after 25 passages. Another interesting potential research 
avenue for GP64 involves pseudotyping and selective targeting of diseased cells (222). 
VSV, a virus non-pathogenic to humans, was designed to express the HIV-1 receptor 
CD4 and co-receptor CXCR4, and was shown to infect, propagate, and kill T cells 
infected with HIV. For similar potential baculovirus applications, studies of GP64 could 
be particulary helpful as it itself accumulates at the cell surface, and possesses all the 
signals necessary for cell surface display and for effective incorporation into baculovirus 
virions. Currently, commercial vectors are already available that utilize GP64 signals to 
display glycoproteins of interest at the cell surface in a eukaryotic virus display system. 
The above examples of applied GP64 research are encouraging and may in the future 
yield many practical uses. A continued fundamental approach to the study of GP64 
structure and function will be essential to provide the framework for such applications, in 
particular to understand the requirements for virion entry into host and non-host cells, 
and the role of GP64 in the production of budded virions. Hopefully, continued GP64 
research will also yield clues towards the intriguing questions of when and how GP64 
was acquired, and how this acquisition may have impacted the evolution of the family of 
viruses we now know as the Baculoviridae. 
150 
References 
1. Ahrens, C. H., R. L. Q. Russell, C. J. Funk, J. T. Evans, S. H. Harwood, and G. F. Rohrmann (1997). 
The sequence of the Orgyia pseudotsugata Multinucleocapsid Nuclear Polyhedrosis virus genome. 
Virol. 229: 381-399. 
2. Ayres, M. D., S. C. Howard, J. Kuzio, M. Lopez-Ferber, and R. D. Possee (1994). The complete DNA 
sequence of Autographa californica Nuclear Polyhedrosis virus. Virol. 202: 586-605. 
3. Barsoum, J., R. Brown, M. McKee, and F. M. Boyce (1997). Efficient transduction of mammalian cells 
by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Ther. 8: 
2011-8. 
4. Barth, B. U., M. Suomalainen, P. Liljestrom, and H. Garoff (1992). Alphavirus assembly and entry role 
of the cytoplasmic tail of the E1 Spike subunit. J. Virol. 66: 7560-7564. 
5. Blissard, G. W. (1996). Baculovirus - Insect Cell Interactions. Cytotechnology. 20: 73-93. 
6. Blissard, G. W., P. H. Kogan, R. Wei, and G. F. Rohrmann (1992). A synthetic early promoter from a 
baculovirus: Roles of the TATA box and conserved start site CAGT sequence in basal levels of 
transcription. Virology. 190:783-793. 
7. Blissard, G. W., and G. F. Rohrmann (1990). Baculovirus diversity and molecular biology. Annu. Rev. 
Entomol. 35: 127-155. 
8. Blissard, G. W., and G. F. Rohrmann (1991). Baculovirus gp64 gene expression: Analysis of 
sequences modulating early transcription and transactivation by IE1. J. Virol. 65: 5820-5827. 
9. Blissard, G. W., and G. F. Rohrmann (1989). Location, sequence, transcriptional mapping, and 
temporal expression of the gp64 envelope glycoprotein gene of the Orgyia pseudotsugata 
Multicapsid Nuclear Polyhedrosis virus. Virol. 170: 537-555. 
10. Blissard, G. W., and J. R. Wenz (1992). Baculovirus GP64 envelope glycoprotein is sufficient to 
mediate pH-dependent membrane fusion. J. Virol. 66: 6829-6835. 
11. Bohn, W., G. Rutter, H. Hohenberg, K. Mannweiler, and P. Nobis (1986). Involvement of actin 
filaments in budding of Measles virus: studies on cytoskeletons of infected cells. Virol. 149: 91-106. 
12. Boyce, F. M., and N. L. R. Bucher (1996). Baculovirus-mediated gene transfer into mammalian cells. 
Proc. Natl. Acad. Sci. USA. 93: 2348-2352. 
13. Bradford, M. B., G. W. Blissard, and G. F. Rohrmann (1990). Characterization of the infection cycle of 
the Orgyia pseudotsugata Multicapsid Nuclear Polyhedrosis virus in Lymantria dispar cells. J. Gen. 
Virol. 71: 2841 -2846. 
14. Braunagel, S. C , and M. D. Summers (1994). Autographa californica nuclear polyhedrosis virus, PDV, 
and ECV viral envelopes and nucleocapsids: Structural proteins, antigens, lipid and fatty acid profiles. 
Virol. 202: 315-328. 
15. Brown, D. A., and J. K. Rose (1992). Sorting of GPI-anchored proteins to glycolipid-enriched 
membrane subdomains during transport to the apical cell surface. Cell. 68: 533-44. 
16. Brusca, J., M. Summers, J. Couch, and L. Courtney (1986). Autographa californica Nuclear 
Polyhedrosis virus efficiently enters but does not replicate in poikilothermic vertebrate cells. Intervirol. 
26: 207-222. 
17. Bulach, D. M., C. A. Kumar, A. Zaia, B. Liang, and D. E. Tribe (1999). Group II nucleopolyhedrovirus 
subgroups revealed by phylogenetic analysis of polyhedrin and DNA polymerase gene sequences 
[In Process Citation], J. Invert. Pathol. 73: 59-73. 
18. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley (1994). Structure of influenza 
haemagglutinin at the pH of membrane fusion. Nature. 371: 37-43. 
153 
19. Carbonell, L. F., and L. K. Miller (1987). Baculovirus interaction with nontarget organisms: a virus-
borne reporter gene is not expressed in two mammalian cell lines. Appl. Environ. Microbiol. 53: 1412-
1417. 
20. Carr, C. M., and P. S. Kim (1994). Flu virus invasion: halfway there. Science. 266: 234-236. 
21 . Carstens, E. B., S. T. Tjia, and W. Doerfler (1979). Infection of Spodoptera frugiperda cells wilh 
Autographs californica Nuclear Polyhedrosis virus. I. Synthesis of intracellular proteins after virus 
infection. Virol. 99: 368-398. 
22. Casadaban, M. J. J., A. Martinez-Arias, S. K. Shapira, and J. Chou (1981). Beta-galactosidase gene 
fusions for analyzing gene expression in Eschirichia coli and yeast. Meth. Enzymol. 100: 293-308. 
23. Charlton, C. A., and L. E. Volkman (1986). Effect of tunicamycin on the structural proteins and 
infectivity of budded Autographa californica nuclear polyhedrosis virus. Virol. 154: 214-218. 
24. Cheng, R. H., R. J. Kuhn, N. H. Olson, M. G. Rossmann, H. K. Choi, T. J. Smith, and T. S. Baker 
(1995). Nucleocapsid and glycoprotein organization in an enveloped virus. Cell. 80: 621-30. 
25. Chernomordik, L, E. Leikina, M. Cho, and J. Zimmerberg (1995). Control of baculovirus GP64-
induced syncytium formation by membrane lipid composition. J. Virol. 69: 3049-3058. 
26. Clerx, J. M. P., F. Fuller, and D. H. L. Bishop (1983). Tick-borne viruses structurally similar to the 
orthomyxoviruses. Virol. 127: 295-279. 
27. Condreay, J. P., S. M. Witherspoon, W. C. Clay, and T. A. Kost (1999). Transient and stable gene 
expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. 
Sci. U S A 96: 127-32. 
28. Coombs, K., E. Mann, J. Edwards, and D. T. Brown (1981). Effects of chloroquine and cytochalasin B 
on the infection of cells by Sindbis virus and Vesicular Stomatitis virus. J. Virol. 37: 1060-5. 
29. Copeland, C. S., R. W. Doms, E. M. Bolzau, R. G. Webster, and A. Helenius (1986). Assembly of 
Influenza hemagglutinin trimers and its role in intracellular transport. J. Cell. Biol. 103:1179-1192. 
30. Copeland, C. S., K. P. Zimmer, K. R. Wagner, G. A. Healey, I. Mellman, and A. Helenius (1988). 
Folding trimerization and transport are sequential events in the biogenesis of Influenza virus 
hemagglutinin. Cell. 53: 197-210. 
31 . Cosson, P. (1996). Direct interaction between the envelope and matrix proteins of HIV- 1. EMBO J. 
Journal. 15: 5783-5788. 
32. Croizier, G., L. Croizier, O. Argaud, and D. Poudevigne (1994). Extension of Autographa californica 
Nuclear Polyhedrosis virus host range by interspecific replacement of a short DNA sequence in the 
p143 Helicase Gene. Proc. Natl. Acad. Sci. USA. 91: 48-52. 
33. Croizier, G., and H. C. T. Ribeiro (1992). Recombination as a possible major cause of genetic 
heterogeneity in Anticarsia gemmatalis nuclear polyhedrosis virus. Virus Res. 26: 183-196. 
34. D'Onofrio, M., C. M. Starr, M. K. Park, G. D. Holt, R. S. Haltiwanger, G. W. Hart, and J. A. Hanover 
(1988). Partial cDNA sequence encoding a nuclear pore protein modified by O- linked N-
acetylglucosamine. Proc. Natl. Acad. Sci. USA. 85: 9595-9. 
35. Dahlberg, J. E. (1974). Quantitative electron microscopic analysis of the penetration of VSV into L 
cells. Virol. 58: 250-62. 
36. Damsky, C. H., J. B. Sheffield, G. P. Tuszynski, and L. Warren (1977). Is there a role for actin in virus 
budding? J. Cell. Biol. 75: 593-605. 
37. Davidson, D. J., and F. J. Castellino (1991). Asparagine-linked oligosaccharide processing in 
lepidopteran insect cells. Temporal dependence of the nature of the oligosaccharides assembled on 
asparagine-289 of recombinant human plasminogen produced in baculovirus vector infected 
Spodoptera frugiperda (IPLB-SF-21AE) cells. Biochem. 30: 6165-74. 
38. Delaney, W. E. t., and H. C. Isom (1998). Hepatitis B virus replication in human HepG2 cells mediated 
by hepatitis B virus recombinant baculovirus. Hepatol. 28: 1134-46. 
39. Deng, W. P., and J. A. Nickoloff (1992). Site-directed mutagenesis of virtually any plasmid by 
eliminating a unique site. Anal. Biochem. 200: 81-8. 
154 
40. Dijkstra, J. M., N. Visser, T. C. Mettenleiter, and B. G. Klupp (1996). Identification and characterization 
of pseudorabies virus glycoprotein gM as a nonessential virion component. J. Virol. 70: 5684-8. 
41 . Dix, R. D., and R. J. Courtney (1976). Effects of cytochalasin B on Herpes Simplex virus type 1 
replication. Virol. 70:127-35. 
42. Doms, R. W., D. S. Keller, A. Helenius, and W. E. Balch (1987). Role for adenosine triphosphate in 
regulating the assembly and transport of Vesicular Stomatitis virus G protein trimers. J. Cell. Biol. 105: 
1957-1970. 
43. Doms, R. W., R. A. Lamb, J. K. Rose, and A. Helenius (1993). Folding and assembly of viral 
membrane proteins. Virol. 193: 545-562. 
44. Du, X., and S. M. Thiem (1997). Characterization of host range factor 1 (hrf-1) expression in Lymantria 
dispar M nucleopolyhedrovirus- and recombinant Autographa californica M nucleopolyhedrovirus-
infected IPLB-Ld652Y. Virol. 227: 420-430. 
45. Egan, M. A., L. M. Carruth, J. F. Rowell, X. Yu, and R. F. Siliciano (1996). Human immunodeficiency 
virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization 
signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor 
protein. J. Virol. 70: 6547-56. 
46. Ekstrom, M., P. Liljestrom, and H. Garoff (1994). Membrane protein lateral interactions control Semliki 
Forest virus budding. Embo J. 13: 1058-64. 
47. Engelhard, E. K., L. N. W. Kam-Morgan, J. O. Washburn, and L. E. Volkman (1994). The insect 
tracheal system: A conduit for the systemic spread of Autographa californica M nuclear polyhedrosis 
virus. Proc. Natl. Acad. Sci. USA. 91: 3224-3227. 
48. Fantini, J., S. Baghdiguian, N. Yahi, and J. C. Chermann (1991). Selected human immunodeficiency 
virus replicates preferentially through the basolateral surface of differentiated human colon epithelial 
cells. Virol. 185: 904-7. 
49. Federici, B. A., and R. H. Hice (1997). Organization and molecular characterization of genes in the 
polyhedrin region of the Anagrapha falcifera multinucleocapsid NPV. Arch. Virol. 142: 333-348. 
50. Fischer, C, B. Schroth-Diez, A. Herrmann, W. Garten, and H. D. Klenk (1998). Acylation of the 
influenza hemagglutinin modulates fusion activity. Virol. 248: 284-94. 
51 . Flipsen, J. T. M., J. W. M. Martens, M. M. Van-Oers, J. M. Vlak, and J. W. M. Van-Lent (1995). Passage 
of Autographa californica Nuclear Polyhedrosis virus through the midgut epithelium of Spodoptera 
exigua larvae. Virol. 208: 328-335. 
52. Fraser, M. J. (1986). Ultrastructural observations of virion maturation in Autographa californica nuclear 
polyhedrosis virus infected Spodoptera frugiperda cell cultures. J. Ultrastr. Mol. Struct. Res. 95: 189-
195. 
53. Freed, E. O. (1998). HIV-1 gag proteins: diverse functions in the virus life cycle. Virol. 251:1-15. 
54. Freedman-Faulstich, E. Z., and F. J. Fuller (1990). Nucleotide sequence of the tick-borne, 
orthomyxo-like Dhori/lndian/1313/61 virus envelope gene. Virol. 175:10-18. 
55. Frese, M., M. Weeber, F. Weber, V. Speth, and O. Haller (1997). Mx1 sensitivity: Batken virus is an 
orthomyxovirus closely related to Dhori virus. J. Gen. Virol. 78: 2453-8. 
56. Fuchs, L. Y., M. S. Woods, and R. F. Weaver (1983). Viral transcription during Autographa californica 
nuclear polyhedrosis virus infection: A novel RNA polymerase induced in infected Spodoptera 
frugiperda cells. J. Virol. 48: 641-646. 
57. Gabuzda, D. H., A. Lever, E. Terwilliger, and J. Sodroski (1992). Effects of deletions in the 
cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope 
glycoproteins. J. Virol. 66: 3306-15. 
58. Gallagher, P. J., J. M. Henneberry, J. F. Sambrook, and M. J. H. Gething (1992). Glycosylation 
requirements for intracellular transport and function of the hemagglutinin in Influenza virus. J. Virol. 
66: 7136-7145. 
155 
59. Garcia Maruniak, A., O. H. O. Pavan, and J. E. Maruniak (1996). A variable region of Anticarsia 
gemmatalis nuclear polyhedrosis virus contains tandemly repeated DNA sequences. Virus Res. 4 1 : 
123-132. 
60. Garoff, H., R. Hewson, and D. J. E. Opstelten (1998). Virus maturation by budding. Microbiol. Mol. 
Biol. Rev. 62: 1171-90. 
61 . Garoff, H., and K. Simons (1974). Location of the spike glycoproteins in the Semliki Forest virus 
membrane. Proc. Natl. Acad. Sci. US A. 71: 3988-92. 
62. Garrity, D. B., M.-J. Chang, and G. W. Blissard (1997). Late promoter selection in the baculovirus gp64 
envelope fusion protein gene. Virol. 231: 167-181. 
63. Gaudin, Y., J. Sturgis, M. Doumith, A. Barge, B. Robert, and R. W. Ruigrok (1997). Conformational 
flexibility and polymerization of Vesicular Stomatitis virus matrix protein. J. Mol. Biol. 274: 816-25. 
64. Gheysen, D., E. Jacobs, F. De Foresta, C. Thiriart, M. Francotte, D. Thines, and M. De Wilde (1989). 
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-
infected insect cells. Cell. 59: 103-112. 
65. Gill, S. C, and P. H. von Hippel (1989). Calculation of protein extinction coefficients from amino acid 
data. Anal. Biochem. 182: 319-326. 
66. Giuffre, R. M., D. R. Tovell, C. M. Kay, and D. L. Tyrrell (1982). Evidence for an interaction between 
the membrane protein of a paramyxovirus and actin. J. Virol. 42: 963-8. 
67. Goepfert, P. A., G. Wang, and M. J. Mulligan (1995). Identification of an ER retrieval signal in a 
retroviral glycoprotein. Cell. 82: 543-4. 
68. Goldstein, N. I., and A. H. Mcintosh (1980). Glycoproteins of nuclear polyhedrosis viruses. Arch. Virol. 
64: 119-26. 
69. Gollins, S. W., and J. S. Porterfield (1986). The uncoating and infectivity of the flavivirus West Nile on 
interaction with cells: effects of pH and ammonium chloride. J. Gen. Virol. 67: 1941-1950. 
70. Gombart, A. F., G. W. Blissard, and G. F. Rohrmann (1989). Characterization of the genetic 
organization of the Hind-Ill M region of the multicapsid nuclear polyhedrosis virus of Orgyia 
pseudotsugata reveals major differences among baculoviruses. J. Gen. Virol. 70: 1815-1828. 
71 . Gottlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine (1991). Effect of mutations affecting 
the p6 gag protein on Human Immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA. 
88: 3195-9. 
72. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine (1989). Role of capsid precursor processing and 
myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. 
Acad. Sci. USA. 86: 5781-5. 
73. Granados, R. R. (1978). Early events in the infection of Heliothis zea midgut cells by a baculovirus. 
Virol. 90: 170-174. 
74. Granados, R. R., and K. A. Lawler (1981). In vivo pathway of Autographa californica baculovirus 
invasion and infection. Virol. I08: 297-308. 
75. Granados, R. R., G. X. Li, A. C. G. Derksen, and K. A. Mckenna (1994). A new insect cell line from 
Trichoplusia ni (BTI-Tn-5B1 -4) susceptible to Trichoplusia ni single enveloped nuclear polyhedrosis 
virus. J. Invert. Pathol. 64: 260-266. 
76. Granados, R. R., and K. A. Williams (1986). In vivo infection and replication of Baculoviruses, vol. I. 
Biological properties and molecular biology. CRC Press, Boca Raton, Florida. 
77. Greber, U. F., M. Willetts, P. Webster, and A. Helenius (1993). Stepwise dismantling of adenovirus 2 
during entry into cells. Cell. 75: 477-486. 
78. Greenspan, G. L., B. G. Corsaro, P. R. Hughes, and R. R. Granados (1991). In-vivo enhancement of 
baculovirus infection by the viral enhancing factor of a granulosis virus of the cabbage looper 
Trichoplusia ni (Lepidoptera: noctuidae). J. Invert. Pathol. 58: 203-210. 
79. Griffin, J. A., and R. W. Compans (1979). Effect of cytochalasin B on the maturation of enveloped 
viruses. J. Exp. Med. 150: 379-91. 
156 
80. Guarino, L. A., M. A. Gonzalez, and M. D. Summers (1986). Complete sequence and enhancer 
function of the homologous DNA regions of Autographs californica nuclear polyhedrosis virus. J. 
Virol. 60: 224-229. 
81 . Guarino, L. A., and M. D. Summers (1986). Functional mapping of a trans-activating gene required for 
expression of a baculovirus delayed-early gene. J. Virol. 57: 563-571. 
82. Guarino, L. A., B. Xu, J. Jin, and W. Dong (1998). A virus-encoded RNA polymerase purified from 
baculovirus-infected cells. J. Virol. 72: 7985-91. 
83. Guinea, R., and L Carrasco (1995). Requirement for vacuolar proton-ATPase activity during entry of 
influenza virus into cells. J. Virol. 69: 2306-12. 
84. Hall, D. C. A., K. M. B. Caradoc-Davies, and V. K. Ward (1998). Analysis of the Epiphyas postvittana 
nucleopolyhedrovirus gp64 gene, vol. 1998. 
85. Hart, G. W., R. S. Haltiwanger, G. D. Holt, and W. G. Kelly (1989). Glycosylate in the nucleus and 
cytoplasm. Annu. Rev. Biochem. 58: 841 -874. 
86. Harty, R. N., J. Paragas, M. Sudol, and P. Palese (1999). A proline-rich motif within the matrix protein 
of Vesicular Stomatitis virus and Rabies virus interacts with WW domains of cellular proteins: 
implications for viral budding. J. Virol. 73: 2921-9. 
87. Hefferon, K. L, A. G. P. Oomens, S. A. Monsma, C. M. Finnerty, and G. W. Blissard (1999). Host cell 
receptor binding by baculovirus GP64 and kinetics of virion entry. Virol. 258: 455-68. 
88. Heggeness, M. H., P. R. Smith, and P. W. Choppin (1982). In vitro assembly of the nonglycosylated 
membrane protein (M) of Sendai virus. Proc. Natl. Acad. Sci. USA. 79: 6232-6. 
89. Helenius, A., M. Marsh, and J. White (1982). Inhibition of Semliki Forest virus penetration by 
lysosomotropic weak bases. J. Gen. Virol. 58 Pt 1: 47-61. 
90. Hess, R. T., and L. A. Falcon (1977). Observations on the interaction of baculoviruses with the plasma 
membrane. J. Gen. Virol. 36: 525-530. 
91 . Higgins, D. G., and P. M. Sharp (1989). Fast and sensitive multiple sequence alignments on a 
microcomputer. Comput. Appl. Biosci. 5: 151-3. 
92. Hill, C. P., D. Worthylake, D. P. Bancroft, A. M. Christensen, and W. I. Sundquist (1996). Crystal 
structures of the trimeric Human Immunodeficiency virus type 1 matrix protein: implications for 
membrane association and assembly. Proc. Natl. Acad. Sci. USA. 93: 3099-104. 
93. Hill, J. E., and P. Faulkner (1994). Identification of the gp67 gene of a baculovirus pathogenic to the 
spruce budworm, Choristoneura fumiferana multinucleocapsid nuclear polyhedrosis virus. J. Gen. 
Virol. 75: 1811-1813. 
94. Hill, J. E., J. Kuzio, J. A. Wilson, E. A. Mackinnon, and P. Faulkner (1993). Nucleotide sequence of 
the p74 gene of a baculovirus pathogenic to the spruce budworm Choristoneur fumiferana 
multicapsid nuclear polyhedrosis virus. Biochim. Biophys. Acta. 1172: 187-189. 
95. Hink, W. F. (1970). Established insect cell line from the cabbage looper, Trichoplusia ni. Nature. 226: 
466-467. 
96. Hofmann, C , V. Sandig, G. Jennings, M. Rudolph, P. Schlag, and M. Strauss (1995). Efficient gene 
transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA. 92: 10099-
10103. 
97. Hohmann, A. W., and P. Faulkner (1983). Monoclonal antibodies to baculovirus structural proteins: 
Determination of specificities by Western blot analysis. Virol. 125: 432-444. 
98. Hong, T., M. D. Summers, and S. C. Braunagel (1997). N-terminal sequences from Autographa 
californica Nuclear Polyhedrosis virus envelope proteins ODV-E66 and ODV-E25 are sufficient to 
direct reporter proteins to the nuclear envelope, intranuclear microvesicles, and the envleope of 
occlusion derived virus. Proc. Natl. Acad. Sci. USA. 94: 4050-4055. 
99. Horton, H. M., and J. P. Burand (1993). Saturable attachment sites for polyhedron-derived 
baculovirus on insect cells and evidence for entry via direct membrane fusion. J. Virol. 67: 1860-
1868. 
157 
100. Hu, N. T., Y. F. Lu, Y. Hashimoto, S. Maeda, and R. F. Hou (1994). The p10 gene of natural isolates of 
Bombyx mori Nuclear Polyhedrosis virus encodes a truncated protein with an M(r) of 7700. J. Gen. 
Virol. 75: 2085-8. 
101. Hu, Z. (1998). Ph.D. thesis, ISBN 90-5485-917-2. Agricultural University Wageningen, the 
Netherlands. 
102. Hu, Z. H., B. M. Arif, J. S. Sun, X. W. Chen, D. Zuidema, R. W. Goldbach, and J. M. Vlak (1998). 
Genetic organization of the Hindlll-I region of the Single-nucleocapsid Nucleopolyhedrovirus of 
Buzura suppressaria. Virus Res. 55: 71-82. 
103. Huang, X. F., R. W. Compans, S. Chen, R. A. Lamb, and P. Arvan (1997). Polarized apical targeting 
directed by the signal-anchor region of simian virus 5 hemagglutinin-neuraminidase. J. Biol. Chem. 
272: 27598-27604. 
104. Hughes, P. R., N. A. M. VanBeek, and H. A. Wood (1986). A modified droplet feeding method for 
rapid assay of Bacillus thuringiensis and baculoviruses in Noctuid larvae. J. Invert. Path. 48:187-192. 
105. Hughes, P. R., and H. A. Wood (1981). A synchronous peroral technique for the bioassay of insect 
viruses. J. Invert. Pathol. 37: 154-159. 
106. Hurtley, S. M., D. G. Bole, H. Hoover Litty, A. Helenius, and C. S. Copeland (1989). Interactions of 
misfolded Influenza virus hemagglutinin with binding protein Bip. J. Cell. Biol. 108: 2117-2126. 
107. Hurtley, S. M., and A. Helenius (1989). Protein oligomerization in the endoplasmic reticulum. Ann. 
Rev. Cell. Biol. 5: 277-307. 
108. Ivanova, L, and M. J. Schlesinger (1993). Site-directed mutations in the Sindbis virus E2 
glycoprotein identify palmitoylation sites and affect virus budding. J. Virol. 67: 2546-51. 
109. Jansen, J. J. M., W. R. Mulder, C. G. L J. De, J. M. Vlak, and G. W. J. De (1991). In-vitro expression of 
bovine opsin using recombinant baculovirus and the role of glutamic acid 134 in opsin biosynthesis 
and glycosylation. Biochim. Biophys. Acta. 1089: 68-76. 
110. Januszeski, M. M., P. M. Cannon, D. Chen, Y. Rozenberg, and W. F. Anderson (1997). Functional 
analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 7 1 : 3613-
9. 
111. Jarvis, D. L, J. A. G. W. Fleming, G. R. Kovacs, M. D. Summers, and L. A. Guarino (1990). Use of early 
baculovirus promoters for continuous expression and efficient processing of foreign gene products 
in stably transformed lepidopteran cells. Bio/Technology. 8: 950-955. 
112. Jarvis, D. L, and A. Garcia (1994). Biosynthesis and processing of the Autographa californica Nuclear 
Polyhedrosis virus GP64 protein. Virol. 205: 300-313. 
113. Jarvis, D. L, and L. A. Guarino (1995). Continuous foreign gene expression in transformed 
Lepidopteran insect cells, p. 187-202. In: Baculovirus Expression Protocols. C. Richardson (ed.), vol. 
Methods in Molecular Biology Vol. 39. Humana Press Inc., Totowa, NJ. 
114. Jarvis, D. L., C. Oker-Blom, and M. D. Summers (1990). Role of glycosylation in the transport of 
recombinant glycoproteins through the secretory pathway of lepidopteran insect cells. J. Cell. 
Biochem. 42: 181-191. 
115. Jarvis, D. L., L. Wills, G. Burow, and D. A. Bohlmeyer (1998). Mutational analysis of the N-linked 
glycans on Autographa californica nucleopolyhedrovirus gp64. J. Virol. 72: 9459-9469. 
116. Jin, H., G. P. Leser, and R. A. Lamb (1994). The Influenza virus hemagglutinin cytoplasmic tail is not 
essential for virus assembly or infectivity. EMBO J. Journal. 13: 5504-5515. 
117. Jin, H., G. P. Leser, J. Zhang, and R. A. Lamb (1997). The Influenza virus hemagglutinin and 
neuraminidase cytoplasmic tails control particle shape. EMBO J. 16: 1236-1247. 
118. Jin, H., K. Subbarao, S. Bagai, G. P. Leser, B. R. Murphy, and R. A. Lamb (1996). Palmitylation of the 
Influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity. J. Virol. 70: 1406-
1414. 
119. Jin,T., B. Qi, and Y. Qi (1998). Leucania separata multiple nuclear polyhedrosis virus genome DNA 
3336bp fragment including p94 gene and another four ORFs. 
158 
120. Johnson, D. W., and J. E. Maruniak (1989). Physical map of Anticarsia gemmatalis Nuclear 
Polyhedrosis virus AgMNPV-2 DNA. J. Gen. Virol. 70: 1877-1884. 
121. Johnson, J. E., W. Rodgers, and J. K. Rose (1998). A plasma membrane localization signal in the HIV-
1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and 
incorporation into VSV virions. Virol. 251: 244-52. 
122. Jourdan, N., M. Maurice, D. Delautier, A. M. Quero, A. L. Servin, and G. Trugnan (1997). Rotavirus is 
released from the apical surface of cultured human intestinal cells through nonconventional vesicular 
transport that bypasses the Golgi apparatus. J. Virol. 71: 8268-78. 
123. Justice, P. A., W. Sun, Y. Li, Z. Ye, P. R. Grigera, and R. R. Wagner (1995). Membrane vesiculation 
function and exocytosis of wild-type and mutant matrix proteins of Vesicular Stomatitis virus. J. Virol. 
69: 3156-60. 
124. Kahn, J. S., M. J. Schnell, L. Buonocore, and J. K. Rose (1999). Recombinant Vesicular Stomatitis 
virus expressing Respiratory Syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate 
infection and cell fusion. Virol. 254: 81-91. 
125. Kamita, S. G., and S. Maeda (1993). Inhibition of Bombyx mori Nuclear Polyhedrosis virus (NPV) 
replication by the putative DNA helicase gene of Autographa californica NPV. J. Virol. 67: 6239-
6245. 
126. Kawamoto, F., C. Suto, N. Kumada, and M. Kobayashi (1977). Cytoplasmic budding of a Nuclear 
Polyhedrosis virus and comparative ultrastructural studies of envelopes. Microbiol. Immunol. 21 : 255-
65. 
127. Keddie, B. A., G. W. Aponte, and L. E. Volkman (1989). The pathway of infection of Autographa 
californica nuclear polyhedrosis virus in an insect host. Science. 243:1728-1730. 
128. Keddie, B. A., and L. E. Volkman (1985). Infectivity difference between the two phenotypes of 
Autographa californica nuclear polyhedrosis virus: Importance of the 64K envelope glycoprotein. J. 
Gen. Virol. 66: 1195-1200. 
129. Klenk, H. D., and R. Rott (1980). Cotranslational and posttranslational processing of viral 
glycoproteins. Curr. Top. Microbiol. Immunol. 90: 19-48. 
130. Klupp, B. G., J. Baumeister, P. Dietz, H. Granzow, and T. C. Mettenleiter (1998). Pseudorabies virus 
glycoprotein gK is a virion structural component involved in virus release but is not required for entry. 
J. Virol. 72: 1949-58. 
131. Knipe, D. M., D. Baltimore, and H. F. Lodish (1977). Maturation of viral proteins in cells infected with 
temperature- sensitive mutants of Vesicular Stomatitis virus. J. Virol. 21:1149-58. 
132. Kogan, P. H., and G. W. Blissard (1994). A baculovirus gp64 early promoter is activated by host 
transcription factor binding to CACGTG and GATA elements. J. Virol. 68: 813-822. 
133. Kogan, P. H., X. Chen, and G. W. Blissard (1995). Overlapping TATA-dependent and TATA-
independent early promoter activities in the baculovirus gp64 envelope fusion protein gene. J. Virol. 
69: 1452-1461. 
134. Kool, M., C. H. Ahrens, J. M. Vlak, and G. R. Rohrmann (1995). Replication of baculovirus DNA. J. 
Gen. Virol. 76:2103-2118. 
135. Kool, M., J. T. M. Voeten, R. W. Goldbach, J. Tramper, and J. M. Vlak (1993). Identification of seven 
putative origins of Autographa californica multiple nucleocapsid nuclear polyhedrosis virus DNA 
replication. J. Gen. Virol. 74: 2661-2668. 
136. Kornfeld, R., and S. Kornfeld (1985). Assembly of asparagine-linked oligosaccharides. Ann. Rev. 
Biochem. 54: 631-664. 
137. Kretzschmar, E., L. Buonocore, M. J. Schnell, and J. K. Rose (1997). High-efficiency incorporation of 
functional Influenza virus glycoproteins into recombinant Vesicular Stomatitis viruses. J. Virol. 7 1 : 
5982-5989. 
159 
138. Kubelka, V., F. Altmann, G. Kornfeld, and L. Marz (1994). Structures of the N-linked oligosaccharides 
of the membrane glycoproteins from three lepidopteran cell lines (Sf-21, IZD-Mb-0503, Bm-N). Arch. 
Biochem. Biophys. 308: 148-57. 
139. Kundu, A., R. T. Avalos, C. M. Sanderson, and D. P. Nayak (1996). Transmembrane domain of 
Influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK 
cells. J. Virol. 70:6508-15. 
140. Kuroda, K., H. Geyer, R. Geyer, W. Doerfler, and H.-D. Klenk (1990). The oligosaccharides of 
Influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virol. 174: 418-429. 
141. Kuzio, J., M. N. Pearson, S. H. Harwood, C. J. Funk, J. T. Evans, J. M. Slavicek, and G. F. Rohrmann 
(1999). Sequence and analysis of the genome of a baculovirus pathogenic for Lymantria dispar. Virol. 
253: 17-34. 
142. Kyte, J., and R. F. Doolittle (I982). A simple method for displaying the hydropathic character of a 
protein. J. Mol. Biol. 157: 105-132. 
143. Lamb, R. A. (1993). Paramyxovirus fusion: A hypothesis for changes. Virol. 197: 1-11. 
144. Lamb, R. A., and R. M. Krug (1996). Orthomyxoviridae, p. 1353-1396. In: Fields Virology.. Lippincott-
Raven, Philadelphia. 
145. Lamb, R. A., S. L. Zebedee, and C. D. Richardson (1985). Influenza virus M2 protein is an integral 
membrane protein expressed on the infected-cell surface. Cell. 40: 627-33. 
146. Leahy, M. B., J. T. Dessens, F. Weber, G. Kochs, and P. A. Nuttall (1997). The fourth genus in the 
Orthomyxoviridae: Sequence analyses of two Thogoto virus polymerase proteins and comparison 
with Influenza Viruses. Virus Res. 50: 215-224. 
147. Leikina, E., H. O. Onaran, and J. Zimmerberg (1992). Acidic pH induces fusion of cells infected with 
baculovirus to form syncytia. FEBS Letters. 304: 221-224. 
148. Lenard, J., and D. K. Miller (1982). Uncoating of enveloped viruses. Cell. 28: 5-6. 
149. Liu, C, and G. M. Air (1993). Selection and characterization of a neuraminidase-minus mutant of 
Influenza virus and its rescue by cloned neuraminidase genes. Virol. 194: 403-7. 
150. Lodge, R., L. Delamarre, J. P. Lalonde, J. Alvarado, D. A. Sanders, M. C. Dokhelar, E. A. Cohen, and 
G. Lemay (1997). Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral 
targeting signal in their viral envelope glycoprotein. J. Virol. 71: 5696-702. 
151. Lodge, R., H. Gottlinger, D. Gabuzda, E. A. Cohen, and G. Lemay (1994). The intracytoplasmic 
domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. 
J. Virol. 68: 4857-61. 
152. Lu, A., and L. K. Miller (1996). Species-specific effects of the hcf-1 gene on baculovirus virulence. J. 
Virol. 70: 5123-5130. 
153. Luytjes, W., M. Krystal, M. Enami, J. D. Pavin, and P. Palese (1989). Amplification, expression, and 
packaging of foreign gene by Influenza virus. Cell. 59: 1107-13. 
154. Maeda, S., S. G. Kamita, and A. Kondo (1993). Host range expansion of Autographa californica 
Nuclear Polyhedrosis virus (NPV) following recombination of a 0.6-Kilobase-pair DNA fragment 
originating from Bombyx mori NPV. J. Virol. 67: 6234-6238. 
155. Majima, K., S. Gomi, T. Ohkawa, S. G. Kamita, and S. Maeda (1996). Complete nucleotide sequence 
of the 128,413 bp-long genome of the baculovirus BmNPV. 
156. Majima, K., R. Kobara, and S. Maeda (1993). Divergence and evolution of homologous regions of 
Bombyx mori Nuclear Polyhedrosis virus. J. Virol. 67: 7513-7521. 
157. Markovic, I., H. Pulyaeva, A. Sokoloff, and L. V. Chemomordik (1998). Membrane fusion mediated by 
baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J. Cell. Biol. 
143: 1155-66. 
158. Marsh, M., and A. Helenius (1980). Adsorptive endocytosis of Semliki Forest virus. J. Mol. Biol. 142: 
439-54. 
160 
159. Marsh, M., and A. Helenius (1989). Virus entry Into animal cells. Advances in Virus Research. 36: 
107-151. 
160. Martin, K., and A. Helenius (1991). Transport of incoming Influenza virus nucleocapsids into the 
nucleus. J. Virol. 65: 232-244. 
161. Maruniak, J. W., and M. D. Summers (1981). Autographa californica nuclear polyhedrosis virus 
phosphoproteins and synthesis of intracellular proteins after virus infection. Virol. 109: 25-34. 
162. Matlin, K. S., H. Reggio, A. Helenius, and K. Simons (1982). Pathway of Vesicular Stomatitis virus 
entry leading to infection. J. Mol. Biol. 156: 609-31. 
163. Mebatsion, T., M. Konig, and K. K. Conzelmann (1996). Budding of Rabies virus particles in the 
absence of the spike glycoprotein. Cell. 84: 941-951. 
164. Melikyan, G. B., H. Jin, R. A. Lamb, and F. S. Cohen (1997). The role of the cytoplasmic tail region of 
Influenza virus hemagglutinin in formation and growth of fusion pores. Virol. 235:118-128. 
165. Metsikko, K., and H. Garoff (1990). Oligomers of the cytoplasmic domain of the p62/E2 membrane 
protein of Semliki Forest virus bind to the nucleocapsid in vitro. J. Virol. 64: 4678-83. 
166. Metsikko, K., and K. Simons (1986). The budding mechanism of spikeless Vesicular Stomatitis virus 
particles. EMBO. J. 5: 1913-20. 
167. Miller, L. K. (ed.) (1997). The Baculoviruses. Plenum Press, New York. 
168. Miller, L. K.,and A. Lu (1997). The molecular basis of baculovirus host range, p. pp 217-236. In: The 
Baculoviruses. L. K. Miller (ed.). Plenum Press, New York. 
169. Miller, M. L, and D. T. Brown (1992). Morphogenesis of Sindbis virus in three subclones of Aedes 
albopictus (mosquito) cells. J. Virol. 66: 4180-90. 
170. Mitnaul, L. J., M. R. Castrucci, K. G. Murti, and Y. Kawaoka (1996). The cytoplasmic tail of influenza A 
virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in 
mice but is not essential for virus replication. J. Virol. 70: 873-879. 
171. Monsma, S. A., and G. W. Blissard (1995). Identification of a membrane fusion domain and an 
oligomerization domain in the baculovirus GP64 Envelope Fusion Protein. J. Virol. 69: 2583-2595. 
172. Monsma, S. A., A. G. P. Oomens, and G. W. Blissard (1996). The GP64 Envelope Fusion Protein is 
an essential baculovirus protein required for cell to cell transmission of infection. J. Virol. 70: 4607-
4616. 
173. Morse, M. A., A. C. Marriott, and P. A. Nuttall (1992). The glycoprotein of Thogoto virus (a tick-borne 
orthomyxo-like virus) is related to the baculovirus glycoprotein gp64. Virol. 186: 640-646. 
174. Mulligan, M. J., G. V. Yamshchikov, G. D. Ritter, Jr., F. Gao, M. J. Jin, C. D. Nail, C. P. Spies, B. H. 
Hahn, and R. W. Compans (1992). Cytoplasmic domain truncation enhances fusion activity by the 
exterior glycoprotein complex of Human Immunodeficiency virus type 2 in selected cell types. J. Virol. 
66: 3971-5. 
175. Nairn, H. Y., B. Amarneh, N. T. Ktistakis, and M. G. Roth (1992). Effects of altering palmitylation sites 
on biosynthesis and function of the Influenza virus hemagglutinin. J. Virol. 66: 7585-8. 
176. Nermut, M. V., D. J. Hockley, J. B. Jowett, I. M. Jones, M. Garreau, and D. Thomas (1994). Fullerene-
like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. 
Virol. 198:288-96. 
177. O'Reilly, D. R., L. K. Miller, and V. A. Luckow (1992). Baculovirus expression vectors, a laboratory 
manual. W. H. Freeman and Co., New York. 
178. Oellig, C, B. Happ, T. Mueller, and W. Doerfler (1987). Overlapping sets of viral RNA species reflect 
the array of polypeptides in the Eco-RI J and N fragments, map positions 81.2 to 85.0 of the 
Autographa californica nuclear polyhedrosis virus genome. J. Virol. 61: 3048-3057. 
179. Ohkawa, T., K. Majima, and S. Maeda (1994). A cysteine protease encoded by the baculovirus 
Bombyx mori Nuclear Polyhedrosis virus. J. Virol. 68: 6619-25. 
180. Ohuchi, M., C. Fischer, R. Ohuchi, A. Herwig, and H. D. Klenk (1998). Elongation of the cytoplasmic 
tail interferes with the fusion activity of Influenza virus hemagglutinin. J. Virol. 72: 3554-9. 
161 
181. Olszewski, J., and L. K. Miller (1997). A role of baculovirus GP41 in budded virus production. Virol. 
233: 292-301. 
182. Ono, A., M. Huang, and E. O. Freed (1997). Characterization of human immunodeficiency virus type 
1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. 
Virol. 71:4409-18. 
183. Oomens, A. G. P., and G. W. Blissard (1999). Requirement for GP64 to drive efficient budding of 
Autographa californica Multicapsid Nucleopolyhedrovirus. Virol. 254: 297-314. 
184. Oomens, A. G. P., S. A. Monsma, and G. W. Blissard (1995). The baculovirus GP64 Envelope Fusion 
Protein: synthesis, oligomerization, and processing. Virol. 209: 592-603. 
185. Owens, R. J., J. W. Dubay, E. Hunter, and R. W. Compans (1991). Human Immunodeficiency virus 
envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. 
Sci. U S A 88: 3987-91. 
186. Owens, R. J., and J. K. Rose (1993). Cytoplasmic domain requirement for incorporation of a foreign 
envelope protein into Vesicular Stomatitis virus. J. Virol. 67: 360-5. 
187. Paillart, J. C , and H. G. Gottlinger (1999). Opposing effects of Human Immunodeficiency virus type 1 
matrix mutations support a myristyl switch model of gag membrane targeting. J. Virol. 73: 2604-12. 
188. Palese, P., K. Tobita, M. Ueda, and R. W. Compans (1974). Characterization of temperature sensitive 
Influenza virus mutants defective in neuraminidase. Virol. 61 : 397-410. 
189. Palhan, V. B., and K. P. Gopinathan (1996). The plOgeneof Bombyx mori nuclear polyhedrosis virus 
is highly conserved amongst baculoviruses and hypertranscribed from the TAAG motif, vol. 1996. 
190. Parent, L. J., R. P. Bennett, R. C. Craven, T. D. Nelle, N. K. Krishna, J. B. Bowzard, C. B. Wilson, B. A. 
Puffer, R. C. Montelaro, and J. W. Wills (1995). Positionally independent and exchangeable late 
budding functions of the Rous sarcoma virus and Human Immunodeficiency virus Gag proteins. J. 
Virol. 69: 5455-60. 
191. Pattnaik, A. K., D. J. Brown, and D. P. Nayak (1986). Formation of Influenza virus particles lacking 
hemagglutinin on the viral envelope. J. Virol. 60: 994-1001. 
192. Pavan, O. H. P., and H. C. T. Ribeiro (1989). Selection of a baculovirus strain with a bivalent 
insecticidal activity. Mem. Inst. Oswaldo Cruz 84: 63-65. 
193. Payne, L. G., and K. Kristensson (1982). The effect of cytochalasin D and monensin on enveloped 
Vaccinia virus release. Arch. Virol. 74: 11-20. 
194. Pearson, M. N., and G. F. Rohrmann (1995). Lymantria d/spar Nuclear Polyhedrosis virus homologous 
regions: Characterization of their ability to function as replication origins. J. Virol. 69: 213-221. 
195. Plonsky, I., M. S. Cho, A. G. P. Oomens, G. W. Blissard, and J. Zimmerberg (1999). An analysis of the 
role of the target membrane on the gp64-induced fusion pore. Virol. 253: 65-76. 
196. Plonsky, I., E. Leikina, A. G. P. Oomens, G. W. Blissard, J. Zimmerberg, and L. Chernomordik (1997). 
The target membrane influences the pH-dependence and kinetics of viral fusion. Biophys. J. 72: 
A300. 
197. Plonsky, I., and J. Zimmerberg (1996). The initial fusion pore induced by baculovirus GP64 is large 
and forms quickly. J. Cell. Biol. 135: 1831-1839. 
198. Poloumienko, A., and P. Krell (1996). Identification of the putative p22, gp16, calyx protein, p25, 
exonuclease and p26 genes of a baculovirus pathogenic to the spruce budworm, CfMNPV. 
199. Poloumienko, A., and P. Krell (1997). New protein in the p22-gp67 intergenic region of the CfMNPV. 
200. Ponimaskin, E., and M. F. Schmidt (1998). Domain-structure of cytoplasmic border region is main 
determinant for palmitoylation of Influenza virus hemagglutinin (H7). Virol. 249: 325-35. 
201. Portela, A., L. D. Jones, and P. Nuttall (1992). Identification of viral structural polypeptides of Thogoto 
virus, a tick-borne orthomyxo-like virus and functions associated with the glycoprotein. J. Gen. Virol. 
73: 2823-2830. 
202. Rao, Z., A. S. Belyaev, E. Fry, P. Roy, I. M. Jones, and D. I. Stuart (1995). Crystal structure of SIV 
matrix antigen and implications for virus assembly. Nature. 378: 743-7. 
162 
203. Ray, F. A., and J. A. Nickoloff (1992). Site-specific mutagenesis of almost any plasmid using a PCR-
based version of unique site elimination. Biotechniques. 13: 342-346. 
204. Rice, C. M., and J. H. Strauss (1981). Nucleotide sequence of the 26S mRNA of Sindbis virus and 
deduced sequence of the encoded virus structural proteins. Proc, Natl. Acad. Sci. USA. 78: 2062-
6. 
205. Ritter, G. D., Jr., M. J. Mulligan, S. L. Lydy, and R. W. Compans (1993). Cell fusion activity of the 
Simian Immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virol. 
197: 255-64. 
206. Roberts, S. R., and J. S. Manning (1993). The major envelope glycoprotein of the extracellular virion 
of Autographa californica Nuclear Polyhedrosis virus possesses at least three distinct neutralizing 
epitopes. Virus Res. 28: 285-297. 
207. Roberts, T. E., and P. Faulkner (1989). Fatty acid acylation of the 67K envelope glycoprotein of a 
baculovirus Autographa californica nuclear polyhedrosis virus. Virol. 172: 377-381. 
208. Rodriguez-Boulan, E., and D. D. Sabatini (1978). Asymmetric budding of viruses in epithelial 
monolayers: a model system for study of epithelial polarity. Proc. Natl. Acad. Aci. USA. 75: 5071-
5075. 
209. Rohrmann, G. F. (1992). Baculovirus structural proteins. J. Gen. Virol. 73: 749-761. 
210. Roizman, B., and A. E. Sears (1996). Herpes Simplex viruses and their replication, p. 2231-2295. In: 
Fields Virology. . Lippincott-Raven, Philadelphia. 
211. Rolls, M. M., P. Webster, N. H. Balba, and J. K. Rose (1994). Novel infectious particles generated by 
expression of the Vesicular Stomatitis virus glycoprotein from a self-replicating RNA. Cell. 79: 497-
506. 
212. Rose, J. K., G. A. Adams, and C. J. Gallione (1984). The presence of cysteine in the cytoplasmic 
domain of the Vesicular Stomatitis virus glycoprotein is required for palmitate addition. Proc. Natl. 
Acad. Sci. U S A 81: 2050-4. 
213. Rossen, J. W., R. de Beer, G. J. Godeke, M. J. Raamsman, M. C. Horzinek, H. Vennema, and P. J. 
Rottier (1998). The viral spike protein is not involved in the polarized sorting of Coronaviruses in 
epithelial cells. J. Virol. 72: 497-503. 
214. Roth, M. G., R. V. Srinivas, and R. W. Compans (1983). Basolateral maturation of retroviruses in 
polarized epithelial cells. J. Virol. 45: 1065-1070. 
215. Ruta, M., M. J. Murray, M. C. Webb, and D. Kabat (1979). A Murine Leukemia virus mutant with a 
temperature-sensitive defect in membrane glycoprotein synthesis. Cell. 16: 77-88. 
216. Ryan, C, L. Ivanova, and M. J. Schlesinger (1998). Effects of site-directed mutations of 
transmembrane cysteines in Sindbis virus E1 and E2 glycoproteins on palmitylation and virus 
replication. Virol. 249: 62-7. 
217. Salzwedel, K., J. T. West, Jr., M. J. Mulligan, and E. Hunter (1998). Retention of the human 
Immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum does not redirect 
virus assembly from the plasma membrane. J. Virol. 72: 7523-31. 
218. Sandig, V., C. Hofmann, S. Steinert, G. Jennings, P. Schlag, and M. Strauss (1996). Gene transfer 
into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7: 1937-45. 
219. Scheiffele, P., A. Rietveld, T. Wilk, and K. Simons (1999). Influenza viruses select ordered lipid 
domains during budding from the plasma membrane. J. Biol. Chem. 274: 2038-44. 
220. Scheiffele, P., M. G. Roth, and K. Simons (1997). Interaction of Influenza virus haemagglutinin with 
sphingolipid- cholesterol membrane domains via its transmembrane domain. EMBO J. 16: 5501 -8. 
221. Schnell, M. J., L. Buonocore, E. Boritz, H. P. Ghosh, R. Chemish, and J. K. Rose (1998). 
Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding 
of Vesicular Stomatitis virus. EMBO J. 17: 1289-1296. 
163 
222. Schnell, M. J., L. Buonocore, E. Kretzschmar, E. Johnson, and J. K. Rose (1996). Foreign 
glycoproteins expressed from recombinant Vesicular Stomatitis viruses are incorporated efficiently 
into virus particles. Proc. Natl. Acad. Sci. USA. 93: 11359-11365. 
223. Schnell, M. J., J. E. Johnson, L. Buonocore, and J. K. Rose (1997). Construction of a novel virus that 
targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90: 849-857. 
224. Schnitzer, T. J., C. Dickson, and R. A. Weiss (1979). Morphological and biochemical characterization 
of viral particles produced by the ts045 mutant of Vesicular Stomatitis virus at restrictive temperature. 
J. Virol. 29: 185-95. 
225. Schultz, A. M., L. E. Henderson, and S. Oroszlan (1988). Fatty acylation of proteins. Annu. Rev. Cell. 
Biol. 4: 611-47. 
226. Shields, A., W. N. Witte, E. Rothenberg, and D. Baltimore (1978). High frequency of aberrant 
expression of Moloney Murine Leukemia virus in clonal infections. Cell. 14: 601-9. 
227. Shoji, I., H. Aizaki, H. Tani, K. Ishii, T. Chiba, I. Saito, T. Miyamura, and Y. Matsuura (1997). Efficient 
gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. 
Gen. Virol. 78: 2657-2664. 
228. Silverstein, S. C, R. M. Steinman, and Z. A. Cohn (1977). Endocytosis. Annu. Rev. Biochem. 46: 
669-722. 
229. Simons, K., and E. Ikonen (1997). Functional rafts in cell membranes. Nature. 387: 569-72. 
230. Simpson, D. A., and R. A. Lamb (1992). Alterations of Influenza virus hemagglutinin cytoplasmic tail 
modulate virus infectivity. J. Virol. 66: 790-803. 
231. Slack, J. M., J. Kuzio, and P. Faulkner (1995). Characterization of v-cath, a cathepsin L-like proteinase 
expressed by the baculovirus Autographs californica Multiple Nuclear Polyhedrosis virus. J. Gen. 
Virol. 76: 1091-1098. 
232. Smith, G. E., and M. D. Summers (1978). Analysis of baculovirus genomes with restriction 
endonucleases. Virol. 89: 517-527. 
233. Southern, P. J., and P. Berg (1982). Transformation of mammalian cells to antibiotic resistance with a 
bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Gen. 1: 327-341. 
234. Spearman, P., R. Horton, L. Ratner, and I. Kuli-Zade (1997). Membrane binding of Human 
Immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch 
mechanism. J. Virol. 71: 6582-92. 
235. Spies, C. P., and R. W. Compans (1994). Effects of cytoplasmic domain length on cell surface 
expression and syncytium-forming capacity of the Simian Immunodeficiency virus envelope 
glycoprotein. Virol. 203: 8-19. 
236. Stephens, E. B., and R. W. Compans (1988). Assembly of animal viruses at cellular membranes. 
Annu. Rev. Microbiol. 42: 489-516. 
237. Stiles, B., and H. A. Wood (1983). A study of the glycoproteins of Autographa californica Nuclear 
Polyhedrosis virus (AcNPV). Virol. 131: 230-241. 
238. Straubinger, R. M., K. Hong, D. S. Friend, and D. Papahadjopoulos (1983). Endocytosis of liposomes 
and intracellular fate of encapsulated molecules: encounter with a low pH compartment after 
internalization in coated vesicles. Cell. 32: 1069-79. 
239. Strauss, E. G. (1978). Mutants of Sindbis virus. III. Host polypeptides present in purified HR and ts103 
virus particles. J. Virol. 28: 466-74. 
240. Sturzenbecker, L. J., M. Nibert, D. Furlong, and B. N. Fields (1987). Intracellular digestion of Reovirus 
particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61: 2351-61. 
241. Sudol, M. (1996). Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 65: 113-32. 
242. Sudol, M., P. Bork, A. Einbond, K. Kastury, T. Druck, M. Negrini, K. Huebner, and D. Lehman (1995). 
Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel 
protein module, the WW domain. J. Biol. Chem. 270: 14733-41. 
164 
243. Summers, M. D. (1971). Electron microscopic observations of granulosis virus entry, uncoating and 
replication processes during infection of the midgut cells of Trichoplusia ni. J. Ultrastr. Res. 35: 606-
625. 
244. Summers, M. D., and G. E. Smith (1987). A manual of methods for baculovirus vectors and insect cell 
culture procedures. Texas Agricultural Experiment Station Bulletin. 
245. Suomalainen, M., and H. Garoff (1994). Incorporation of homologous and heterologous proteins into 
the envelope of Moloney Murine Leukemia virus. J. Virol. 68: 4879-4889. 
246. Suomalainen, M., P. Liljestrom, and H. Garoff (1992). Spike protein-nucleocapsid interactions drive 
the budding of alphaviruses. J. Virol. 66: 4737-4747. 
247. Sussman, D. J. (1995). 24-hour assay for estimating the titer of beta-galactosidase expressing 
baculovirus. Biotechniques. 18: 50-51. 
248. Takimoto, T., T. Bousse, E. C. Coronel, R. A. Scroggs, and A. Portner (1998). Cytoplasmic domain of 
Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J. 
Virol. 72: 9747-54. 
249. Tanada, Y., R. T. Hess, and E. M. Omi (1975). Invasion of a nuclear polyhedrosis virus in midgut of the 
armyworm Pseudaletia unipuncta, and the enhancement of a synergistic enzyme. J. Invert. Pathol. 
26: 99-104. 
250. Theilmann, D. A., and S. Stewart (1992). Molecular analysis of the trans-activating ie-2 gene of Orgyia 
pseudotsugata Multicapsid Nuclear Polyhedrosis virus. Virol. 187: 84-96. 
251. Thomas, D. C, C. B. Brewer, and M. G. Roth (1993). Vesicular Stomatitis virus glycoprotein contains a 
dominant cytoplasmic basolateral sorting signal critically dependent upon a tyrosine. J. Biol. Chem. 
268: 3313-20. 
252. Tubulekas, I., and P. Liljestrom (1998). Suppressors of cleavage-site mutations in the p62 envelope 
protein of Semliki Forest virus reveal dynamics in spike structure and function. J. Virol. 72: 2825-31. 
253. Van Oers, M. M., J. T. M. Flipsen, C. B. E. M. Reusken, E. L. Sliwinsky, R. W. Goldbach, and J. M. Vlak 
(1993). Functional domains of the p10 protein of Autographa californica Nuclear Polyhedrosis virus. 
J. Gen. Virol. 74: 563-574. 
254. Vennema, H., G. J. Godeke, J. W. Rossen, W. F. Voorhout, M. C. Horzinek, D. J. Opstelten, and P. J. 
Rottier (1996). Nucleocapsid-independent assembly of Coronavirus-like particles by co- expression 
of viral envelope protein genes. Embo J. 15: 2020-8. 
255. Vlak, J. M., and G. F. Rohrmann (1985). The nature of polyhedrin. In: Viral insecticides of biological 
control. K. Maramorosch and K. E. Sherman (ed.). Academic Press, New York. 
256. Vlak, J. M., A. Schouten, M. Usmany, G. J. Belsham, E. C. Klinge Roode, A. J. Maule, J. W. M. 
VanLent, and D. Zuidema (1990). Expression of Cauliflower Mosaic virus Gene I using a baculovirus 
vector based upon the P10 gene and a novel selection method. Virol. 179: 312-320. 
257. Vlcek, C, V. Benes, Z. Lu, G. F. Kutish, V. Paces, D. Rock, G. J. Letchworth, and M. Schwyzer 
(1995). Nucleotide sequence analysis of a30-kb region of the bovine herpesvirus 1 genome which 
exhibits a colinear gene arrangement with the UL21 to UL4 genes of Herpes Simplex virus. Virol. 
210: 100-8. 
258. Volkman, L. E. (1986). The 64K envelope protein of budded Autographa californica Nuclear 
Polyhedrosis virus. Curr. Top. Microbiol. Immunol. 131: 103-118. 
259. Volkman, L. E., G. W. Blissard, P. Friesen, B. A. Keddie, R. Possee, and D. A. Theilmann (1995). 
Baculoviridae: Taxonomic structure and properties of the family. Arch. Virol. Sixth report of the 
international committee for the taxonomy of viruses. Supplement 10: 104-113. 
260. Volkman, L. E., and P. A. Goldsmith (1984). Budded Autographa californica NPV 64K protein: further 
biochemical analysis and effects of postimmunoprecipitation sample preparation conditions. Virol. 
139: 295-302. 
165 
261. Volkman, L. E., and P. A. Goldsmith (1985). Mechanism of neutralization of budded Autographs 
californica Nuclear Polyhedrosis virus by a monoclonal antibody: Inhibition of entry by adsorptive 
endocytosis. Virol. 143: 185-195. 
262. Volkman, L E., and P. A. Goldsmith (1988). Resistance of the 64K protein of budded Autographa 
californica nuclear polyhedrosis virus to functional inactivation by proteolysis. Virol. 166: 285-289. 
263. Volkman, L. E., P. A. Goldsmith, and R. Hess (1987). Evidence for microfilament involvement in 
budded Autographa californica Nuclear Polyhedrosis virus production. Virol. 156: 32-39. 
264. Volkman, L. E., P. A. Goldsmith, R. T. Hess, and P. Faulkner (1984). Neutralization of budded 
Autographa californica NPV by a monoclonal antibody: Identification of the target antigen. Virol. 133: 
354-362. 
265. Volkman, L. E., and M. D. Summers (1977). Autographa californica nuclear polyhedrosis virus: 
Comparitive infectivity of the occluded, alkali-liberated, and nonoccluded forms. J. Invert. Pathol. 30: 
102-103. 
266. Volkman, L. E., M. D. Summers, and C. H. Hsieh (1976). Occluded and nonoccluded nuclear 
polyhedrosis virus grown in Trichoplusia ni comparative neutralization, comparative infectivity, and in 
vitro growth studies. J. Virol. 19: 820-832. 
267. Von Heijne, G., and Y. Gavel (1988). Topogenic signals in integral membrane proteins. Eur. J. 
Biochem. 174:671-678. 
268. Wahlberg, J. M., and H. Garoff (1992). Membrane fusion process of Semliki Forest virus. I: Low pH-
induced rearrangement in spike protein quaternary structure precedes virus penetration into cells. J. 
Cell. Biol. 116:339-48. 
269. Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon (1985). Nucleotide sequence of the 
AIDS virus, LAV. Cell. 40: 9-17. 
270. Wang, P., D. A. Hammer, and R. R. Granados (1997). Binding and fusion of Autographa californica 
nucleopolyhedrovirus to cultured insect cells. J. Gen. Virol. 78: 3081-9. 
271. Whitford, M., and P. Faulkner (1992). Nucleotide sequence and transcriptional analysis of a gene 
encoding gp41 a structural glycoprotein of the baculovirus Autographa californica nuclear 
polyhedrosis virus. J. Virol. 66: 4763-4768. 
272. Whitford, M., and P. Faulkner (1992). A structural polypeptide of the baculovirus Autographa 
californica Nuclear Polyhedrosis virus contains O-linked N-acetylglucosamine. J. Virol. 66: 3324-
3329. 
273. Whitford, M., S. Stewart, J. Kuzio, and P. Faulkner (1989). Identification and sequence analysis of a 
gene encoding gp67, an abundant envelope glycoprotein of the baculovirus Autographa californica 
Nuclear Polyhedrosis virus. J. Virol. 63: 1393-1399. 
274. Whitt, M. A., and J. S. Manning (1988). A phosphorylated 34-kDa protein and a subpopulation of 
polyhedrin are thiol linked to the carbohydrate layer surrounding a baculovirus occlusion body. Virol. 
163: 33-42. 
275. Whitt, M. A., and J. K. Rose (1991). Fatty acid acylation is not required for membrane fusion activity or 
glycoprotein assembly into VSV virions. Virol. 185: 875-8. 
276. Wickham, T. J., M. L. Shuler, D. A. Hammer, R. R. Granados, and H. A. Wood (1992). Equilibrium and 
kinetic analysis of Autographa californica Nuclear Polyhedrosis virus attachment to different insect cell 
lines. J. Gen. Virol. 73: 3185-3194. 
277. Wilk, T., T. Pfeiffer, and V. Bosch (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 
despite truncation of the C-terminal tail of the env gene product. Virol. 189: 167-77. 
278. Wills, J. W., C. E. Cameron, C. B. Wilson, Y. Xiang, R. P. Bennett, and J. Leis (1994). An assembly 
domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 68: 6605-18. 
279. Wilson, I. A., J. J. Skehel, and D. C. Wiley (1981). Structure of the haemagglutinin membrane 
glycoprotein of Influenza virus at 3 A resolution. Nature. 289: 366-73. 
166 
280. Wilson, J. A., J. E. Hill, J. Kuzio, and P. Faulkner (1995). Characterization of the baculovirus 
Choristoneura fumiferana multicapsid Nuclear Polyhedrosis virus p10 gene indicates that the 
polypeptide contains a coiled-coil domain. J. Gen. Virol. 76: 2923-2932. 
281. Xiang, Y., C. E. Cameron, J. W. Wills, and J. Leis (1996). Fine mapping and characterization of the 
Rous sarcoma virus Pr76gag late assembly domain. J. Virol. 70: 5695-700. 
282. Xie, W. D., B. Arif, P. Dobos, and P. J. Krell (1995). Identification and analysis of a putative origin of 
DNA replication in the Choristoneura fumiferana Multicapsid Nuclear Polyhedrosis virus genome. 
Virol. 209:409-419. 
283. Yao, J., E. G. Strauss, and J. H. Strauss (1998). Molecular genetic study of the interaction of Sindbis 
virus E2 with Ross River virus E1 for virus budding. J. Virol. 72: 1418-23. 
284. Young, J. D., D. Tsuchiya, D. E. Sandlin, and M. J. Holroyde (1979). Enzymic O-glycosylation of 
synthetic peptides from sequences in basic myelin protein. Biochem. 18: 4444-8. 
285. Yu, Y. G., D. S. King, and Y. K. Shin (1994). Insertion of a coiled-coil peptide from Influenza virus 
hemagglutinin into membranes. Science. 266: 274-276. 
286. Zanotto, P. M., B. D. Kessing, and J. E. Maruniak (1993). Phylogenetic interrelationships among 
baculoviruses: evolutionary rates and host associations. J. Invert. Pathol. 62:147-164. 
287. Zanotto, P. M. D. A., M. J. Sampaio, D. W. Johnson, T. L. Rocha, and J. E. Maruniak (1992). The 
Anticarsia gemmatalis Nuclear Polyhedrosis virus polyhedrin gene region: sequence analysis, gene 
product and structural comparisons. J. Gen. Virol. 73: 1049-1056. 
288. Zebedee, S. L, and R. A. Lamb (1988). Influenza A virus M2 protein: monoclonal antibody restriction 
of virus growth and detection of M2 in virions. J. Virol. 62: 2762-72. 
289. Zhang, Y., X. Wu, and Z. Li (1995). P70 genes of BmNPV and AcMNPV, vol. 1995. 
290. Zhao, H., M. Ekstrom, and H. Garoff (1998). The M1 and NP proteins of Influenza A virus form homo-
but not heterooligomeric complexes when coexpressed in BHK-21 cells. J. Gen. Virol. 79: 2435-46. 
291. Zhao, H., and H. Garoff (1992). Role of cell surface spikes in alphavirus budding. J. Virol. 66: 7089-
7095. 
292. Zhao, H., B. Lindqvist, H. Garoff, C. H. Von Bonsdorff, and P. Liljestrom (1994). A tyrosine-based 
motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J. 
13: 4204-4211. 
293. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh (1994). Identification of a membrane-binding 
domain within the amino-terminal region of Human Immunodeficiency virus type 1 Gag protein which 
interacts with acidic phospholipids. J. Virol. 68: 2556-69. 
294. Zhou, W., and M. D. Resh (1996). Differential membrane binding of the Human Immunodeficiency 
virus type 1 matrix protein. J. Virol. 70: 8540-8. 
295. Zuidema, D., A. Schouten, M. Usmany, A. J. Maule, G. J. Belsham, J. Roosien, E. C. Klinge Roode, J. 
W. M. VanLent, and J. M. Vlak (1990). Expression of Cauliflower Mosaic virus gene I in insect cells 
using a novel polyhedrin-based baculovirus expression vector. J. Gen. Virol. 71: 2201-2210. 
167 
Summary 
The Baculoviridae are a family of large, enveloped, double-stranded DNA 
viruses, that cause severe disease in the larvae of mostly lepidopteran insects. 
Baculoviruses have been studied with the aim of developing alternatives to chemical 
pest control, and later for their potential as systems for foreign gene expression and to 
address fundamental virological questions. The Baculoviridae are divided into two 
genera: the Granuloviruses (GVs) and the Nucleopolyhedroviruses (NPVs). The viruses 
studied in this thesis, Autographa californica, Orgyia pseudotsugata, and Anticarsia 
gemmatalis Multicapsid Nucleopolyhedroviruses (AcMNPV, OpMNPV and AgMNPV), 
fall within the NPV genus. A striking characteristic of the NPVs is the presence of two 
different phenotypes with distinct roles in the infection cycle. Important differences 
between these two phenotypes are the lipid and protein compositions of their 
envelopes and the type of host cells they infect. Budded virus (BV) is the phenotype 
responsible for systemic infection of the insect host, and GP64 is the major envelope 
glycoprotein of this phenotype. GP64 is absent from the envelope of the other 
phenotype, the occlusion-derived virus (ODV), which serves to initiate baculovirus 
infection in midgut epithelial cells. GP64 was shown to be a glycosylated, 
phosphorylated and acylated protein, present at early and late stages of the infection 
cycle. Based on estimations of mass on non-reducing SDS-PAGE, GP64 was 
speculated to exist as both trimeric and tetrameric forms. Several observations 
contributed to the belief that GP64 was important for BV entry into the host cell by 
endocytosis: 1) antibodies to GP64, as well as lipophilic amines, inhibited BV infectivity 
at a step beyond virus binding to host cells, 2) GP64 induced low-pH mediated 
membrane fusion when expressed alone at the surface of cells, 3) a monoclonal 
antibody to GP64 inhibited this low pH-induced membrane fusion capacity. Because of 
GP64's presence at sites where viral budding occurred, roles for GP64 in virus exit were 
suspected, but never demonstrated. In this thesis, structural and functional aspects of 
GP64 were examined with the aim to expand our knowledge about the role of GP64 in 
BV exit/transmission and entry, within the baculovirus infection cycle. 
In the first experimental chapter (chapter 2), an anti-GP64 antiserum was 
generated, and used to examine the kinetics of OpMNPV GP64 synthesis, 
oligomerization, and carbohydrate processing. Immunoprecipitation, pulse label, and 
pulse-chase analyses showed that OpMNPV GP64 is produced during a large part of 
the infection cycle, and undergoes a rapid but inefficient oligomerization step. While 
carbohydrate addition was rapid, carbohydrate processing occurred with half-times of 
45 to 75 min and appeared to be the rate-limiting step in maturation of GP64. In 
addition, a difference in carbohydrate processing efficiency was demonstrated between 
the early and late phases of the infection cycle. Mass spec of a highly purified, soluble 
form of OpMNPV GP64 revealed that two high molecular weight forms of GP64, typically 
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observed on non-reducing gels, are both homotrimers. The different forms may be the 
result of differential disulfide bonding. 
Next, the role of GP64 in the infection cycle was addressed by examining 
AcMNPV infectivity in the complete absence of GP64 (chapter 3). Because GP64 was 
suspected to be an essential BV protein, OpMNPV GP64- expressing Sf9 cells were 
generated for complementation during propagation of an AcMNPV recombinant 
gp64null virus (vAc642). This gp64null virus was able to propagate in Sf9 cells when 
GP64 was complemented. However, by detection of an included lacZ marker gene and 
comparison to wild-type AcMNPV, vAc64Z failed to transmit from Sf9 to Sf9 cell in the 
absence of GP64 complementation, both in cell culture as in Trichoplusia ni larvae. 
Thus, this result demonstrated a critical role for GP64 in virus transmission. 
Whether the block in virus transmission was due to a defect in BV production or 
to production of non-infectious BV, was the next question we sought to address (chapter 
4). A budding assay was designed to compare BV budding in the presence (wild-type 
AcMNPV) or absence of GP64 (gp64null virus). A second generation gp64null virus 
(vAc64) was generated and used for these studies. In the absence of GP64, budding 
appeared to be reduced by ~ 98%. Hence, the earlier observed block in viral 
transmission was likely and predominantly a result of decreased virus budding. 
Because the highly charged GP64 cytoplasmic tail domain (CTD) is predicted to be in a 
position to interact with cytoplasmic viral and/or cellular factors, it became the next 
target in the pursuit of the role of GP64 in BV budding. Recombinant viruses carrying 
deletions or modifications in the GP64 CTD and/or portions of the transmembrane (TM) 
domain were generated and examined by the earlier developed budding assay. The 
complete, seven amino acid, predicted CTD was found to be dispensable for 
propagation of AcMNPV in cell culture, for GP64 surface localization, and low pH-
induced membrane fusion. Virus budding however was reduced by ~ 50%, and 
incorporation of GP64 into virions by 63%, thus indicating that the presence of the CTD 
domain may confer an advantage. Removal of 11 and 14 amino acids resulted in more 
dramatic effects. Membrane-anchoring of these GP64s was significantly affected, and 
viral budding was 4-22% and 2% respectively compared to a control virus with a wild-
type GP64. The virus carrying a truncation of 14 amino acids was unable to propagate 
efficiently in Sf9 cells, indicating a possible role for amino acids -12, -13, and -14 from 
the C-terminus. A recombinant virus, vAc-CA3Ra, in which all arginines were replaced 
with alanines, was in all measurable aspects indistinguishable from virus carrying a 
wild-type GP64, demonstrating that the CTD charge is not essential. 
In chapter 5, the role of GP64 in BV binding and entry into host cells was 
examined by a single cell infectivity assay. In this assay, inactivated virus as well as a 
highly purified, soluble form of OpMNPV GP64, competed with AcMNPV BV during a 1 
hr viral adsorption period at 4°C, resulting in a reduced number of infected Sf9 cells. 
This suggests that AcMNPV GP64 is a host cell receptor binding protein. In addition, 
entry kinetics of the BV phenotype were examined. After binding, BV entered Sf9 cells 
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with a half-time of ~ 12.5 min, and fusion of the viral and endosomal membrane 
(presumably to release the NC into the cytoplasm) occurred with a half-time of ~ 25 min. 
The last experimental chapter (chapter 6) describes the mapping and analysis of 
the gp64 genomic region in baculovirus Anticarsia gemmatalis Multicapsid 
Nucleopolyhedrovirus (AgMNPV). This virus is extensively utilized in the protection of 
soybean crop in Brazil, and demonstrates well the baculovirus potential for insect pest 
control. To examine the relatedness of AgMNPV to other NPVs, the gp64 genomic 
region of AgMNPV (containing 19 ORFs of > 50 amino acids) was analyzed and 
compared to the corresponding regions in four other baculoviruses. In addition, a 
multiple alignment of GP64s from seven baculoviruses and envelope proteins of two 
orthomyxoviruses was performed, demonstrating that 1) baculovirus GP64s are highly 
conserved (74.5 to 78.6% amino acid identity), 2) among baculoviruses, AgMNPV GP64 
is the least conserved in the TM domain and its CTD is truncated, 3) between 
baculovirus GP64 and Thogoto/Dhori virus envelope proteins, clusters of amino acid 
conservation can be identified, which may be useful in designing approaches to map 
key functional domains of GP64. 
Finally, because virus budding is a poorly understood area of baculovirology, the 
general discussion includes a review of selected literature regarding the role of viral 
spike proteins in exit of enveloped viruses from host cells. In addition, a few GP64 
research topics that are not addressed experimentally in this thesis, are included to 
complement our understanding of GP64. Next, evolutionary implications of the various 
experimental results are discussed with regard to the significance of the GP64 protein, 
and the relationship between GP64 and Thogoto and Dhori virus envelope proteins. 
The discussion is concluded with a note on what the current avenues of GP64 research 
are and what these may lead to in the future. 
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Samenvatting 
Virussen behorende tot de familie Baculoviridae bezitten een dubbelstrengs 
DNA genoom en zijn van een lipidemembraan voorzien. Baculovirussen infecteren 
alleen geleedpotigen, voomamelijk rupsen van insecten uit de orde Lepidoptera. Zij 
werden bestudeerd met als doel net ontwikkelen van alternatieven voor chemische 
insectenbestrijding, en later vanwege hun potentieel als eiwitproductiesystemen en ter 
beantwoording van fundamenteel virologische vraagstukken. De Baculoviridae worden 
verdeeld in twee genera, de Granulovirussen (GVs) en de Kernpolyedervirussen 
(NPVs). De virussen die ik in dit proefschrift behandel, Autographa californica, Orgyia 
pseudotsugata, and Anticarsia gemmatalis Multicapsid Nucleopolyhedroviruses 
(AcMNPV, OpMNPV en AgMNPV), behoren tot de NPVs. Een opvallende karakteristiek 
van de NPVs is het voorkomen van twee verschillende phenotypen, die een 
afzonderlijke rol spelen in de infectiecyclus. Belangrijke verschillen tussen deze twee 
phenotypen zijn de lipide- en eiwitcompositie van hun membraan en het type 
gastheercel dat zij infecteren. Budded virus (BV) is het phenotype verantwoordelijk voor 
de systemische infectie van de gastheer, en GP64 is een viraal membraan 
glycoproteTne dat in relatief grote hoeveelheid aanwezig is in de lipidemembraan van 
dit phenotype. GP64 komt niet voor in het tweede phenotype, het occlusion-derived 
virus (ODV), welktot doel heeft de gastheerinfectie te initieren in de epitheelcellen van 
het darmkanaal. Door anderen werd reeds aangetoond dat GP64 geglycosileerd, 
gefosforileerd en geacyleerd is, en aanwezig is gedurende de vroege en late stadia 
van de infectiecyclus. Gebaseerd op de relatieve molecuulmassa op niet-reducerende 
eiwitgels, werd gespeculeerd dat GP64 voorkomt als trimeren en tetrameren. Een 
aantal observaties resulteerden in de hypothese dat GP64 een belangrijke factor is in 
het binnendringen van het BV phenotype in de gastheercel d.m.v. endocytose: 1) anti-
GP64 antilichamen, en ook lipofiele aminegroepen, blokkeren infectiviteit van BV in een 
stadium voorbij de binding van virus aan cellen, 2) GP64 veroorzaakt lage pH-
afhankelijke membraanfusie, wanneer het afzonderlijk in Sf9 cellen tot expressie wordt 
gebracht, 3) een monoclonaal antilichaam, gericht tegen GP64, blokkeert deze 
membraanfusiecapaciteit. Omdat GP64 voorkomt op locaties waar virusbudding 
plaatsvindt, vermoedde men ook een rol in het naar buiten treden uit de gastheercel. 
Zo'n rol werd echter nog niet gedemonstreerd. In dit proefschrift worden structurele en 
functionele aspecten van GP64 onderzocht, met als doel onze kennis uit te breiden 
omtrent de rol van GP64 in het binnendringen en uittreden van de gastheercel, binnen 
de infectiecyclus. 
In het eerste experimentele hoofdstuk (2) werd een anti-OpMNPV GP64 
polyclonaal antilichaam geproduceerd. Dit werd gebruikt om de synthese, de 
oligomerisatie en de carbohydraat-modificatie van GP64 te bestuderen. Analyses m.b.v. 
immunoprecipitatie, 'pulse label1, en 'pulse-chase' technieken, toonden aan dat GP64 
gedurende het grootste gedeelte van de infectiecyclus geproduceerd wordt, en dat het 
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een snelle maar inefficiente oligomerizering ondergaat. Het aanhechten van 
carbohydraatgroepen geschiedt snel. Echter, de modificatie van die groepen is een 
relatief langzaam proces en is mogelijk de stap die de snelheid van maturatie en 
transport van GP64 het meest bemvloedt. Bovendien werd een verschil aangetoond in 
efficientie van GP64-carbohydraatmodificatie tussen het vroege en late stadium van de 
infectiecyclus. Een gezuiverde vorm van OpMNPV GP64 in oplossing werd 
onderworpen aan massaspectometrie. Daarmee werd duidelijk dat twee verschillende 
vormen van GP64 met hoog-moleculaire massa, zoals die op een niet-reducerende 
eiwitgel worden waargenomen, beide homo-trimeren zijn. De twee waargenomen 
vormen zijn waarschijnlijk het gevolg van alternatief gevormde zwavelbruggen. 
Vervolgens werd de rol van GP64 in de infectiecyclus bekeken, door de 
infectiviteit van AcMNPV te onderzoeken in de afwezigheid van GP64 (hoofdstuk 3). 
Omdat werd vermoed dat GP64 een essentieel baculoviruseiwit is, werden GP64-
producerende Sf9 cellen geproduceerd ter aanlevering van GP64 tijdens de productie 
van een gp64-negatief virus (vAc64Z). D.m.v. een lacZ markergen werd aangetoond dat 
dit gp64-negatief virus zich zonder problemen repliceerde, wanneer GP64 door de 
cellijn werd aangeleverd. Wanneer GP64 niet werd aangeleverd, bleek het gp64-
negatieve virus niet in staat naburige Sf9 cellen te infecteren, zowel in celcultuur als in 
Trichoplusia ni rupsen. Hiermee werd een belangrijke rol voor GP64 gedemonstreerd, 
namelijk het verbreiden van de infectie van eel tot eel. 
Het was niet bekend of dit defect in het verbreiden van infectie veroorzaakt werd 
door een gebrek aan virusbudding, of dat de budding onveranderd was maar dat de 
gevormde virussen niet infectieus waren. Deze vraag werd beantwoord in hoofdstuk 4. 
Een budding-assay werd opgezet, waarin AcMNPV en het gp64-negatief virus konden 
worden vergeleken. Een tweede generatie gp64-negatief virus (vAc64) werd gebruikt 
voor die studie. Bij afwezigheid van GP64 bleek virusbudding gereduceerd te zijn met 
98%. Het virustransmissiedefect van het gp64-negatief virus was daarom 
hoogstwaarschijnlijk een buddingdefect. Omdat het positief geladen, cytoplasmatische 
domein (CTD) van GP64 mogelijk interacties aangaat met cytoplasmatische factoren 
(viraal of cellulair), werd het CTD het volgend doel van onderzoek naar virus budding. 
Recombinante virussen met een gp64 gen, gemodificeerd in CTD of transmembraan 
(TM) domein, werden geproduceerd en onderworpen aan het eerdergenoemde 
budding-assay. Dit wees uit dat het zeven aminozuren lange, hypothetische CTD niet 
nodig was voor vermeerdering van AcMNPV in celcultuur, voor GP64-transport naar het 
plasmamembraan en voor de lage pH-gei'nduceerde membraanfusie functie. Echter, 
virusbudding was met 50% gereduceerd en de opname van GP64 in het BV met 63%, 
wat erop duidde dat het bezit van een CTD voor AcMNPV mogelijk een voordeel 
oplevert. Verwijdering van 11 en 14 aminozuren van het C-terminale eind van GP64 
(virussen vAc-C-11 en vAc-C-14) had verdergaande gevolgen. Membraanverankering 
in deze mutanten was drastisch gereduceerd en virusbudding was respectievelijk 4-
22% en 2%, vergeleken met niet-gemodificeerd GP64. Het virus vAc-C-14 was 
bovendien als enige niet in staat zich efficient te vermeerderen in Sf9 cellen, wat op 
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een mogelijke rol duidt voor aminozuren op positie 12, 13, en 14 van net C-terminale 
eind. Een recombinant virus, waarin alle arginine-residuen van het CTD waren 
vervangen door alanine, gedroeg zich in alle meetbare aspecten identiek aan wild-type 
AcMNPV. Dit betekent dat de lading van het CTD niet essentieel is. 
In hoofdstuk 5 werd de rol van GP64 in het binden aan, en binnendringen van de 
gastheercel onderzocht, d.m.v. een 'single-cell infectivity assay'. In dit assay 
competeerden zowel ge'inactiveerd virus als gezuiverd OpMNPV GP64 in oplossing, 
met AcMNPV gedurende een virusinfectieperiode van 1 uur bij 4°C, resulterend in een 
reductie van het aantal ge'infecteerde Sf9 cellen. Dit suggereert dat GP64 een 
gastheercelreceptor-bindend eiwit is. Ook werd de kinetiek van een aantal stappen in 
het virusendocytose proces gemeten. Na binding werd virus met een half-time van 12.5 
minuten opgenomen door de gastheercel en fusie van de viraal en endosoom 
membranen (vermoedelijk ter introductie van het nucleocapside in het cytoplasma) 
geschiedde met een half-time van 25 minuten. 
In het laatste experimentele hoofdstuk werd een genomisch segment, waarin het 
gp64 gen, van AgMNPV gelocaliseerd en geanalyseerd. Dit virus wordt uitgebreid 
toegepast bij het beschermen van soyaboon gewas in Brazilie, en is een goed 
voorbeeld van het potentieel van baculovirussen voor insectenbestrijding. Om de 
verwantschap van AgMNPV met andere baculovirussen te bepalen werd dit genomisch 
segment, dat 19 leesramen van > 50 aminozuren bevat, geanalyseerd en vergeleken 
met de corresponderende genoomregio's in vier andere baculovirussen. Ook werd een 
verwantschapsanalyse uitgevoerd met zeven baculovirus GP64 eiwitten en twee 
verwante membraanglycoprote'inen van de Thogoto-achtige virussen Thogoto virus 
(THO) en Dhori virus (DHO) (familie Orthomyxoviridae). Deze analyse toonde aan dat 
1) baculovirus GP64 eiwitten zijn zeer geconserveerd (74.5 tot 78.6% 
aminozuuridentiteit), 2) bij de baculovirussen is AgMNPV GP64 het minst 
geconserveerd in het TM-domein, en het CTD is slechts 2 aminozuren lang, 3) Tussen 
baculovirus GP64 en THO- en DHO- membraanglycoprote'inen kunnen locale gebieden 
onderscheiden worden met een hoog percentage identieke aminozuren. Deze locale 
gebieden kunnen mogelijk behulpzaam zijn bij het bedenken van strategieen om de 
locatie en functie van belangrijke, geconserveerde domeinen van GP64 te bepalen. 
Omdat in het onderzoek van baculovirussen weinig bekend is over virusbudding, 
wordt in de algemene discussie (hoofdstuk 7) een overzicht gegeven van 
geselecteerde literatuur betreffende budding van virussen met een lipidemembraan en 
de rol van het CTD daarin. Daarnaast wordt een aantal GP64 onderzoeksgebieden 
behandeld die in dit proefschrift niet aan de orde zijn gekomen, maar een belangrijke 
aanvulling zijn op de gepresenteerde experimentele resultaten. Vervolgens wordt de 
evolutionaire implicatie van de experimentele resultaten besproken, betreffende de 
betekenis van GP64 voor de Baculoviridae en de relatie tussen GP64 en de 
membraanglycoprote'inen van THO- en DHO- virussen. De discussie wordt besloten 
met een korte omschrijving van het huidige GP64 onderzoek, en waar dit in de 
toekomst toe kan leiden. 
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